1	A	a	DT	_	3	NMOD
2	mouse	mouse	NN	_	3	NMOD
3	model	model	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	sitosterolemia	sitosterolemia	NN	_	4	PMOD
6	:	:	:	_	3	P
7	absence	absence	NN	_	14	SBJ
8	of	of	IN	_	7	NMOD
9	Abcg8	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	8	PMOD
12	-	-	HYPH	_	11	P
13	2	0	CD	_	11	NMOD
14	results	result	VBZ	_	3	DEP
15	in	in	IN	_	14	ADV
16	failure	failure	NN	_	15	PMOD
17	to	to	TO	_	16	NMOD
18	secrete	secrete	VB	_	17	IM
19	biliary	biliary	JJ	_	20	NMOD
20	cholesterol	cholesterol	NN	_	18	OBJ

1	Abstract	abstract	NN	_	0	ROOT

1	Background	background	NN	_	0	ROOT

1	Mutations	mutation	NNS	_	37	SBJ
2	in	in	IN	_	1	LOC
3	either	either	DT	_	2	PMOD
4	of	of	IN	_	3	NMOD
5	two	two	CD	_	6	NMOD
6	genes	gene	NNS	_	4	PMOD
7	comprising	comprise	VBG	_	6	NMOD
8	the	the	DT	_	10	NMOD
9	STSL	stsl	NN	_	10	NMOD
10	locus	locus	NN	_	7	OBJ
11	,	,	,	_	3	P
12	ATP	atp	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	binding	bind	VBG	_	15	NMOD
15	cassette	cassette	NN	_	17	NMOD
16	(	(	-LRB-	_	17	P
17	ABC	abc	NN	_	20	NMOD
18	)	)	-RRB-	_	20	P
19	-	-	HYPH	_	17	P
20	transporters	transporter	NNS	_	21	NMOD
21	ABCG5	abcg0	NN	_	3	APPO
22	(	(	-LRB-	_	21	P
23	encoding	encode	VBG	_	21	NMOD
24	sterolin	sterolin	NN	_	23	OBJ
25	-	-	HYPH	_	24	P
26	1	0	CD	_	24	NMOD
27	)	)	-RRB-	_	21	P
28	and	and	CC	_	21	COORD
29	ABCG8	abcg0	NN	_	28	CONJ
30	(	(	-LRB-	_	29	P
31	encoding	encode	VBG	_	29	NMOD
32	sterolin	sterolin	NN	_	31	OBJ
33	-	-	HYPH	_	32	P
34	2	0	CD	_	32	NMOD
35	)	)	-RRB-	_	29	P
36	,	,	,	_	37	P
37	result	result	VBP	_	0	ROOT
38	in	in	IN	_	37	ADV
39	sitosterolemia	sitosterolemia	NN	_	38	PMOD
40	,	,	,	_	39	P
41	a	a	DT	_	45	NMOD
42	rare	rare	JJ	_	45	NMOD
43	autosomal	autosomal	JJ	_	44	AMOD
44	recessive	recessive	JJ	_	45	NMOD
45	disorder	disorder	NN	_	39	APPO
46	of	of	IN	_	45	NMOD
47	sterol	sterol	NN	_	48	NMOD
48	trafficking	trafficking	NN	_	46	PMOD
49	characterized	characterize	VBN	_	45	NMOD
50	by	by	IN	_	49	LGS
51	increased	increase	VBN	_	55	NMOD
52	plasma	plasma	NN	_	55	NMOD
53	plant	plant	NN	_	54	NMOD
54	sterol	sterol	NN	_	55	NMOD
55	levels	level	NNS	_	50	PMOD
56	.	.	.	_	37	P

1	Based	base	VBN	_	19	ADV
2	upon	upon	IN	_	1	PMOD
3	the	the	DT	_	4	NMOD
4	genetics	genetics	NNS	_	2	PMOD
5	of	of	IN	_	4	NMOD
6	sitosterolemia	sitosterolemia	NN	_	5	PMOD
7	,	,	,	_	19	P
8	ABCG5	abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	sterolin	sterolin	NN	_	19	SBJ
11	-	-	HYPH	_	10	P
12	1	0	CD	_	10	NMOD
13	and	and	CC	_	10	COORD
14	ABCG8	abcg0	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	sterolin	sterolin	NN	_	13	CONJ
17	-	-	HYPH	_	16	P
18	2	0	CD	_	16	NMOD
19	are	be	VBP	_	0	ROOT
20	hypothesized	hypothesize	VBN	_	19	VC
21	to	to	TO	_	20	OPRD
22	function	function	VB	_	21	IM
23	as	as	IN	_	22	ADV
24	obligate	obligate	JJ	_	25	NMOD
25	heterodimers	heterodimers	NNS	_	23	PMOD
26	.	.	.	_	19	P

1	No	no	DT	_	3	NMOD
2	phenotypic	phenotypic	JJ	_	3	NMOD
3	difference	difference	NN	_	4	SBJ
4	has	have	VBZ	_	0	ROOT
5	yet	yet	RB	_	4	TMP
6	been	be	VBN	_	4	VC
7	described	describe	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	humans	human	NNS	_	8	PMOD
10	with	with	IN	_	9	NMOD
11	complete	complete	JJ	_	12	NMOD
12	defects	defect	NNS	_	10	PMOD
13	in	in	IN	_	12	LOC
14	either	either	CC	_	15	COORD
15	ABCG5	abcg0	NN	_	13	PMOD
16	or	or	CC	_	15	COORD
17	ABCG8	abcg0	NN	_	16	CONJ
18	.	.	.	_	4	P

1	These	these	DT	_	2	NMOD
2	proteins	protein	NNS	_	11	SBJ
3	,	,	,	_	11	P
4	based	base	VBN	_	11	ADV
5	upon	upon	IN	_	4	PMOD
6	the	the	DT	_	7	NMOD
7	defects	defect	NNS	_	5	PMOD
8	in	in	IN	_	7	LOC
9	humans	human	NNS	_	8	PMOD
10	,	,	,	_	11	P
11	are	be	VBP	_	0	ROOT
12	responsible	responsible	JJ	_	11	PRD
13	for	for	IN	_	12	AMOD
14	regulating	regulate	VBG	_	13	PMOD
15	dietary	dietary	JJ	_	17	NMOD
16	sterol	sterol	NN	_	17	NMOD
17	entry	entry	NN	_	14	OBJ
18	and	and	CC	_	17	COORD
19	biliary	biliary	JJ	_	21	NMOD
20	sterol	sterol	NN	_	21	NMOD
21	secretion	secretion	NN	_	18	CONJ
22	.	.	.	_	11	P

1	Methods	method	NNS	_	0	ROOT

1	In	in	IN	_	10	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	mimic	mimic	VB	_	3	IM
5	the	the	DT	_	7	NMOD
6	human	human	JJ	_	7	NMOD
7	disease	disease	NN	_	4	OBJ
8	,	,	,	_	10	P
9	we	we	PRP	_	10	SBJ
10	created	create	VBD	_	0	ROOT
11	,	,	,	_	10	P
12	by	by	IN	_	10	MNR
13	a	a	DT	_	15	NMOD
14	targeted	target	VBN	_	15	NMOD
15	disruption	disruption	NN	_	12	PMOD
16	,	,	,	_	10	P
17	a	a	DT	_	19	NMOD
18	mouse	mouse	NN	_	19	NMOD
19	model	model	NN	_	10	OBJ
20	of	of	IN	_	19	NMOD
21	sitosterolemia	sitosterolemia	NN	_	20	PMOD
22	resulting	result	VBG	_	19	NMOD
23	in	in	IN	_	22	ADV
24	Abcg8	abcg0	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	sterolin	sterolin	NN	_	29	NMOD
27	-	-	HYPH	_	26	P
28	2	0	CD	_	26	NMOD
29	deficiency	deficiency	NN	_	23	PMOD
30	alone	alone	RB	_	29	NMOD
31	.	.	.	_	10	P

1	Homozygous	homozygous	JJ	_	3	NMOD
2	knockout	knockout	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	viable	viable	JJ	_	4	PRD
6	and	and	CC	_	4	COORD
7	exhibit	exhibit	VBP	_	6	CONJ
8	sitosterolemia	sitosterolemia	NN	_	7	OBJ
9	.	.	.	_	4	P

1	Results	result	NNS	_	0	ROOT

1	Mice	mouse	NNS	_	5	SBJ
2	deficient	deficient	JJ	_	1	NMOD
3	in	in	IN	_	1	NMOD
4	Abcg8	abcg0	NN	_	3	PMOD
5	have	have	VBP	_	0	ROOT
6	significantly	significantly	RB	_	7	AMOD
7	increased	increase	VBN	_	8	NMOD
8	plasma	plasma	NN	_	15	NMOD
9	and	and	CC	_	8	COORD
10	tissue	tissue	NN	_	12	NMOD
11	plant	plant	NN	_	12	NMOD
12	sterol	sterol	NN	_	13	NMOD
13	levels	level	NNS	_	9	CONJ
14	(	(	-LRB-	_	15	P
15	sitosterol	sitosterol	NN	_	5	OBJ
16	and	and	CC	_	15	COORD
17	campesterol	campesterol	NN	_	16	CONJ
18	)	)	-RRB-	_	15	P
19	consistent	consistent	JJ	_	15	NMOD
20	with	with	IN	_	19	AMOD
21	sitosterolemia	sitosterolemia	NN	_	20	PMOD
22	.	.	.	_	5	P

1	Interestingly	interestingly	RB	_	8	ADV
2	,	,	,	_	8	P
3	Abcg5	abcg0	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	sterolin	sterolin	NN	_	8	SBJ
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	was	be	VBD	_	0	ROOT
9	expressed	express	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	both	both	CC	_	12	COORD
12	liver	liver	NN	_	10	PMOD
13	and	and	CC	_	12	COORD
14	intestine	intestine	NN	_	13	CONJ
15	in	in	IN	_	9	LOC
16	Abcg8	abcg0	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	sterolin	sterolin	NN	_	21	AMOD
19	-	-	HYPH	_	18	P
20	2	0	CD	_	18	NMOD
21	deficient	deficient	JJ	_	22	NMOD
22	mice	mouse	NNS	_	15	PMOD
23	and	and	CC	_	8	COORD
24	continued	continue	VBD	_	23	CONJ
25	to	to	TO	_	24	OPRD
26	show	show	VB	_	25	IM
27	an	an	DT	_	29	NMOD
28	apical	apical	JJ	_	29	NMOD
29	expression	expression	NN	_	26	OBJ
30	.	.	.	_	8	P

1	Remarkably	remarkably	RB	_	6	ADV
2	,	,	,	_	6	P
3	Abcg8	abcg0	NN	_	4	AMOD
4	deficient	deficient	JJ	_	5	NMOD
5	mice	mouse	NNS	_	6	SBJ
6	had	have	VBD	_	0	ROOT
7	an	an	DT	_	9	NMOD
8	impaired	impaired	JJ	_	9	NMOD
9	ability	ability	NN	_	6	OBJ
10	to	to	TO	_	9	NMOD
11	secrete	secrete	VB	_	10	IM
12	cholesterol	cholesterol	NN	_	11	OBJ
13	into	into	IN	_	11	DIR
14	bile	bile	NN	_	13	PMOD
15	,	,	,	_	6	P
16	but	but	CC	_	6	COORD
17	still	still	RB	_	18	ADV
18	maintained	maintain	VBD	_	16	CONJ
19	the	the	DT	_	20	NMOD
20	ability	ability	NN	_	18	OBJ
21	to	to	TO	_	20	NMOD
22	secrete	secrete	VB	_	21	IM
23	sitosterol	sitosterol	NN	_	22	OBJ
24	.	.	.	_	6	P

1	We	we	PRP	_	3	SBJ
2	also	also	RB	_	3	ADV
3	report	report	VBP	_	0	ROOT
4	an	an	DT	_	6	NMOD
5	intermediate	intermediate	JJ	_	6	NMOD
6	phenotype	phenotype	NN	_	3	OBJ
7	in	in	IN	_	6	LOC
8	the	the	DT	_	14	NMOD
9	heterozygous	heterozygous	JJ	_	14	NMOD
10	Abcg8	abcg0	NN	_	14	NMOD
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	-	-	SYM	_	10	P
14	mice	mouse	NNS	_	7	PMOD
15	that	that	WDT	_	16	SBJ
16	are	be	VBP	_	14	NMOD
17	not	not	RB	_	16	ADV
18	sitosterolemic	sitosterolemic	JJ	_	16	PRD
19	,	,	,	_	16	P
20	but	but	CC	_	16	COORD
21	have	have	VBP	_	20	CONJ
22	a	a	DT	_	24	NMOD
23	decreased	decrease	VBN	_	24	NMOD
24	level	level	NN	_	21	OBJ
25	of	of	IN	_	24	NMOD
26	biliary	biliary	JJ	_	28	NMOD
27	sterol	sterol	NN	_	28	NMOD
28	secretion	secretion	NN	_	25	PMOD
29	relative	relative	JJ	_	21	ADV
30	to	to	IN	_	29	AMOD
31	wild	wild	JJ	_	33	NMOD
32	-	-	HYPH	_	31	P
33	type	type	NN	_	34	NMOD
34	mice	mouse	NNS	_	30	PMOD
35	.	.	.	_	3	P

1	Conclusion	conclusion	NN	_	0	ROOT

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	Abcg8	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	10	SBJ
8	-	-	HYPH	_	7	P
9	2	0	CD	_	7	NMOD
10	is	be	VBZ	_	4	SUB
11	necessary	necessary	JJ	_	10	PRD
12	for	for	IN	_	11	AMOD
13	biliary	biliary	JJ	_	15	NMOD
14	sterol	sterol	NN	_	15	NMOD
15	secretion	secretion	NN	_	12	PMOD
16	and	and	CC	_	4	COORD
17	that	that	IN	_	16	CONJ
18	loss	loss	NN	_	25	SBJ
19	of	of	IN	_	18	NMOD
20	Abcg8	abcg0	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	sterolin	sterolin	NN	_	19	PMOD
23	-	-	HYPH	_	22	P
24	2	0	CD	_	22	NMOD
25	has	have	VBZ	_	17	SUB
26	a	a	DT	_	29	NMOD
27	more	more	RBR	_	28	AMOD
28	profound	profound	JJ	_	29	NMOD
29	effect	effect	NN	_	25	OBJ
30	upon	upon	IN	_	29	NMOD
31	biliary	biliary	JJ	_	33	NMOD
32	cholesterol	cholesterol	NN	_	33	NMOD
33	secretion	secretion	NN	_	30	PMOD
34	than	than	IN	_	29	NMOD
35	sitosterol	sitosterol	NN	_	34	PMOD
36	.	.	.	_	3	P

1	Since	since	IN	_	18	PRP
2	biliary	biliary	JJ	_	4	NMOD
3	sitosterol	sitosterol	NN	_	4	NMOD
4	secretion	secretion	NN	_	5	SBJ
5	is	be	VBZ	_	1	SUB
6	preserved	preserve	VBN	_	5	VC
7	,	,	,	_	6	P
8	although	although	IN	_	6	ADV
9	not	not	RB	_	11	ADV
10	elevated	elevated	JJ	_	11	PRD
11	in	in	IN	_	8	SUB
12	the	the	DT	_	14	NMOD
13	sitosterolemic	sitosterolemic	JJ	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	,	,	,	_	18	P
16	this	this	DT	_	17	NMOD
17	observation	observation	NN	_	18	SBJ
18	suggests	suggest	VBZ	_	0	ROOT
19	that	that	IN	_	18	OBJ
20	mechanisms	mechanism	NNS	_	29	SBJ
21	other	other	JJ	_	20	NMOD
22	than	than	IN	_	21	AMOD
23	by	by	IN	_	22	PMOD
24	Abcg8	abcg0	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	sterolin	sterolin	NN	_	23	PMOD
27	-	-	HYPH	_	26	P
28	2	0	CD	_	26	NMOD
29	may	may	MD	_	19	SUB
30	be	be	VB	_	29	VC
31	responsible	responsible	JJ	_	30	PRD
32	for	for	IN	_	31	AMOD
33	its	its	PRP$	_	34	NMOD
34	secretion	secretion	NN	_	32	PMOD
35	into	into	IN	_	34	NMOD
36	bile	bile	NN	_	35	PMOD
37	.	.	.	_	18	P

1	Background	background	NN	_	0	ROOT

1	Absorption	absorption	NN	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	dietary	dietary	JJ	_	4	NMOD
4	cholesterol	cholesterol	NN	_	2	PMOD
5	from	from	IN	_	1	NMOD
6	the	the	DT	_	7	NMOD
7	intestine	intestine	NN	_	5	PMOD
8	is	be	VBZ	_	0	ROOT
9	an	an	DT	_	11	NMOD
10	important	important	JJ	_	11	NMOD
11	part	part	NN	_	8	PRD
12	of	of	IN	_	11	NMOD
13	cholesterol	cholesterol	NN	_	14	NMOD
14	homeostasis	homeostasis	NN	_	12	PMOD
15	and	and	CC	_	8	COORD
16	represents	represent	VBZ	_	15	CONJ
17	the	the	DT	_	19	NMOD
18	initial	initial	JJ	_	19	NMOD
19	step	step	NN	_	16	OBJ
20	that	that	WDT	_	21	SBJ
21	allows	allow	VBZ	_	19	NMOD
22	dietary	dietary	JJ	_	23	NMOD
23	cholesterol	cholesterol	NN	_	24	SBJ
24	to	to	TO	_	21	OPRD
25	exert	exert	VB	_	24	IM
26	its	its	PRP$	_	28	NMOD
27	metabolic	metabolic	JJ	_	28	NMOD
28	effects	effect	NNS	_	25	OBJ
29	.	.	.	_	8	P

1	A	a	DT	_	4	NMOD
2	typical	typical	JJ	_	4	NMOD
3	western	western	NNP	_	4	NMOD
4	diet	diet	NN	_	5	SBJ
5	contains	contain	VBZ	_	0	ROOT
6	relatively	relatively	RB	_	7	AMOD
7	equal	equal	JJ	_	8	NMOD
8	amounts	amount	NNS	_	5	OBJ
9	of	of	IN	_	8	NMOD
10	cholesterol	cholesterol	NN	_	13	NMOD
11	and	and	CC	_	10	COORD
12	non-cholesterol	non-cholesterol	JJ	_	11	CONJ
13	sterols	sterol	NNS	_	9	PMOD
14	,	,	,	_	13	P
15	mainly	mainly	RB	_	17	NMOD
16	plant	plant	NN	_	17	NMOD
17	sterols	sterol	NNS	_	13	APPO
18	,	,	,	_	8	P
19	of	of	IN	_	27	NMOD
20	which	which	WDT	_	19	PMOD
21	about	about	IN	_	22	QMOD
22	55	0	CD	_	23	NMOD
23	%	%	NN	_	28	SBJ
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	27	NMOD
26	dietary	dietary	JJ	_	27	NMOD
27	cholesterol	cholesterol	NN	_	24	PMOD
28	is	be	VBZ	_	8	NMOD
29	absorbed	absorb	VBN	_	28	VC
30	and	and	CC	_	29	COORD
31	retained	retain	VBN	_	30	CONJ
32	compared	compare	VBN	_	29	ADV
33	to	to	IN	_	32	PMOD
34	~	~	SYM	_	35	P
35	1	0	CD	_	36	NMOD
36	%	%	NN	_	33	PMOD
37	of	of	IN	_	36	NMOD
38	the	the	DT	_	41	NMOD
39	dietary	dietary	JJ	_	41	NMOD
40	non-cholesterol	non-cholesterol	JJ	_	41	NMOD
41	sterols	sterol	NNS	_	37	PMOD
42	[	[	-LRB-	_	43	P
43	1	0	CD	_	5	PRN
44	-	-	SYM	_	45	P
45	3	0	CD	_	43	NMOD
46	]	]	-RRB-	_	43	P
47	.	.	.	_	5	P

1	Schoenheimer	schoenheimer	NNP	_	2	SBJ
2	recognized	recognize	VBD	_	0	ROOT
3	more	more	JJR	_	6	NMOD
4	than	than	IN	_	3	QMOD
5	75	0	CD	_	3	QMOD
6	years	year	NNS	_	7	AMOD
7	ago	ago	RB	_	2	TMP
8	that	that	IN	_	2	OBJ
9	only	only	RB	_	10	NMOD
10	cholesterol	cholesterol	NN	_	16	SBJ
11	,	,	,	_	10	P
12	not	not	CC	_	10	COORD
13	non-cholesterol	non-cholesterol	JJ	_	14	NMOD
14	sterols	sterol	NNS	_	12	CONJ
15	,	,	,	_	16	P
16	is	be	VBZ	_	8	SUB
17	absorbed	absorb	VBN	_	16	VC
18	in	in	IN	_	17	LOC
19	the	the	DT	_	20	NMOD
20	intestine	intestine	NN	_	18	PMOD
21	,	,	,	_	17	P
22	although	although	IN	_	17	ADV
23	the	the	DT	_	26	NMOD
24	exact	exact	JJ	_	26	NMOD
25	molecular	molecular	JJ	_	26	NMOD
26	mechanisms	mechanism	NNS	_	33	SBJ
27	by	by	IN	_	32	MNR
28	which	which	WDT	_	27	PMOD
29	preferential	preferential	JJ	_	31	NMOD
30	cholesterol	cholesterol	NN	_	31	NMOD
31	absorption	absorption	NN	_	32	SBJ
32	occurs	occur	VBZ	_	26	NMOD
33	has	have	VBZ	_	22	SUB
34	not	not	RB	_	33	ADV
35	been	be	VBN	_	33	VC
36	fully	fully	RB	_	35	ADV
37	elucidated	elucidate	VBN	_	35	VC
38	[	[	-LRB-	_	39	P
39	4	0	CD	_	37	PRN
40	]	]	-RRB-	_	39	P
41	.	.	.	_	2	P

1	Similarly	similarly	RB	_	13	ADV
2	,	,	,	_	13	P
3	although	although	IN	_	13	ADV
4	the	the	DT	_	5	NMOD
5	liver	liver	NN	_	6	SBJ
6	secretes	secrete	VBZ	_	3	SUB
7	free	free	JJ	_	8	NMOD
8	cholesterol	cholesterol	NN	_	6	OBJ
9	into	into	IN	_	6	DIR
10	bile	bile	NN	_	9	PMOD
11	,	,	,	_	13	P
12	it	it	PRP	_	13	SBJ
13	can	can	MD	_	0	ROOT
14	preferentially	preferentially	RB	_	13	ADV
15	excrete	excrete	VB	_	13	VC
16	non-cholesterol	non-cholesterol	JJ	_	17	NMOD
17	sterols	sterol	NNS	_	15	OBJ
18	into	into	IN	_	15	DIR
19	bile	bile	NN	_	18	PMOD
20	and	and	CC	_	13	COORD
21	the	the	DT	_	22	NMOD
22	mechanism	mechanism	NN	_	29	SBJ
23	(	(	-LRB-	_	22	P
24	s	s	AFX	_	22	NMOD
25	)	)	-RRB-	_	22	P
26	of	of	IN	_	22	NMOD
27	this	this	DT	_	28	NMOD
28	process	process	NN	_	26	PMOD
29	has	have	VBZ	_	20	CONJ
30	yet	yet	RB	_	29	TMP
31	to	to	TO	_	29	OPRD
32	be	be	VB	_	31	IM
33	elucidated	elucidate	VBN	_	32	VC
34	as	as	RB	_	35	AMOD
35	well	well	RB	_	33	TMP
36	.	.	.	_	13	P

1	Only	only	RB	_	2	AMOD
2	recently	recently	RB	_	13	TMP
3	,	,	,	_	13	P
4	through	through	IN	_	13	MNR
5	the	the	DT	_	6	NMOD
6	study	study	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	a	a	DT	_	11	NMOD
9	rare	rare	JJ	_	11	NMOD
10	human	human	JJ	_	11	NMOD
11	disease	disease	NN	_	7	PMOD
12	,	,	,	_	13	P
13	have	have	VB	_	0	ROOT
14	clues	clue	NNS	_	13	SBJ
15	to	to	IN	_	14	NMOD
16	this	this	DT	_	17	NMOD
17	process	process	NN	_	15	PMOD
18	been	be	VBN	_	13	VC
19	revealed	reveal	VBN	_	18	VC
20	.	.	.	_	13	P

1	Sitosterolemia	sitosterolemia	NN	_	3	NMOD
2	(	(	-LRB-	_	3	P
3	MIM	mim	NN	_	11	SBJ
4	210250	0	CD	_	3	NMOD
5	,	,	,	_	3	P
6	also	also	RB	_	7	ADV
7	known	know	VBN	_	3	NMOD
8	as	as	IN	_	7	ADV
9	phytosterolemia	phytosterolemia	NN	_	8	PMOD
10	)	)	-RRB-	_	3	P
11	is	be	VBZ	_	0	ROOT
12	a	a	DT	_	18	NMOD
13	rare	rare	JJ	_	18	NMOD
14	autosomal	autosomal	JJ	_	18	NMOD
15	,	,	,	_	18	P
16	recessively	recessively	RB	_	17	AMOD
17	inherited	inherit	VBN	_	18	NMOD
18	disorder	disorder	NN	_	11	PRD
19	characterized	characterize	VBN	_	18	NMOD
20	by	by	IN	_	19	LGS
21	elevated	elevate	VBN	_	27	NMOD
22	blood	blood	NN	_	27	NMOD
23	and	and	CC	_	22	COORD
24	tissue	tissue	NN	_	23	CONJ
25	plant	plant	NN	_	26	NMOD
26	sterol	sterol	NN	_	27	NMOD
27	levels	level	NNS	_	20	PMOD
28	[	[	-LRB-	_	29	P
29	5	0	CD	_	11	PRN
30	]	]	-RRB-	_	29	P
31	.	.	.	_	11	P

1	Affected	affect	VBN	_	2	NMOD
2	individuals	individual	NNS	_	3	SBJ
3	can	can	MD	_	0	ROOT
4	develop	develop	VB	_	3	VC
5	tendon	tendon	NN	_	10	NMOD
6	and	and	CC	_	5	COORD
7	/	/	HYPH	_	6	P
8	or	or	CC	_	6	COORD
9	tuberous	tuberous	JJ	_	6	CONJ
10	xanthomas	xanthoma	NNS	_	4	OBJ
11	,	,	,	_	10	P
12	hemolytic	hemolytic	JJ	_	13	NMOD
13	episodes	episode	NNS	_	10	CONJ
14	,	,	,	_	13	P
15	arthralgias	arthralgia	NNS	_	13	CONJ
16	,	,	,	_	15	P
17	arthritis	arthritis	NN	_	15	CONJ
18	,	,	,	_	17	P
19	and	and	CC	_	17	COORD
20	premature	premature	JJ	_	21	NMOD
21	atherosclerosis	atherosclerosis	NN	_	19	CONJ
22	[	[	-LRB-	_	4	P
23	6	0	CD	_	25	NMOD
24	,	,	,	_	25	P
25	7	0	CD	_	4	OBJ
26	]	]	-RRB-	_	4	P
27	.	.	.	_	3	P

1	Sitosterolemic	sitosterolemic	JJ	_	2	NMOD
2	patients	patient	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	diagnostically	diagnostically	RB	_	5	AMOD
5	elevated	elevate	VBN	_	9	NMOD
6	plasma	plasma	NN	_	8	NMOD
7	plant	plant	NN	_	8	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	levels	level	NNS	_	14	NMOD
10	(	(	-LRB-	_	14	P
11	for	for	IN	_	14	NMOD
12	example	example	NN	_	11	PMOD
13	,	,	,	_	14	P
14	sitosterol	sitosterol	NN	_	3	OBJ
15	,	,	,	_	14	P
16	campesterol	campesterol	NN	_	14	CONJ
17	,	,	,	_	16	P
18	stigmasterol	stigmasterol	NN	_	16	CONJ
19	,	,	,	_	18	P
20	and	and	CC	_	18	COORD
21	avenosterol	avenosterol	NN	_	20	CONJ
22	,	,	,	_	21	P
23	etc.	etc.	FW	_	21	CONJ
24	)	)	-RRB-	_	14	P
25	and	and	CC	_	14	COORD
26	their	their	PRP$	_	31	NMOD
27	5	0	CD	_	29	AMOD
28	-	-	HYPH	_	27	P
29	saturated	saturate	VBN	_	31	NMOD
30	stanol	stanol	NN	_	31	NMOD
31	metabolites	metabolite	NNS	_	25	CONJ
32	,	,	,	_	31	P
33	particularly	particularly	RB	_	34	NMOD
34	sitostanol	sitostanol	NN	_	31	APPO
35	,	,	,	_	31	P
36	with	with	IN	_	31	NMOD
37	normal	normal	JJ	_	43	NMOD
38	or	or	CC	_	37	COORD
39	only	only	RB	_	40	AMOD
40	moderately	moderately	RB	_	41	AMOD
41	increased	increase	VBN	_	38	CONJ
42	cholesterol	cholesterol	NN	_	43	NMOD
43	levels	level	NNS	_	36	PMOD
44	.	.	.	_	3	P

1	Clinical	clinical	JJ	_	2	NMOD
2	studies	study	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	shown	show	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	affected	affect	VBN	_	7	NMOD
7	individuals	individual	NNS	_	8	SBJ
8	hyperabsorb	hyperabsorb	VBP	_	5	SUB
9	all	all	DT	_	11	NMOD
10	dietary	dietary	JJ	_	11	NMOD
11	sterols	sterol	NNS	_	8	OBJ
12	(	(	-LRB-	_	14	P
13	thus	thus	RB	_	14	ADV
14	have	have	VBP	_	11	PRN
15	lost	lose	VBN	_	14	VC
16	the	the	DT	_	17	NMOD
17	ability	ability	NN	_	15	OBJ
18	to	to	TO	_	17	NMOD
19	restrict	restrict	VB	_	18	IM
20	the	the	DT	_	22	NMOD
21	sterol	sterol	NN	_	22	NMOD
22	species	specie	NNS	_	19	OBJ
23	absorbed	absorb	VBN	_	22	NMOD
24	)	)	-RRB-	_	14	P
25	and	and	CC	_	8	COORD
26	have	have	VBP	_	25	CONJ
27	lost	lose	VBN	_	26	VC
28	the	the	DT	_	29	NMOD
29	ability	ability	NN	_	27	OBJ
30	to	to	TO	_	29	NMOD
31	excrete	excrete	VB	_	30	IM
32	sterols	sterol	NNS	_	31	OBJ
33	into	into	IN	_	31	DIR
34	bile	bile	NN	_	33	PMOD
35	[	[	-LRB-	_	38	P
36	8	0	CD	_	38	NMOD
37	,	,	,	_	38	P
38	9	0	CD	_	4	PRN
39	]	]	-RRB-	_	38	P
40	.	.	.	_	3	P

1	Infusion	infusion	NN	_	9	SBJ
2	of	of	IN	_	1	NMOD
3	sitosterol	sitosterol	NN	_	2	PMOD
4	and	and	CC	_	3	COORD
5	cholesterol	cholesterol	NN	_	4	CONJ
6	into	into	IN	_	1	NMOD
7	normal	normal	JJ	_	8	NMOD
8	individuals	individual	NNS	_	6	PMOD
9	leads	lead	VBZ	_	0	ROOT
10	to	to	IN	_	9	ADV
11	a	a	DT	_	15	NMOD
12	rapid	rapid	JJ	_	15	NMOD
13	and	and	CC	_	12	COORD
14	preferential	preferential	JJ	_	13	CONJ
15	excretion	excretion	NN	_	10	PMOD
16	of	of	IN	_	15	NMOD
17	sitosterol	sitosterol	NN	_	16	PMOD
18	into	into	IN	_	15	NMOD
19	bile	bile	NN	_	18	PMOD
20	,	,	,	_	9	P
21	but	but	CC	_	9	COORD
22	in	in	IN	_	28	LOC
23	sitosterolemic	sitosterolemic	JJ	_	24	NMOD
24	individuals	individual	NNS	_	22	PMOD
25	biliary	biliary	JJ	_	26	NMOD
26	sterol	sterol	NN	_	27	NMOD
27	secretion	secretion	NN	_	28	SBJ
28	is	be	VBZ	_	21	CONJ
29	almost	almost	RB	_	30	AMOD
30	absent	absent	JJ	_	28	PRD
31	[	[	-LRB-	_	34	P
32	7	0	CD	_	34	NMOD
33	,	,	,	_	34	P
34	9	0	CD	_	9	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	9	P

1	Previous	previous	JJ	_	2	NMOD
2	studies	study	NNS	_	5	SBJ
3	on	on	IN	_	2	NMOD
4	sitosterolemia	sitosterolemia	NN	_	3	PMOD
5	have	have	VBP	_	0	ROOT
6	suggested	suggest	VBN	_	5	VC
7	a	a	DT	_	8	NMOD
8	defect	defect	NN	_	6	OBJ
9	involving	involve	VBG	_	8	NMOD
10	a	a	DT	_	14	NMOD
11	putative	putative	JJ	_	14	NMOD
12	sterol	sterol	NN	_	14	NMOD
13	'	'	``	_	14	P
14	transporter	transporter	NN	_	9	OBJ
15	'	'	''	_	14	P
16	expressed	express	VBN	_	14	NMOD
17	in	in	IN	_	16	LOC
18	the	the	DT	_	21	NMOD
19	intestinal	intestinal	JJ	_	21	NMOD
20	brush	brush	NN	_	21	NMOD
21	border	border	NN	_	17	PMOD
22	and	and	CC	_	21	COORD
23	/	/	HYPH	_	22	P
24	or	or	CC	_	22	COORD
25	the	the	DT	_	28	NMOD
26	hepatic	hepatic	JJ	_	28	NMOD
27	canalicular	canalicular	JJ	_	28	NMOD
28	membrane	membrane	NN	_	22	CONJ
29	[	[	-LRB-	_	32	P
30	10	0	CD	_	32	NMOD
31	,	,	,	_	32	P
32	11	0	CD	_	6	PRN
33	]	]	-RRB-	_	32	P
34	.	.	.	_	5	P

1	Genetic	genetic	JJ	_	2	NMOD
2	analyses	analysis	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	sitosterolemia	sitosterolemia	NN	_	5	NMOD
5	pedigrees	pedigree	NNS	_	3	PMOD
6	allowed	allow	VBD	_	0	ROOT
7	the	the	DT	_	8	NMOD
8	mapping	mapping	NN	_	6	OBJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	STSL	stsl	NN	_	12	NMOD
12	locus	locus	NN	_	9	PMOD
13	to	to	IN	_	8	NMOD
14	human	human	JJ	_	16	NMOD
15	chromosome	chromosome	NN	_	16	NMOD
16	2p21	0p0	NN	_	13	PMOD
17	,	,	,	_	16	P
18	between	between	IN	_	16	LOC
19	D2S2294	d0s0	NN	_	18	PMOD
20	and	and	CC	_	19	COORD
21	D2S2298	d0s0	NN	_	20	CONJ
22	[	[	-LRB-	_	25	P
23	12	0	CD	_	25	NMOD
24	,	,	,	_	25	P
25	13	0	CD	_	6	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	6	P

1	By	by	IN	_	20	MNR
2	using	use	VBG	_	1	PMOD
3	positional	positional	JJ	_	4	NMOD
4	cloning	cloning	NN	_	5	NMOD
5	procedures	procedure	NNS	_	2	OBJ
6	or	or	CC	_	1	COORD
7	by	by	IN	_	6	CONJ
8	screening	screen	VBG	_	7	PMOD
9	for	for	IN	_	8	ADV
10	genes	gene	NNS	_	9	PMOD
11	induced	induce	VBN	_	10	NMOD
12	by	by	IN	_	11	LGS
13	exposure	exposure	NN	_	12	PMOD
14	to	to	IN	_	13	NMOD
15	LXR	lxr	NN	_	16	NMOD
16	agonists	agonist	NNS	_	14	PMOD
17	,	,	,	_	20	P
18	two	two	CD	_	19	NMOD
19	groups	group	NNS	_	20	SBJ
20	identified	identify	VBD	_	0	ROOT
21	not	not	CC	_	22	COORD
22	one	one	CD	_	25	NMOD
23	but	but	CC	_	22	COORD
24	two	two	CD	_	23	CONJ
25	genes	gene	NNS	_	20	OBJ
26	,	,	,	_	25	P
27	ABCG5	abcg0	NN	_	25	APPO
28	and	and	CC	_	27	COORD
29	ABCG8	abcg0	NN	_	28	CONJ
30	,	,	,	_	25	P
31	which	which	WDT	_	32	SBJ
32	encode	encode	VBP	_	25	NMOD
33	the	the	DT	_	35	NMOD
34	proteins	protein	NNS	_	35	NMOD
35	sterolin	sterolin	NN	_	32	OBJ
36	-	-	HYPH	_	35	P
37	1	0	CD	_	35	NMOD
38	and	and	CC	_	35	COORD
39	sterolin	sterolin	NN	_	38	CONJ
40	-	-	HYPH	_	39	P
41	2	0	CD	_	39	NMOD
42	,	,	,	_	35	P
43	mutations	mutation	NNS	_	46	SBJ
44	of	of	IN	_	43	NMOD
45	which	which	WDT	_	44	PMOD
46	cause	cause	VBP	_	35	NMOD
47	sitosterolemia	sitosterolemia	NN	_	46	OBJ
48	[	[	-LRB-	_	49	P
49	14	0	CD	_	20	PRN
50	-	-	SYM	_	51	P
51	16	0	CD	_	49	NMOD
52	]	]	-RRB-	_	49	P
53	.	.	.	_	20	P

1	Interestingly	interestingly	RB	_	12	ADV
2	,	,	,	_	12	P
3	complete	complete	JJ	_	4	NMOD
4	mutation	mutation	NN	_	12	SBJ
5	in	in	IN	_	4	LOC
6	either	either	CC	_	7	COORD
7	ABCG5	abcg0	NN	_	5	PMOD
8	alone	alone	RB	_	7	NMOD
9	or	or	CC	_	7	COORD
10	ABCG8	abcg0	NN	_	9	CONJ
11	alone	alone	RB	_	10	NMOD
12	is	be	VBZ	_	0	ROOT
13	not	not	RB	_	15	COORD
14	only	only	RB	_	13	ADV
15	necessary	necessary	JJ	_	12	PRD
16	,	,	,	_	15	P
17	but	but	CC	_	15	COORD
18	sufficient	sufficient	JJ	_	17	CONJ
19	to	to	TO	_	18	AMOD
20	cause	cause	VB	_	19	IM
21	the	the	DT	_	22	NMOD
22	disease	disease	NN	_	20	OBJ
23	[	[	-LRB-	_	24	P
24	14	0	CD	_	12	PRN
25	]	]	-RRB-	_	24	P
26	.	.	.	_	12	P

1	To	to	IN	_	8	TMP
2	date	date	NN	_	1	PMOD
3	,	,	,	_	8	P
4	no	no	DT	_	5	NMOD
5	patient	patient	NN	_	8	SBJ
6	with	with	IN	_	5	NMOD
7	sitosterolemia	sitosterolemia	NN	_	6	PMOD
8	has	have	VBZ	_	0	ROOT
9	been	be	VBN	_	8	VC
10	identified	identify	VBN	_	9	VC
11	with	with	IN	_	5	NMOD
12	mutations	mutation	NNS	_	11	PMOD
13	in	in	IN	_	12	LOC
14	both	both	DT	_	15	NMOD
15	genes	gene	NNS	_	13	PMOD
16	.	.	.	_	8	P

1	Based	base	VBN	_	23	ADV
2	upon	upon	IN	_	1	PMOD
3	these	these	DT	_	4	NMOD
4	data	datum	NNS	_	2	PMOD
5	,	,	,	_	4	P
6	and	and	CC	_	4	COORD
7	the	the	DT	_	8	NMOD
8	similarity	similarity	NN	_	6	CONJ
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	14	NMOD
11	clinical	clinical	JJ	_	14	NMOD
12	and	and	CC	_	11	COORD
13	biochemical	biochemical	JJ	_	12	CONJ
14	phenotype	phenotype	NN	_	9	PMOD
15	,	,	,	_	23	P
16	sterolin	sterolin	NN	_	23	SBJ
17	-	-	HYPH	_	16	P
18	1	0	CD	_	16	NMOD
19	and	and	CC	_	16	COORD
20	sterolin	sterolin	NN	_	19	CONJ
21	-	-	HYPH	_	20	P
22	2	0	CD	_	20	NMOD
23	are	be	VBP	_	0	ROOT
24	hypothesized	hypothesize	VBN	_	23	VC
25	to	to	TO	_	24	OPRD
26	function	function	VB	_	25	IM
27	as	as	IN	_	26	ADV
28	obligate	obligate	JJ	_	29	NMOD
29	heterodimers	heterodimers	NNS	_	27	PMOD
30	.	.	.	_	23	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	also	also	RB	_	2	ADV
4	supported	support	VBN	_	2	VC
5	by	by	IN	_	4	LGS
6	the	the	DT	_	7	NMOD
7	fact	fact	NN	_	5	PMOD
8	that	that	IN	_	7	NMOD
9	each	each	DT	_	13	SBJ
10	of	of	IN	_	9	NMOD
11	these	these	DT	_	12	NMOD
12	proteins	protein	NNS	_	10	PMOD
13	is	be	VBZ	_	8	SUB
14	a	a	DT	_	18	NMOD
15	'	'	``	_	18	P
16	half	half	NN	_	18	NMOD
17	-	-	HYPH	_	16	P
18	transporter	transporter	NN	_	13	PRD
19	'	'	''	_	18	P
20	,	,	,	_	18	P
21	containing	contain	VBG	_	18	NMOD
22	six	six	CD	_	24	NMOD
23	transmembrane	transmembrane	NN	_	24	NMOD
24	domains	domain	NNS	_	21	OBJ
25	,	,	,	_	24	P
26	and	and	CC	_	24	COORD
27	not	not	RB	_	26	ADV
28	the	the	DT	_	31	NMOD
29	classical	classical	JJ	_	31	NMOD
30	12	0	CD	_	31	NMOD
31	transmembrane	transmembrane	NN	_	26	CONJ
32	characteristic	characteristic	JJ	_	31	NMOD
33	of	of	IN	_	32	AMOD
34	functional	functional	JJ	_	36	NMOD
35	ABC	abc	NN	_	36	NMOD
36	transporters	transporter	NNS	_	33	PMOD
37	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	exact	exact	JJ	_	3	NMOD
3	function	function	NN	_	9	SBJ
4	of	of	IN	_	3	NMOD
5	these	these	DT	_	7	NMOD
6	two	two	CD	_	7	NMOD
7	proteins	protein	NNS	_	4	PMOD
8	still	still	RB	_	9	TMP
9	remains	remain	VBZ	_	0	ROOT
10	unknown	unknown	JJ	_	9	PRD
11	but	but	CC	_	9	COORD
12	recent	recent	JJ	_	13	NMOD
13	studies	study	NNS	_	14	SBJ
14	have	have	VBP	_	11	CONJ
15	shown	show	VBN	_	14	VC
16	that	that	IN	_	15	OBJ
17	overexpression	overexpression	NN	_	27	SBJ
18	of	of	IN	_	17	NMOD
19	ABCG5	abcg0	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	ABCG8	abcg0	NN	_	18	PMOD
22	in	in	IN	_	17	LOC
23	a	a	DT	_	26	NMOD
24	transgenic	transgenic	JJ	_	25	NMOD
25	mouse	mouse	NN	_	26	NMOD
26	model	model	NN	_	22	PMOD
27	results	result	VBZ	_	16	SUB
28	in	in	IN	_	27	ADV
29	an	an	DT	_	33	NMOD
30	increased	increase	VBN	_	33	NMOD
31	biliary	biliary	JJ	_	32	NMOD
32	cholesterol	cholesterol	NN	_	33	NMOD
33	concentration	concentration	NN	_	28	PMOD
34	and	and	CC	_	33	COORD
35	a	a	DT	_	38	NMOD
36	50	0	CD	_	37	NMOD
37	%	%	NN	_	38	NMOD
38	reduction	reduction	NN	_	34	CONJ
39	in	in	IN	_	38	NMOD
40	the	the	DT	_	42	NMOD
41	fractional	fractional	JJ	_	42	NMOD
42	absorption	absorption	NN	_	39	PMOD
43	of	of	IN	_	42	NMOD
44	dietary	dietary	JJ	_	45	NMOD
45	cholesterol	cholesterol	NN	_	43	PMOD
46	[	[	-LRB-	_	47	P
47	17	0	CD	_	9	PRN
48	]	]	-RRB-	_	47	P
49	.	.	.	_	9	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	suggested	suggest	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	ABCG5	abcg0	NN	_	9	SBJ
7	and	and	CC	_	6	COORD
8	ABCG8	abcg0	NN	_	7	CONJ
9	act	act	VBP	_	5	SUB
10	as	as	IN	_	9	ADV
11	mutual	mutual	JJ	_	12	NMOD
12	chaperones	chaperone	NNS	_	10	PMOD
13	for	for	IN	_	12	NMOD
14	both	both	CC	_	15	COORD
15	maturation	maturation	NN	_	13	PMOD
16	and	and	CC	_	15	COORD
17	correct	correct	JJ	_	19	NMOD
18	apical	apical	JJ	_	19	NMOD
19	targeting	targeting	NN	_	16	CONJ
20	.	.	.	_	2	P

1	Co-expression	co-expression	NN	_	4	SBJ
2	of	of	IN	_	1	NMOD
3	both	both	DT	_	2	PMOD
4	was	be	VBD	_	0	ROOT
5	required	require	VBN	_	4	VC
6	for	for	IN	_	5	PRP
7	apical	apical	JJ	_	8	NMOD
8	trafficking	trafficking	NN	_	6	PMOD
9	in	in	IN	_	8	NMOD
10	a	a	DT	_	13	NMOD
11	polarized	polarize	VBN	_	13	NMOD
12	cell	cell	NN	_	13	NMOD
13	line	line	NN	_	9	PMOD
14	,	,	,	_	9	P
15	as	as	RB	_	9	COORD
16	well	well	RB	_	15	ADV
17	in	in	FW	_	18	AMOD
18	vivo	vivo	FW	_	15	CONJ
19	using	use	VBG	_	5	MNR
20	Abcg5	abcg0	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	Abcg8	abcg0	NN	_	25	NMOD
23	double	double	RB	_	25	NMOD
24	-	-	HYPH	_	23	P
25	knockout	knockout	NN	_	26	NMOD
26	mice	mouse	NNS	_	19	OBJ
27	[	[	-LRB-	_	30	P
28	18	0	CD	_	30	NMOD
29	,	,	,	_	30	P
30	19	0	CD	_	5	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	4	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	no	no	DT	_	5	NMOD
4	functional	functional	JJ	_	5	NMOD
5	assay	assay	NN	_	6	SBJ
6	has	have	VBZ	_	0	ROOT
7	yet	yet	RB	_	6	TMP
8	been	be	VBN	_	6	VC
9	developed	develop	VBN	_	8	VC
10	to	to	TO	_	9	PRP
11	demonstrate	demonstrate	VB	_	10	IM
12	whether	whether	IN	_	11	OBJ
13	or	or	CC	_	12	COORD
14	not	not	RB	_	12	ADV
15	the	the	DT	_	19	NMOD
16	two	two	CD	_	19	NMOD
17	half	half	NN	_	19	NMOD
18	-	-	HYPH	_	17	P
19	transporters	transporter	NNS	_	20	SBJ
20	function	function	VBP	_	12	SUB
21	as	as	IN	_	20	ADV
22	homo	homo	AFX	_	21	PMOD
23	-	-	HYPH	_	22	P
24	or	or	CC	_	22	COORD
25	heterodimers	heterodimers	NNS	_	24	CONJ
26	and	and	CC	_	12	COORD
27	whether	whether	IN	_	26	CONJ
28	they	they	PRP	_	30	SBJ
29	selectively	selectively	RB	_	30	ADV
30	pump	pump	VB	_	27	SUB
31	sterols	sterol	NNS	_	30	OBJ
32	.	.	.	_	6	P

1	Likewise	likewise	RB	_	10	ADV
2	,	,	,	_	10	P
3	the	the	DT	_	5	NMOD
4	cellular	cellular	JJ	_	5	NMOD
5	localization	localization	NN	_	10	SBJ
6	of	of	IN	_	5	NMOD
7	these	these	DT	_	9	NMOD
8	two	two	CD	_	9	NMOD
9	proteins	protein	NNS	_	6	PMOD
10	has	have	VBZ	_	0	ROOT
11	yet	yet	RB	_	10	TMP
12	to	to	TO	_	10	OPRD
13	be	be	VB	_	12	IM
14	shown	show	VBN	_	13	VC
15	in	in	IN	_	14	LOC
16	a	a	DT	_	17	NMOD
17	model	model	NN	_	15	PMOD
18	deficient	deficient	JJ	_	17	NMOD
19	in	in	IN	_	18	AMOD
20	either	either	CC	_	21	COORD
21	Abcg5	abcg0	NN	_	19	PMOD
22	or	or	CC	_	21	COORD
23	Abcg8	abcg0	NN	_	22	CONJ
24	alone	alone	RB	_	21	NMOD
25	.	.	.	_	10	P

1	A	a	DT	_	3	NMOD
2	mouse	mouse	NN	_	3	NMOD
3	model	model	NN	_	10	SBJ
4	disrupting	disrupt	VBG	_	3	NMOD
5	both	both	CC	_	6	COORD
6	Abcg5	abcg0	NN	_	4	OBJ
7	and	and	CC	_	6	COORD
8	Abcg8	abcg0	NN	_	7	CONJ
9	simultaneously	simultaneously	RB	_	4	TMP
10	results	result	VBZ	_	0	ROOT
11	in	in	IN	_	10	ADV
12	a	a	DT	_	13	NMOD
13	phenotype	phenotype	NN	_	11	PMOD
14	similar	similar	JJ	_	13	NMOD
15	to	to	IN	_	14	AMOD
16	that	that	DT	_	15	PMOD
17	of	of	IN	_	16	NMOD
18	the	the	DT	_	20	NMOD
19	human	human	JJ	_	20	NMOD
20	disease	disease	NN	_	17	PMOD
21	[	[	-LRB-	_	22	P
22	20	0	CD	_	10	PRN
23	]	]	-RRB-	_	22	P
24	.	.	.	_	10	P

1	However	however	RB	_	4	ADV
2	,	,	,	_	4	P
3	it	it	PRP	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	important	important	JJ	_	4	PRD
6	to	to	TO	_	4	OPRD
7	point	point	VB	_	6	IM
8	out	out	RP	_	7	PRT
9	that	that	IN	_	7	OBJ
10	the	the	DT	_	12	NMOD
11	human	human	JJ	_	12	NMOD
12	disease	disease	NN	_	13	SBJ
13	is	be	VBZ	_	9	SUB
14	caused	cause	VBN	_	13	VC
15	by	by	IN	_	14	LGS
16	complete	complete	JJ	_	17	NMOD
17	mutation	mutation	NN	_	15	PMOD
18	in	in	IN	_	17	LOC
19	one	one	CD	_	18	PMOD
20	or	or	CC	_	19	COORD
21	the	the	DT	_	22	NMOD
22	other	other	JJ	_	20	CONJ
23	gene	gene	NN	_	22	NMOD
24	,	,	,	_	23	P
25	but	but	CC	_	23	COORD
26	not	not	RB	_	25	ADV
27	both	both	DT	_	25	CONJ
28	simultaneously	simultaneously	RB	_	27	NMOD
29	.	.	.	_	4	P

1	We	we	PRP	_	2	SBJ
2	hypothesized	hypothesize	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	disruption	disruption	NN	_	13	SBJ
5	of	of	IN	_	4	NMOD
6	only	only	RB	_	7	NMOD
7	one	one	CD	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	12	NMOD
10	half	half	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	transporters	transporter	NNS	_	8	PMOD
13	would	would	MD	_	3	SUB
14	result	result	VB	_	13	VC
15	in	in	IN	_	14	ADV
16	sitosterolemia	sitosterolemia	NN	_	15	PMOD
17	and	and	CC	_	13	COORD
18	selective	selective	JJ	_	19	NMOD
19	loss	loss	NN	_	23	SBJ
20	of	of	IN	_	19	NMOD
21	either	either	DT	_	22	NMOD
22	sterolin	sterolin	NN	_	20	PMOD
23	may	may	MD	_	17	CONJ
24	show	show	VB	_	23	VC
25	a	a	DT	_	27	NMOD
26	differential	differential	JJ	_	27	NMOD
27	effect	effect	NN	_	24	OBJ
28	on	on	IN	_	27	NMOD
29	the	the	DT	_	31	NMOD
30	biliary	biliary	JJ	_	31	NMOD
31	secretion	secretion	NN	_	28	PMOD
32	of	of	IN	_	31	NMOD
33	sterols	sterol	NNS	_	32	PMOD
34	or	or	CC	_	31	COORD
35	intestinal	intestinal	JJ	_	36	NMOD
36	absorption	absorption	NN	_	34	CONJ
37	of	of	IN	_	36	NMOD
38	sterols	sterol	NNS	_	37	PMOD
39	.	.	.	_	2	P

1	These	these	DT	_	2	NMOD
2	studies	study	NNS	_	3	SBJ
3	are	be	VBP	_	0	ROOT
4	difficult	difficult	JJ	_	3	PRD
5	to	to	TO	_	4	AMOD
6	test	test	VB	_	5	IM
7	in	in	IN	_	6	LOC
8	humans	human	NNS	_	7	PMOD
9	,	,	,	_	3	P
10	as	as	IN	_	3	PRP
11	the	the	DT	_	13	NMOD
12	target	target	NN	_	13	NMOD
13	organs	organ	NNS	_	14	SBJ
14	are	be	VBP	_	10	SUB
15	relatively	relatively	RB	_	16	AMOD
16	inaccessible	inaccessible	JJ	_	14	PRD
17	.	.	.	_	3	P

1	In	in	IN	_	9	PRP
2	order	order	NN	_	1	PMOD
3	to	to	TO	_	2	NMOD
4	test	test	VB	_	3	IM
5	this	this	DT	_	6	NMOD
6	hypothesis	hypothesis	NN	_	4	OBJ
7	,	,	,	_	9	P
8	we	we	PRP	_	9	SBJ
9	report	report	VBP	_	0	ROOT
10	a	a	DT	_	12	NMOD
11	mouse	mouse	NN	_	12	NMOD
12	model	model	NN	_	9	OBJ
13	that	that	WDT	_	14	SBJ
14	has	have	VBZ	_	12	NMOD
15	a	a	DT	_	18	NMOD
16	selective	selective	JJ	_	18	NMOD
17	genetic	genetic	JJ	_	18	NMOD
18	mutation	mutation	NN	_	14	OBJ
19	of	of	IN	_	18	NMOD
20	Abcg8	abcg0	NN	_	19	PMOD
21	.	.	.	_	9	P

1	Mice	mouse	NNS	_	6	SBJ
2	homozygous	homozygous	JJ	_	1	NMOD
3	for	for	IN	_	2	AMOD
4	Abcg8	abcg0	NN	_	5	NMOD
5	loss	loss	NN	_	3	PMOD
6	exhibit	exhibit	VBP	_	0	ROOT
7	many	many	JJ	_	6	OBJ
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	characteristics	characteristic	NNS	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	the	the	DT	_	14	NMOD
13	human	human	JJ	_	14	NMOD
14	disease	disease	NN	_	15	NMOD
15	sitosterolemia	sitosterolemia	NN	_	11	PMOD
16	.	.	.	_	6	P

1	In	in	IN	_	5	ADV
2	addition	addition	NN	_	1	PMOD
3	,	,	,	_	5	P
4	we	we	PRP	_	5	SBJ
5	report	report	VBP	_	0	ROOT
6	studies	study	NNS	_	5	OBJ
7	of	of	IN	_	6	NMOD
8	biliary	biliary	JJ	_	10	NMOD
9	sterol	sterol	NN	_	10	NMOD
10	secretion	secretion	NN	_	7	PMOD
11	that	that	WDT	_	12	SBJ
12	show	show	VBP	_	6	NMOD
13	that	that	IN	_	12	OBJ
14	despite	despite	IN	_	22	ADV
15	forced	forced	JJ	_	16	NMOD
16	secretion	secretion	NN	_	14	PMOD
17	,	,	,	_	22	P
18	Abcg8	abcg0	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	deficient	deficient	JJ	_	21	NMOD
21	animals	animal	NNS	_	22	SBJ
22	can	can	MD	_	13	SUB
23	not	not	RB	_	22	ADV
24	secrete	secrete	VB	_	22	VC
25	cholesterol	cholesterol	NN	_	24	OBJ
26	into	into	IN	_	24	DIR
27	bile	bile	NN	_	26	PMOD
28	,	,	,	_	24	P
29	although	although	IN	_	24	ADV
30	sitosterol	sitosterol	NN	_	31	NMOD
31	secretion	secretion	NN	_	32	SBJ
32	seemed	seem	VBD	_	29	SUB
33	unaffected	unaffected	JJ	_	32	OPRD
34	.	.	.	_	5	P

1	Methods	method	NNS	_	0	ROOT

1	Targeting	targeting	NN	_	2	NMOD
2	vector	vector	NN	_	3	NMOD
3	construction	construction	NN	_	0	ROOT
4	and	and	CC	_	3	COORD
5	generation	generation	NN	_	4	CONJ
6	of	of	IN	_	5	NMOD
7	knockout	knockout	NN	_	8	NMOD
8	mice	mouse	NNS	_	6	PMOD

1	A	a	DT	_	10	NMOD
2	mouse	mouse	NN	_	3	AMOD
3	genomic	genomic	JJ	_	10	NMOD
4	bacterial	bacterial	JJ	_	6	NMOD
5	artificial	artificial	JJ	_	6	NMOD
6	chromosome	chromosome	NN	_	8	NMOD
7	(	(	-LRB-	_	8	P
8	BAC	bac	NN	_	10	NMOD
9	)	)	-RRB-	_	10	P
10	library	library	NN	_	31	SBJ
11	(	(	-LRB-	_	25	P
12	CitbCJ7	citbcj0	NN	_	25	DEP
13	,	,	,	_	25	P
14	ES	e	NN	_	15	NMOD
15	cell	cell	NN	_	18	NMOD
16	line	line	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	129Sv	0sv	NN	_	25	DEP
19	,	,	,	_	25	P
20	Research	research	NNP	_	21	NMOD
21	Genetics	genetics	NNP	_	25	DEP
22	,	,	,	_	21	P
23	Inc.	inc.	NNP	_	21	NMOD
24	,	,	,	_	25	P
25	Huntsville	huntsville	NNP	_	10	PRN
26	,	,	,	_	25	P
27	AL	al	NNP	_	25	APPO
28	,	,	,	_	27	P
29	USA	usa	NNP	_	27	APPO
30	)	)	-RRB-	_	25	P
31	was	be	VBD	_	0	ROOT
32	screened	screen	VBN	_	31	VC
33	by	by	IN	_	32	MNR
34	using	use	VBG	_	33	PMOD
35	primers	primer	NNS	_	34	OBJ
36	designed	design	VBN	_	35	NMOD
37	from	from	IN	_	36	ADV
38	the	the	DT	_	39	NMOD
39	sequences	sequence	NNS	_	37	PMOD
40	of	of	IN	_	39	NMOD
41	mouse	mouse	NN	_	45	NMOD
42	Abcg5	abcg0	NN	_	45	NMOD
43	and	and	CC	_	42	COORD
44	Abcg8	abcg0	NN	_	43	CONJ
45	cDNA	cdna	NN	_	40	PMOD
46	as	as	IN	_	34	ADV
47	previously	previously	RB	_	48	ADV
48	reported	report	VBN	_	46	SUB
49	[	[	-LRB-	_	50	P
50	21	0	CD	_	32	PRN
51	]	]	-RRB-	_	50	P
52	.	.	.	_	31	P

1	A	a	DT	_	4	NMOD
2	positive	positive	JJ	_	4	NMOD
3	BAC	bac	NN	_	4	NMOD
4	clone	clone	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	used	use	VBN	_	5	VC
7	as	as	IN	_	6	MNR
8	a	a	DT	_	9	NMOD
9	template	template	NN	_	7	PMOD
10	to	to	TO	_	6	PRP
11	amplify	amplify	VB	_	10	IM
12	genomic	genomic	JJ	_	14	NMOD
13	DNA	dna	NN	_	14	NMOD
14	fragments	fragment	NNS	_	11	OBJ
15	of	of	IN	_	14	NMOD
16	Abcg8	abcg0	NN	_	15	PMOD
17	.	.	.	_	5	P

1	Long	long	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	fragment	fragment	NN	_	8	NMOD
4	polymerase	polymerase	NN	_	6	NMOD
5	chain	chain	NN	_	6	NMOD
6	reaction	reaction	NN	_	8	NMOD
7	(	(	-LRB-	_	8	P
8	PCR	pcr	NN	_	10	SBJ
9	)	)	-RRB-	_	10	P
10	was	be	VBD	_	0	ROOT
11	performed	perform	VBN	_	10	VC
12	using	use	VBG	_	11	MNR
13	Expanded	expanded	NN	_	17	NMOD
14	Long	long	JJ	_	16	NMOD
15	Template	template	NN	_	16	NMOD
16	PCR	pcr	NN	_	17	NMOD
17	system	system	NN	_	18	NMOD
18	kit	kit	NN	_	12	OBJ
19	(	(	-LRB-	_	22	P
20	Roche	roche	NNP	_	22	NMOD
21	Applied	applied	NNP	_	22	NMOD
22	Science	science	NNP	_	18	PRN
23	,	,	,	_	22	P
24	Indianapolis	indianapolis	NNP	_	22	APPO
25	,	,	,	_	24	P
26	IA	ia	NNP	_	24	APPO
27	,	,	,	_	26	P
28	USA	usa	NNP	_	26	APPO
29	)	)	-RRB-	_	22	P
30	.	.	.	_	10	P

1	An	an	DT	_	11	NMOD
2	approximately	approximately	RB	_	3	QMOD
3	4.5	0	CD	_	4	NMOD
4	kb	kb	NN	_	11	NMOD
5	'	'	``	_	11	P
6	long	long	JJ	_	8	NMOD
7	-	-	HYPH	_	6	P
8	arm	arm	NN	_	11	NMOD
9	'	'	''	_	11	P
10	genomic	genomic	JJ	_	11	NMOD
11	fragment	fragment	NN	_	20	SBJ
12	containing	contain	VBG	_	11	NMOD
13	partial	partial	JJ	_	14	NMOD
14	exon	exon	NN	_	12	OBJ
15	1	0	CD	_	14	NMOD
16	to	to	IN	_	14	NMOD
17	partial	partial	JJ	_	18	NMOD
18	exon	exon	NN	_	16	PMOD
19	3	0	CD	_	18	NMOD
20	was	be	VBD	_	0	ROOT
21	inserted	insert	VBN	_	20	VC
22	into	into	IN	_	21	DIR
23	the	the	DT	_	30	NMOD
24	Pml	pml	NN	_	30	NMOD
25	I	i	CD	_	24	NMOD
26	restriction	restriction	NN	_	28	AMOD
27	-	-	HYPH	_	26	P
28	cloning	clone	VBG	_	30	NMOD
29	site	site	NN	_	30	NMOD
30	A	a	NN	_	22	PMOD
31	of	of	IN	_	30	NMOD
32	OSDUPDEL	osdupdel	NN	_	33	NMOD
33	vector	vector	NN	_	31	PMOD
34	.	.	.	_	20	P

1	The	the	DT	_	8	NMOD
2	'	'	``	_	8	P
3	short	short	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	arm	arm	NN	_	8	NMOD
6	'	'	''	_	8	P
7	genomic	genomic	JJ	_	8	NMOD
8	fragment	fragment	NN	_	19	SBJ
9	,	,	,	_	8	P
10	containing	contain	VBG	_	8	NMOD
11	partial	partial	JJ	_	12	NMOD
12	exon	exon	NN	_	10	OBJ
13	4	0	CD	_	12	NMOD
14	to	to	IN	_	12	NMOD
15	partial	partial	JJ	_	16	NMOD
16	exon	exon	NN	_	14	PMOD
17	6	0	CD	_	16	NMOD
18	,	,	,	_	19	P
19	was	be	VBD	_	0	ROOT
20	cloned	clone	VBN	_	19	VC
21	into	into	IN	_	20	DIR
22	the	the	DT	_	26	NMOD
23	Not	not	NN	_	24	NMOD
24	I	i	NN	_	26	NMOD
25	-	-	HYPH	_	24	P
26	Kpn	kpn	NN	_	21	PMOD
27	I	i	CD	_	26	NMOD
28	of	of	IN	_	26	NMOD
29	cloning	clone	VBG	_	31	NMOD
30	site	site	NN	_	31	NMOD
31	B	b	NN	_	28	PMOD
32	.	.	.	_	19	P

1	Homologous	homologous	JJ	_	2	NMOD
2	targeting	targeting	NN	_	3	SBJ
3	would	would	MD	_	0	ROOT
4	result	result	VB	_	3	VC
5	in	in	IN	_	4	ADV
6	complete	complete	JJ	_	7	NMOD
7	intron	intron	NN	_	5	PMOD
8	3	0	CD	_	7	NMOD
9	,	,	,	_	7	P
10	partial	partial	JJ	_	11	NMOD
11	exon	exon	NN	_	7	CONJ
12	3	0	CD	_	11	NMOD
13	and	and	CC	_	11	COORD
14	partial	partial	JJ	_	15	NMOD
15	exon	exon	NN	_	13	CONJ
16	4	0	CD	_	15	NMOD
17	replacement	replacement	NN	_	15	NMOD
18	by	by	IN	_	17	NMOD
19	the	the	DT	_	23	NMOD
20	neomycin	neomycin	NN	_	23	NMOD
21	-	-	HYPH	_	20	P
22	resistance	resistance	JJ	_	20	NMOD
23	cassette	cassette	NN	_	18	PMOD
24	,	,	,	_	4	P
25	resulting	result	VBG	_	4	ADV
26	in	in	IN	_	25	ADV
27	the	the	DT	_	28	NMOD
28	disruption	disruption	NN	_	26	PMOD
29	of	of	IN	_	28	NMOD
30	the	the	DT	_	34	NMOD
31	ABC	abc	NN	_	33	NMOD
32	Walker	walker	NN	_	33	NMOD
33	A	a	NN	_	34	NMOD
34	motif	motif	NN	_	29	PMOD
35	(	(	-LRB-	_	37	P
36	Figure	figure	NN	_	37	NMOD
37	1a	0a	NN	_	4	PRN
38	)	)	-RRB-	_	37	P
39	.	.	.	_	3	P

1	ES	e	NN	_	2	NMOD
2	cells	cell	NNS	_	11	SBJ
3	(	(	-LRB-	_	9	P
4	129	0	CD	_	6	NMOD
5	/	/	HYPH	_	4	P
6	SvEvTac	svevtac	NN	_	9	NMOD
7	-	-	HYPH	_	6	P
8	cell	cell	NN	_	9	NMOD
9	line	line	NN	_	2	PRN
10	)	)	-RRB-	_	9	P
11	were	be	VBD	_	0	ROOT
12	electroporated	electroporated	VBN	_	11	VC
13	with	with	IN	_	12	MNR
14	the	the	DT	_	18	NMOD
15	linearized	linearize	VBN	_	17	NMOD
16	targeting	targeting	NN	_	17	NMOD
17	vector	vector	NN	_	18	NMOD
18	DNA	dna	NN	_	13	PMOD
19	and	and	CC	_	11	COORD
20	cultured	culture	VBN	_	19	CONJ
21	on	on	IN	_	20	LOC
22	sub-confluent	sub-confluent	JJ	_	24	NMOD
23	embryonic	embryonic	JJ	_	24	NMOD
24	fibroblasts	fibroblast	NNS	_	21	PMOD
25	.	.	.	_	11	P

1	Transfected	transfected	VBN	_	3	NMOD
2	cell	cell	NN	_	3	NMOD
3	colonies	colony	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	selected	select	VBN	_	4	VC
6	by	by	IN	_	5	LGS
7	culturing	culture	VBG	_	6	PMOD
8	cells	cell	NNS	_	7	OBJ
9	in	in	IN	_	7	LOC
10	medium	medium	NN	_	9	PMOD
11	containing	contain	VBG	_	10	NMOD
12	200	0	CD	_	13	NMOD
13	μg	μg	NN	_	16	NMOD
14	/	/	SYM	_	15	P
15	mL	ml	NN	_	13	NMOD
16	G418	g0	NN	_	11	OBJ
17	(	(	-LRB-	_	19	P
18	Life	life	NNP	_	19	NMOD
19	Technologies	technology	NNP	_	16	PRN
20	,	,	,	_	19	P
21	Rockville	rockville	NNP	_	19	APPO
22	,	,	,	_	21	P
23	MD	md	NNP	_	21	APPO
24	,	,	,	_	23	P
25	USA	usa	NNP	_	23	APPO
26	)	)	-RRB-	_	19	P
27	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	ES	e	NN	_	3	NMOD
3	cells	cell	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	screened	screen	VBN	_	4	VC
6	for	for	IN	_	5	PRP
7	homologous	homologous	JJ	_	8	NMOD
8	recombination	recombination	NN	_	6	PMOD
9	by	by	IN	_	5	MNR
10	PCR	pcr	NN	_	9	PMOD
11	with	with	IN	_	5	MNR
12	the	the	DT	_	14	NMOD
13	forward	forward	JJ	_	14	NMOD
14	primer	primer	NN	_	11	PMOD
15	,	,	,	_	14	P
16	neoF	neof	NN	_	21	NMOD
17	(	(	-LRB-	_	21	P
18	5	0	CD	_	21	NMOD
19	'	'	SYM	_	21	P
20	-	-	HYPH	_	18	P
21	GGGTCGTTTGTTCGGATCAA	gggtcgtttgttcggatcaa	NN	_	14	APPO
22	-	-	HYPH	_	21	P
23	3	0	CD	_	21	NMOD
24	'	'	SYM	_	21	P
25	)	)	-RRB-	_	21	P
26	from	from	IN	_	21	NMOD
27	neo	neo	NN	_	28	NMOD
28	cassette	cassette	NN	_	26	PMOD
29	,	,	,	_	14	P
30	and	and	CC	_	14	COORD
31	reverse	reverse	JJ	_	32	NMOD
32	primer	primer	NN	_	34	NMOD
33	intron	intron	NN	_	34	NMOD
34	6R	0r	NN	_	39	NMOD
35	(	(	-LRB-	_	39	P
36	5	0	CD	_	39	NMOD
37	'	'	SYM	_	36	P
38	-	-	HYPH	_	36	P
39	ACCAGTTGGTCCTAGCTCGA	accagttggtcctagctcga	NN	_	30	CONJ
40	-	-	HYPH	_	39	P
41	3	0	CD	_	39	NMOD
42	'	'	SYM	_	39	P
43	)	)	-RRB-	_	39	P
44	,	,	,	_	39	P
45	which	which	WDT	_	46	SBJ
46	is	be	VBZ	_	39	NMOD
47	located	locate	VBN	_	46	VC
48	outside	outside	IN	_	47	LOC
49	the	the	DT	_	51	NMOD
50	targeting	target	VBG	_	51	NMOD
51	construct	construct	NN	_	48	PMOD
52	in	in	IN	_	47	LOC
53	mouse	mouse	NN	_	55	NMOD
54	Abcg8	abcg0	NN	_	55	NMOD
55	intron	intron	NN	_	52	PMOD
56	6	0	CD	_	55	NMOD
57	.	.	.	_	4	P

1	Positively	positively	RB	_	2	AMOD
2	targeted	target	VBN	_	5	NMOD
3	ES	e	NN	_	4	NMOD
4	cell	cell	NN	_	5	NMOD
5	clones	clone	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	confirmed	confirm	VBN	_	6	VC
8	by	by	IN	_	7	MNR
9	Southern	southern	NNP	_	10	NMOD
10	blotting	blotting	NN	_	8	PMOD
11	,	,	,	_	7	P
12	using	use	VBG	_	7	MNR
13	ES	e	NN	_	14	NMOD
14	cell	cell	NN	_	15	NMOD
15	DNA	dna	NN	_	12	OBJ
16	digested	digest	VBN	_	15	NMOD
17	by	by	IN	_	16	MNR
18	BamHI	bamhi	NN	_	17	PMOD
19	and	and	CC	_	18	COORD
20	a	a	DT	_	21	NMOD
21	probe	probe	NN	_	19	CONJ
22	comprising	comprise	VBZ	_	21	NMOD
23	of	of	IN	_	22	ADV
24	a	a	DT	_	28	NMOD
25	562	0	CD	_	26	NMOD
26	bp	bp	NN	_	28	NMOD
27	PCR	pcr	NN	_	28	NMOD
28	fragment	fragment	NN	_	23	PMOD
29	from	from	IN	_	28	NMOD
30	partial	partial	JJ	_	31	NMOD
31	intron	intron	NN	_	29	PMOD
32	2	0	CD	_	31	NMOD
33	and	and	CC	_	31	COORD
34	exon	exon	NN	_	33	CONJ
35	3	0	CD	_	34	NMOD
36	of	of	IN	_	31	NMOD
37	Abcg8	abcg0	NN	_	38	NMOD
38	gene	gene	NN	_	36	PMOD
39	.	.	.	_	6	P

1	Positively	positively	RB	_	2	AMOD
2	targeted	target	VBN	_	4	NMOD
3	ES	e	NN	_	4	NMOD
4	cells	cell	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	microinjected	microinjected	VBN	_	5	VC
7	into	into	IN	_	6	DIR
8	C57BL6	c0bl0	NN	_	9	NMOD
9	blastocysts	blastocyst	NNS	_	7	PMOD
10	and	and	CC	_	6	COORD
11	transplanted	transplant	VBN	_	10	CONJ
12	into	into	IN	_	11	DIR
13	pseudopregnant	pseudopregnant	JJ	_	14	NMOD
14	recipients	recipient	NNS	_	12	PMOD
15	.	.	.	_	5	P

1	Five	five	CD	_	4	NMOD
2	highly	highly	RB	_	3	AMOD
3	chimeric	chimeric	JJ	_	4	NMOD
4	mice	mouse	NNS	_	16	SBJ
5	(	(	-LRB-	_	11	P
6	agouti	agouti	JJ	_	8	NMOD
7	coat	coat	NN	_	8	NMOD
8	color	color	NN	_	11	DEP
9	,	,	,	_	11	P
10	three	three	CD	_	11	NMOD
11	males	male	NNS	_	4	PRN
12	and	and	CC	_	11	COORD
13	two	two	CD	_	14	NMOD
14	females	female	NNS	_	12	CONJ
15	)	)	-RRB-	_	11	P
16	were	be	VBD	_	0	ROOT
17	isolated	isolate	VBN	_	16	VC
18	and	and	CC	_	17	COORD
19	bred	breed	VBN	_	18	CONJ
20	with	with	IN	_	19	ADV
21	C57BL	c0bl	NN	_	23	NMOD
22	/	/	HYPH	_	21	P
23	6J	0j	NN	_	24	NMOD
24	mice	mouse	NNS	_	20	PMOD
25	to	to	TO	_	19	PRP
26	generate	generate	VB	_	25	IM
27	germ	germ	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	line	line	NN	_	30	NMOD
30	transmission	transmission	NN	_	31	AMOD
31	heterozygous	heterozygous	JJ	_	32	NMOD
32	mice	mouse	NNS	_	26	OBJ
33	of	of	IN	_	32	NMOD
34	Abcg8	abcg0	NN	_	35	NMOD
35	gene	gene	NN	_	36	NMOD
36	disruption	disruption	NN	_	33	PMOD
37	.	.	.	_	16	P

1	Heterozygous	heterozygous	JJ	_	3	NMOD
2	offspring	offspring	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	back	back	RB	_	7	ADV
6	-	-	HYPH	_	5	P
7	crossed	cross	VBN	_	4	VC
8	to	to	IN	_	7	ADV
9	C57BL	c0bl	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	6J	0j	NN	_	12	NMOD
12	mice	mouse	NNS	_	8	PMOD
13	(	(	-LRB-	_	16	P
14	n	n	NN	_	16	SBJ
15	>	>	SYM	_	16	P
16	5	0	CD	_	12	PRN
17	)	)	-RRB-	_	16	P
18	to	to	TO	_	7	PRP
19	produce	produce	VB	_	18	IM
20	disrupted	disrupt	VBN	_	21	NMOD
21	line	line	NN	_	19	OBJ
22	and	and	CC	_	7	COORD
23	inter-crossed	inter-crossed	VBN	_	22	CONJ
24	to	to	TO	_	23	PRP
25	generate	generate	VB	_	24	IM
26	knockout	knockout	NN	_	27	NMOD
27	mice	mouse	NNS	_	25	OBJ
28	.	.	.	_	4	P

1	Animals	animal	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	diets	diet	NNS	_	2	CONJ

1	All	all	DT	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	maintained	maintain	VBN	_	3	VC
5	on	on	IN	_	4	ADV
6	a	a	DT	_	9	NMOD
7	standard	standard	JJ	_	9	NMOD
8	rodent	rodent	NN	_	9	NMOD
9	chow	chow	NN	_	17	NMOD
10	(	(	-LRB-	_	17	P
11	Harlan	harlan	NNP	_	12	NMOD
12	Teklad	teklad	NNP	_	17	NMOD
13	mouse	mouse	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	rat	rat	NN	_	17	NMOD
16	diet	diet	NN	_	17	NMOD
17	LM	lm	NN	_	5	PMOD
18	-	-	HYPH	_	17	P
19	485	0	CD	_	17	NMOD
20	)	)	-RRB-	_	17	P
21	which	which	WDT	_	22	SBJ
22	contained	contain	VBD	_	17	NMOD
23	61	0	CD	_	24	NMOD
24	mg	mg	NN	_	27	NMOD
25	/	/	SYM	_	26	P
26	kg	kg	NN	_	24	NMOD
27	cholesterol	cholesterol	NN	_	22	OBJ
28	,	,	,	_	27	P
29	31	0	CD	_	30	NMOD
30	mg	mg	NN	_	33	NMOD
31	/	/	SYM	_	32	P
32	kg	kg	NN	_	30	NMOD
33	campesterol	campesterol	NN	_	27	CONJ
34	,	,	,	_	33	P
35	and	and	CC	_	33	COORD
36	105	0	CD	_	37	NMOD
37	mg	mg	NN	_	40	NMOD
38	/	/	SYM	_	39	P
39	kg	kg	NN	_	37	NMOD
40	sitosterol	sitosterol	NN	_	35	CONJ
41	,	,	,	_	4	P
42	given	give	VBN	_	4	CONJ
43	free	free	JJ	_	44	NMOD
44	access	access	NN	_	42	OBJ
45	to	to	IN	_	44	NMOD
46	water	water	NN	_	45	PMOD
47	and	and	CC	_	42	COORD
48	maintained	maintain	VBN	_	47	CONJ
49	at	at	IN	_	48	ADV
50	25	0	CD	_	51	NMOD
51	°C	°c	NN	_	49	PMOD
52	with	with	IN	_	48	ADV
53	a	a	DT	_	63	NMOD
54	12	0	CD	_	56	NMOD
55	-	-	HYPH	_	54	P
56	h	h	NN	_	61	NMOD
57	light	light	JJ	_	56	NMOD
58	,	,	,	_	61	P
59	12	0	CD	_	61	NMOD
60	-	-	HYPH	_	59	P
61	h	h	NN	_	63	NMOD
62	dark	dark	JJ	_	61	NMOD
63	cycle	cycle	NN	_	52	PMOD
64	.	.	.	_	3	P

1	All	all	DT	_	2	NMOD
2	animals	animal	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	housed	house	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	the	the	DT	_	7	NMOD
7	facilities	facility	NNS	_	5	PMOD
8	for	for	IN	_	7	NMOD
9	laboratory	laboratory	NN	_	10	NMOD
10	animals	animal	NNS	_	8	PMOD
11	provided	provide	VBN	_	7	NMOD
12	by	by	IN	_	11	LGS
13	the	the	DT	_	14	NMOD
14	Division	division	NNP	_	19	NMOD
15	of	of	IN	_	14	NMOD
16	Laboratory	laboratory	NNP	_	17	NMOD
17	Animal	animal	NNP	_	18	NMOD
18	Resources	resource	NNP	_	15	PMOD
19	ACLAM	aclam	NNP	_	12	PMOD
20	.	.	.	_	3	P

1	The	the	DT	_	8	NMOD
2	Institutional	institutional	NNP	_	3	NMOD
3	Animal	animal	NNP	_	4	NMOD
4	Care	care	NNP	_	8	NMOD
5	and	and	CC	_	4	COORD
6	Research	research	NNP	_	5	CONJ
7	Advisory	advisory	NNP	_	8	NMOD
8	Committee	committee	NNP	_	15	SBJ
9	at	at	IN	_	8	LOC
10	Medical	medical	NNP	_	11	NMOD
11	University	university	NNP	_	9	PMOD
12	of	of	IN	_	11	NMOD
13	South	south	NNP	_	14	NMOD
14	Carolina	carolina	NNP	_	12	PMOD
15	approved	approve	VBD	_	0	ROOT
16	all	all	DT	_	17	NMOD
17	experiments	experiment	NNS	_	15	OBJ
18	.	.	.	_	15	P

1	Genotyping	genotyping	NN	_	0	ROOT
2	by	by	IN	_	1	NMOD
3	PCR	pcr	NN	_	2	PMOD

1	Mouse	mouse	NN	_	2	NMOD
2	tail	tail	NN	_	3	NMOD
3	DNA	dna	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	isolated	isolate	VBN	_	4	VC
6	and	and	CC	_	5	COORD
7	purified	purify	VBN	_	6	CONJ
8	by	by	IN	_	5	MNR
9	cutting	cut	VBG	_	8	PMOD
10	approximately	approximately	RB	_	11	QMOD
11	0.5	0	CD	_	12	NMOD
12	cm	cm	NN	_	9	OBJ
13	of	of	IN	_	12	NMOD
14	mouse	mouse	NN	_	15	NMOD
15	tail	tail	NN	_	13	PMOD
16	and	and	CC	_	9	COORD
17	digesting	digest	VBG	_	16	CONJ
18	it	it	PRP	_	17	OBJ
19	in	in	IN	_	17	LOC
20	500	0	CD	_	21	NMOD
21	μl	μl	NN	_	23	NMOD
22	lysis	lysis	NN	_	23	NMOD
23	buffer	buffer	NN	_	19	PMOD
24	(	(	-LRB-	_	29	P
25	50	0	CD	_	26	NMOD
26	mM	mm	NN	_	29	NMOD
27	Tris	tris	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	HCl	hcl	NN	_	23	PRN
30	,	,	,	_	29	P
31	pH	ph	NN	_	29	APPO
32	8.0	0	CD	_	31	NMOD
33	,	,	,	_	29	P
34	100	0	CD	_	35	NMOD
35	mM	mm	NN	_	36	NMOD
36	EDTA	edta	NN	_	29	APPO
37	,	,	,	_	36	P
38	125	0	CD	_	39	NMOD
39	mM	mm	NN	_	40	NMOD
40	NaCl	nacl	NN	_	36	APPO
41	,	,	,	_	40	P
42	1	0	CD	_	43	NMOD
43	%	%	NN	_	44	NMOD
44	SDS	sd	NN	_	40	APPO
45	,	,	,	_	44	P
46	200	0	CD	_	47	NMOD
47	μg	μg	NN	_	49	NMOD
48	Proteinase	proteinase	NN	_	49	NMOD
49	K	k	NN	_	44	APPO
50	)	)	-RRB-	_	29	P
51	with	with	IN	_	17	ADV
52	rocking	rock	VBG	_	51	PMOD
53	overnight	overnight	RB	_	52	TMP
54	at	at	IN	_	52	NMOD
55	55	0	CD	_	56	NMOD
56	°C	°c	NN	_	54	PMOD
57	.	.	.	_	4	P

1	200	0	CD	_	2	NMOD
2	μl	μl	NN	_	4	NMOD
3	saturated	saturate	VBN	_	4	NMOD
4	NaCl	nacl	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	added	add	VBN	_	5	VC
7	into	into	IN	_	6	DIR
8	digested	digested	JJ	_	9	NMOD
9	solution	solution	NN	_	7	PMOD
10	with	with	IN	_	6	ADV
11	vigorous	vigorous	JJ	_	12	NMOD
12	shaking	shake	VBG	_	10	PMOD
13	for	for	IN	_	12	TMP
14	at	at	RB	_	15	QMOD
15	least	least	RBS	_	16	QMOD
16	60	0	CD	_	17	NMOD
17	seconds	second	NNS	_	13	PMOD
18	.	.	.	_	5	P

1	Mixed	mix	VBN	_	2	NMOD
2	solution	solution	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	spun	spin	VBN	_	3	VC
5	down	down	RP	_	4	PRT
6	at	at	IN	_	4	ADV
7	maximum	maximum	JJ	_	8	NMOD
8	speed	speed	NN	_	6	PMOD
9	in	in	IN	_	4	LOC
10	top	top	JJ	_	13	NMOD
11	micro	micro	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	centrifuge	centrifuge	NN	_	9	PMOD
14	for	for	IN	_	4	TMP
15	20	0	CD	_	16	NMOD
16	min	min	NN	_	14	PMOD
17	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	supernatant	supernatant	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	transferred	transfer	VBN	_	3	VC
5	to	to	IN	_	4	DIR
6	a	a	DT	_	8	NMOD
7	new	new	JJ	_	8	NMOD
8	tube	tube	NN	_	5	PMOD
9	with	with	IN	_	4	ADV
10	equal	equal	JJ	_	14	NMOD
11	volume	volume	NN	_	14	NMOD
12	100	0	CD	_	13	NMOD
13	%	%	NN	_	14	NMOD
14	EtOH	etoh	NN	_	9	PMOD
15	and	and	CC	_	4	COORD
16	mixed	mix	VBN	_	15	CONJ
17	by	by	IN	_	16	MNR
18	inversion	inversion	NN	_	17	PMOD
19	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	DNA	dna	NN	_	3	NMOD
3	pellet	pellet	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	washed	wash	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	70	0	CD	_	8	NMOD
8	%	%	NN	_	9	NMOD
9	EtOH	etoh	NN	_	6	PMOD
10	and	and	CC	_	5	COORD
11	resuspended	resuspend	VBD	_	10	CONJ
12	in	in	IN	_	11	LOC
13	100	0	CD	_	16	NMOD
14	–	–	SYM	_	13	P
15	150	0	CD	_	13	QMOD
16	μl	μl	NN	_	18	NMOD
17	TE	te	NN	_	18	NMOD
18	buffer	buffer	NN	_	12	PMOD
19	.	.	.	_	4	P

1	UV	uv	NN	_	2	NMOD
2	spectrophotometry	spectrophotometry	NN	_	5	SBJ
3	and	and	CC	_	2	COORD
4	electrophoresis	electrophoresis	NN	_	3	CONJ
5	were	be	VBD	_	0	ROOT
6	used	use	VBN	_	5	VC
7	to	to	TO	_	6	PRP
8	analyze	analyze	VB	_	7	IM
9	the	the	DT	_	10	NMOD
10	quality	quality	NN	_	8	OBJ
11	and	and	CC	_	10	COORD
12	quantity	quantity	NN	_	11	CONJ
13	of	of	IN	_	10	NMOD
14	the	the	DT	_	16	NMOD
15	genomic	genomic	JJ	_	16	NMOD
16	DNA	dna	NN	_	13	PMOD
17	.	.	.	_	5	P

1	Genotyping	genotyping	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	performed	perform	VBN	_	2	VC
4	by	by	IN	_	3	LGS
5	multiplex	multiplex	JJ	_	7	NMOD
6	PCR	pcr	NN	_	7	NMOD
7	reaction	reaction	NN	_	4	PMOD
8	using	use	VBG	_	3	MNR
9	three	three	CD	_	11	NMOD
10	separate	separate	JJ	_	11	NMOD
11	primers	primer	NNS	_	17	NMOD
12	(	(	-LRB-	_	17	P
13	two	two	CD	_	17	NMOD
14	Abcg8	abcg0	NN	_	17	NMOD
15	gene	gene	NN	_	16	AMOD
16	specific	specific	JJ	_	17	NMOD
17	primers	primer	NNS	_	8	OBJ
18	,	,	,	_	17	P
19	mg8	mg0	NN	_	21	NMOD
20	-	-	HYPH	_	19	P
21	in3F	in0f	NN	_	25	NMOD
22	5	0	CD	_	25	NMOD
23	'	'	SYM	_	22	P
24	-	-	HYPH	_	22	P
25	CCCAATGATGAATGAGACGCT	cccaatgatgaatgagacgct	NN	_	17	CONJ
26	-	-	HYPH	_	25	P
27	3	0	CD	_	25	NMOD
28	'	'	SYM	_	25	P
29	,	,	,	_	25	P
30	mg8	mg0	NN	_	32	NMOD
31	-	-	HYPH	_	30	P
32	R9	r0	NN	_	36	NMOD
33	5	0	CD	_	36	NMOD
34	'	'	SYM	_	33	P
35	-	-	HYPH	_	33	P
36	TTTGTCACGCTGGGCCTGG	tttgtcacgctgggcctgg	NN	_	25	APPO
37	-	-	HYPH	_	36	P
38	3	0	CD	_	36	NMOD
39	'	'	SYM	_	36	P
40	and	and	CC	_	25	COORD
41	neoF	neof	NN	_	40	CONJ
42	for	for	IN	_	41	NMOD
43	identification	identification	NN	_	42	PMOD
44	of	of	IN	_	43	NMOD
45	Abcg8	abcg0	NN	_	47	NMOD
46	target	target	NN	_	47	NMOD
47	status	status	NN	_	44	PMOD
48	)	)	-RRB-	_	2	P
49	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	PCR	pcr	NN	_	3	NMOD
3	reaction	reaction	NN	_	4	SBJ
4	consisted	consist	VBD	_	0	ROOT
5	of	of	IN	_	4	ADV
6	1x	0x	NN	_	8	NMOD
7	PCR	pcr	NN	_	8	NMOD
8	buffer	buffer	NN	_	36	NMOD
9	(	(	-LRB-	_	12	P
10	1.5	0	CD	_	11	NMOD
11	mM	mm	NN	_	12	NMOD
12	MgCl2	mgcl0	NN	_	8	PRN
13	,	,	,	_	12	P
14	16	0	CD	_	15	NMOD
15	mM	mm	NN	_	19	NMOD
16	(	(	-LRB-	_	17	P
17	NH4	nh0	NN	_	19	PRN
18	)	)	-RRB-	_	17	P
19	2SO4	0so0	NN	_	12	APPO
20	,	,	,	_	19	P
21	0.1	0	CD	_	22	NMOD
22	mM	mm	NN	_	23	NMOD
23	dNTPs	dntps	NNS	_	19	APPO
24	,	,	,	_	23	P
25	67	0	CD	_	26	NMOD
26	mM	mm	NN	_	29	NMOD
27	Tris	tris	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	HCl	hcl	NN	_	23	APPO
30	(	(	-LRB-	_	31	P
31	pH	ph	NN	_	29	PRN
32	8.8	0	CD	_	31	NMOD
33	)	)	-RRB-	_	31	P
34	)	)	-RRB-	_	12	P
35	1	0	CD	_	36	NMOD
36	μM	μm	NN	_	5	PMOD
37	of	of	IN	_	36	NMOD
38	each	each	DT	_	39	NMOD
39	primer	primer	NN	_	37	PMOD
40	,	,	,	_	36	P
41	water	water	NN	_	36	CONJ
42	and	and	CC	_	41	COORD
43	1.0	0	CD	_	44	NMOD
44	units	unit	NNS	_	42	CONJ
45	of	of	IN	_	44	NMOD
46	Taq	taq	NN	_	47	NMOD
47	polymerase	polymerase	NN	_	45	PMOD

1	The	the	DT	_	2	NMOD
2	reactions	reaction	NNS	_	3	SBJ
3	were	be	VBD	_	9	DEP
4	cycled	cycle	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	follows	follow	VBZ	_	5	SUB
7	:	:	:	_	9	P
8	94	0	CD	_	9	NMOD
9	°C	°c	NN	_	0	ROOT
10	for	for	IN	_	9	TMP
11	30	0	CD	_	12	NMOD
12	sec	sec	NN	_	10	PMOD
13	,	,	,	_	9	P
14	60	0	CD	_	15	NMOD
15	°C	°c	NN	_	9	APPO
16	for	for	IN	_	15	TMP
17	30	0	CD	_	18	NMOD
18	sec	sec	NN	_	16	PMOD
19	,	,	,	_	15	P
20	72	0	CD	_	21	NMOD
21	°C	°c	NN	_	15	APPO
22	for	for	IN	_	21	TMP
23	1	0	CD	_	24	NMOD
24	min	min	NN	_	22	PMOD
25	for	for	IN	_	9	TMP
26	35	0	CD	_	27	NMOD
27	cycles	cycle	NNS	_	25	PMOD
28	.	.	.	_	9	P

1	The	the	DT	_	3	NMOD
2	PCR	pcr	NN	_	3	NMOD
3	products	product	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	identified	identify	VBN	_	4	VC
6	by	by	IN	_	5	MNR
7	electrophoresis	electrophoresis	NN	_	6	PMOD
8	.	.	.	_	4	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	0	ROOT

1	To	to	TO	_	7	PRP
2	confirm	confirm	VB	_	1	IM
3	PCR	pcr	NN	_	4	NMOD
4	results	result	NNS	_	2	OBJ
5	,	,	,	_	7	P
6	DNAs	dna	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	digested	digest	VBN	_	7	VC
9	with	with	IN	_	8	MNR
10	Bam	bam	NN	_	11	NMOD
11	HI	hi	NN	_	9	PMOD
12	,	,	,	_	8	P
13	subjected	subject	VBN	_	8	CONJ
14	to	to	IN	_	13	ADV
15	electrophoresis	electrophoresis	NN	_	14	PMOD
16	in	in	IN	_	13	LOC
17	a	a	DT	_	21	NMOD
18	0.6	0	CD	_	19	NMOD
19	%	%	NN	_	21	NMOD
20	agarose	agarose	NN	_	21	NMOD
21	gel	gel	NN	_	16	PMOD
22	and	and	CC	_	13	COORD
23	transferred	transfer	VBN	_	22	CONJ
24	to	to	IN	_	23	DIR
25	nylon	nylon	NN	_	26	NMOD
26	membrane	membrane	NN	_	24	PMOD
27	.	.	.	_	7	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	filters	filter	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	hybridized	hybridize	VBN	_	4	VC
6	with	with	IN	_	5	ADV
7	a	a	DT	_	11	NMOD
8	562	0	CD	_	9	NMOD
9	bp	bp	NN	_	11	NMOD
10	PCR	pcr	NN	_	11	NMOD
11	fragment	fragment	NN	_	6	PMOD
12	from	from	IN	_	11	NMOD
13	partial	partial	JJ	_	14	NMOD
14	intron	intron	NN	_	12	PMOD
15	2	0	CD	_	14	NMOD
16	and	and	CC	_	14	COORD
17	exon	exon	NN	_	16	CONJ
18	3	0	CD	_	17	NMOD
19	of	of	IN	_	14	NMOD
20	Abcg8	abcg0	NN	_	26	NMOD
21	32P	0p	NN	_	25	AMOD
22	-	-	HYPH	_	21	P
23	randomly	randomly	RB	_	25	AMOD
24	-	-	HYPH	_	23	P
25	labeled	label	VBN	_	26	NMOD
26	probe	probe	NN	_	19	PMOD
27	as	as	IN	_	5	ADV
28	previously	previously	RB	_	29	TMP
29	described	describe	VBN	_	27	SUB
30	[	[	-LRB-	_	31	P
31	22	0	CD	_	5	PRN
32	]	]	-RRB-	_	31	P
33	.	.	.	_	4	P

1	Northern	northern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	0	ROOT

1	Isolation	isolation	NN	_	28	SBJ
2	of	of	IN	_	1	NMOD
3	liver	liver	NN	_	7	NMOD
4	and	and	CC	_	3	COORD
5	intestinal	intestinal	JJ	_	4	CONJ
6	total	total	JJ	_	7	NMOD
7	RNA	rna	NN	_	2	PMOD
8	from	from	IN	_	7	NMOD
9	Abcg8	abcg0	NN	_	23	NMOD
10	+	+	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	+	+	SYM	_	9	P
13	,	,	,	_	9	P
14	Abcg8	abcg0	NN	_	9	CONJ
15	+	+	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	-	-	SYM	_	14	P
18	and	and	CC	_	14	COORD
19	Abcg8	abcg0	NN	_	18	CONJ
20	-	-	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	mice	mouse	NNS	_	8	PMOD
24	and	and	CC	_	1	COORD
25	Northern	northern	NNP	_	26	NMOD
26	blot	blot	NN	_	27	NMOD
27	analyses	analysis	NNS	_	24	CONJ
28	were	be	VBD	_	0	ROOT
29	performed	perform	VBN	_	28	VC
30	as	as	IN	_	29	ADV
31	previously	previously	RB	_	32	TMP
32	described	describe	VBN	_	30	SUB
33	[	[	-LRB-	_	34	P
34	23	0	CD	_	29	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	28	P

1	The	the	DT	_	2	NMOD
2	probe	probe	NN	_	5	SBJ
3	for	for	IN	_	2	NMOD
4	Abcg5	abcg0	NN	_	3	PMOD
5	was	be	VBD	_	0	ROOT
6	1964	0	CD	_	7	NMOD
7	bp	bp	NN	_	5	PRD
8	(	(	-LRB-	_	17	P
9	nt	nt	NN	_	10	NMOD
10	136	0	CD	_	17	DEP
11	–	–	SYM	_	12	P
12	2099	0	CD	_	10	NMOD
13	,	,	,	_	17	P
14	GeneBank™	genebank™	NNP	_	17	NMOD
15	accession	accession	NN	_	17	NMOD
16	no.	no.	NN	_	17	NMOD
17	AH011511	ah0	NN	_	5	PRN
18	)	)	-RRB-	_	17	P
19	and	and	CC	_	5	COORD
20	the	the	DT	_	21	NMOD
21	probe	probe	NN	_	24	SBJ
22	for	for	IN	_	21	NMOD
23	Abcg8	abcg0	NN	_	22	PMOD
24	was	be	VBD	_	19	CONJ
25	2019	0	CD	_	26	NMOD
26	bp	bp	NN	_	24	PRD
27	(	(	-LRB-	_	36	P
28	nt	nt	NN	_	29	NMOD
29	103	0	CD	_	36	DEP
30	–	–	SYM	_	31	P
31	2126	0	CD	_	29	NMOD
32	,	,	,	_	36	P
33	GeneBank™	genebank™	NNP	_	36	NMOD
34	accession	accession	NN	_	36	NMOD
35	no.	no.	NN	_	36	NMOD
36	AH011518	ah0	NN	_	24	PRN
37	)	)	-RRB-	_	36	P
38	.	.	.	_	5	P

1	Reverse	reverse	JJ	_	2	NMOD
2	Transcription	transcription	NN	_	4	NMOD
3	(	(	-LRB-	_	4	P
4	RT	rt	NN	_	7	NMOD
5	)	)	-RRB-	_	7	P
6	-	-	HYPH	_	4	P
7	PCR	pcr	NN	_	0	ROOT

1	To	to	TO	_	17	PRP
2	confirm	confirm	VB	_	1	IM
3	that	that	IN	_	2	OBJ
4	there	there	EX	_	5	SBJ
5	was	be	VBD	_	3	SUB
6	no	no	DT	_	8	NMOD
7	alternative	alternative	JJ	_	8	NMOD
8	splicing	splicing	NN	_	5	PRD
9	of	of	IN	_	8	NMOD
10	the	the	DT	_	12	NMOD
11	disrupted	disrupt	VBN	_	12	NMOD
12	allele	allele	NN	_	9	PMOD
13	,	,	,	_	17	P
14	RT	rt	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	PCR	pcr	NN	_	17	SBJ
17	was	be	VBD	_	0	ROOT
18	performed	perform	VBN	_	17	VC
19	on	on	IN	_	18	ADV
20	cDNAs	cdna	NNS	_	19	PMOD
21	of	of	IN	_	20	NMOD
22	pooled	pool	VBN	_	24	NMOD
23	mouse	mouse	NN	_	24	NMOD
24	liver	liver	NN	_	21	PMOD
25	.	.	.	_	17	P

1	Briefly	briefly	RB	_	20	ADV
2	,	,	,	_	20	P
3	samples	sample	NNS	_	20	SBJ
4	of	of	IN	_	3	NMOD
5	total	total	JJ	_	6	NMOD
6	RNA	rna	NN	_	4	PMOD
7	(	(	-LRB-	_	9	P
8	0.5	0	CD	_	9	NMOD
9	μg	μg	NN	_	6	PRN
10	)	)	-RRB-	_	9	P
11	from	from	IN	_	6	NMOD
12	pooled	pool	VBN	_	14	NMOD
13	mouse	mouse	NN	_	14	NMOD
14	livers	liver	NNS	_	11	PMOD
15	(	(	-LRB-	_	18	P
16	n	n	NN	_	18	SBJ
17	=	=	SYM	_	18	P
18	4	0	CD	_	3	PRN
19	)	)	-RRB-	_	18	P
20	were	be	VBD	_	0	ROOT
21	reverse	reverse	RB	_	22	ADV
22	transcribed	transcribe	VBN	_	20	VC
23	according	accord	VBG	_	22	ADV
24	to	to	IN	_	23	PMOD
25	the	the	DT	_	31	NMOD
26	SuperScript™	superscript™	NNP	_	31	NMOD
27	First	$#ORD#$	JJ	_	29	NMOD
28	-	-	HYPH	_	27	P
29	Strand	strand	NN	_	30	NMOD
30	Synthesis	synthesis	NN	_	31	NMOD
31	System	system	NN	_	24	PMOD
32	(	(	-LRB-	_	33	P
33	Invitrogen	invitrogen	NNP	_	31	PRN
34	,	,	,	_	33	P
35	Carlsbad	carlsbad	NNP	_	33	APPO
36	,	,	,	_	35	P
37	CA	ca	NNP	_	35	APPO
38	,	,	,	_	37	P
39	USA	usa	NNP	_	37	APPO
40	)	)	-RRB-	_	33	P
41	using	use	VBG	_	22	MNR
42	random	random	JJ	_	43	NMOD
43	hexamers	hexamers	NNS	_	41	OBJ
44	in	in	IN	_	41	LOC
45	a	a	DT	_	49	NMOD
46	final	final	JJ	_	49	NMOD
47	total	total	JJ	_	48	NMOD
48	reaction	reaction	NN	_	49	NMOD
49	volume	volume	NN	_	44	PMOD
50	of	of	IN	_	49	NMOD
51	20	0	CD	_	52	NMOD
52	μl	μl	NN	_	50	PMOD
53	.	.	.	_	20	P

1	RT	rt	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	PCR	pcr	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	performed	perform	VBN	_	4	VC
6	using	use	VBG	_	5	MNR
7	primers	primer	NNS	_	17	NMOD
8	located	locate	VBN	_	7	NMOD
9	outside	outside	IN	_	8	LOC
10	of	of	IN	_	9	PMOD
11	the	the	DT	_	13	NMOD
12	targeted	target	VBN	_	13	NMOD
13	region	region	NN	_	10	PMOD
14	:	:	:	_	17	P
15	F1	f0	NN	_	17	NMOD
16	(	(	-LRB-	_	17	P
17	CCTCAGCTGGTGAGGAGGTG	cctcagctggtgaggaggtg	NN	_	6	OBJ
18	)	)	-RRB-	_	17	P
19	with	with	IN	_	17	NMOD
20	R1	r0	NN	_	22	NMOD
21	(	(	-LRB-	_	22	P
22	GATGGAGAAGGTGAAGTTGCC	gatggagaaggtgaagttgcc	NN	_	19	PMOD
23	)	)	-RRB-	_	17	P
24	,	,	,	_	17	P
25	F2	f0	NN	_	27	NMOD
26	(	(	-LRB-	_	27	P
27	ATTTCCAATGACTTCCGGGAC	atttccaatgacttccgggac	NN	_	17	CONJ
28	)	)	-RRB-	_	27	P
29	with	with	IN	_	27	NMOD
30	R1	r0	NN	_	29	PMOD
31	and	and	CC	_	27	COORD
32	F3	f0	NN	_	34	NMOD
33	(	(	-LRB-	_	34	P
34	CTGGAAGACGGGCTGTACACT	ctggaagacgggctgtacact	NN	_	31	CONJ
35	)	)	-RRB-	_	34	P
36	with	with	IN	_	34	NMOD
37	R1	r0	NN	_	36	PMOD
38	,	,	,	_	6	P
39	to	to	TO	_	6	PRP
40	produce	produce	VB	_	39	IM
41	expected	expect	VBN	_	43	NMOD
42	product	product	NN	_	43	NMOD
43	lengths	length	NNS	_	40	OBJ
44	of	of	IN	_	43	NMOD
45	1449	0	CD	_	50	NMOD
46	,	,	,	_	45	P
47	654	0	CD	_	45	CONJ
48	and	and	CC	_	47	COORD
49	429	0	CD	_	48	CONJ
50	bp	bp	NN	_	44	PMOD
51	respectively	respectively	RB	_	50	NMOD
52	in	in	IN	_	40	LOC
53	wild	wild	JJ	_	55	NMOD
54	-	-	HYPH	_	53	P
55	type	type	NN	_	56	NMOD
56	cDNA	cdna	NN	_	52	PMOD
57	.	.	.	_	4	P

1	Quantitative	quantitative	JJ	_	4	NMOD
2	RT	rt	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	PCR	pcr	NN	_	0	ROOT

1	Primers	primer	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	based	base	VBN	_	2	VC
4	upon	upon	IN	_	3	ADV
5	previously	previously	RB	_	6	AMOD
6	published	publish	VBN	_	8	NMOD
7	primer	primer	NN	_	8	NMOD
8	sets	set	NNS	_	4	PMOD
9	[	[	-LRB-	_	10	P
10	24	0	CD	_	3	PRN
11	-	-	SYM	_	12	P
12	26	0	CD	_	10	NMOD
13	]	]	-RRB-	_	10	P
14	or	or	CC	_	3	COORD
15	designed	design	VBN	_	14	CONJ
16	using	use	VBG	_	15	MNR
17	MacVector	macvector	NNP	_	16	OBJ
18	,	,	,	_	3	P
19	which	which	WDT	_	20	SBJ
20	were	be	VBD	_	1	NMOD
21	designed	design	VBN	_	20	VC
22	from	from	IN	_	21	ADV
23	either	either	CC	_	24	COORD
24	mRNA	mrna	NN	_	22	PMOD
25	or	or	CC	_	24	COORD
26	cDNA	cdna	NN	_	25	CONJ
27	to	to	TO	_	21	PRP
28	avoid	avoid	VB	_	27	IM
29	the	the	DT	_	30	NMOD
30	amplification	amplification	NN	_	28	OBJ
31	of	of	IN	_	30	NMOD
32	potentially	potentially	RB	_	33	AMOD
33	contaminating	contaminate	VBG	_	35	NMOD
34	genomic	genomic	JJ	_	35	NMOD
35	DNA	dna	NN	_	31	PMOD
36	in	in	IN	_	30	LOC
37	the	the	DT	_	40	NMOD
38	total	total	JJ	_	40	NMOD
39	RNA	rna	NN	_	40	NMOD
40	sample	sample	NN	_	36	PMOD
41	(	(	-LRB-	_	42	P
42	Table	table	NN	_	3	PRN
43	1	0	CD	_	42	NMOD
44	)	)	-RRB-	_	42	P
45	.	.	.	_	2	P

1	Samples	sample	NNS	_	18	SBJ
2	of	of	IN	_	1	NMOD
3	total	total	JJ	_	4	NMOD
4	RNA	rna	NN	_	2	PMOD
5	(	(	-LRB-	_	7	P
6	0.5	0	CD	_	7	NMOD
7	μg	μg	NN	_	4	PRN
8	)	)	-RRB-	_	7	P
9	from	from	IN	_	4	NMOD
10	pooled	pool	VBN	_	12	NMOD
11	mouse	mouse	NN	_	12	NMOD
12	livers	liver	NNS	_	9	PMOD
13	(	(	-LRB-	_	16	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	4	0	CD	_	1	PRN
17	)	)	-RRB-	_	16	P
18	were	be	VBD	_	0	ROOT
19	reverse	reverse	RB	_	20	ADV
20	transcribed	transcribe	VBN	_	18	VC
21	according	accord	VBG	_	20	MNR
22	to	to	IN	_	21	PMOD
23	the	the	DT	_	29	NMOD
24	SuperScript™	superscript™	NNP	_	29	NMOD
25	First	$#ORD#$	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	Strand	strand	NN	_	28	NMOD
28	Synthesis	synthesis	NN	_	29	NMOD
29	System	system	NN	_	22	PMOD
30	(	(	-LRB-	_	31	P
31	Invitrogen	invitrogen	NNP	_	29	PRN
32	,	,	,	_	31	P
33	Carlsbad	carlsbad	NNP	_	31	APPO
34	,	,	,	_	33	P
35	CA	ca	NNP	_	33	APPO
36	,	,	,	_	35	P
37	USA	usa	NNP	_	35	APPO
38	)	)	-RRB-	_	31	P
39	using	use	VBG	_	20	MNR
40	random	random	JJ	_	41	NMOD
41	hexamers	hexamers	NNS	_	39	OBJ
42	with	with	IN	_	41	NMOD
43	a	a	DT	_	47	NMOD
44	final	final	JJ	_	47	NMOD
45	total	total	JJ	_	46	NMOD
46	reaction	reaction	NN	_	47	NMOD
47	volume	volume	NN	_	42	PMOD
48	of	of	IN	_	47	NMOD
49	20	0	CD	_	50	NMOD
50	μl	μl	NN	_	48	PMOD
51	.	.	.	_	18	P

1	Quantitative	quantitative	JJ	_	4	NMOD
2	RT	rt	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	PCR	pcr	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	performed	perform	VBN	_	5	VC
7	on	on	IN	_	6	ADV
8	a	a	DT	_	15	NMOD
9	PE	pe	NN	_	10	NMOD
10	Biosystems	biosystems	NNP	_	15	NMOD
11	GeneAmp®	geneamp®	NNP	_	15	NMOD
12	5700	0	CD	_	15	NMOD
13	sequence	sequence	NN	_	14	NMOD
14	Detection	detection	NN	_	15	NMOD
15	System	system	NN	_	7	PMOD
16	(	(	-LRB-	_	18	P
17	Forest	forest	NNP	_	18	NMOD
18	City	city	NNP	_	15	PRN
19	,	,	,	_	18	P
20	CA	ca	NNP	_	18	APPO
21	,	,	,	_	20	P
22	USA	usa	NNP	_	20	APPO
23	)	)	-RRB-	_	18	P
24	.	.	.	_	5	P

1	Standard	standard	JJ	_	3	NMOD
2	reaction	reaction	NN	_	3	NMOD
3	volume	volume	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	10	0	CD	_	6	NMOD
6	μl	μl	NN	_	4	PRD
7	containing	contain	VBG	_	6	NMOD
8	1	0	CD	_	15	NMOD
9	×	×	SYM	_	8	P
10	QuantiTect	quantitect	NNP	_	15	NMOD
11	SYBR	sybr	NNP	_	15	NMOD
12	Green	green	NNP	_	15	NMOD
13	PCR	pcr	NN	_	15	NMOD
14	master	master	NN	_	15	NMOD
15	mix	mix	NN	_	7	OBJ
16	(	(	-LRB-	_	17	P
17	Qiagen	qiagen	NNP	_	6	PRN
18	,	,	,	_	17	P
19	Valencia	valencia	NNP	_	17	APPO
20	,	,	,	_	19	P
21	CA	ca	NNP	_	19	APPO
22	,	,	,	_	21	P
23	USA	usa	NNP	_	21	APPO
24	)	)	-RRB-	_	17	P
25	,	,	,	_	6	P
26	0.002	0	CD	_	27	NMOD
27	U	u	NN	_	30	NMOD
28	AmpErase	amperase	NN	_	30	NMOD
29	UNG	ung	NN	_	30	NMOD
30	enzyme	enzyme	NN	_	6	CONJ
31	(	(	-LRB-	_	33	P
32	PE	pe	NN	_	33	NMOD
33	Biosystems	biosystems	NNP	_	30	PRN
34	,	,	,	_	33	P
35	Forest	forest	NNP	_	36	NMOD
36	City	city	NNP	_	33	APPO
37	,	,	,	_	36	P
38	CA	ca	NNP	_	36	APPO
39	,	,	,	_	38	P
40	USA	usa	NNP	_	38	APPO
41	)	)	-RRB-	_	33	P
42	,	,	,	_	30	P
43	0.7	0	CD	_	44	NMOD
44	μl	μl	NN	_	30	CONJ
45	of	of	IN	_	44	NMOD
46	cDNA	cdna	NN	_	47	NMOD
47	template	template	NN	_	45	PMOD
48	from	from	IN	_	44	NMOD
49	reverse	reverse	JJ	_	50	NMOD
50	transcription	transcription	NN	_	51	NMOD
51	reaction	reaction	NN	_	48	PMOD
52	as	as	IN	_	44	NMOD
53	above	above	RB	_	52	LOC
54	and	and	CC	_	44	COORD
55	100	0	CD	_	58	NMOD
56	–	–	SYM	_	55	P
57	500	0	CD	_	55	QMOD
58	nM	nm	NN	_	54	CONJ
59	of	of	IN	_	58	NMOD
60	oligonucleotide	oligonucleotide	NN	_	61	NMOD
61	primers	primer	NNS	_	59	PMOD
62	.	.	.	_	4	P

1	Initial	initial	JJ	_	2	NMOD
2	steps	step	NNS	_	7	SBJ
3	of	of	IN	_	2	NMOD
4	RT	rt	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	PCR	pcr	NN	_	3	PMOD
7	were	be	VBD	_	0	ROOT
8	two	two	CD	_	9	NMOD
9	minutes	minute	NNS	_	7	PRD
10	at	at	IN	_	9	NMOD
11	50	0	CD	_	12	NMOD
12	°C	°c	NN	_	10	PMOD
13	for	for	IN	_	9	NMOD
14	UNG	ung	NN	_	15	NMOD
15	activation	activation	NN	_	13	PMOD
16	,	,	,	_	9	P
17	followed	follow	VBN	_	9	NMOD
18	by	by	IN	_	17	LGS
19	a	a	DT	_	22	NMOD
20	15	0	CD	_	21	NMOD
21	minute	minute	NN	_	22	NMOD
22	hold	hold	NN	_	18	PMOD
23	at	at	IN	_	22	NMOD
24	95	0	CD	_	25	NMOD
25	°C	°c	NN	_	23	PMOD
26	.	.	.	_	7	P

1	Cycles	cycle	NNS	_	7	SBJ
2	(	(	-LRB-	_	5	P
3	n	n	NN	_	5	SBJ
4	=	=	SYM	_	5	P
5	40	0	CD	_	1	PRN
6	)	)	-RRB-	_	5	P
7	consisted	consist	VBD	_	0	ROOT
8	of	of	IN	_	7	ADV
9	a	a	DT	_	12	NMOD
10	15	0	CD	_	11	NMOD
11	second	$#ORD#$	JJ	_	12	NMOD
12	melt	melt	NN	_	8	PMOD
13	at	at	IN	_	12	NMOD
14	95	0	CD	_	15	NMOD
15	°C	°c	NN	_	13	PMOD
16	,	,	,	_	12	P
17	followed	follow	VBN	_	12	NMOD
18	by	by	IN	_	17	LGS
19	a	a	DT	_	24	NMOD
20	1	0	CD	_	21	NMOD
21	minute	minute	NN	_	24	NMOD
22	annealing	annealing	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	extension	extension	NN	_	18	PMOD
25	at	at	IN	_	24	NMOD
26	60	0	CD	_	27	NMOD
27	°C	°c	NN	_	25	PMOD
28	.	.	.	_	7	P

1	The	the	DT	_	3	NMOD
2	final	final	JJ	_	3	NMOD
3	step	step	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	a	a	DT	_	8	NMOD
6	60	0	CD	_	7	NMOD
7	°C	°c	NN	_	8	NMOD
8	incubation	incubation	NN	_	4	PRD
9	for	for	IN	_	8	TMP
10	1	0	CD	_	11	NMOD
11	minute	minute	NN	_	9	PMOD
12	.	.	.	_	4	P

1	At	at	IN	_	9	TMP
2	the	the	DT	_	3	NMOD
3	end	end	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	run	run	NN	_	4	PMOD
7	,	,	,	_	9	P
8	samples	sample	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	heated	heat	VBN	_	9	VC
11	to	to	IN	_	10	ADV
12	95	0	CD	_	13	NMOD
13	°C	°c	NN	_	11	PMOD
14	with	with	IN	_	10	TMP
15	a	a	DT	_	17	NMOD
16	ramp	ramp	NN	_	17	NMOD
17	time	time	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	20	0	CD	_	20	NMOD
20	minutes	minute	NNS	_	18	PMOD
21	to	to	TO	_	10	PRP
22	construct	construct	VB	_	21	IM
23	dissociation	dissociation	NN	_	24	NMOD
24	curves	curve	NNS	_	22	OBJ
25	to	to	TO	_	22	PRP
26	ensure	ensure	VB	_	25	IM
27	that	that	IN	_	26	OBJ
28	single	single	JJ	_	30	NMOD
29	PCR	pcr	NN	_	30	NMOD
30	products	product	NNS	_	31	SBJ
31	were	be	VBD	_	27	SUB
32	obtained	obtain	VBN	_	31	VC
33	.	.	.	_	9	P

1	All	all	DT	_	2	NMOD
2	reactions	reaction	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	performed	perform	VBN	_	3	VC
5	in	in	IN	_	4	MNR
6	triplicate	triplicate	NN	_	5	PMOD
7	.	.	.	_	3	P

1	Threshold	threshold	NN	_	2	NMOD
2	cycle	cycle	NN	_	4	NMOD
3	(	(	-LRB-	_	4	P
4	CT	ct	NN	_	6	NMOD
5	)	)	-RRB-	_	6	P
6	analysis	analysis	NN	_	10	SBJ
7	of	of	IN	_	6	NMOD
8	all	all	DT	_	9	NMOD
9	samples	sample	NNS	_	7	PMOD
10	was	be	VBD	_	0	ROOT
11	set	set	VBN	_	10	VC
12	at	at	IN	_	11	ADV
13	0.5	0	CD	_	16	NMOD
14	relative	relative	JJ	_	15	NMOD
15	fluorescence	fluorescence	NN	_	16	NMOD
16	units	unit	NNS	_	12	PMOD
17	.	.	.	_	10	P

1	The	the	DT	_	3	NMOD
2	relative	relative	JJ	_	3	NMOD
3	quantities	quantity	NNS	_	23	SBJ
4	of	of	IN	_	3	NMOD
5	message	message	NN	_	4	PMOD
6	of	of	IN	_	3	NMOD
7	genes	gene	NNS	_	6	PMOD
8	of	of	IN	_	7	NMOD
9	interest	interest	NN	_	8	PMOD
10	from	from	IN	_	3	NMOD
11	the	the	DT	_	14	NMOD
12	mouse	mouse	NN	_	13	NMOD
13	liver	liver	NN	_	14	NMOD
14	samples	sample	NNS	_	10	PMOD
15	used	use	VBN	_	14	NMOD
16	in	in	IN	_	15	LOC
17	real	real	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	time	time	NN	_	22	NMOD
20	RT	rt	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	PCR	pcr	NN	_	16	PMOD
23	were	be	VBD	_	0	ROOT
24	normalized	normalize	VBN	_	23	VC
25	to	to	IN	_	24	ADV
26	cyclophilin	cyclophilin	NN	_	25	PMOD
27	to	to	TO	_	24	PRP
28	compensate	compensate	VB	_	27	IM
29	for	for	IN	_	28	ADV
30	variations	variation	NNS	_	29	PMOD
31	in	in	IN	_	30	NMOD
32	input	input	NN	_	33	NMOD
33	RNA	rna	NN	_	34	NMOD
34	amounts	amount	NNS	_	31	PMOD
35	.	.	.	_	23	P

1	The	the	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	analyzed	analyze	VBN	_	3	VC
5	using	use	VBG	_	4	MNR
6	the	the	DT	_	10	NMOD
7	comparative	comparative	JJ	_	10	NMOD
8	threshold	threshold	NN	_	9	NMOD
9	cycle	cycle	NN	_	10	NMOD
10	method	method	NN	_	12	NMOD
11	(	(	-LRB-	_	12	P
12	CT	ct	NN	_	5	OBJ
13	)	)	-RRB-	_	3	P
14	.	.	.	_	3	P

1	Briefly	briefly	RB	_	6	ADV
2	,	,	,	_	6	P
3	the	the	DT	_	5	NMOD
4	CT	ct	NN	_	5	NMOD
5	values	value	NNS	_	6	SBJ
6	are	be	VBP	_	0	ROOT
7	averaged	average	VBN	_	6	VC
8	,	,	,	_	7	P
9	from	from	IN	_	7	ADV
10	the	the	DT	_	11	NMOD
11	triplicates	triplicate	NNS	_	9	PMOD
12	defining	define	VBG	_	11	NMOD
13	a	a	DT	_	17	NMOD
14	Δ	δ	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	CT	ct	NN	_	17	NMOD
17	value	value	NN	_	12	OBJ
18	calculated	calculate	VBN	_	17	NMOD
19	by	by	IN	_	18	MNR
20	taking	take	VBG	_	19	PMOD
21	the	the	DT	_	23	NMOD
22	average	average	JJ	_	23	NMOD
23	CT	ct	NN	_	20	OBJ
24	of	of	IN	_	23	NMOD
25	the	the	DT	_	26	NMOD
26	gene	gene	NN	_	24	PMOD
27	of	of	IN	_	26	NMOD
28	interest	interest	NN	_	27	PMOD
29	and	and	CC	_	20	COORD
30	subtracting	subtract	VBG	_	29	CONJ
31	it	it	PRP	_	30	OBJ
32	from	from	IN	_	30	ADV
33	the	the	DT	_	35	NMOD
34	average	average	JJ	_	35	NMOD
35	CT	ct	NN	_	32	PMOD
36	of	of	IN	_	35	NMOD
37	cyclophilin	cyclophilin	NN	_	36	PMOD
38	.	.	.	_	6	P

1	The	the	DT	_	4	NMOD
2	ΔΔ	δδ	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	CT	ct	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	calculated	calculate	VBN	_	5	VC
7	by	by	IN	_	6	MNR
8	subtracting	subtract	VBG	_	7	PMOD
9	the	the	DT	_	17	NMOD
10	average	average	JJ	_	17	NMOD
11	Δ	δ	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	CT	ct	NN	_	17	NMOD
14	(	(	-LRB-	_	15	P
15	calibrator	calibrator	NN	_	13	PRN
16	)	)	-RRB-	_	15	P
17	values	value	NNS	_	8	OBJ
18	from	from	IN	_	8	ADV
19	the	the	DT	_	22	NMOD
20	Δ	δ	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	CT	ct	NN	_	18	PMOD
23	(	(	-LRB-	_	24	P
24	sample	sample	NN	_	22	PRN
25	)	)	-RRB-	_	24	P
26	.	.	.	_	5	P

1	The	the	DT	_	3	NMOD
2	relative	relative	JJ	_	3	NMOD
3	quantification	quantification	NN	_	4	SBJ
4	was	be	VBD	_	0	ROOT
5	then	then	RB	_	4	TMP
6	calculated	calculate	VBN	_	4	VC
7	by	by	IN	_	6	LGS
8	the	the	DT	_	14	NMOD
9	expression	expression	NN	_	14	NMOD
10	2	0	CD	_	14	NMOD
11	-	-	SYM	_	14	P
12	AverageΔΔ	averageδδ	NN	_	14	NMOD
13	-	-	SYM	_	14	P
14	CT	ct	NN	_	7	PMOD
15	.	.	.	_	4	P

1	The	the	DT	_	3	NMOD
2	mRNA	mrna	NN	_	3	NMOD
3	quantity	quantity	NN	_	11	SBJ
4	for	for	IN	_	3	NMOD
5	the	the	DT	_	6	NMOD
6	calibrator	calibrator	NN	_	4	PMOD
7	(	(	-LRB-	_	9	P
8	wild	wild	JJ	_	9	NMOD
9	type	type	NN	_	6	PRN
10	)	)	-RRB-	_	9	P
11	was	be	VBD	_	0	ROOT
12	expressed	express	VBN	_	11	VC
13	as	as	IN	_	12	ADV
14	1	0	CD	_	13	PMOD
15	and	and	CC	_	11	COORD
16	all	all	DT	_	18	NMOD
17	other	other	JJ	_	18	NMOD
18	quantities	quantity	NNS	_	19	SBJ
19	were	be	VBD	_	15	CONJ
20	expressed	express	VBN	_	19	VC
21	as	as	IN	_	20	ADV
22	a	a	DT	_	24	NMOD
23	fold	fold	NN	_	24	NMOD
24	difference	difference	NN	_	21	PMOD
25	relative	relative	JJ	_	24	NMOD
26	to	to	IN	_	25	AMOD
27	the	the	DT	_	28	NMOD
28	calibrator	calibrator	NN	_	26	PMOD
29	(	(	-LRB-	_	31	P
30	wild	wild	JJ	_	31	NMOD
31	type	type	NN	_	28	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	11	P

1	Plasma	plasma	NN	_	2	NMOD
2	lipid	lipid	NN	_	3	NMOD
3	analysis	analysis	NN	_	0	ROOT
4	by	by	IN	_	3	NMOD
5	fast	fast	JJ	_	6	NMOD
6	protein	protein	NN	_	8	NMOD
7	liquid	liquid	NN	_	8	NMOD
8	chromatography	chromatography	NN	_	4	PMOD

1	Following	follow	VBG	_	33	TMP
2	16	0	CD	_	3	NMOD
3	hrs	hr	NNS	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	fasting	fasting	NN	_	4	PMOD
6	,	,	,	_	33	P
7	blood	blood	NN	_	8	NMOD
8	samples	sample	NNS	_	33	SBJ
9	(	(	-LRB-	_	12	P
10	n	n	NN	_	12	SBJ
11	=	=	SYM	_	12	P
12	3	0	CD	_	8	PRN
13	)	)	-RRB-	_	12	P
14	from	from	IN	_	8	NMOD
15	each	each	DT	_	14	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	32	NMOD
18	Abcg8	abcg0	NN	_	32	NMOD
19	+	+	SYM	_	18	P
20	/	/	HYPH	_	18	P
21	+	+	SYM	_	18	P
22	,	,	,	_	18	P
23	Abcg8	abcg0	NN	_	18	CONJ
24	+	+	SYM	_	23	P
25	/	/	HYPH	_	23	P
26	-	-	SYM	_	23	P
27	and	and	CC	_	23	COORD
28	Abcg8	abcg0	NN	_	27	CONJ
29	-	-	SYM	_	28	P
30	/	/	HYPH	_	28	P
31	-	-	SYM	_	28	P
32	mice	mouse	NNS	_	16	PMOD
33	were	be	VBD	_	0	ROOT
34	collected	collect	VBN	_	33	VC
35	from	from	IN	_	34	ADV
36	the	the	DT	_	41	NMOD
37	retro	retro	JJ	_	39	AMOD
38	-	-	HYPH	_	37	P
39	orbital	orbital	JJ	_	41	NMOD
40	venous	venous	NN	_	41	NMOD
41	plexus	plexus	NN	_	35	PMOD
42	using	use	VBG	_	34	MNR
43	heparinized	heparinized	VBN	_	45	NMOD
44	capillary	capillary	JJ	_	45	NMOD
45	tubes	tube	NNS	_	42	OBJ
46	under	under	IN	_	34	ADV
47	isoflurane	isoflurane	NN	_	48	NMOD
48	anesthesia	anesthesia	NN	_	46	PMOD
49	,	,	,	_	34	P
50	and	and	CC	_	34	COORD
51	placed	place	VBN	_	50	CONJ
52	into	into	IN	_	51	DIR
53	precooled	precooled	JJ	_	54	NMOD
54	tubes	tube	NNS	_	52	PMOD
55	containing	contain	VBG	_	54	NMOD
56	10	0	CD	_	57	NMOD
57	μl	μl	NN	_	55	OBJ
58	of	of	IN	_	57	NMOD
59	0.5	0	CD	_	60	NMOD
60	M	m	NN	_	61	NMOD
61	EDTA	edta	NN	_	58	PMOD
62	.	.	.	_	33	P

1	Equal	equal	JJ	_	2	NMOD
2	volumes	volume	NNS	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	plasma	plasma	NN	_	3	PMOD
5	from	from	IN	_	4	NMOD
6	each	each	DT	_	7	NMOD
7	genotype	genotype	NN	_	5	PMOD
8	were	be	VBD	_	0	ROOT
9	pooled	pool	VBN	_	8	VC
10	and	and	CC	_	8	COORD
11	100	0	CD	_	12	NMOD
12	μL	μl	NN	_	17	SBJ
13	of	of	IN	_	12	NMOD
14	the	the	DT	_	16	NMOD
15	pooled	pool	VBN	_	16	NMOD
16	sample	sample	NN	_	13	PMOD
17	were	be	VBD	_	10	CONJ
18	injected	inject	VBN	_	17	VC
19	and	and	CC	_	18	COORD
20	fractionated	fractionate	VBN	_	19	CONJ
21	by	by	IN	_	18	MNR
22	fast	fast	JJ	_	23	NMOD
23	protein	protein	NN	_	25	NMOD
24	liquid	liquid	NN	_	25	NMOD
25	chromatography	chromatography	NN	_	27	NMOD
26	(	(	-LRB-	_	27	P
27	FPLC	fplc	NN	_	21	PMOD
28	)	)	-RRB-	_	18	P
29	using	use	VBG	_	18	MNR
30	a	a	DT	_	36	NMOD
31	Superose	superose	NN	_	36	NMOD
32	6	0	CD	_	31	NMOD
33	HR10	hr0	NN	_	36	NMOD
34	/	/	HYPH	_	33	P
35	30	0	CD	_	33	NMOD
36	column	column	NN	_	29	OBJ
37	(	(	-LRB-	_	40	P
38	Pharmacia	pharmacia	NNP	_	40	NMOD
39	Biotech	biotech	NNP	_	40	NMOD
40	Inc.	inc.	NNP	_	36	PRN
41	,	,	,	_	40	P
42	Piscataway	piscataway	NNP	_	40	APPO
43	,	,	,	_	42	P
44	NJ	nj	NNP	_	42	APPO
45	,	,	,	_	44	P
46	USA	usa	NNP	_	44	APPO
47	)	)	-RRB-	_	40	P
48	and	and	CC	_	18	COORD
49	analyzed	analyze	VBN	_	48	CONJ
50	as	as	IN	_	49	ADV
51	described	describe	VBN	_	50	SUB
52	[	[	-LRB-	_	53	P
53	27	0	CD	_	8	PRN
54	]	]	-RRB-	_	53	P
55	.	.	.	_	8	P

1	Sterol	sterol	NN	_	2	NMOD
2	composition	composition	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	plasma	plasma	NN	_	3	PMOD
5	and	and	CC	_	4	COORD
6	tissues	tissue	NNS	_	5	CONJ

1	Following	follow	VBG	_	24	TMP
2	a	a	DT	_	6	NMOD
3	four	four	CD	_	5	NMOD
4	-	-	HYPH	_	3	P
5	hour	hour	NN	_	6	NMOD
6	fast	fast	NN	_	1	PMOD
7	of	of	IN	_	6	NMOD
8	12	0	CD	_	10	NMOD
9	-	-	HYPH	_	8	P
10	week	week	NN	_	12	AMOD
11	-	-	HYPH	_	10	P
12	old	old	JJ	_	13	NMOD
13	mice	mouse	NNS	_	7	PMOD
14	fed	feed	VBN	_	13	NMOD
15	on	on	IN	_	14	ADV
16	regular	regular	JJ	_	19	NMOD
17	rodent	rodent	NN	_	18	NMOD
18	chow	chow	NN	_	19	NMOD
19	diet	diet	NN	_	15	PMOD
20	;	;	:	_	24	P
21	blood	blood	NN	_	24	SBJ
22	and	and	CC	_	21	COORD
23	tissues	tissue	NNS	_	22	CONJ
24	were	be	VBD	_	0	ROOT
25	collected	collect	VBN	_	24	VC
26	under	under	IN	_	25	ADV
27	isofluorane	isofluorane	NN	_	28	NMOD
28	anesthesia	anesthesia	NN	_	26	PMOD
29	from	from	IN	_	25	ADV
30	each	each	DT	_	29	PMOD
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	47	NMOD
33	Abcg8	abcg0	NN	_	47	NMOD
34	+	+	SYM	_	33	P
35	/	/	HYPH	_	33	P
36	+	+	SYM	_	33	P
37	,	,	,	_	33	P
38	Abcg8	abcg0	NN	_	33	CONJ
39	+	+	SYM	_	38	P
40	/	/	HYPH	_	38	P
41	-	-	SYM	_	38	P
42	and	and	CC	_	38	COORD
43	Abcg8	abcg0	NN	_	42	CONJ
44	-	-	SYM	_	43	P
45	/	/	HYPH	_	43	P
46	-	-	SYM	_	43	P
47	mice	mouse	NNS	_	31	PMOD
48	(	(	-LRB-	_	51	P
49	n	n	NN	_	51	SBJ
50	=	=	SYM	_	51	P
51	3	0	CD	_	47	PRN
52	for	for	IN	_	51	ADV
53	each	each	DT	_	54	NMOD
54	group	group	NN	_	52	PMOD
55	)	)	-RRB-	_	51	P
56	.	.	.	_	24	P

1	Blood	blood	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	collected	collect	VBN	_	2	VC
4	from	from	IN	_	3	ADV
5	the	the	DT	_	10	NMOD
6	retro	retro	JJ	_	8	AMOD
7	-	-	HYPH	_	6	P
8	orbital	orbital	JJ	_	10	NMOD
9	venous	venous	NN	_	10	NMOD
10	plexus	plexus	NN	_	4	PMOD
11	by	by	IN	_	3	MNR
12	heparinized	heparinized	VBN	_	14	NMOD
13	glass	glass	NN	_	14	NMOD
14	tube	tube	NN	_	11	PMOD
15	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	animals	animal	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	sacrificed	sacrifice	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	cervical	cervical	JJ	_	7	NMOD
7	dislocation	dislocation	NN	_	5	PMOD
8	for	for	IN	_	4	PRP
9	tissue	tissue	NN	_	10	NMOD
10	collection	collection	NN	_	8	PMOD
11	.	.	.	_	3	P

1	Plasma	plasma	NN	_	6	SBJ
2	(	(	-LRB-	_	4	P
3	100	0	CD	_	4	NMOD
4	μl	μl	NN	_	1	PRN
5	)	)	-RRB-	_	4	P
6	was	be	VBD	_	0	ROOT
7	saponified	saponify	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	1	0	CD	_	10	NMOD
10	N	n	NN	_	11	NMOD
11	NaOH	naoh	NN	_	8	PMOD
12	for	for	IN	_	7	TMP
13	one	one	CD	_	14	NMOD
14	hour	hour	NN	_	12	PMOD
15	,	,	,	_	6	P
16	1.5	0	CD	_	17	NMOD
17	mL	ml	NN	_	18	NMOD
18	water	water	NN	_	19	SBJ
19	added	add	VBD	_	6	GAP
20	and	and	CC	_	19	COORD
21	sterols	sterol	NNS	_	22	SBJ
22	extracted	extract	VBN	_	20	GAP
23	with	with	IN	_	22	ADV
24	three	three	CD	_	26	NMOD
25	sequential	sequential	JJ	_	26	NMOD
26	portions	portion	NNS	_	23	PMOD
27	of	of	IN	_	26	NMOD
28	1.5	0	CD	_	29	NMOD
29	mL	ml	NN	_	31	NMOD
30	ethyl	ethyl	NN	_	31	NMOD
31	acetate	acetate	NN	_	27	PMOD
32	,	,	,	_	31	P
33	containing	contain	VBG	_	31	NMOD
34	70	0	CD	_	35	NMOD
35	μg	μg	NN	_	38	NMOD
36	5α	0α	NN	_	38	NMOD
37	-	-	HYPH	_	36	P
38	cholestane	cholestane	NN	_	33	OBJ
39	as	as	IN	_	38	NMOD
40	an	an	DT	_	42	NMOD
41	internal	internal	JJ	_	42	NMOD
42	standard	standard	NN	_	39	PMOD
43	,	,	,	_	22	P
44	pooled	pool	VBN	_	22	CONJ
45	and	and	CC	_	44	COORD
46	dried	dry	VBN	_	45	CONJ
47	.	.	.	_	6	P

1	Mouse	mouse	NN	_	4	NMOD
2	tissues	tissue	NNS	_	4	NMOD
3	(	(	-LRB-	_	4	P
4	liver	liver	NN	_	10	SBJ
5	,	,	,	_	4	P
6	spleen	spleen	NN	_	4	CONJ
7	and	and	CC	_	6	COORD
8	brain	brain	NN	_	7	CONJ
9	)	)	-RRB-	_	10	P
10	were	be	VBD	_	0	ROOT
11	weighed	weigh	VBN	_	10	VC
12	,	,	,	_	11	P
13	homogenized	homogenize	VBN	_	11	VC
14	in	in	IN	_	13	LOC
15	1	0	CD	_	16	NMOD
16	mL	ml	NN	_	21	NMOD
17	phosphate	phosphate	NN	_	18	NMOD
18	buffer	buffer	NN	_	19	NMOD
19	saline	saline	NN	_	21	NMOD
20	(	(	-LRB-	_	21	P
21	PBS	pb	NN	_	14	PMOD
22	)	)	-RRB-	_	21	P
23	with	with	IN	_	21	NMOD
24	a	a	DT	_	26	NMOD
25	dounce	dounce	NN	_	26	NMOD
26	homogenizer	homogenizer	NN	_	23	PMOD
27	(	(	-LRB-	_	29	P
28	15	0	CD	_	29	NMOD
29	strokes	stroke	NNS	_	26	PRN
30	at	at	IN	_	29	NMOD
31	500	0	CD	_	32	NMOD
32	rpm	rpm	NN	_	30	PMOD
33	)	)	-RRB-	_	29	P
34	and	and	CC	_	26	COORD
35	a	a	DT	_	37	NMOD
36	small	small	JJ	_	37	NMOD
37	aliquot	aliquot	NN	_	34	CONJ
38	of	of	IN	_	37	NMOD
39	the	the	DT	_	41	NMOD
40	whole	whole	JJ	_	41	NMOD
41	homogenate	homogenate	NN	_	38	PMOD
42	assayed	assay	VBN	_	41	NMOD
43	for	for	IN	_	42	ADV
44	protein	protein	NN	_	45	NMOD
45	concentration	concentration	NN	_	43	PMOD
46	.	.	.	_	10	P

1	Aliquots	aliquot	NNS	_	9	SBJ
2	for	for	IN	_	1	NMOD
3	sterol	sterol	NN	_	4	NMOD
4	analysis	analysis	NN	_	2	PMOD
5	from	from	IN	_	1	NMOD
6	whole	whole	JJ	_	8	NMOD
7	tissue	tissue	NN	_	8	NMOD
8	homogenates	homogenate	NNS	_	5	PMOD
9	were	be	VBD	_	0	ROOT
10	extracted	extract	VBN	_	9	VC
11	as	as	IN	_	10	MNR
12	described	describe	VBN	_	11	SUB
13	above	above	RB	_	12	LOC
14	.	.	.	_	9	P

1	Dried	dry	VBN	_	3	NMOD
2	sterol	sterol	NN	_	3	NMOD
3	samples	sample	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	derivatized	derivatized	VBN	_	4	VC
6	as	as	IN	_	5	ADV
7	trimethylsilylethers	trimethylsilylethers	NNS	_	6	PMOD
8	,	,	,	_	5	P
9	redissolved	redissolved	VBN	_	5	VC
10	in	in	IN	_	9	LOC
11	10	0	CD	_	12	NMOD
12	μL	μl	NN	_	13	NMOD
13	hexane	hexane	NN	_	10	PMOD
14	and	and	CC	_	4	COORD
15	2	0	CD	_	16	NMOD
16	μL	μl	NN	_	17	NMOD
17	samples	sample	NNS	_	18	SBJ
18	were	be	VBD	_	14	CONJ
19	injected	inject	VBN	_	18	VC
20	into	into	IN	_	19	DIR
21	a	a	DT	_	23	NMOD
22	capillary	capillary	JJ	_	23	NMOD
23	column	column	NN	_	20	PMOD
24	(	(	-LRB-	_	27	P
25	26	0	CD	_	26	NMOD
26	m	m	NN	_	27	NMOD
27	length	length	NN	_	23	PRN
28	,	,	,	_	27	P
29	0.32	0	CD	_	30	NMOD
30	mm	mm	NN	_	31	NMOD
31	ID	id	NN	_	27	APPO
32	,	,	,	_	31	P
33	0.45	0	CD	_	34	NMOD
34	mm	mm	NN	_	35	NMOD
35	OD	od	NN	_	31	APPO
36	)	)	-RRB-	_	27	P
37	coated	coat	VBN	_	23	NMOD
38	with	with	IN	_	37	MNR
39	liquid	liquid	JJ	_	42	NMOD
40	CpWAX	cpwax	NN	_	42	NMOD
41	57	0	CD	_	42	NMOD
42	CB	cb	NN	_	38	PMOD
43	(	(	-LRB-	_	44	P
44	Chrompak	chrompak	NNP	_	42	PRN
45	,	,	,	_	44	P
46	Bridgewater	bridgewater	NNP	_	44	APPO
47	,	,	,	_	46	P
48	NJ	nj	NNP	_	46	APPO
49	,	,	,	_	48	P
50	USA	usa	NNP	_	48	APPO
51	)	)	-RRB-	_	44	P
52	in	in	IN	_	23	LOC
53	a	a	DT	_	58	NMOD
54	Hewlett	hewlett	NNP	_	56	NMOD
55	-	-	HYPH	_	54	P
56	Packard	packard	NNP	_	58	NMOD
57	Gas	gas	NNP	_	58	NMOD
58	Chromatograph	chromatograph	NNP	_	52	PMOD
59	equipped	equip	VBN	_	58	NMOD
60	with	with	IN	_	59	ADV
61	a	a	DT	_	64	NMOD
62	flame	flame	NN	_	63	NMOD
63	ionization	ionization	NN	_	64	NMOD
64	detector	detector	NN	_	60	PMOD
65	[	[	-LRB-	_	66	P
66	28	0	CD	_	4	PRN
67	]	]	-RRB-	_	66	P
68	.	.	.	_	4	P

1	Concentrations	concentration	NNS	_	7	SBJ
2	of	of	IN	_	1	NMOD
3	plasma	plasma	NN	_	6	NMOD
4	and	and	CC	_	3	COORD
5	tissue	tissue	NN	_	4	CONJ
6	sterols	sterol	NNS	_	2	PMOD
7	were	be	VBD	_	0	ROOT
8	reported	report	VBN	_	7	VC
9	as	as	IN	_	8	ADV
10	mg	mg	NN	_	19	NMOD
11	/	/	SYM	_	12	P
12	dL	dl	NN	_	10	NMOD
13	and	and	CC	_	10	COORD
14	μg	μg	NN	_	13	CONJ
15	/	/	SYM	_	16	P
16	g	g	NN	_	14	NMOD
17	wet	wet	JJ	_	18	NMOD
18	weight	weight	NN	_	19	NMOD
19	tissue	tissue	NN	_	9	PMOD
20	,	,	,	_	8	P
21	respectively	respectively	RB	_	8	ADV
22	.	.	.	_	7	P

1	Polyclonal	polyclonal	JJ	_	3	NMOD
2	antibody	antibody	NN	_	3	NMOD
3	production	production	NN	_	0	ROOT

1	Three	three	CD	_	9	NMOD
2	separate	separate	JJ	_	9	NMOD
3	polyclonal	polyclonal	JJ	_	9	NMOD
4	anti-Abcg5	anti-abcg0	JJ	_	9	NMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	4	DEP
7	-	-	HYPH	_	6	P
8	1	0	CD	_	6	NMOD
9	antibodies	antibody	NNS	_	10	SBJ
10	have	have	VBP	_	0	ROOT
11	been	be	VBN	_	10	VC
12	raised	raise	VBN	_	11	VC
13	as	as	IN	_	12	MNR
14	previously	previously	RB	_	15	TMP
15	described	describe	VBN	_	13	SUB
16	[	[	-LRB-	_	21	P
17	20	0	CD	_	21	NMOD
18	,	,	,	_	21	P
19	29	0	CD	_	21	NMOD
20	,	,	,	_	21	P
21	30	0	CD	_	12	PRN
22	]	]	-RRB-	_	21	P
23	.	.	.	_	10	P

1	In	in	IN	_	10	LOC
2	experiments	experiment	NNS	_	1	PMOD
3	,	,	,	_	10	P
4	anti-Abcg5	anti-abcg0	JJ	_	9	NMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	4	DEP
7	-	-	HYPH	_	6	P
8	1	0	CD	_	6	NMOD
9	antibodies	antibody	NNS	_	10	SBJ
10	are	be	VBP	_	0	ROOT
11	labelled	label	VBN	_	10	VC
12	as	as	IN	_	11	MNR
13	follows	follow	VBZ	_	12	SUB
14	:	:	:	_	10	P

1	1	0	LS	_	3	DEP
2	)	)	-RRB-	_	1	P
3	SC	sc	NN	_	0	ROOT
4	–	–	:	_	3	P
5	from	from	IN	_	3	DEP
6	the	the	DT	_	8	NMOD
7	Patel	patel	NNP	_	8	NMOD
8	group	group	NN	_	5	PMOD
9	,	,	,	_	3	P
10	2	0	LS	_	12	DEP
11	)	)	-RRB-	_	10	P
12	AMC	amc	NN	_	3	CONJ
13	–	–	:	_	12	P
14	from	from	IN	_	12	DEP
15	the	the	DT	_	19	NMOD
16	AMC	amc	NNP	_	18	NMOD
17	Liver	liver	NNP	_	18	NMOD
18	Center	center	NNP	_	19	NMOD
19	group	group	NN	_	14	PMOD
20	,	,	,	_	12	P
21	and	and	CC	_	12	COORD
22	3	0	LS	_	24	DEP
23	)	)	-RRB-	_	22	P
24	UTSW	utsw	NN	_	21	CONJ
25	–	–	:	_	24	P
26	from	from	IN	_	24	DEP
27	the	the	DT	_	29	NMOD
28	Hobbs	hobbs	NNP	_	29	NMOD
29	group	group	NN	_	26	PMOD
30	.	.	.	_	3	P

1	Membrane	membrane	NN	_	2	NMOD
2	protein	protein	NN	_	3	NMOD
3	preparations	preparation	NNS	_	0	ROOT

1	Total	total	JJ	_	2	NMOD
2	membranes	membrane	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	prepared	prepare	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	taking	take	VBG	_	5	PMOD
7	approximately	approximately	RB	_	8	QMOD
8	500	0	CD	_	9	NMOD
9	mg	mg	NN	_	6	OBJ
10	of	of	IN	_	9	NMOD
11	liver	liver	NN	_	12	NMOD
12	tissue	tissue	NN	_	10	PMOD
13	cut	cut	VBD	_	12	NMOD
14	into	into	IN	_	13	ADV
15	small	small	JJ	_	16	NMOD
16	pieces	piece	NNS	_	14	PMOD
17	and	and	CC	_	13	COORD
18	homogenized	homogenize	VBN	_	17	CONJ
19	in	in	IN	_	18	LOC
20	ice	ice	NN	_	21	AMOD
21	cold	cold	JJ	_	23	NMOD
22	lysis	lysis	NN	_	23	NMOD
23	buffer	buffer	NN	_	19	PMOD
24	(	(	-LRB-	_	29	P
25	5	0	CD	_	26	NMOD
26	mM	mm	NN	_	27	NMOD
27	Tris	tris	NN	_	29	NMOD
28	-	-	HYPH	_	27	P
29	pH	ph	NN	_	23	PRN
30	7.5	0	CD	_	29	NMOD
31	,	,	,	_	29	P
32	250	0	CD	_	33	NMOD
33	mM	mm	NN	_	34	NMOD
34	sucrose	sucrose	NN	_	29	APPO
35	with	with	IN	_	29	NMOD
36	protease	protease	NN	_	37	NMOD
37	inhibitors	inhibitor	NNS	_	35	PMOD
38	)	)	-RRB-	_	29	P
39	by	by	IN	_	18	LGS
40	a	a	DT	_	42	NMOD
41	dounce	dounce	NN	_	42	NMOD
42	homogenizer	homogenizer	NN	_	39	PMOD
43	times	times	IN	_	42	NMOD
44	10	0	CD	_	45	NMOD
45	strokes	stroke	NNS	_	43	PMOD
46	.	.	.	_	3	P

1	Samples	sample	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	then	then	RB	_	2	TMP
4	subjected	subject	VBN	_	2	VC
5	to	to	IN	_	4	ADV
6	centrifugation	centrifugation	NN	_	9	NMOD
7	–	–	:	_	9	P
8	1300	0	CD	_	9	NMOD
9	g	g	NN	_	5	PMOD
10	for	for	IN	_	9	TMP
11	10	0	CD	_	12	NMOD
12	minutes	minute	NNS	_	10	PMOD
13	at	at	IN	_	9	NMOD
14	4	0	CD	_	15	NMOD
15	°C	°c	NN	_	13	PMOD
16	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	supernant	supernant	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	saved	save	VBN	_	3	VC
5	and	and	CC	_	3	COORD
6	the	the	DT	_	7	NMOD
7	pellet	pellet	NN	_	8	SBJ
8	was	be	VBD	_	5	CONJ
9	resuspended	resuspend	VBN	_	8	VC
10	and	and	CC	_	9	COORD
11	again	again	RB	_	12	TMP
12	subjected	subject	VBN	_	10	CONJ
13	to	to	IN	_	12	ADV
14	dounce	dounce	NN	_	15	NMOD
15	homogenization	homogenization	NN	_	13	PMOD
16	times	times	IN	_	15	NMOD
17	10	0	CD	_	18	NMOD
18	strokes	stroke	NNS	_	16	PMOD
19	then	then	RB	_	20	TMP
20	centrifuged	centrifuge	VBD	_	9	VC
21	1000	0	CD	_	22	NMOD
22	g	g	NN	_	20	ADV
23	for	for	IN	_	20	TMP
24	10	0	CD	_	25	NMOD
25	minutes	minute	NNS	_	23	PMOD
26	at	at	IN	_	20	ADV
27	4	0	CD	_	28	NMOD
28	°C	°c	NN	_	26	PMOD
29	.	.	.	_	3	P

1	This	this	DT	_	2	NMOD
2	step	step	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	repeated	repeat	VBN	_	3	VC
5	twice	twice	RB	_	7	TMP
6	each	each	DT	_	7	NMOD
7	time	time	NN	_	4	TMP
8	with	with	IN	_	4	ADV
9	the	the	DT	_	10	NMOD
10	supernant	supernant	NN	_	11	SBJ
11	being	be	VBG	_	8	PMOD
12	collected	collect	VBN	_	11	VC
13	and	and	CC	_	12	COORD
14	kept	keep	VBN	_	13	CONJ
15	on	on	IN	_	14	OPRD
16	ice	ice	NN	_	15	PMOD
17	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	supernants	supernants	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	then	then	RB	_	3	TMP
5	pooled	pool	VBN	_	3	VC
6	and	and	CC	_	5	COORD
7	subjected	subject	VBN	_	6	CONJ
8	to	to	IN	_	7	ADV
9	ultracentrifugation	ultracentrifugation	NN	_	8	PMOD
10	at	at	IN	_	9	NMOD
11	100,000	0	CD	_	12	NMOD
12	g	g	NN	_	10	PMOD
13	for	for	IN	_	7	TMP
14	60	0	CD	_	15	NMOD
15	minutes	minute	NNS	_	13	PMOD
16	at	at	IN	_	7	ADV
17	4	0	CD	_	18	NMOD
18	°C	°c	NN	_	16	PMOD
19	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	supernant	supernant	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	removed	remove	VBN	_	3	VC
5	and	and	CC	_	3	COORD
6	the	the	DT	_	7	NMOD
7	pellet	pellet	NN	_	8	SBJ
8	was	be	VBD	_	5	CONJ
9	resuspended	resuspend	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	lysis	lysis	NN	_	12	NMOD
12	buffer	buffer	NN	_	10	PMOD
13	.	.	.	_	3	P

1	Plasma	plasma	NN	_	2	NMOD
2	membranes	membrane	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	prepared	prepare	VBN	_	3	VC
5	as	as	IN	_	4	ADV
6	previously	previously	RB	_	7	TMP
7	described	describe	VBN	_	5	SUB
8	[	[	-LRB-	_	9	P
9	31	0	CD	_	4	PRN
10	]	]	-RRB-	_	9	P
11	.	.	.	_	3	P

1	Protein	protein	NN	_	2	NMOD
2	sample	sample	NN	_	3	NMOD
3	concentrations	concentration	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	then	then	RB	_	4	TMP
6	determined	determine	VBN	_	4	VC
7	by	by	IN	_	6	LGS
8	Bio	bio	NNP	_	10	NMOD
9	-	-	HYPH	_	8	P
10	Rad	rad	NNP	_	13	NMOD
11	protein	protein	NN	_	12	AMOD
12	colormetric	colormetric	JJ	_	13	NMOD
13	assay	assay	NN	_	7	PMOD
14	per	per	IN	_	6	ADV
15	manufacturer	manufacturer	NN	_	17	NMOD
16	's	's	POS	_	15	NMOD
17	protocol	protocol	NN	_	14	PMOD
18	(	(	-LRB-	_	19	P
19	BioRad	biorad	NNP	_	17	PRN
20	,	,	,	_	19	P
21	Hercules	hercules	NNP	_	19	APPO
22	,	,	,	_	21	P
23	CA	ca	NNP	_	21	APPO
24	,	,	,	_	23	P
25	USA	usa	NNP	_	23	APPO
26	)	)	-RRB-	_	19	P
27	.	.	.	_	4	P

1	50	0	CD	_	2	NMOD
2	μg	μg	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	membrane	membrane	NN	_	5	NMOD
5	proteins	protein	NNS	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	then	then	RB	_	6	TMP
8	resolved	resolve	VBN	_	6	VC
9	on	on	IN	_	8	LOC
10	7.5	0	CD	_	11	NMOD
11	%	%	NN	_	14	NMOD
12	SDS	sd	NN	_	14	NMOD
13	acrylamide	acrylamide	NN	_	14	NMOD
14	gel	gel	NN	_	9	PMOD
15	.	.	.	_	6	P

1	Immunoblotting	immunoblotting	NN	_	0	ROOT

1	Proteins	protein	NNS	_	7	SBJ
2	resolved	resolve	VBN	_	1	NMOD
3	by	by	IN	_	2	LGS
4	SDS	sd	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	PAGE	page	NN	_	3	PMOD
7	were	be	VBD	_	0	ROOT
8	transferred	transfer	VBN	_	7	VC
9	to	to	IN	_	8	DIR
10	nitrocellulose	nitrocellulose	NN	_	11	NMOD
11	membranes	membrane	NNS	_	9	PMOD
12	.	.	.	_	7	P

1	Membranes	membrane	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	then	then	RB	_	2	TMP
4	blocked	block	VBN	_	2	VC
5	for	for	IN	_	4	TMP
6	one	one	CD	_	7	NMOD
7	hour	hour	NN	_	5	PMOD
8	in	in	IN	_	4	LOC
9	5	0	CD	_	10	NMOD
10	%	%	NN	_	12	NMOD
11	dry	dry	JJ	_	12	NMOD
12	milk	milk	NN	_	8	PMOD
13	in	in	IN	_	4	LOC
14	PBS	pb	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	T	t	NN	_	20	NMOD
17	(	(	-LRB-	_	20	P
18	Phosphate	phosphate	NN	_	19	AMOD
19	Buffered	buffer	VBN	_	20	NMOD
20	saline	saline	NN	_	13	PMOD
21	and	and	CC	_	20	COORD
22	0.1	0	CD	_	23	NMOD
23	%	%	NN	_	24	NMOD
24	Tween	tween	NN	_	21	CONJ
25	20	0	CD	_	24	NMOD
26	)	)	-RRB-	_	2	P
27	.	.	.	_	2	P

1	Blots	blot	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	then	then	RB	_	2	TMP
4	probed	probe	VBN	_	2	VC
5	with	with	IN	_	4	MNR
6	primary	primary	JJ	_	7	NMOD
7	antibody	antibody	NN	_	5	PMOD
8	against	against	IN	_	7	NMOD
9	Abcg5	abcg0	NN	_	8	PMOD
10	in	in	IN	_	4	LOC
11	5	0	CD	_	12	NMOD
12	%	%	NN	_	13	NMOD
13	milk	milk	NN	_	10	PMOD
14	in	in	IN	_	4	LOC
15	PBS	pb	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	T	t	NN	_	14	PMOD
18	overnight	overnight	RB	_	4	TMP
19	at	at	IN	_	4	LOC
20	4	0	CD	_	21	NMOD
21	°C	°c	NN	_	19	PMOD
22	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	blot	blot	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	then	then	RB	_	5	TMP
5	washed	wash	VBN	_	3	VC
6	three	three	CD	_	7	NMOD
7	times	time	NNS	_	5	TMP
8	for	for	IN	_	5	TMP
9	five	five	CD	_	10	NMOD
10	minutes	minute	NNS	_	8	PMOD
11	in	in	IN	_	5	LOC
12	TBS	tb	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	T	t	NN	_	24	NMOD
15	(	(	-LRB-	_	24	P
16	Tris	tris	NN	_	17	AMOD
17	Buffered	buffer	VBN	_	18	NMOD
18	Saline	saline	NN	_	24	NMOD
19	/	/	HYPH	_	18	P
20	0.1	0	CD	_	21	NMOD
21	%	%	NN	_	24	NMOD
22	Tween	tween	NN	_	24	NMOD
23	-	-	HYPH	_	22	P
24	20	0	NN	_	11	PMOD
25	)	)	-RRB-	_	5	P
26	with	with	IN	_	5	MNR
27	150	0	CD	_	28	NMOD
28	mM	mm	NN	_	29	NMOD
29	NaCl	nacl	NN	_	26	PMOD
30	,	,	,	_	5	P
31	and	and	CC	_	5	COORD
32	secondarily	secondarily	RB	_	33	ADV
33	stained	stain	VBN	_	31	CONJ
34	with	with	IN	_	33	ADV
35	goat	goat	NN	_	37	NMOD
36	-	-	HYPH	_	35	P
37	anti-rabbit	anti-rabbit	NN	_	38	AMOD
38	conjugated	conjugate	VBN	_	43	NMOD
39	HRP	hrp	NN	_	43	NMOD
40	1	0	CD	_	43	NMOD
41	:	:	SYM	_	42	P
42	10,000	0	CD	_	40	NMOD
43	dilution	dilution	NN	_	34	PMOD
44	in	in	IN	_	33	LOC
45	5	0	CD	_	46	NMOD
46	%	%	NN	_	47	NMOD
47	milk	milk	NN	_	44	PMOD
48	in	in	IN	_	33	LOC
49	PBS	pb	NN	_	51	NMOD
50	-	-	HYPH	_	49	P
51	T	t	NN	_	48	PMOD
52	for	for	IN	_	33	TMP
53	one	one	CD	_	54	NMOD
54	hour	hour	NN	_	52	PMOD
55	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	blot	blot	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	again	again	RB	_	3	TMP
5	washed	wash	VBN	_	3	VC
6	three	three	CD	_	7	NMOD
7	times	time	NNS	_	5	TMP
8	for	for	IN	_	5	TMP
9	five	five	CD	_	10	NMOD
10	minutes	minute	NNS	_	8	PMOD
11	in	in	IN	_	5	LOC
12	TBS	tb	NN	_	14	NMOD
13	-	-	HYPH	_	12	P
14	T	t	NN	_	11	PMOD
15	with	with	IN	_	5	MNR
16	150	0	CD	_	17	NMOD
17	mM	mm	NN	_	18	NMOD
18	NaCl	nacl	NN	_	15	PMOD
19	then	then	RB	_	20	TMP
20	covered	cover	VBN	_	5	VC
21	in	in	IN	_	20	LOC
22	Western	western	NNP	_	23	NMOD
23	Lightning®	lightning®	NNP	_	26	NMOD
24	Chemiluminescence	chemiluminescence	NNP	_	26	NMOD
25	Reagent	reagent	NNP	_	26	NMOD
26	Plus	plus	NNP	_	21	PMOD
27	(	(	-LRB-	_	30	P
28	PerkinElmer	perkinelmer	NNP	_	30	NMOD
29	Life	life	NNP	_	30	NMOD
30	Sciences	science	NNP	_	26	PRN
31	,	,	,	_	30	P
32	Inc.	inc.	NNP	_	30	NMOD
33	Boston	boston	NNP	_	30	LOC
34	,	,	,	_	33	P
35	MA	ma	NNP	_	33	APPO
36	,	,	,	_	35	P
37	USA	usa	NNP	_	35	APPO
38	)	)	-RRB-	_	30	P
39	,	,	,	_	20	P
40	wrapped	wrap	VBN	_	20	CONJ
41	in	in	IN	_	40	ADV
42	plastic	plastic	NN	_	41	PMOD
43	,	,	,	_	40	P
44	exposed	expose	VBN	_	40	CONJ
45	to	to	IN	_	44	ADV
46	film	film	NN	_	45	PMOD
47	and	and	CC	_	44	COORD
48	developed	develop	VBN	_	47	CONJ
49	.	.	.	_	3	P

1	Immunohistochemical	immunohistochemical	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Snap	snap	RB	_	3	AMOD
2	-	-	HYPH	_	1	P
3	frozen	freeze	VBN	_	7	NMOD
4	liver	liver	NN	_	7	NMOD
5	and	and	CC	_	4	COORD
6	intestine	intestine	NN	_	5	CONJ
7	tissue	tissue	NN	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	cut	cut	VBN	_	8	VC
10	to	to	TO	_	9	PRP
11	produce	produce	VB	_	10	IM
12	8	0	CD	_	13	NMOD
13	μm	μm	NN	_	14	AMOD
14	thick	thick	JJ	_	16	NMOD
15	frozen	frozen	JJ	_	16	NMOD
16	sections	section	NNS	_	11	OBJ
17	,	,	,	_	8	P
18	air	air	NN	_	20	DEP
19	-	-	HYPH	_	18	P
20	dried	dry	VBN	_	8	CONJ
21	for	for	IN	_	20	TMP
22	30	0	CD	_	23	NMOD
23	minutes	minute	NNS	_	21	PMOD
24	onto	onto	IN	_	20	DIR
25	glass	glass	NN	_	26	NMOD
26	slides	slide	NNS	_	24	PMOD
27	and	and	CC	_	20	COORD
28	stored	store	VBN	_	27	CONJ
29	at	at	IN	_	28	ADV
30	-	-	SYM	_	31	P
31	80	0	CD	_	32	NMOD
32	°C	°c	NN	_	29	PMOD
33	until	until	IN	_	28	TMP
34	required	require	VBN	_	33	SUB
35	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	slides	slide	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	stained	stain	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	hematoxylin	hematoxylin	NN	_	5	PMOD
7	,	,	,	_	4	P
8	rinsed	rinse	VBD	_	4	CONJ
9	three	three	CD	_	10	NMOD
10	times	time	NNS	_	8	TMP
11	with	with	IN	_	8	MNR
12	PBS	pb	NN	_	11	PMOD
13	,	,	,	_	8	P
14	fixed	fix	VBN	_	8	CONJ
15	for	for	IN	_	14	TMP
16	10	0	CD	_	17	NMOD
17	min	min	NN	_	15	PMOD
18	with	with	IN	_	14	MNR
19	cooled	cool	VBN	_	20	NMOD
20	methanol	methanol	NN	_	18	PMOD
21	at	at	IN	_	14	ADV
22	-	-	SYM	_	23	P
23	20	0	CD	_	24	NMOD
24	°C	°c	NN	_	21	PMOD
25	and	and	CC	_	14	COORD
26	then	then	RB	_	27	TMP
27	rinsed	rinse	VBD	_	25	CONJ
28	three	three	CD	_	29	NMOD
29	times	time	NNS	_	27	TMP
30	with	with	IN	_	27	MNR
31	PBS	pb	NN	_	30	PMOD
32	.	.	.	_	3	P

1	Slides	slide	NNS	_	5	SBJ
2	for	for	IN	_	1	NMOD
3	antibody	antibody	NN	_	4	NMOD
4	staining	staining	NN	_	2	PMOD
5	were	be	VBD	_	0	ROOT
6	initially	initially	RB	_	5	TMP
7	blocked	block	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	PBS	pb	NN	_	12	NMOD
10	/	/	HYPH	_	9	P
11	0.1	0	CD	_	12	NMOD
12	M	m	NN	_	18	NMOD
13	glycine	glycine	NN	_	16	NMOD
14	/	/	HYPH	_	13	P
15	10	0	CD	_	16	NMOD
16	%	%	NN	_	18	NMOD
17	goat	goat	NN	_	18	NMOD
18	serum	serum	NN	_	8	PMOD
19	for	for	IN	_	7	TMP
20	60	0	CD	_	21	NMOD
21	min	min	NN	_	19	PMOD
22	at	at	IN	_	7	ADV
23	room	room	NN	_	24	NMOD
24	temperature	temperature	NN	_	22	PMOD
25	then	then	RB	_	26	TMP
26	incubated	incubate	VBN	_	7	VC
27	with	with	IN	_	26	ADV
28	anti-sterolin	anti-sterolin	JJ	_	31	NMOD
29	-	-	HYPH	_	28	P
30	1	0	CD	_	28	AMOD
31	antibody	antibody	NN	_	27	PMOD
32	(	(	-LRB-	_	36	P
33	1	0	CD	_	36	NMOD
34	:	:	SYM	_	35	P
35	15	0	CD	_	33	NMOD
36	dilution	dilution	NN	_	31	PRN
37	)	)	-RRB-	_	36	P
38	overnight	overnight	RB	_	26	TMP
39	at	at	IN	_	26	ADV
40	4	0	CD	_	41	NMOD
41	°C	°c	NN	_	39	PMOD
42	.	.	.	_	5	P

1	The	the	DT	_	2	NMOD
2	slides	slide	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	washed	wash	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	1	0	CD	_	8	NMOD
7	×	×	SYM	_	6	P
8	PBS	pb	NN	_	5	PMOD
9	and	and	CC	_	4	COORD
10	incubated	incubate	VBN	_	9	CONJ
11	with	with	IN	_	10	ADV
12	secondary	secondary	JJ	_	13	NMOD
13	antibody	antibody	NN	_	11	PMOD
14	(	(	-LRB-	_	26	P
15	goat	goat	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	anti-rabbit	anti-rabbit	NN	_	18	NMOD
18	IgG	igg	NN	_	26	DEP
19	conjugated	conjugate	VBN	_	18	NMOD
20	with	with	IN	_	19	ADV
21	rhodamine	rhodamine	NN	_	20	PMOD
22	,	,	,	_	26	P
23	1	0	CD	_	26	NMOD
24	:	:	SYM	_	25	P
25	1000	0	CD	_	23	NMOD
26	dilution	dilution	NN	_	13	PRN
27	)	)	-RRB-	_	26	P
28	for	for	IN	_	10	TMP
29	30	0	CD	_	30	NMOD
30	min	min	NN	_	28	PMOD
31	at	at	IN	_	10	ADV
32	room	room	NN	_	33	NMOD
33	temperature	temperature	NN	_	31	PMOD
34	,	,	,	_	4	P
35	washed	wash	VBD	_	4	VC
36	and	and	CC	_	35	COORD
37	then	then	RB	_	38	TMP
38	observed	observe	VBN	_	36	CONJ
39	under	under	IN	_	38	LOC
40	an	an	DT	_	46	NMOD
41	Olympus	olympus	NNP	_	46	NMOD
42	BX	bx	NN	_	46	NMOD
43	-	-	HYPH	_	42	P
44	5	0	CD	_	42	NMOD
45	confocal	confocal	JJ	_	46	NMOD
46	microscope	microscope	NN	_	39	PMOD
47	with	with	IN	_	46	NMOD
48	Fluoview	fluoview	NNP	_	47	PMOD
49	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	sections	section	NNS	_	9	SBJ
3	stained	stain	VBN	_	2	NMOD
4	at	at	IN	_	3	LOC
5	the	the	DT	_	8	NMOD
6	AMC	amc	NNP	_	8	NMOD
7	Liver	liver	NNP	_	8	NMOD
8	Center	center	NNP	_	4	PMOD
9	were	be	VBD	_	0	ROOT
10	fixed	fix	VBN	_	9	VC
11	in	in	IN	_	10	LOC
12	100	0	CD	_	13	NMOD
13	%	%	NN	_	14	NMOD
14	acetone	acetone	NN	_	11	PMOD
15	for	for	IN	_	10	TMP
16	30	0	CD	_	17	NMOD
17	min	min	NN	_	15	PMOD
18	at	at	IN	_	10	ADV
19	room	room	NN	_	20	NMOD
20	temperature	temperature	NN	_	18	PMOD
21	,	,	,	_	10	P
22	blocked	block	VBD	_	10	VC
23	in	in	IN	_	22	LOC
24	a	a	DT	_	25	NMOD
25	solution	solution	NN	_	23	PMOD
26	of	of	IN	_	25	NMOD
27	PBS	pb	NN	_	30	NMOD
28	/	/	HYPH	_	27	P
29	0.05	0	CD	_	30	NMOD
30	%	%	NN	_	40	NMOD
31	Tween	tween	NNP	_	36	NMOD
32	-	-	HYPH	_	31	P
33	20	0	CD	_	31	NMOD
34	/	/	HYPH	_	31	P
35	5	0	CD	_	36	NMOD
36	%	%	NN	_	40	NMOD
37	goat	goat	NN	_	38	NMOD
38	serum	serum	NN	_	40	NMOD
39	(	(	-LRB-	_	40	P
40	GS	g	NN	_	26	PMOD
41	)	)	-RRB-	_	40	P
42	for	for	IN	_	22	TMP
43	one	one	CD	_	44	NMOD
44	hour	hour	NN	_	42	PMOD
45	,	,	,	_	10	P
46	then	then	RB	_	47	TMP
47	incubated	incubate	VBN	_	10	VC
48	with	with	IN	_	47	ADV
49	Anti-sterolin	anti-sterolin	NN	_	48	PMOD
50	-	-	HYPH	_	49	P
51	1	0	CD	_	49	NMOD
52	(	(	-LRB-	_	56	P
53	1	0	CD	_	56	NMOD
54	:	:	SYM	_	55	P
55	40	0	CD	_	53	NMOD
56	dilution	dilution	NN	_	49	PRN
57	)	)	-RRB-	_	56	P
58	and	and	CC	_	49	COORD
59	anti-Bsep	anti-bsep	JJ	_	58	CONJ
60	(	(	-LRB-	_	64	P
61	1	0	CD	_	64	NMOD
62	:	:	SYM	_	63	P
63	200	0	CD	_	61	NMOD
64	dilution	dilution	NN	_	59	PRN
65	)	)	-RRB-	_	64	P
66	diluted	dilute	VBN	_	49	NMOD
67	in	in	IN	_	66	LOC
68	PBS	pb	NN	_	72	NMOD
69	/	/	HYPH	_	68	P
70	Tween	tween	NN	_	72	NMOD
71	/	/	HYPH	_	70	P
72	GS	g	NN	_	67	PMOD
73	,	,	,	_	66	P
74	for	for	IN	_	66	TMP
75	one	one	CD	_	76	NMOD
76	hour	hour	NN	_	74	PMOD
77	.	.	.	_	9	P

1	Thereafter	thereafter	RB	_	4	TMP
2	,	,	,	_	4	P
3	slides	slide	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	washed	wash	VBN	_	4	VC
6	3	0	CD	_	9	NMOD
7	×	×	SYM	_	6	P
8	10	0	CD	_	9	NMOD
9	min	min	NN	_	5	TMP
10	in	in	IN	_	5	LOC
11	PBS	pb	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	Tween	tween	NN	_	10	PMOD
14	and	and	CC	_	4	COORD
15	the	the	DT	_	17	NMOD
16	secondary	secondary	JJ	_	17	NMOD
17	antibody	antibody	NN	_	22	NMOD
18	(	(	-LRB-	_	22	P
19	goat	goat	NN	_	21	NMOD
20	-	-	HYPH	_	19	P
21	anti-rabbit	anti-rabbit	NN	_	22	NMOD
22	Alexa	alexa	NNP	_	25	SBJ
23	488	0	CD	_	22	NMOD
24	)	)	-RRB-	_	25	P
25	was	be	VBD	_	14	CONJ
26	applied	apply	VBN	_	25	VC
27	in	in	IN	_	26	ADV
28	1	0	CD	_	31	NMOD
29	:	:	SYM	_	30	P
30	1000	0	CD	_	28	NMOD
31	dilution	dilution	NN	_	27	PMOD
32	in	in	IN	_	26	LOC
33	PBST	pbst	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	GS	g	NN	_	32	PMOD
36	for	for	IN	_	26	TMP
37	one	one	CD	_	38	NMOD
38	hour	hour	NN	_	36	PMOD
39	at	at	IN	_	26	ADV
40	room	room	NN	_	41	NMOD
41	temperature	temperature	NN	_	39	PMOD
42	.	.	.	_	4	P

1	After	after	IN	_	10	TMP
2	washing	wash	VBG	_	1	PMOD
3	for	for	IN	_	2	TMP
4	3	0	CD	_	7	NMOD
5	×	×	SYM	_	4	P
6	10	0	CD	_	7	NMOD
7	min	min	NN	_	3	PMOD
8	the	the	DT	_	9	NMOD
9	sections	section	NNS	_	10	SBJ
10	were	be	VBD	_	0	ROOT
11	mounted	mount	VBN	_	10	VC
12	in	in	IN	_	11	LOC
13	Dapi	dapi	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	Dapco	dapco	NN	_	16	NMOD
16	solution	solution	NN	_	12	PMOD
17	.	.	.	_	10	P

1	Fluorescence	fluorescence	NN	_	2	NMOD
2	microscopy	microscopy	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	done	do	VBN	_	3	VC
5	with	with	IN	_	4	ADV
6	a	a	DT	_	10	NMOD
7	Leica	leica	NNP	_	10	NMOD
8	DM	dm	NN	_	9	NMOD
9	RA2	ra0	NN	_	10	NMOD
10	microscope	microscope	NN	_	5	PMOD
11	equipped	equip	VBN	_	10	NMOD
12	with	with	IN	_	11	MNR
13	a	a	DT	_	17	NMOD
14	Leica	leica	NNP	_	17	NMOD
15	DC350F	dc0f	NN	_	17	NMOD
16	photo	photo	NN	_	17	NMOD
17	camera	camera	NN	_	12	PMOD
18	.	.	.	_	3	P

1	For	for	IN	_	12	PRP
2	Dapi	dapi	NNP	_	3	NMOD
3	staining	staining	NN	_	1	PMOD
4	,	,	,	_	12	P
5	359	0	CD	_	6	NMOD
6	nm	nm	NN	_	12	SBJ
7	(	(	-LRB-	_	10	P
8	30.38	0	CD	_	9	NMOD
9	ms	m	NN	_	10	NMOD
10	exposure	exposure	NN	_	6	PRN
11	)	)	-RRB-	_	10	P
12	was	be	VBD	_	0	ROOT
13	used	use	VBN	_	12	VC
14	and	and	CC	_	12	COORD
15	for	for	IN	_	31	PRP
16	Abcg5	abcg0	NN	_	19	NMOD
17	and	and	CC	_	16	COORD
18	Bsep	bsep	NN	_	17	CONJ
19	staining	staining	NN	_	15	PMOD
20	,	,	,	_	31	P
21	514	0	CD	_	22	NMOD
22	nm	nm	NN	_	31	SBJ
23	(	(	-LRB-	_	29	P
24	for	for	IN	_	29	DEP
25	both	both	DT	_	24	PMOD
26	:	:	:	_	29	P
27	1654.34	0	CD	_	28	NMOD
28	ms	m	NN	_	29	NMOD
29	exposure	exposure	NN	_	22	PRN
30	)	)	-RRB-	_	29	P
31	was	be	VBD	_	14	CONJ
32	used	use	VBN	_	31	VC
33	and	and	CC	_	31	COORD
34	the	the	DT	_	35	NMOD
35	pictures	picture	NNS	_	36	SBJ
36	were	be	VBD	_	33	CONJ
37	analyzed	analyze	VBN	_	36	VC
38	and	and	CC	_	37	COORD
39	overlaid	overlay	VBN	_	38	CONJ
40	using	use	VBG	_	37	MNR
41	FW4000	fw0	NN	_	42	NMOD
42	software	software	NN	_	40	OBJ
43	(	(	-LRB-	_	44	P
44	Leica	leica	NNP	_	42	PRN
45	)	)	-RRB-	_	44	P
46	.	.	.	_	12	P

1	Transfection	transfection	NN	_	0	ROOT
2	and	and	CC	_	1	COORD
3	immunostaining	immunostaining	NN	_	2	CONJ
4	of	of	IN	_	1	NMOD
5	COS	co	NN	_	8	NMOD
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	cells	cell	NNS	_	4	PMOD

1	COS	co	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	cells	cell	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	transiently	transiently	RB	_	5	ADV
7	transfected	transfected	VBN	_	5	VC
8	with	with	IN	_	7	MNR
9	pCMV	pcmv	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	mouse	mouse	NN	_	12	NMOD
12	Abcg5	abcg0	NN	_	19	NMOD
13	and	and	CC	_	12	COORD
14	pCMV	pcmv	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	mouse	mouse	NN	_	17	NMOD
17	Abcg8	abcg0	NN	_	13	CONJ
18	expression	expression	NN	_	19	NMOD
19	constructs	construct	NNS	_	8	PMOD
20	using	use	VBG	_	7	MNR
21	the	the	DT	_	24	NMOD
22	Qiagen	qiagen	NNP	_	24	NMOD
23	SuperFect	superfect	NN	_	24	NMOD
24	reagent	reagent	NN	_	20	OBJ
25	per	per	IN	_	7	ADV
26	protocol	protocol	NN	_	25	PMOD
27	(	(	-LRB-	_	28	P
28	Valencia	valencia	NNP	_	7	PRN
29	,	,	,	_	28	P
30	CA	ca	NNP	_	28	APPO
31	,	,	,	_	30	P
32	USA	usa	NNP	_	30	APPO
33	)	)	-RRB-	_	28	P
34	.	.	.	_	5	P

1	Briefly	briefly	RB	_	7	ADV
2	,	,	,	_	7	P
3	COS	co	NN	_	6	NMOD
4	-	-	HYPH	_	3	P
5	1	0	CD	_	3	NMOD
6	cells	cell	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	seeded	seed	VBN	_	7	VC
9	onto	onto	IN	_	8	DIR
10	a	a	DT	_	14	NMOD
11	six	six	CD	_	13	NMOD
12	-	-	HYPH	_	11	P
13	well	well	NN	_	14	NMOD
14	plate	plate	NN	_	9	PMOD
15	the	the	DT	_	16	NMOD
16	day	day	NN	_	8	TMP
17	prior	prior	JJ	_	18	PMOD
18	to	to	IN	_	16	NMOD
19	transfection	transfection	NN	_	18	PMOD
20	to	to	TO	_	8	PRP
21	generate	generate	VB	_	20	IM
22	60	0	CD	_	23	NMOD
23	%	%	NN	_	24	NMOD
24	confluence	confluence	NN	_	21	OBJ
25	when	when	WRB	_	26	TMP
26	grown	grow	VBN	_	21	TMP
27	at	at	IN	_	26	ADV
28	37	0	CD	_	29	NMOD
29	°C	°c	NN	_	27	PMOD
30	and	and	CC	_	29	COORD
31	5	0	CD	_	32	NMOD
32	%	%	NN	_	33	NMOD
33	CO2	co0	NN	_	30	CONJ
34	in	in	IN	_	26	LOC
35	DMEM	dmem	NN	_	34	PMOD
36	supplemented	supplement	VBN	_	35	NMOD
37	with	with	IN	_	36	ADV
38	10	0	CD	_	39	NMOD
39	%	%	NN	_	40	NMOD
40	FBS	fbs	NN	_	37	PMOD
41	,	,	,	_	40	P
42	100	0	CD	_	43	NMOD
43	U	u	NN	_	46	NMOD
44	/	/	SYM	_	45	P
45	ml	ml	NN	_	43	NMOD
46	penicillin	penicillin	NN	_	40	CONJ
47	,	,	,	_	46	P
48	100	0	CD	_	49	NMOD
49	μg	μg	NN	_	52	NMOD
50	/	/	SYM	_	51	P
51	ml	ml	NN	_	49	NMOD
52	streptomycin	streptomycin	NN	_	46	CONJ
53	and	and	CC	_	52	COORD
54	1	0	CD	_	56	NMOD
55	×	×	SYM	_	54	P
56	glutamine	glutamine	NN	_	53	CONJ
57	.	.	.	_	7	P

1	On	on	IN	_	11	TMP
2	the	the	DT	_	3	NMOD
3	day	day	NN	_	1	PMOD
4	of	of	IN	_	3	NMOD
5	transfection	transfection	NN	_	4	PMOD
6	,	,	,	_	11	P
7	2	0	CD	_	8	NMOD
8	μg	μg	NN	_	11	SBJ
9	of	of	IN	_	8	NMOD
10	DNA	dna	NN	_	9	PMOD
11	was	be	VBD	_	0	ROOT
12	mixed	mix	VBN	_	11	VC
13	with	with	IN	_	12	ADV
14	Qiagen	qiagen	NNP	_	15	NMOD
15	SuperFect	superfect	NN	_	16	NMOD
16	reagent	reagent	NN	_	13	PMOD
17	and	and	CC	_	12	COORD
18	incubated	incubate	VBN	_	17	CONJ
19	for	for	IN	_	18	TMP
20	10	0	CD	_	21	NMOD
21	minutes	minute	NNS	_	19	PMOD
22	.	.	.	_	11	P

1	This	this	DT	_	2	NMOD
2	mixture	mixture	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	then	then	RB	_	3	TMP
5	added	add	VBN	_	3	VC
6	to	to	IN	_	5	ADV
7	serum	serum	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	free	free	JJ	_	10	NMOD
10	media	medium	NN	_	6	PMOD
11	and	and	CC	_	5	COORD
12	placed	place	VBN	_	11	CONJ
13	on	on	IN	_	12	LOC
14	the	the	DT	_	15	NMOD
15	cells	cell	NNS	_	13	PMOD
16	to	to	TO	_	12	PRP
17	incubate	incubate	VB	_	16	IM
18	for	for	IN	_	17	TMP
19	two	two	CD	_	20	NMOD
20	hours	hour	NNS	_	18	PMOD
21	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	cells	cell	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	washed	wash	VBN	_	3	VC
5	once	once	RB	_	4	TMP
6	with	with	IN	_	4	ADV
7	1x	0x	NN	_	8	NMOD
8	PBS	pb	NNS	_	6	PMOD
9	and	and	CC	_	3	COORD
10	fresh	fresh	JJ	_	11	NMOD
11	media	medium	NN	_	12	SBJ
12	was	be	VBD	_	9	CONJ
13	added	add	VBN	_	12	VC
14	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	transfected	transfected	VBN	_	3	NMOD
3	cells	cell	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	then	then	RB	_	4	TMP
6	incubated	incubate	VBN	_	4	VC
7	for	for	IN	_	6	TMP
8	48	0	CD	_	9	NMOD
9	hours	hour	NNS	_	7	PMOD
10	to	to	TO	_	6	PRP
11	ensure	ensure	VB	_	10	IM
12	expression	expression	NN	_	11	OBJ
13	and	and	CC	_	6	COORD
14	subsequently	subsequently	RB	_	15	ADV
15	fixed	fix	VBN	_	13	CONJ
16	with	with	IN	_	15	MNR
17	a	a	DT	_	21	NMOD
18	1	0	CD	_	21	NMOD
19	:	:	SYM	_	20	P
20	1	0	CD	_	18	NMOD
21	mixture	mixture	NN	_	16	PMOD
22	of	of	IN	_	21	NMOD
23	acetone	acetone	NN	_	22	PMOD
24	:	:	SYM	_	25	P
25	methanol	methanol	NN	_	23	NMOD
26	.	.	.	_	4	P

1	In	in	IN	_	7	PRP
2	preparation	preparation	NN	_	1	PMOD
3	for	for	IN	_	2	NMOD
4	immunostaining	immunostaining	NN	_	3	PMOD
5	,	,	,	_	7	P
6	cells	cell	NNS	_	7	SBJ
7	were	be	VBD	_	0	ROOT
8	blocked	block	VBN	_	7	VC
9	with	with	IN	_	8	ADV
10	2	0	CD	_	11	NMOD
11	%	%	NN	_	13	NMOD
12	goat	goat	NN	_	13	NMOD
13	serum	serum	NN	_	9	PMOD
14	in	in	IN	_	8	LOC
15	PBS	pb	NN	_	14	PMOD
16	for	for	IN	_	8	TMP
17	30	0	CD	_	18	NMOD
18	minutes	minute	NNS	_	16	PMOD
19	,	,	,	_	8	P
20	then	then	RB	_	21	TMP
21	incubated	incubate	VBN	_	8	CONJ
22	with	with	IN	_	21	ADV
23	1	0	CD	_	26	NMOD
24	:	:	SYM	_	25	P
25	50	0	CD	_	23	NMOD
26	dilution	dilution	NN	_	22	PMOD
27	of	of	IN	_	26	NMOD
28	primary	primary	JJ	_	29	NMOD
29	antibody	antibody	NN	_	30	NMOD
30	anti-Abcg5	anti-abcg0	NN	_	27	PMOD
31	in	in	IN	_	21	LOC
32	2	0	CD	_	33	NMOD
33	%	%	NN	_	37	NMOD
34	goat	goat	NN	_	35	NMOD
35	serum	serum	NN	_	37	NMOD
36	-	-	HYPH	_	35	P
37	PBS	pb	NN	_	31	PMOD
38	for	for	IN	_	21	TMP
39	1.5	0	CD	_	40	NMOD
40	hours	hour	NNS	_	38	PMOD
41	,	,	,	_	21	P
42	and	and	CC	_	21	COORD
43	subsequently	subsequently	RB	_	44	TMP
44	incubated	incubate	VBN	_	42	CONJ
45	with	with	IN	_	44	ADV
46	secondary	secondary	JJ	_	50	NMOD
47	rhodamine	rhodamine	NN	_	50	NMOD
48	anti-rabbit	anti-rabbit	NN	_	50	NMOD
49	IgG	igg	NN	_	50	NMOD
50	antibody	antibody	NN	_	45	PMOD
51	for	for	IN	_	44	TMP
52	30	0	CD	_	53	NMOD
53	minutes	minute	NNS	_	51	PMOD
54	.	.	.	_	7	P

1	Cells	cell	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	then	then	RB	_	2	TMP
4	observed	observe	VBN	_	2	VC
5	under	under	IN	_	4	ADV
6	an	an	DT	_	12	NMOD
7	Olympus	olympus	NNP	_	12	NMOD
8	BX	bx	NN	_	12	NMOD
9	-	-	HYPH	_	8	P
10	5	0	CD	_	8	NMOD
11	confocal	confocal	JJ	_	12	NMOD
12	microscope	microscope	NN	_	5	PMOD
13	with	with	IN	_	12	NMOD
14	Fluoview	fluoview	NNP	_	13	PMOD
15	.	.	.	_	2	P

1	Dynamic	dynamic	JJ	_	4	NMOD
2	biliary	biliary	JJ	_	3	NMOD
3	lipid	lipid	NN	_	4	NMOD
4	collection	collection	NN	_	0	ROOT
5	and	and	CC	_	4	COORD
6	analysis	analysis	NN	_	5	CONJ

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	anaesthetized	anaesthetize	VBN	_	2	VC
4	by	by	IN	_	3	MNR
5	intraperitoneal	intraperitoneal	JJ	_	6	NMOD
6	injection	injection	NN	_	4	PMOD
7	of	of	IN	_	6	NMOD
8	1	0	CD	_	9	NMOD
9	mL	ml	NN	_	14	NMOD
10	/	/	SYM	_	11	P
11	kg	kg	NN	_	9	NMOD
12	fentanyl	fentanyl	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	fluanisone	fluanisone	NN	_	7	PMOD
15	and	and	CC	_	14	COORD
16	10	0	CD	_	17	NMOD
17	mg	mg	NN	_	20	NMOD
18	/	/	SYM	_	19	P
19	kg	kg	NN	_	17	NMOD
20	Diazepam	diazepam	NN	_	15	CONJ
21	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	abdomen	abdomen	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	opened	open	VBN	_	3	VC
5	and	and	CC	_	3	COORD
6	,	,	,	_	5	P
7	after	after	IN	_	17	TMP
8	distal	distal	JJ	_	9	NMOD
9	ligation	ligation	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	13	NMOD
12	bile	bile	NN	_	13	NMOD
13	duct	duct	NN	_	10	PMOD
14	,	,	,	_	17	P
15	the	the	DT	_	16	NMOD
16	gallbladder	gallbladder	NN	_	17	SBJ
17	was	be	VBD	_	5	CONJ
18	cannulated	cannulate	VBN	_	17	VC
19	.	.	.	_	3	P

1	Bile	bile	NN	_	2	NMOD
2	sampling	sampling	NN	_	3	SBJ
3	started	start	VBD	_	0	ROOT
4	directly	directly	RB	_	5	PMOD
5	after	after	IN	_	3	TMP
6	cannulation	cannulation	NN	_	5	PMOD
7	and	and	CC	_	3	COORD
8	was	be	VBD	_	7	CONJ
9	collected	collect	VBN	_	8	VC
10	for	for	IN	_	9	TMP
11	10	0	CD	_	12	NMOD
12	min	min	NN	_	10	PMOD
13	.	.	.	_	3	P

1	Bile	bile	NN	_	2	NMOD
2	flow	flow	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	determined	determine	VBN	_	3	VC
5	gravimetrically	gravimetrically	RB	_	4	MNR
6	.	.	.	_	3	P

1	Biliary	biliary	JJ	_	2	NMOD
2	bile	bile	NN	_	8	NMOD
3	salt	salt	NN	_	8	NMOD
4	,	,	,	_	3	P
5	sterol	sterol	NN	_	3	CONJ
6	and	and	CC	_	5	COORD
7	phospholipid	phospholipid	NN	_	6	CONJ
8	concentrations	concentration	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	determined	determine	VBN	_	9	VC
11	as	as	IN	_	10	MNR
12	described	describe	VBN	_	11	SUB
13	previously	previously	RB	_	12	TMP
14	[	[	-LRB-	_	15	P
15	32	0	CD	_	10	PRN
16	]	]	-RRB-	_	15	P
17	.	.	.	_	9	P

1	To	to	TO	_	12	PRP
2	determine	determine	VB	_	1	IM
3	maximal	maximal	JJ	_	5	NMOD
4	secretion	secretion	NN	_	5	NMOD
5	rates	rate	NNS	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	biliary	biliary	JJ	_	8	NMOD
8	lipid	lipid	NN	_	9	NMOD
9	secretion	secretion	NN	_	6	PMOD
10	,	,	,	_	12	P
11	bile	bile	NN	_	12	SBJ
12	was	be	VBD	_	0	ROOT
13	diverted	divert	VBN	_	12	VC
14	for	for	IN	_	13	TMP
15	90	0	CD	_	16	NMOD
16	min	min	NN	_	14	PMOD
17	to	to	TO	_	13	PRP
18	deplete	deplete	VB	_	17	IM
19	the	the	DT	_	23	NMOD
20	endogenous	endogenous	JJ	_	23	NMOD
21	bile	bile	NN	_	22	NMOD
22	salt	salt	NN	_	23	NMOD
23	pool	pool	NN	_	18	OBJ
24	.	.	.	_	12	P

1	Subsequently	subsequently	RB	_	16	TMP
2	,	,	,	_	16	P
3	tauroursodeoxycholate	tauroursodeoxycholate	NN	_	16	SBJ
4	(	(	-LRB-	_	7	P
5	Sigma	sigma	NNP	_	7	NMOD
6	Chemical	chemical	NNP	_	7	NMOD
7	Co.	co.	NNP	_	3	PRN
8	,	,	,	_	7	P
9	MO	mo	NNP	_	7	APPO
10	,	,	,	_	9	P
11	USA	usa	NNP	_	9	APPO
12	)	)	-RRB-	_	7	P
13	dissolved	dissolve	VBN	_	3	NMOD
14	in	in	IN	_	13	LOC
15	PBS	pb	NN	_	14	PMOD
16	was	be	VBD	_	0	ROOT
17	infused	infuse	VBN	_	16	VC
18	into	into	IN	_	17	DIR
19	the	the	DT	_	21	NMOD
20	jugular	jugular	JJ	_	21	NMOD
21	vein	vein	NN	_	18	PMOD
22	in	in	IN	_	17	ADV
23	stepwise	stepwise	JJ	_	25	NMOD
24	increasing	increase	VBG	_	25	NMOD
25	rates	rate	NNS	_	22	PMOD
26	from	from	IN	_	17	ADV
27	600	0	CD	_	30	NMOD
28	–	–	SYM	_	27	P
29	1,800	0	CD	_	27	QMOD
30	nmol	nmol	NN	_	26	PMOD
31	/	/	SYM	_	32	P
32	min	min	NN	_	30	NMOD
33	/	/	SYM	_	37	P
34	100	0	CD	_	35	NMOD
35	g	g	NN	_	37	NMOD
36	body	body	NN	_	37	NMOD
37	weight	weight	NN	_	30	NMOD
38	.	.	.	_	16	P

1	Bile	bile	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	collected	collect	VBN	_	2	VC
4	in	in	IN	_	3	ADV
5	10	0	CD	_	6	NMOD
6	min	min	NN	_	7	NMOD
7	fractions	fraction	NNS	_	4	PMOD
8	and	and	CC	_	3	COORD
9	analyzed	analyze	VBN	_	8	CONJ
10	for	for	IN	_	9	PRP
11	bile	bile	NN	_	15	NMOD
12	salt	salt	NN	_	15	NMOD
13	and	and	CC	_	12	COORD
14	lipid	lipid	NN	_	13	CONJ
15	content	content	NN	_	10	PMOD
16	.	.	.	_	2	P

1	In	in	IN	_	18	LOC
2	separate	separate	JJ	_	3	NMOD
3	experiments	experiment	NNS	_	1	PMOD
4	,	,	,	_	18	P
5	following	follow	VBG	_	18	TMP
6	distal	distal	JJ	_	7	NMOD
7	ligation	ligation	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	11	NMOD
10	bile	bile	NN	_	11	NMOD
11	duct	duct	NN	_	8	PMOD
12	and	and	CC	_	7	COORD
13	cannulation	cannulation	NN	_	12	CONJ
14	of	of	IN	_	13	NMOD
15	gallbladder	gallbladder	NN	_	14	PMOD
16	,	,	,	_	18	P
17	bile	bile	NN	_	18	SBJ
18	was	be	VBD	_	0	ROOT
19	diverted	divert	VBN	_	18	VC
20	for	for	IN	_	19	TMP
21	30	0	CD	_	22	NMOD
22	minutes	minute	NNS	_	20	PMOD
23	while	while	IN	_	19	TMP
24	mice	mouse	NNS	_	25	SBJ
25	were	be	VBD	_	23	SUB
26	infused	infuse	VBN	_	25	VC
27	with	with	IN	_	26	MNR
28	sterile	sterile	JJ	_	29	NMOD
29	PBS	pb	NN	_	27	PMOD
30	.	.	.	_	18	P

1	Subsequently	subsequently	RB	_	5	TMP
2	,	,	,	_	5	P
3	the	the	DT	_	4	NMOD
4	mice	mouse	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	infused	infuse	VBN	_	5	VC
7	continuously	continuously	RB	_	6	ADV
8	with	with	IN	_	6	ADV
9	1,200	0	CD	_	10	NMOD
10	nmol	nmol	NN	_	8	PMOD
11	/	/	SYM	_	12	P
12	min	min	NN	_	10	NMOD
13	/	/	SYM	_	17	P
14	100	0	CD	_	15	NMOD
15	g	g	NN	_	17	NMOD
16	body	body	NN	_	17	NMOD
17	weight	weight	NN	_	10	NMOD
18	of	of	IN	_	10	NMOD
19	tauroursodeoxycholate	tauroursodeoxycholate	NN	_	18	PMOD
20	and	and	CC	_	5	COORD
21	two	two	CD	_	25	NMOD
22	30	0	CD	_	24	NMOD
23	-	-	HYPH	_	22	P
24	minute	minute	NN	_	25	NMOD
25	fractions	fraction	NNS	_	26	SBJ
26	were	be	VBD	_	20	CONJ
27	collected	collect	VBN	_	26	VC
28	.	.	.	_	5	P

1	Sterol	sterol	NN	_	2	NMOD
2	analyses	analysis	NNS	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	bile	bile	NN	_	3	PMOD
5	was	be	VBD	_	0	ROOT
6	performed	perform	VBN	_	5	VC
7	by	by	IN	_	6	MNR
8	GC	gc	NN	_	9	NMOD
9	analysis	analysis	NN	_	7	PMOD
10	as	as	IN	_	6	ADV
11	described	describe	VBN	_	10	SUB
12	above	above	RB	_	11	LOC
13	.	.	.	_	5	P

1	Assay	assay	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	HMG	hmg	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	CoA	coa	NN	_	2	PMOD
6	and	and	CC	_	1	COORD
7	cholesterol	cholesterol	NN	_	12	NMOD
8	7	0	CD	_	9	NMOD
9	α	α	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	hydroxylase	hydroxylase	NN	_	12	NMOD
12	enzyme	enzyme	NN	_	13	NMOD
13	activity	activity	NN	_	6	CONJ

1	Mouse	mouse	NN	_	2	NMOD
2	liver	liver	NN	_	3	NMOD
3	microsomes	microsome	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	prepared	prepare	VBN	_	4	VC
6	by	by	IN	_	5	MNR
7	differential	differential	JJ	_	8	NMOD
8	centrifugation	centrifugation	NN	_	6	PMOD
9	[	[	-LRB-	_	10	P
10	33	0	CD	_	5	PRN
11	]	]	-RRB-	_	10	P
12	.	.	.	_	4	P

1	Briefly	briefly	RB	_	8	ADV
2	,	,	,	_	8	P
3	0.1	0	CD	_	6	NMOD
4	–	–	SYM	_	3	P
5	0.2	0	CD	_	3	QMOD
6	g	g	NN	_	7	NMOD
7	liver	liver	NN	_	8	SBJ
8	was	be	VBD	_	0	ROOT
9	homogenized	homogenize	VBN	_	8	VC
10	in	in	IN	_	9	LOC
11	a	a	DT	_	15	NMOD
12	Potter	potter	NNP	_	14	NMOD
13	-	-	HYPH	_	12	P
14	Elvjhem	elvjhem	NNP	_	15	NMOD
15	homogenizer	homogenizer	NN	_	10	PMOD
16	with	with	IN	_	15	NMOD
17	five	five	CD	_	18	NMOD
18	volumes	volume	NNS	_	16	PMOD
19	of	of	IN	_	18	NMOD
20	buffer	buffer	NN	_	24	NMOD
21	(	(	-LRB-	_	24	P
22	0.25	0	CD	_	23	NMOD
23	M	m	NN	_	24	NMOD
24	sucrose	sucrose	NN	_	19	PMOD
25	,	,	,	_	24	P
26	0.1	0	CD	_	27	NMOD
27	M	m	NN	_	28	NMOD
28	Tris	tris	NN	_	24	APPO
29	,	,	,	_	28	P
30	0.1	0	CD	_	31	NMOD
31	mM	mm	NN	_	33	NMOD
32	disodium	disodium	NN	_	33	NMOD
33	EDTA	edta	NN	_	28	APPO
34	,	,	,	_	33	P
35	0.1	0	CD	_	36	NMOD
36	mM	mm	NN	_	37	NMOD
37	DTT	dtt	NN	_	33	APPO
38	,	,	,	_	24	P
39	pH	ph	NN	_	24	APPO
40	7.4	0	CD	_	39	NMOD
41	)	)	-RRB-	_	8	P
42	.	.	.	_	8	P

1	Microsomes	microsome	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	isolated	isolate	VBN	_	2	VC
4	by	by	IN	_	3	MNR
5	differential	differential	JJ	_	6	NMOD
6	centrifugation	centrifugation	NN	_	4	PMOD
7	(	(	-LRB-	_	9	P
8	10,000	0	CD	_	9	NMOD
9	g	g	NN	_	6	PRN
10	to	to	IN	_	9	NMOD
11	100,000	0	CD	_	12	NMOD
12	g	g	NN	_	10	PMOD
13	)	)	-RRB-	_	9	P
14	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	pellets	pellet	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	washed	wash	VBN	_	3	VC
5	and	and	CC	_	4	COORD
6	resuspended	resuspend	VBN	_	5	CONJ
7	in	in	IN	_	6	LOC
8	storage	storage	NN	_	9	NMOD
9	buffer	buffer	NN	_	7	PMOD
10	(	(	-LRB-	_	14	P
11	0.1	0	CD	_	12	NMOD
12	M	m	NN	_	14	NMOD
13	dipotassium	dipotassium	NN	_	14	NMOD
14	phosphate	phosphate	NN	_	9	PRN
15	,	,	,	_	14	P
16	0.05	0	CD	_	17	NMOD
17	M	m	NN	_	18	NMOD
18	KCl	kcl	NN	_	14	APPO
19	,	,	,	_	18	P
20	1	0	CD	_	21	NMOD
21	mM	mm	NN	_	22	NMOD
22	DTT	dtt	NN	_	18	APPO
23	,	,	,	_	22	P
24	5	0	CD	_	25	NMOD
25	mM	mm	NN	_	27	NMOD
26	disodium	disodium	NN	_	27	NMOD
27	EDTA	edta	NN	_	22	APPO
28	,	,	,	_	27	P
29	20	0	CD	_	30	NMOD
30	%	%	NN	_	31	NMOD
31	glycerol	glycerol	NN	_	27	APPO
32	,	,	,	_	14	P
33	pH	ph	NN	_	14	APPO
34	7.4	0	CD	_	33	NMOD
35	)	)	-RRB-	_	14	P
36	at	at	IN	_	6	ADV
37	25	0	CD	_	40	NMOD
38	–	–	SYM	_	37	P
39	30	0	CD	_	37	QMOD
40	mg	mg	NN	_	41	NMOD
41	protein	protein	NN	_	36	PMOD
42	/	/	SYM	_	43	P
43	ml	ml	NN	_	41	NMOD
44	.	.	.	_	3	P

1	Protein	protein	NN	_	2	NMOD
2	concentrations	concentration	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	determined	determine	VBN	_	3	VC
5	according	accord	VBG	_	4	MNR
6	to	to	IN	_	5	PMOD
7	the	the	DT	_	8	NMOD
8	method	method	NN	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	Lowry	lowry	NNP	_	9	PMOD
11	et	et	FW	_	12	AMOD
12	al.	al.	FW	_	10	NMOD
13	[	[	-LRB-	_	14	P
14	34	0	CD	_	4	PRN
15	]	]	-RRB-	_	14	P
16	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	activity	activity	NN	_	13	SBJ
3	of	of	IN	_	2	NMOD
4	cholesterol	cholesterol	NN	_	8	NMOD
5	7	0	CD	_	6	NMOD
6	α	α	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	hydroxylase	hydroxylase	NN	_	3	PMOD
9	(	(	-LRB-	_	10	P
10	EC	ec	NN	_	8	PRN
11	1.14.12.17	0	CD	_	10	NMOD
12	)	)	-RRB-	_	10	P
13	was	be	VBD	_	0	ROOT
14	measured	measure	VBN	_	13	VC
15	by	by	IN	_	14	MNR
16	an	an	DT	_	19	NMOD
17	isotope	isotope	NN	_	18	NMOD
18	incorporation	incorporation	NN	_	19	NMOD
19	method	method	NN	_	15	PMOD
20	according	accord	VBG	_	14	MNR
21	to	to	IN	_	20	PMOD
22	Shefer	shefer	NNP	_	21	PMOD
23	et	et	FW	_	24	AMOD
24	al.	al.	FW	_	22	NMOD
25	[	[	-LRB-	_	26	P
26	33	0	CD	_	22	PRN
27	]	]	-RRB-	_	26	P
28	with	with	IN	_	22	NMOD
29	some	some	DT	_	30	NMOD
30	modifications	modification	NNS	_	28	PMOD
31	.	.	.	_	13	P

1	The	the	DT	_	3	NMOD
2	reaction	reaction	NN	_	3	NMOD
3	mixture	mixture	NN	_	10	SBJ
4	(	(	-LRB-	_	8	P
5	final	final	JJ	_	6	NMOD
6	volume	volume	NN	_	8	DEP
7	0.5	0	CD	_	8	NMOD
8	ml	ml	NN	_	3	PRN
9	)	)	-RRB-	_	8	P
10	consisted	consist	VBD	_	0	ROOT
11	of	of	IN	_	10	ADV
12	potassium	potassium	NN	_	13	NMOD
13	phosphate	phosphate	NN	_	14	NMOD
14	buffer	buffer	NN	_	40	NMOD
15	(	(	-LRB-	_	18	P
16	100	0	CD	_	17	NMOD
17	mM	mm	NN	_	18	NMOD
18	K2HPO4	k0hpo0	NN	_	14	PRN
19	,	,	,	_	18	P
20	0.1	0	CD	_	21	NMOD
21	mM	mm	NN	_	22	NMOD
22	EDTA	edta	NN	_	18	APPO
23	,	,	,	_	22	P
24	5	0	CD	_	25	NMOD
25	mM	mm	NN	_	26	NMOD
26	DTT	dtt	NN	_	22	APPO
27	,	,	,	_	26	P
28	30	0	CD	_	29	NMOD
29	mM	mm	NN	_	30	NMOD
30	nicotinamide	nicotinamide	NN	_	26	APPO
31	,	,	,	_	18	P
32	pH	ph	NN	_	18	APPO
33	7.4	0	CD	_	32	NMOD
34	)	)	-RRB-	_	18	P
35	,	,	,	_	14	P
36	[	[	-LRB-	_	37	P
37	14C	0c	NN	_	14	PRN
38	]	]	-RRB-	_	37	P
39	-	-	HYPH	_	14	P
40	cholesterol	cholesterol	NN	_	11	PMOD
41	(	(	-LRB-	_	45	P
42	5	0	CD	_	45	NMOD
43	×	×	SYM	_	42	P
44	105	0	CD	_	42	QMOD
45	dpm	dpm	NN	_	40	PRN
46	)	)	-RRB-	_	45	P
47	solubilized	solubilized	VBN	_	40	NMOD
48	in	in	IN	_	47	ADV
49	50	0	CD	_	50	NMOD
50	μl	μl	NN	_	48	PMOD
51	of	of	IN	_	50	NMOD
52	25	0	CD	_	53	NMOD
53	%	%	NN	_	61	NMOD
54	(	(	-LRB-	_	57	P
55	wt	wt	NN	_	57	NMOD
56	/	/	HYPH	_	55	P
57	vol	vol	NN	_	53	PRN
58	)	)	-RRB-	_	57	P
59	β	β	NN	_	61	NMOD
60	-	-	HYPH	_	59	P
61	cyclodextrin	cyclodextrin	NN	_	51	PMOD
62	(	(	-LRB-	_	66	P
63	final	final	JJ	_	64	NMOD
64	concentration	concentration	NN	_	66	DEP
65	0.8	0	CD	_	66	NMOD
66	%	%	NN	_	61	PRN
67	)	)	-RRB-	_	66	P
68	,	,	,	_	50	P
69	and	and	CC	_	50	COORD
70	50	0	CD	_	73	NMOD
71	–	–	SYM	_	70	P
72	200	0	CD	_	70	QMOD
73	μg	μg	NN	_	69	CONJ
74	of	of	IN	_	73	NMOD
75	microsomal	microsomal	JJ	_	76	NMOD
76	protein	protein	NN	_	74	PMOD
77	.	.	.	_	10	P

1	The	the	DT	_	2	NMOD
2	reaction	reaction	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	initiated	initiate	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	the	the	DT	_	7	NMOD
7	addition	addition	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	NADPH	nadph	NN	_	8	PMOD
10	or	or	CC	_	9	COORD
11	an	an	DT	_	15	NMOD
12	NADPH	nadph	NN	_	14	AMOD
13	-	-	HYPH	_	12	P
14	generating	generate	VBG	_	15	NMOD
15	system	system	NN	_	19	NMOD
16	(	(	-LRB-	_	19	P
17	3.4	0	CD	_	18	NMOD
18	mM	mm	NN	_	19	NMOD
19	NADP+	nadp+	NN	_	10	CONJ
20	,	,	,	_	19	P
21	30	0	CD	_	22	NMOD
22	mM	mm	NN	_	27	NMOD
23	glucose	glucose	NN	_	27	NMOD
24	-	-	HYPH	_	23	P
25	6	0	CD	_	23	NMOD
26	-	-	HYPH	_	23	P
27	phosphate	phosphate	NN	_	19	APPO
28	,	,	,	_	27	P
29	0.3	0	CD	_	30	NMOD
30	U	u	NN	_	27	APPO
31	of	of	IN	_	30	NMOD
32	glucose	glucose	NN	_	36	NMOD
33	-	-	HYPH	_	32	P
34	6	0	CD	_	32	NMOD
35	-	-	HYPH	_	32	P
36	phosphate	phosphate	NN	_	37	NMOD
37	dehydrogenase	dehydrogenase	NN	_	31	PMOD
38	)	)	-RRB-	_	3	P
39	and	and	CC	_	3	COORD
40	continued	continue	VBN	_	39	CONJ
41	for	for	IN	_	40	TMP
42	15	0	CD	_	43	NMOD
43	min	min	NN	_	41	PMOD
44	at	at	IN	_	40	ADV
45	37	0	CD	_	46	NMOD
46	°C	°c	NN	_	44	PMOD
47	.	.	.	_	3	P

1	The	the	DT	_	2	NMOD
2	reaction	reaction	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	stopped	stop	VBN	_	3	VC
5	with	with	IN	_	4	MNR
6	0.5	0	CD	_	7	NMOD
7	ml	ml	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	1	0	CD	_	10	NMOD
10	N	n	NN	_	11	NMOD
11	KOH	koh	NN	_	8	PMOD
12	,	,	,	_	7	P
13	5	0	CD	_	14	NMOD
14	μg	μg	NN	_	7	CONJ
15	of	of	IN	_	14	NMOD
16	butylated	butylate	VBN	_	17	NMOD
17	hydroxytoluene	hydroxytoluene	NN	_	15	PMOD
18	,	,	,	_	14	P
19	and	and	CC	_	14	COORD
20	10	0	CD	_	21	NMOD
21	μl	μl	NN	_	19	CONJ
22	of	of	IN	_	21	NMOD
23	ethanolic	ethanolic	JJ	_	25	NMOD
24	potassium	potassium	NN	_	25	NMOD
25	hydroxide	hydroxide	NN	_	22	PMOD
26	.	.	.	_	3	P

1	[	[	-LRB-	_	2	P
2	3H	0h	NN	_	17	PRN
3	]	]	-RRB-	_	2	P
4	7	0	CD	_	5	NMOD
5	α	α	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	hydroxycholesterol	hydroxycholesterol	NN	_	17	SBJ
8	(	(	-LRB-	_	15	P
9	1	0	CD	_	15	NMOD
10	×	×	SYM	_	9	P
11	104	0	CD	_	9	QMOD
12	dpm	dpm	NN	_	15	NMOD
13	/	/	HYPH	_	12	P
14	5	0	CD	_	15	NMOD
15	μg	μg	NN	_	7	PRN
16	)	)	-RRB-	_	15	P
17	was	be	VBD	_	0	ROOT
18	added	add	VBN	_	17	VC
19	as	as	IN	_	18	ADV
20	an	an	DT	_	23	NMOD
21	internal	internal	JJ	_	22	NMOD
22	recovery	recovery	NN	_	23	NMOD
23	standard	standard	NN	_	19	PMOD
24	.	.	.	_	17	P

1	After	after	IN	_	11	TMP
2	saponification	saponification	NN	_	1	PMOD
3	at	at	IN	_	2	NMOD
4	37	0	CD	_	5	NMOD
5	°C	°c	NN	_	3	PMOD
6	for	for	IN	_	2	TMP
7	one	one	CD	_	8	NMOD
8	hour	hour	NN	_	6	PMOD
9	,	,	,	_	11	P
10	sterols	sterol	NNS	_	11	SBJ
11	were	be	VBD	_	0	ROOT
12	extracted	extract	VBN	_	11	VC
13	twice	twice	RB	_	12	TMP
14	with	with	IN	_	12	MNR
15	3	0	CD	_	16	NMOD
16	ml	ml	NN	_	14	PMOD
17	of	of	IN	_	16	NMOD
18	n	n	NN	_	20	NMOD
19	-	-	HYPH	_	18	P
20	hexane	hexane	NN	_	17	PMOD
21	and	and	CC	_	11	COORD
22	the	the	DT	_	23	NMOD
23	extracts	extract	NNS	_	24	SBJ
24	were	be	VBD	_	21	CONJ
25	evaporated	evaporate	VBN	_	24	VC
26	to	to	IN	_	25	ADV
27	dryness	dryness	NN	_	26	PMOD
28	under	under	IN	_	25	ADV
29	nitrogen	nitrogen	NN	_	28	PMOD
30	.	.	.	_	11	P

1	The	the	DT	_	2	NMOD
2	residue	residue	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	dissolved	dissolve	VBN	_	3	VC
5	in	in	IN	_	4	LOC
6	0.3	0	CD	_	7	NMOD
7	ml	ml	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	n	n	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	hexane	hexane	NN	_	15	NMOD
12	:	:	:	_	15	P
13	2	0	CD	_	15	NMOD
14	-	-	HYPH	_	13	P
15	propanol	propanol	NN	_	8	PMOD
16	(	(	-LRB-	_	20	P
17	97.3	0	CD	_	20	NMOD
18	vol	vol	NN	_	20	NMOD
19	/	/	HYPH	_	18	P
20	vol	vol	NN	_	7	PRN
21	)	)	-RRB-	_	20	P
22	and	and	CC	_	4	COORD
23	applied	apply	VBN	_	22	CONJ
24	to	to	IN	_	23	ADV
25	a	a	DT	_	27	NMOD
26	silica	silica	NN	_	27	NMOD
27	column	column	NN	_	24	PMOD
28	(	(	-LRB-	_	36	P
29	500	0	CD	_	30	NMOD
30	mg	mg	NN	_	36	DEP
31	;	;	:	_	36	P
32	sep	sep	NN	_	34	NMOD
33	-	-	HYPH	_	32	P
34	pak	pak	NN	_	36	DEP
35	,	,	,	_	36	P
36	by	by	IN	_	27	PRN
37	4	0	CD	_	38	NMOD
38	ml	ml	NN	_	36	PMOD
39	of	of	IN	_	38	NMOD
40	n	n	NN	_	42	NMOD
41	-	-	HYPH	_	40	P
42	hexane	hexane	NN	_	46	NMOD
43	:	:	:	_	46	P
44	2	0	CD	_	46	NMOD
45	-	-	HYPH	_	44	P
46	propanol	propanol	NN	_	39	PMOD
47	(	(	-LRB-	_	51	P
48	97.3	0	CD	_	51	NMOD
49	vol	vol	NN	_	51	NMOD
50	/	/	HYPH	_	49	P
51	vol	vol	NN	_	38	PRN
52	)	)	-RRB-	_	51	P
53	)	)	-RRB-	_	36	P

1	7	0	CD	_	2	NMOD
2	α	α	NN	_	4	NMOD
3	-	-	HYPH	_	2	P
4	hydroxycholesterol	hydroxycholesterol	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	eluted	elute	VBN	_	5	VC
7	with	with	IN	_	6	MNR
8	3	0	CD	_	9	NMOD
9	ml	ml	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	n	n	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	hexane	hexane	NN	_	17	NMOD
14	:	:	:	_	17	P
15	2	0	CD	_	17	NMOD
16	-	-	HYPH	_	15	P
17	propanol	propanol	NN	_	10	PMOD
18	(	(	-LRB-	_	22	P
19	80	0	CD	_	22	DEP
20	:	:	SYM	_	21	P
21	20	0	CD	_	19	NMOD
22	vol	vol	NN	_	9	PRN
23	:	:	SYM	_	24	P
24	vol	vol	NN	_	22	NMOD
25	)	)	-RRB-	_	22	P
26	and	and	CC	_	6	COORD
27	further	far	RB	_	28	ADV
28	isolated	isolate	VBN	_	26	CONJ
29	by	by	IN	_	28	MNR
30	TLC	tlc	NN	_	29	PMOD
31	on	on	IN	_	28	LOC
32	silica	silica	NN	_	33	NMOD
33	gel	gel	NN	_	34	NMOD
34	plates	plate	NNS	_	31	PMOD
35	(	(	-LRB-	_	41	P
36	Silica	silica	NN	_	37	NMOD
37	gel	gel	NN	_	41	DEP
38	60	0	CD	_	37	NMOD
39	,	,	,	_	41	P
40	EM	em	NNP	_	41	NMOD
41	Science	science	NNP	_	28	PRN
42	,	,	,	_	41	P
43	Gibbestown	gibbestown	NNP	_	41	APPO
44	,	,	,	_	43	P
45	NJ	nj	NNP	_	43	APPO
46	,	,	,	_	45	P
47	USA	usa	NNP	_	45	APPO
48	)	)	-RRB-	_	41	P
49	with	with	IN	_	28	MNR
50	diethyl	diethyl	NN	_	51	NMOD
51	ether	ether	NN	_	49	PMOD
52	,	,	,	_	28	P
53	and	and	CC	_	28	COORD
54	quantified	quantify	VBN	_	53	CONJ
55	by	by	IN	_	54	MNR
56	liquid	liquid	NN	_	58	NMOD
57	scintillation	scintillation	NN	_	58	NMOD
58	counting	counting	NN	_	55	PMOD
59	using	use	VBG	_	54	MNR
60	Ecolume	ecolume	NNP	_	59	OBJ
61	(	(	-LRB-	_	63	P
62	ICN	icn	NN	_	63	NMOD
63	Radiochemicals	radiochemicals	NNP	_	60	PRN
64	Irvine	irvine	NNP	_	63	LOC
65	,	,	,	_	64	P
66	CA	ca	NNP	_	64	APPO
67	,	,	,	_	66	P
68	USA	usa	NNP	_	66	APPO
69	)	)	-RRB-	_	63	P
70	.	.	.	_	5	P

1	Assays	assay	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	carried	carry	VBN	_	2	VC
4	out	out	RP	_	3	PRT
5	in	in	IN	_	3	ADV
6	duplicate	duplicate	NN	_	5	PMOD
7	with	with	IN	_	3	ADV
8	correction	correction	NN	_	7	PMOD
9	for	for	IN	_	8	NMOD
10	zero	zero	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	time	time	NN	_	13	NMOD
13	controls	control	NNS	_	9	PMOD
14	.	.	.	_	2	P

1	HMG	hmg	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	CoA	coa	NN	_	4	NMOD
4	reductase	reductase	NN	_	9	NMOD
5	(	(	-LRB-	_	6	P
6	EC	ec	NN	_	4	PRN
7	1.1.1.3.4	0	CD	_	6	NMOD
8	)	)	-RRB-	_	6	P
9	activity	activity	NN	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	determined	determine	VBN	_	10	VC
12	according	accord	VBG	_	11	ADV
13	to	to	IN	_	12	PMOD
14	the	the	DT	_	15	NMOD
15	method	method	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	Xu	xu	NNP	_	16	PMOD
18	et	et	FW	_	19	AMOD
19	al.	al.	FW	_	17	NMOD
20	[	[	-LRB-	_	21	P
21	35	0	CD	_	17	PRN
22	]	]	-RRB-	_	21	P
23	with	with	IN	_	11	ADV
24	modifications	modification	NNS	_	23	PMOD
25	as	as	IN	_	11	ADV
26	described	describe	VBN	_	25	SUB
27	[	[	-LRB-	_	28	P
28	36	0	CD	_	26	PRN
29	]	]	-RRB-	_	28	P
30	.	.	.	_	10	P

1	Statistical	statistical	JJ	_	2	NMOD
2	analysis	analysis	NN	_	0	ROOT

1	Data	datum	NNS	_	2	SBJ
2	are	be	VBP	_	0	ROOT
3	shown	show	VBN	_	2	VC
4	as	as	IN	_	3	ADV
5	means	mean	NN	_	7	NMOD
6	±	±	SYM	_	7	P
7	SD	sd	NN	_	4	PMOD
8	.	.	.	_	2	P

1	The	the	DT	_	2	NMOD
2	Student	student	NNP	_	5	NMOD
3	's	's	POS	_	2	NMOD
4	t	t	NN	_	5	NMOD
5	test	test	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	used	use	VBN	_	6	VC
8	to	to	TO	_	7	PRP
9	determine	determine	VB	_	8	IM
10	the	the	DT	_	12	NMOD
11	statistical	statistical	JJ	_	12	NMOD
12	significance	significance	NN	_	9	OBJ
13	of	of	IN	_	12	NMOD
14	differences	difference	NNS	_	13	PMOD
15	between	between	IN	_	14	NMOD
16	the	the	DT	_	17	NMOD
17	groups	group	NNS	_	15	PMOD
18	of	of	IN	_	17	NMOD
19	animals	animal	NNS	_	18	PMOD
20	.	.	.	_	6	P

1	Significance	significance	NN	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	set	set	VBN	_	2	VC
4	at	at	IN	_	3	LOC
5	P	p	NN	_	6	NMOD
6	values	value	NNS	_	4	PMOD
7	<	<	SYM	_	8	P
8	0.05	0	CD	_	6	NMOD
9	.	.	.	_	2	P

1	Results	result	NNS	_	0	ROOT

1	Isolation	isolation	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Abcg8	abcg0	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	sterolin	sterolin	NN	_	8	AMOD
6	-	-	HYPH	_	5	P
7	2	0	CD	_	5	NMOD
8	deficient	deficient	JJ	_	9	NMOD
9	mice	mouse	NNS	_	2	PMOD

1	The	the	DT	_	3	NMOD
2	targeting	target	VBG	_	3	NMOD
3	construct	construct	NN	_	8	SBJ
4	(	(	-LRB-	_	6	P
5	Figure	figure	NN	_	6	NMOD
6	1a	0a	NN	_	3	PRN
7	)	)	-RRB-	_	6	P
8	results	result	VBZ	_	0	ROOT
9	in	in	IN	_	8	ADV
10	the	the	DT	_	12	NMOD
11	potential	potential	JJ	_	12	NMOD
12	disruption	disruption	NN	_	9	PMOD
13	of	of	IN	_	12	NMOD
14	normal	normal	JJ	_	15	NMOD
15	splicing	splicing	NN	_	13	PMOD
16	,	,	,	_	12	P
17	as	as	RB	_	19	ADV
18	well	well	RB	_	19	ADV
19	as	as	IN	_	12	COORD
20	loss	loss	NN	_	19	CONJ
21	of	of	IN	_	20	NMOD
22	some	some	DT	_	24	NMOD
23	coding	code	VBG	_	24	NMOD
24	sequences	sequence	NNS	_	21	PMOD
25	involving	involve	VBG	_	24	NMOD
26	exons	exon	NNS	_	27	NMOD
27	3	0	CD	_	25	OBJ
28	and	and	CC	_	27	COORD
29	4	0	CD	_	28	CONJ
30	.	.	.	_	8	P

1	After	after	IN	_	25	TMP
2	ES	e	NN	_	3	NMOD
3	cell	cell	NN	_	4	NMOD
4	electroporation	electroporation	NN	_	1	PMOD
5	with	with	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	linearized	linearize	VBN	_	10	NMOD
8	targeted	target	VBN	_	10	NMOD
9	plasmid	plasmid	NN	_	10	NMOD
10	DNA	dna	NN	_	5	PMOD
11	,	,	,	_	25	P
12	two	two	CD	_	16	NMOD
13	homologous	homologous	JJ	_	16	NMOD
14	recombinant	recombinant	JJ	_	16	NMOD
15	ES	e	NN	_	16	NMOD
16	clones	clone	NNS	_	25	SBJ
17	(	(	-LRB-	_	16	P
18	out	out	IN	_	16	NMOD
19	of	of	IN	_	18	PMOD
20	58	0	CD	_	22	NMOD
21	ES	e	NN	_	22	NMOD
22	clones	clone	NNS	_	19	PMOD
23	screened	screen	VBN	_	22	NMOD
24	)	)	-RRB-	_	25	P
25	were	be	VBD	_	0	ROOT
26	identified	identify	VBN	_	25	VC
27	.	.	.	_	25	P

1	Blastocyst	blastocyst	NN	_	2	NMOD
2	injection	injection	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	these	these	DT	_	3	PMOD
5	resulted	result	VBD	_	0	ROOT
6	in	in	IN	_	5	ADV
7	five	five	CD	_	10	NMOD
8	highly	highly	RB	_	9	AMOD
9	chimeric	chimeric	JJ	_	10	NMOD
10	mice	mouse	NNS	_	6	PMOD
11	(	(	-LRB-	_	13	P
12	three	three	CD	_	13	NMOD
13	males	male	NNS	_	10	PRN
14	,	,	,	_	13	P
15	two	two	CD	_	16	NMOD
16	females	female	NNS	_	13	APPO
17	)	)	-RRB-	_	13	P
18	.	.	.	_	5	P

1	One	one	CD	_	2	NMOD
2	male	male	NN	_	14	SBJ
3	and	and	CC	_	2	COORD
4	one	one	CD	_	5	NMOD
5	female	female	NN	_	3	CONJ
6	,	,	,	_	2	P
7	both	both	DT	_	8	DEP
8	from	from	IN	_	2	NMOD
9	the	the	DT	_	12	NMOD
10	same	same	JJ	_	12	NMOD
11	ES	e	NN	_	12	NMOD
12	clone	clone	NN	_	8	PMOD
13	,	,	,	_	14	P
14	showed	show	VBD	_	0	ROOT
15	germline	germline	NN	_	14	DEP
16	transmission	transmission	NN	_	14	DEP
17	and	and	CC	_	14	COORD
18	the	the	DT	_	20	NMOD
19	female	female	JJ	_	20	NMOD
20	line	line	NN	_	21	SBJ
21	was	be	VBD	_	17	CONJ
22	used	use	VBN	_	21	VC
23	to	to	TO	_	22	PRP
24	establish	establish	VB	_	23	IM
25	a	a	DT	_	27	NMOD
26	multi-generational	multi-generational	JJ	_	27	NMOD
27	colony	colony	NN	_	24	OBJ
28	bred	breed	VBN	_	27	NMOD
29	onto	onto	IN	_	28	ADV
30	a	a	DT	_	34	NMOD
31	C57Bl	c0bl	NN	_	33	NMOD
32	/	/	HYPH	_	31	P
33	6J	0j	NN	_	34	NMOD
34	background	background	NN	_	29	PMOD
35	.	.	.	_	14	P

1	Heterozygous	heterozygous	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	fertile	fertile	JJ	_	3	PRD
5	and	and	CC	_	3	COORD
6	gave	give	VBD	_	5	CONJ
7	rise	rise	NN	_	6	OBJ
8	to	to	IN	_	6	ADV
9	normal	normal	JJ	_	11	NMOD
10	litter	litter	JJ	_	11	NMOD
11	sizes	size	NNS	_	8	PMOD
12	.	.	.	_	3	P

1	Breeding	breed	VBG	_	4	SBJ
2	heterozygous	heterozygous	JJ	_	3	NMOD
3	animals	animal	NNS	_	1	OBJ
4	led	lead	VBD	_	0	ROOT
5	to	to	IN	_	4	ADV
6	wild	wild	JJ	_	8	NMOD
7	-	-	HYPH	_	6	P
8	type	type	NN	_	13	NMOD
9	,	,	,	_	13	P
10	heterozygous	heterozygous	JJ	_	13	NMOD
11	and	and	CC	_	10	COORD
12	homozygous	homozygous	JJ	_	11	CONJ
13	knockout	knockout	NN	_	14	NMOD
14	mice	mouse	NNS	_	5	PMOD
15	in	in	IN	_	14	LOC
16	the	the	DT	_	19	NMOD
17	expected	expect	VBN	_	19	NMOD
18	Mendelian	mendelian	JJ	_	19	NMOD
19	distribution	distribution	NN	_	15	PMOD
20	(	(	-LRB-	_	23	P
21	data	datum	NNS	_	23	SBJ
22	not	not	RB	_	23	ADV
23	shown	show	VBN	_	4	PRN
24	)	)	-RRB-	_	23	P
25	.	.	.	_	4	P

1	Although	although	IN	_	7	ADV
2	not	not	RB	_	3	ADV
3	quantitative	quantitative	JJ	_	1	SUB
4	,	,	,	_	7	P
5	Northern	northern	NNP	_	6	NMOD
6	analyses	analysis	NNS	_	7	SBJ
7	showed	show	VBD	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	while	while	IN	_	23	ADV
10	the	the	DT	_	12	NMOD
11	knockout	knockout	NN	_	12	NMOD
12	mice	mouse	NNS	_	13	SBJ
13	showed	show	VBD	_	9	SUB
14	no	no	DT	_	16	NMOD
15	detectable	detectable	JJ	_	16	NMOD
16	mRNA	mrna	NN	_	13	OBJ
17	for	for	IN	_	16	NMOD
18	Abcg8	abcg0	NN	_	17	PMOD
19	,	,	,	_	23	P
20	expression	expression	NN	_	23	SBJ
21	of	of	IN	_	20	NMOD
22	Abcg5	abcg0	NN	_	21	PMOD
23	appeared	appear	VBD	_	8	SUB
24	unaltered	unaltered	JJ	_	23	OPRD
25	(	(	-LRB-	_	27	P
26	Figure	figure	NN	_	27	NMOD
27	1c	0c	NN	_	7	PRN
28	)	)	-RRB-	_	27	P
29	.	.	.	_	7	P

1	To	to	TO	_	38	PRP
2	exclude	exclude	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	possibility	possibility	NN	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	alternative	alternative	JJ	_	7	NMOD
7	splicing	splicing	NN	_	5	PMOD
8	with	with	IN	_	7	NMOD
9	the	the	DT	_	10	NMOD
10	production	production	NN	_	8	PMOD
11	of	of	IN	_	10	NMOD
12	a	a	DT	_	21	NMOD
13	non-functional	non-functional	JJ	_	21	NMOD
14	but	but	CC	_	13	COORD
15	truncated	truncate	VBN	_	14	CONJ
16	Abcg8	abcg0	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	sterolin	sterolin	NN	_	21	NMOD
19	-	-	HYPH	_	18	P
20	2	0	CD	_	18	NMOD
21	protein	protein	NN	_	11	PMOD
22	that	that	WDT	_	23	SBJ
23	may	may	MD	_	21	NMOD
24	serve	serve	VB	_	23	VC
25	as	as	IN	_	24	ADV
26	a	a	DT	_	27	NMOD
27	chaperone	chaperone	NN	_	25	PMOD
28	for	for	IN	_	27	NMOD
29	Abcg5	abcg0	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	sterolin	sterolin	NN	_	28	PMOD
32	-	-	HYPH	_	31	P
33	1	0	CD	_	31	NMOD
34	,	,	,	_	38	P
35	RT	rt	NN	_	37	NMOD
36	-	-	HYPH	_	35	P
37	PCR	pcr	NN	_	38	SBJ
38	was	be	VBD	_	0	ROOT
39	performed	perform	VBN	_	38	VC
40	on	on	IN	_	39	ADV
41	cDNA	cdna	NN	_	40	PMOD
42	reverse	reverse	RB	_	43	ADV
43	transcribed	transcribe	VBN	_	41	NMOD
44	from	from	IN	_	43	ADV
45	total	total	JJ	_	47	NMOD
46	liver	liver	NN	_	47	NMOD
47	RNA	rna	NN	_	44	PMOD
48	from	from	IN	_	47	NMOD
49	Abcg8	abcg0	NN	_	51	AMOD
50	-	-	HYPH	_	49	P
51	deficient	deficient	JJ	_	52	NMOD
52	mice	mouse	NNS	_	48	PMOD
53	.	.	.	_	38	P

1	No	no	DT	_	2	NMOD
2	mRNA	mrna	NN	_	9	SBJ
3	for	for	IN	_	2	NMOD
4	Abcg8	abcg0	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	3	PMOD
7	-	-	HYPH	_	6	P
8	2	0	CD	_	6	NMOD
9	was	be	VBD	_	0	ROOT
10	detected	detect	VBN	_	9	VC
11	containing	contain	VBG	_	2	NMOD
12	any	any	DT	_	13	NMOD
13	sequences	sequence	NNS	_	11	OBJ
14	downstream	downstream	RB	_	13	LOC
15	of	of	IN	_	14	AMOD
16	exon	exon	NN	_	15	PMOD
17	4	0	CD	_	16	NMOD
18	in	in	IN	_	10	LOC
19	the	the	DT	_	23	NMOD
20	Abcg8	abcg0	NN	_	22	AMOD
21	-	-	HYPH	_	20	P
22	deficient	deficient	JJ	_	23	NMOD
23	mice	mouse	NNS	_	18	PMOD
24	,	,	,	_	10	P
25	whether	whether	IN	_	10	ADV
26	primers	primer	NNS	_	27	SBJ
27	were	be	VBD	_	25	SUB
28	located	locate	VBN	_	27	VC
29	in	in	IN	_	28	LOC
30	exons	exon	NNS	_	31	NMOD
31	4	0	CD	_	29	PMOD
32	and	and	CC	_	31	COORD
33	13	0	CD	_	32	CONJ
34	,	,	,	_	31	P
35	exons	exon	NNS	_	36	NMOD
36	9	0	CD	_	31	CONJ
37	and	and	CC	_	36	COORD
38	13	0	CD	_	37	CONJ
39	or	or	CC	_	36	COORD
40	exons	exon	NNS	_	41	NMOD
41	10	0	CD	_	39	CONJ
42	and	and	CC	_	41	COORD
43	13	0	CD	_	42	CONJ
44	(	(	-LRB-	_	48	P
45	Figure	figure	NN	_	48	NMOD
46	1d	0d	NN	_	48	NMOD
47	,	,	,	_	48	P
48	1e	0e	NN	_	10	PRN
49	)	)	-RRB-	_	48	P
50	.	.	.	_	9	P

1	This	this	DT	_	2	SBJ
2	demonstrates	demonstrate	VBZ	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	if	if	IN	_	18	ADV
5	an	an	DT	_	8	NMOD
6	alternatively	alternatively	RB	_	7	AMOD
7	spliced	splice	VBN	_	8	NMOD
8	message	message	NN	_	9	SBJ
9	could	could	MD	_	4	SUB
10	potentially	potentially	RB	_	9	ADV
11	code	code	VB	_	9	VC
12	for	for	IN	_	11	ADV
13	a	a	DT	_	15	NMOD
14	truncated	truncate	VBN	_	15	NMOD
15	protein	protein	NN	_	12	PMOD
16	,	,	,	_	18	P
17	it	it	PRP	_	18	SBJ
18	is	be	VBZ	_	3	SUB
19	not	not	RB	_	18	ADV
20	detectable	detectable	JJ	_	18	PRD
21	in	in	IN	_	18	LOC
22	the	the	DT	_	26	NMOD
23	Abcg8	abcg0	NN	_	25	AMOD
24	-	-	HYPH	_	23	P
25	deficient	deficient	JJ	_	26	NMOD
26	mice	mouse	NNS	_	21	PMOD
27	.	.	.	_	2	P

1	The	the	DT	_	5	NMOD
2	membrane	membrane	NN	_	4	AMOD
3	-	-	HYPH	_	2	P
4	spanning	span	VBG	_	5	NMOD
5	domains	domain	NNS	_	12	SBJ
6	of	of	IN	_	5	NMOD
7	Abcg8	abcg0	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	sterolin	sterolin	NN	_	6	PMOD
10	-	-	HYPH	_	9	P
11	2	0	CD	_	9	NMOD
12	are	be	VBP	_	0	ROOT
13	encoded	encode	VBN	_	12	VC
14	by	by	IN	_	13	LGS
15	exons	exon	NNS	_	16	NMOD
16	9	0	CD	_	14	PMOD
17	–	–	SYM	_	18	P
18	13	0	CD	_	16	NMOD
19	.	.	.	_	12	P

1	Sterol	sterol	NN	_	2	NMOD
2	levels	level	NNS	_	0	ROOT
3	in	in	IN	_	2	LOC
4	Abcg8	abcg0	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	9	AMOD
7	-	-	HYPH	_	6	P
8	2	0	CD	_	6	NMOD
9	deficient	deficient	JJ	_	10	NMOD
10	animals	animal	NNS	_	3	PMOD

1	Elevated	elevated	JJ	_	3	NMOD
2	plant	plant	NN	_	3	NMOD
3	sterols	sterol	NNS	_	8	SBJ
4	in	in	IN	_	3	LOC
5	tissue	tissue	NN	_	4	PMOD
6	and	and	CC	_	5	COORD
7	plasma	plasma	NN	_	6	CONJ
8	are	be	VBP	_	0	ROOT
9	diagnostic	diagnostic	JJ	_	8	PRD
10	of	of	IN	_	9	AMOD
11	sitosterolemia	sitosterolemia	NN	_	10	PMOD
12	.	.	.	_	8	P

1	Sterol	sterol	NN	_	2	NMOD
2	levels	level	NNS	_	25	SBJ
3	,	,	,	_	2	P
4	as	as	IN	_	2	ADV
5	determined	determine	VBN	_	4	SUB
6	by	by	IN	_	5	MNR
7	gas	gas	NN	_	8	NMOD
8	chromatography	chromatography	NN	_	10	NMOD
9	(	(	-LRB-	_	10	P
10	GC	gc	NN	_	12	NMOD
11	)	)	-RRB-	_	12	P
12	analysis	analysis	NN	_	6	PMOD
13	,	,	,	_	2	P
14	in	in	IN	_	2	LOC
15	plasma	plasma	NN	_	14	PMOD
16	and	and	CC	_	15	COORD
17	tissues	tissue	NNS	_	16	CONJ
18	of	of	IN	_	15	NMOD
19	the	the	DT	_	24	NMOD
20	Abcg8	abcg0	NN	_	24	NMOD
21	-	-	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	-	-	SYM	_	20	P
24	mice	mouse	NNS	_	18	PMOD
25	are	be	VBP	_	0	ROOT
26	shown	show	VBN	_	25	VC
27	in	in	IN	_	26	LOC
28	Table	table	NN	_	27	PMOD
29	2	0	CD	_	28	NMOD
30	.	.	.	_	25	P

1	There	there	EX	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	4	NMOD
4	differences	difference	NNS	_	2	PRD
5	in	in	IN	_	4	NMOD
6	tissue	tissue	NN	_	7	NMOD
7	weights	weight	NNS	_	5	PMOD
8	between	between	IN	_	4	NMOD
9	wild	wild	JJ	_	10	NMOD
10	types	type	NNS	_	8	PMOD
11	,	,	,	_	10	P
12	heterozygotes	heterozygote	NNS	_	10	CONJ
13	and	and	CC	_	12	COORD
14	knockouts	knockout	NNS	_	13	CONJ
15	.	.	.	_	2	P

1	Plasma	plasma	NN	_	2	NMOD
2	cholesterol	cholesterol	NN	_	3	NMOD
3	levels	level	NNS	_	10	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	9	NMOD
6	homozygous	homozygous	JJ	_	9	NMOD
7	and	and	CC	_	6	COORD
8	heterozygous	heterozygous	JJ	_	7	CONJ
9	mice	mouse	NNS	_	4	PMOD
10	were	be	VBD	_	0	ROOT
11	decreased	decrease	VBN	_	10	VC
12	by	by	IN	_	11	EXT
13	52	0	CD	_	14	NMOD
14	%	%	NN	_	12	PMOD
15	and	and	CC	_	14	COORD
16	26	0	CD	_	17	NMOD
17	%	%	NN	_	15	CONJ
18	,	,	,	_	11	P
19	respectively	respectively	RB	_	11	ADV
20	,	,	,	_	11	P
21	compared	compare	VBN	_	11	ADV
22	to	to	IN	_	21	PMOD
23	those	those	DT	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	28	NMOD
28	mice	mouse	NNS	_	24	PMOD
29	(	(	-LRB-	_	36	P
30	n	n	NN	_	32	SBJ
31	=	=	SYM	_	32	P
32	3	0	CD	_	36	DEP
33	all	all	DT	_	34	NMOD
34	groups	group	NNS	_	36	DEP
35	,	,	,	_	36	P
36	Table	table	NN	_	11	PRN
37	2	0	CD	_	36	NMOD
38	)	)	-RRB-	_	36	P
39	.	.	.	_	10	P

1	Plant	plant	NN	_	2	NMOD
2	sterols	sterol	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	almost	almost	RB	_	5	AMOD
5	undetectable	undetectable	JJ	_	3	PRD
6	in	in	IN	_	3	LOC
7	wild	wild	JJ	_	9	NMOD
8	-	-	HYPH	_	7	P
9	type	type	NN	_	12	NMOD
10	and	and	CC	_	9	COORD
11	heterozygous	heterozygous	JJ	_	10	CONJ
12	mice	mouse	NNS	_	6	PMOD
13	,	,	,	_	3	P
14	but	but	CC	_	3	COORD
15	were	be	VBD	_	14	CONJ
16	significantly	significantly	RB	_	15	ADV
17	elevated	elevate	VBN	_	15	VC
18	in	in	IN	_	17	LOC
19	Abcg8	abcg0	NN	_	23	NMOD
20	-	-	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	mice	mouse	NNS	_	18	PMOD
24	.	.	.	_	3	P

1	Plasma	plasma	NN	_	5	NMOD
2	campesterol	campesterol	NN	_	5	NMOD
3	and	and	CC	_	2	COORD
4	sitosterol	sitosterol	NN	_	3	CONJ
5	levels	level	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	eight	eight	CD	_	11	AMOD
8	-	-	HYPH	_	7	P
9	and	and	CC	_	7	COORD
10	36-fold	0-fold	RB	_	9	CONJ
11	higher	high	JJR	_	6	PRD
12	in	in	IN	_	6	LOC
13	Abcg8	abcg0	NN	_	17	NMOD
14	-	-	SYM	_	13	P
15	/	/	HYPH	_	13	P
16	-	-	SYM	_	13	P
17	mice	mouse	NNS	_	12	PMOD
18	compared	compare	VBN	_	6	ADV
19	to	to	IN	_	18	PMOD
20	wild	wild	JJ	_	22	NMOD
21	-	-	HYPH	_	20	P
22	type	type	NN	_	23	NMOD
23	mice	mouse	NNS	_	19	PMOD
24	(	(	-LRB-	_	32	P
25	8.76	0	CD	_	32	NMOD
26	±	±	SYM	_	25	P
27	2.10	0	CD	_	25	QMOD
28	and	and	CC	_	25	COORD
29	18.52	0	CD	_	28	CONJ
30	±	±	SYM	_	29	P
31	5.03	0	CD	_	29	QMOD
32	mg	mg	NN	_	6	PRN
33	/	/	SYM	_	34	P
34	dL	dl	NN	_	32	NMOD
35	,	,	,	_	32	P
36	respectively	respectively	RB	_	32	NMOD
37	,	,	,	_	32	P
38	versus	versus	CC	_	32	COORD
39	1.14	0	CD	_	46	NMOD
40	±	±	SYM	_	39	P
41	0.69	0	CD	_	39	QMOD
42	and	and	CC	_	39	COORD
43	0.50	0	CD	_	42	CONJ
44	±	±	SYM	_	43	P
45	0.55	0	CD	_	43	QMOD
46	mg	mg	NN	_	38	CONJ
47	/	/	SYM	_	48	P
48	dL	dl	NN	_	46	NMOD
49	)	)	-RRB-	_	32	P
50	.	.	.	_	6	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	difference	difference	NN	_	2	PRD
6	in	in	IN	_	5	NMOD
7	the	the	DT	_	11	NMOD
8	plasma	plasma	NN	_	10	NMOD
9	plant	plant	NN	_	10	NMOD
10	sterol	sterol	NN	_	11	NMOD
11	levels	level	NNS	_	6	PMOD
12	between	between	IN	_	2	ADV
13	heterozygous	heterozygous	JJ	_	18	NMOD
14	and	and	CC	_	13	COORD
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	14	CONJ
18	mice	mouse	NNS	_	12	PMOD
19	.	.	.	_	2	P

1	Liver	liver	NN	_	2	NMOD
2	cholesterol	cholesterol	NN	_	3	NMOD
3	content	content	NN	_	11	SBJ
4	of	of	IN	_	3	NMOD
5	the	the	DT	_	10	NMOD
6	Abcg8	abcg0	NN	_	10	NMOD
7	-	-	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	-	-	SYM	_	6	P
10	mice	mouse	NNS	_	4	PMOD
11	was	be	VBD	_	0	ROOT
12	reduced	reduce	VBN	_	11	VC
13	by	by	IN	_	12	EXT
14	~	~	SYM	_	15	P
15	50	0	CD	_	16	NMOD
16	%	%	NN	_	13	PMOD
17	relative	relative	JJ	_	12	ADV
18	to	to	IN	_	17	AMOD
19	wild	wild	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	type	type	NN	_	22	NMOD
22	liver	liver	NN	_	18	PMOD
23	(	(	-LRB-	_	27	P
24	1202	0	CD	_	27	NMOD
25	±	±	SYM	_	24	P
26	264	0	CD	_	24	QMOD
27	μg	μg	NN	_	12	PRN
28	/	/	SYM	_	32	P
29	g	g	NN	_	32	NMOD
30	wet	wet	JJ	_	31	NMOD
31	weight	weight	NN	_	32	NMOD
32	tissue	tissue	NN	_	27	NMOD
33	,	,	,	_	27	P
34	versus	versus	CC	_	27	COORD
35	2280	0	CD	_	38	NMOD
36	±	±	SYM	_	35	P
37	310	0	CD	_	35	QMOD
38	μg	μg	NN	_	34	CONJ
39	/	/	SYM	_	43	P
40	g	g	NN	_	43	NMOD
41	wet	wet	JJ	_	42	NMOD
42	weight	weight	NN	_	43	NMOD
43	tissue	tissue	NN	_	38	NMOD
44	,	,	,	_	27	P
45	respectively	respectively	RB	_	27	NMOD
46	)	)	-RRB-	_	27	P
47	.	.	.	_	11	P

1	The	the	DT	_	4	NMOD
2	reduced	reduce	VBN	_	4	NMOD
3	cholesterol	cholesterol	NN	_	4	NMOD
4	content	content	NN	_	5	SBJ
5	was	be	VBD	_	0	ROOT
6	offset	offset	VBN	_	5	VC
7	by	by	IN	_	6	LGS
8	a	a	DT	_	10	NMOD
9	five-fold	five-fold	RB	_	10	NMOD
10	increase	increase	NN	_	7	PMOD
11	in	in	IN	_	10	NMOD
12	campesterol	campesterol	NN	_	11	PMOD
13	and	and	CC	_	10	COORD
14	a	a	DT	_	16	NMOD
15	22-fold	0-fold	RB	_	16	NMOD
16	increase	increase	NN	_	13	CONJ
17	in	in	IN	_	16	NMOD
18	sitosterol	sitosterol	NN	_	17	PMOD
19	(	(	-LRB-	_	27	P
20	233.9	0	CD	_	27	NMOD
21	±	±	SYM	_	20	P
22	48.1	0	CD	_	20	QMOD
23	and	and	CC	_	20	COORD
24	376.3	0	CD	_	23	CONJ
25	±	±	SYM	_	24	P
26	96.1	0	CD	_	24	QMOD
27	μg	μg	NN	_	10	PRN
28	/	/	SYM	_	32	P
29	g	g	NN	_	32	NMOD
30	wet	wet	JJ	_	31	NMOD
31	weight	weight	NN	_	32	NMOD
32	tissue	tissue	NN	_	27	NMOD
33	,	,	,	_	27	P
34	respectively	respectively	RB	_	27	NMOD
35	)	)	-RRB-	_	27	P
36	in	in	IN	_	10	LOC
37	Abcg8	abcg0	NN	_	41	NMOD
38	-	-	SYM	_	37	P
39	/	/	HYPH	_	37	P
40	-	-	SYM	_	37	P
41	knockout	knockout	NN	_	42	NMOD
42	mice	mouse	NNS	_	36	PMOD
43	compared	compare	VBN	_	10	NMOD
44	to	to	IN	_	43	PMOD
45	wild	wild	JJ	_	47	NMOD
46	-	-	HYPH	_	45	P
47	type	type	NN	_	48	NMOD
48	mice	mouse	NNS	_	44	PMOD
49	(	(	-LRB-	_	66	P
50	52.2	0	CD	_	57	NMOD
51	±	±	SYM	_	50	P
52	15.0	0	CD	_	50	QMOD
53	and	and	CC	_	50	COORD
54	16.7	0	CD	_	53	CONJ
55	±	±	SYM	_	54	P
56	8.6	0	CD	_	54	QMOD
57	μg	μg	NN	_	66	DEP
58	/	/	SYM	_	62	P
59	g	g	NN	_	62	NMOD
60	wet	wet	JJ	_	61	NMOD
61	weight	weight	NN	_	62	NMOD
62	tissue	tissue	NN	_	57	NMOD
63	,	,	,	_	57	P
64	respectively	respectively	RB	_	57	NMOD
65	,	,	,	_	66	P
66	Table	table	NN	_	6	PRN
67	2	0	CD	_	66	NMOD
68	)	)	-RRB-	_	66	P
69	.	.	.	_	5	P

1	There	there	EX	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	no	no	DT	_	5	NMOD
4	significant	significant	JJ	_	5	NMOD
5	differences	difference	NNS	_	2	PRD
6	of	of	IN	_	5	NMOD
7	liver	liver	NN	_	8	NMOD
8	cholesterol	cholesterol	NN	_	12	NMOD
9	or	or	CC	_	8	COORD
10	plant	plant	NN	_	11	NMOD
11	sterol	sterol	NN	_	9	CONJ
12	contents	content	NNS	_	6	PMOD
13	between	between	IN	_	5	NMOD
14	Abcg8	abcg0	NN	_	23	NMOD
15	+	+	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	+	+	SYM	_	14	P
18	and	and	CC	_	14	COORD
19	Abcg8	abcg0	NN	_	18	CONJ
20	+	+	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	mice	mouse	NNS	_	13	PMOD
24	.	.	.	_	2	P

1	Spleen	spleen	NN	_	2	NMOD
2	sterol	sterol	NN	_	3	NMOD
3	contents	content	NNS	_	4	SBJ
4	reflected	reflect	VBD	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	liver	liver	NN	_	7	NMOD
7	profiles	profile	NNS	_	4	OBJ
8	(	(	-LRB-	_	9	P
9	Table	table	NN	_	4	PRN
10	2	0	CD	_	9	NMOD
11	)	)	-RRB-	_	9	P
12	.	.	.	_	4	P

1	No	no	DT	_	3	NMOD
2	significant	significant	JJ	_	3	NMOD
3	differences	difference	NNS	_	8	SBJ
4	in	in	IN	_	3	NMOD
5	brain	brain	NN	_	7	NMOD
6	sterol	sterol	NN	_	7	NMOD
7	contents	content	NNS	_	4	PMOD
8	were	be	VBD	_	0	ROOT
9	observed	observe	VBN	_	8	VC
10	,	,	,	_	9	P
11	as	as	IN	_	9	ADV
12	would	would	MD	_	11	SUB
13	be	be	VB	_	12	VC
14	expected	expect	VBN	_	13	VC
15	,	,	,	_	9	P
16	since	since	IN	_	9	PRP
17	the	the	DT	_	20	NMOD
18	blood	blood	NN	_	19	NMOD
19	brain	brain	NN	_	20	NMOD
20	barrier	barrier	NN	_	21	SBJ
21	is	be	VBZ	_	16	SUB
22	intact	intact	JJ	_	21	PRD
23	and	and	CC	_	21	COORD
24	prevents	prevent	VBZ	_	23	CONJ
25	entry	entry	NN	_	24	OBJ
26	of	of	IN	_	25	NMOD
27	these	these	DT	_	28	NMOD
28	sterols	sterol	NNS	_	26	PMOD
29	in	in	IN	_	24	LOC
30	sitosterolemia	sitosterolemia	NN	_	29	PMOD
31	(	(	-LRB-	_	32	P
32	Table	table	NN	_	9	PRN
33	2	0	CD	_	32	NMOD
34	)	)	-RRB-	_	32	P
35	.	.	.	_	8	P

1	There	there	EX	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	only	only	RB	_	2	ADV
4	traces	trace	NNS	_	2	PRD
5	of	of	IN	_	4	NMOD
6	plant	plant	NN	_	7	NMOD
7	sterols	sterol	NNS	_	5	PMOD
8	in	in	IN	_	2	LOC
9	the	the	DT	_	10	NMOD
10	brains	brain	NNS	_	8	PMOD
11	from	from	IN	_	10	NMOD
12	knockout	knockout	NN	_	13	NMOD
13	animals	animal	NNS	_	11	PMOD
14	,	,	,	_	2	P
15	reflecting	reflect	VBG	_	2	ADV
16	blood	blood	NN	_	17	NMOD
17	contamination	contamination	NN	_	15	OBJ
18	during	during	IN	_	17	TMP
19	tissue	tissue	NN	_	20	NMOD
20	harvesting	harvesting	NN	_	18	PMOD
21	.	.	.	_	2	P

1	Interestingly	interestingly	RB	_	11	ADV
2	,	,	,	_	11	P
3	the	the	DT	_	4	NMOD
4	majority	majority	NN	_	11	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	elevated	elevate	VBN	_	10	NMOD
8	tissue	tissue	NN	_	10	NMOD
9	plant	plant	NN	_	10	NMOD
10	sterols	sterol	NNS	_	5	PMOD
11	are	be	VBP	_	0	ROOT
12	unesterified	unesterified	JJ	_	11	PRD
13	.	.	.	_	11	P

1	The	the	DT	_	2	NMOD
2	livers	liver	NNS	_	17	SBJ
3	of	of	IN	_	2	NMOD
4	Abcg8	abcg0	NN	_	7	NMOD
5	+	+	SYM	_	7	P
6	/	/	HYPH	_	7	P
7	+	+	SYM	_	16	NMOD
8	,	,	,	_	7	P
9	+	+	SYM	_	11	P
10	/	/	HYPH	_	11	P
11	-	-	SYM	_	7	CONJ
12	and	and	CC	_	11	COORD
13	-	-	SYM	_	15	P
14	/	/	HYPH	_	15	P
15	-	-	SYM	_	12	CONJ
16	mice	mouse	NNS	_	3	PMOD
17	have	have	VBP	_	0	ROOT
18	relatively	relatively	RB	_	19	AMOD
19	similar	similar	JJ	_	20	NMOD
20	levels	level	NNS	_	17	OBJ
21	of	of	IN	_	20	NMOD
22	esterified	esterified	JJ	_	23	NMOD
23	cholesterol	cholesterol	NN	_	21	PMOD
24	(	(	-LRB-	_	26	P
25	Figure	figure	NN	_	26	NMOD
26	2a	0a	NN	_	17	PRN
27	)	)	-RRB-	_	26	P
28	.	.	.	_	17	P

1	However	however	RB	_	4	ADV
2	,	,	,	_	4	P
3	there	there	EX	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	little	little	JJ	_	8	NMOD
6	if	if	IN	_	5	PRN
7	any	any	DT	_	6	SUB
8	esterification	esterification	NN	_	4	PRD
9	of	of	IN	_	8	NMOD
10	sitosterol	sitosterol	NN	_	9	PMOD
11	or	or	CC	_	10	COORD
12	campesterol	campesterol	NN	_	11	CONJ
13	(	(	-LRB-	_	17	P
14	Figure	figure	NN	_	17	NMOD
15	2b	0b	NN	_	17	NMOD
16	,	,	,	_	17	P
17	2c	0c	NN	_	8	PRN
18	)	)	-RRB-	_	17	P
19	consistent	consistent	JJ	_	4	ADV
20	with	with	IN	_	19	AMOD
21	previous	previous	JJ	_	22	NMOD
22	findings	finding	NNS	_	20	PMOD
23	[	[	-LRB-	_	26	P
24	37	0	CD	_	26	NMOD
25	,	,	,	_	26	P
26	38	0	CD	_	4	PRN
27	]	]	-RRB-	_	26	P
28	.	.	.	_	4	P

1	Thus	thus	RB	_	10	ADV
2	all	all	DT	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	expansion	expansion	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	tissue	tissue	NN	_	9	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	pools	pool	NNS	_	6	PMOD
10	are	be	VBP	_	0	ROOT
11	as	as	IN	_	10	PRD
12	free	free	JJ	_	13	NMOD
13	sterols	sterol	NNS	_	11	PMOD
14	.	.	.	_	10	P

1	FPLC	fplc	NN	_	2	NMOD
2	analyses	analysis	NNS	_	16	SBJ
3	for	for	IN	_	2	NMOD
4	sterols	sterol	NNS	_	3	PMOD
5	(	(	-LRB-	_	4	P
6	measured	measure	VBN	_	4	NMOD
7	enzymatically	enzymatically	RB	_	6	ADV
8	and	and	CC	_	6	COORD
9	thus	thus	RB	_	10	ADV
10	reflecting	reflect	VBG	_	8	CONJ
11	total	total	JJ	_	12	NMOD
12	sterols	sterol	NNS	_	10	OBJ
13	)	)	-RRB-	_	4	P
14	and	and	CC	_	4	COORD
15	triglycerides	triglyceride	NNS	_	14	CONJ
16	were	be	VBD	_	0	ROOT
17	performed	perform	VBN	_	16	VC
18	on	on	IN	_	17	ADV
19	plasma	plasma	NN	_	20	NMOD
20	samples	sample	NNS	_	18	PMOD
21	from	from	IN	_	20	NMOD
22	fasted	fast	VBN	_	23	NMOD
23	animals	animal	NNS	_	21	PMOD
24	fed	feed	VBN	_	23	NMOD
25	a	a	DT	_	28	NMOD
26	regular	regular	JJ	_	28	NMOD
27	chow	chow	NN	_	28	NMOD
28	diet	diet	NN	_	24	OBJ
29	.	.	.	_	16	P

1	No	no	DT	_	3	NMOD
2	significant	significant	JJ	_	3	NMOD
3	differences	difference	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	observed	observe	VBN	_	4	VC
6	for	for	IN	_	5	ADV
7	the	the	DT	_	9	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	profiles	profile	NNS	_	6	PMOD
10	(	(	-LRB-	_	12	P
11	Figure	figure	NN	_	12	NMOD
12	3a	0a	NN	_	5	PRN
13	)	)	-RRB-	_	12	P
14	,	,	,	_	4	P
15	but	but	CC	_	4	COORD
16	surprisingly	surprisingly	RB	_	25	ADV
17	,	,	,	_	25	P
18	the	the	DT	_	24	NMOD
19	Abcg8	abcg0	NN	_	23	NMOD
20	-	-	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	knockout	knockout	NN	_	24	NMOD
24	mice	mouse	NNS	_	25	SBJ
25	had	have	VBD	_	15	CONJ
26	a	a	DT	_	30	NMOD
27	significantly	significantly	RB	_	28	AMOD
28	higher	high	JJR	_	30	NMOD
29	triglyceride	triglyceride	NN	_	30	NMOD
30	level	level	NN	_	25	OBJ
31	in	in	IN	_	30	LOC
32	the	the	DT	_	35	NMOD
33	LDL	ldl	NN	_	34	NMOD
34	lipoprotein	lipoprotein	NN	_	35	NMOD
35	fractions	fraction	NNS	_	31	PMOD
36	compared	compare	VBN	_	30	NMOD
37	to	to	IN	_	36	PMOD
38	wild	wild	JJ	_	40	NMOD
39	-	-	HYPH	_	38	P
40	type	type	NN	_	43	NMOD
41	and	and	CC	_	40	COORD
42	heterozygous	heterozygous	JJ	_	41	CONJ
43	mice	mouse	NNS	_	37	PMOD
44	(	(	-LRB-	_	46	P
45	Figure	figure	NN	_	46	NMOD
46	3b	0b	NN	_	25	PRN
47	)	)	-RRB-	_	46	P
48	.	.	.	_	4	P

1	The	the	DT	_	2	NMOD
2	size	size	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	5	NMOD
5	peak	peak	NN	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	variable	variable	JJ	_	6	PRD
8	between	between	IN	_	6	ADV
9	different	different	JJ	_	11	NMOD
10	littermate	littermate	NN	_	11	NMOD
11	analyses	analysis	NNS	_	8	PMOD
12	,	,	,	_	6	P
13	but	but	CC	_	6	COORD
14	is	be	VBZ	_	13	CONJ
15	always	always	RB	_	14	ADV
16	increased	increased	JJ	_	14	PRD
17	in	in	IN	_	14	LOC
18	the	the	DT	_	20	NMOD
19	knockout	knockout	NN	_	20	NMOD
20	animals	animal	NNS	_	17	PMOD
21	.	.	.	_	6	P

1	Total	total	JJ	_	4	NMOD
2	plasma	plasma	NN	_	3	NMOD
3	triglyceride	triglyceride	NN	_	4	NMOD
4	levels	level	NNS	_	12	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	11	NMOD
7	Abcg8	abcg0	NN	_	11	NMOD
8	-	-	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	-	-	SYM	_	7	P
11	mice	mouse	NNS	_	5	PMOD
12	were	be	VBD	_	0	ROOT
13	slightly	slightly	RB	_	14	AMOD
14	higher	high	JJR	_	12	PRD
15	(	(	-LRB-	_	44	P
16	79.2	0	CD	_	19	NMOD
17	±	±	SYM	_	16	P
18	14	0	CD	_	16	QMOD
19	mg	mg	NN	_	44	DEP
20	/	/	SYM	_	21	P
21	dL	dl	NN	_	19	NMOD
22	compared	compare	VBN	_	19	NMOD
23	to	to	IN	_	22	PMOD
24	the	the	DT	_	30	NMOD
25	wild	wild	JJ	_	26	NMOD
26	type	type	NN	_	30	NMOD
27	63.4	0	CD	_	30	NMOD
28	±	±	SYM	_	27	P
29	13	0	CD	_	27	QMOD
30	mg	mg	NN	_	23	PMOD
31	/	/	SYM	_	32	P
32	dL	dl	NN	_	30	NMOD
33	and	and	CC	_	30	COORD
34	heterozygotes	heterozygote	NNS	_	38	NMOD
35	46.6	0	CD	_	38	NMOD
36	±	±	SYM	_	35	P
37	12	0	CD	_	35	QMOD
38	mg	mg	NN	_	33	CONJ
39	/	/	SYM	_	40	P
40	dL	dl	NN	_	38	NMOD
41	,	,	,	_	44	P
42	n	n	NN	_	44	SBJ
43	=	=	SYM	_	44	P
44	3	0	CD	_	12	PRN
45	for	for	IN	_	44	ADV
46	all	all	DT	_	47	NMOD
47	genotypes	genotype	NNS	_	45	PMOD
48	)	)	-RRB-	_	44	P
49	.	.	.	_	12	P

1	Preliminary	preliminary	JJ	_	2	NMOD
2	analyses	analysis	NNS	_	10	SBJ
3	of	of	IN	_	2	NMOD
4	proteins	protein	NNS	_	3	PMOD
5	in	in	IN	_	4	NMOD
6	the	the	DT	_	9	NMOD
7	isolated	isolate	VBN	_	9	NMOD
8	FPLC	fplc	NN	_	9	NMOD
9	fractions	fraction	NNS	_	5	PMOD
10	did	do	VBD	_	0	ROOT
11	not	not	RB	_	10	ADV
12	show	show	VB	_	10	VC
13	any	any	DT	_	15	NMOD
14	qualitative	qualitative	JJ	_	15	NMOD
15	changes	change	NNS	_	12	OBJ
16	in	in	IN	_	15	LOC
17	apolipoproteins	apolipoproteins	NNS	_	18	NMOD
18	B	b	NN	_	16	PMOD
19	,	,	,	_	18	P
20	E	e	NN	_	18	CONJ
21	,	,	,	_	20	P
22	AI	ai	NN	_	20	CONJ
23	,	,	,	_	22	P
24	or	or	CC	_	22	COORD
25	AII	aii	NN	_	24	CONJ
26	.	.	.	_	10	P

1	The	the	DT	_	2	NMOD
2	significance	significance	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	7	NMOD
5	triglyceride	triglyceride	NN	_	6	AMOD
6	rich	rich	JJ	_	7	NMOD
7	peak	peak	NN	_	3	PMOD
8	remains	remain	VBZ	_	0	ROOT
9	unclear	unclear	JJ	_	8	PRD
10	at	at	IN	_	8	TMP
11	present	present	JJ	_	10	PMOD
12	.	.	.	_	8	P

1	Liver	liver	NN	_	3	NMOD
2	gene	gene	NN	_	3	NMOD
3	expression	expression	NN	_	7	SBJ
4	and	and	CC	_	3	COORD
5	enzyme	enzyme	NN	_	6	NMOD
6	activity	activity	NN	_	4	CONJ
7	change	change	VBP	_	0	ROOT
8	in	in	IN	_	7	LOC
9	Abcg8	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	14	AMOD
12	-	-	HYPH	_	11	P
13	2	0	CD	_	11	NMOD
14	deficient	deficient	JJ	_	15	NMOD
15	mice	mouse	NNS	_	8	PMOD

1	To	to	TO	_	26	PRP
2	investigate	investigate	VB	_	1	IM
3	the	the	DT	_	4	NMOD
4	effects	effect	NNS	_	2	OBJ
5	of	of	IN	_	4	NMOD
6	a	a	DT	_	7	NMOD
7	deficiency	deficiency	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	Abcg8	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	8	PMOD
12	-	-	HYPH	_	11	P
13	2	0	CD	_	11	NMOD
14	on	on	IN	_	4	NMOD
15	the	the	DT	_	16	NMOD
16	genes	gene	NNS	_	14	PMOD
17	that	that	WDT	_	18	SBJ
18	regulate	regulate	VBP	_	16	NMOD
19	sterol	sterol	NN	_	20	NMOD
20	metabolism	metabolism	NN	_	18	OBJ
21	,	,	,	_	26	P
22	quantitative	quantitative	JJ	_	25	NMOD
23	RT	rt	NN	_	25	NMOD
24	-	-	HYPH	_	23	P
25	PCR	pcr	NN	_	26	SBJ
26	was	be	VBD	_	0	ROOT
27	performed	perform	VBN	_	26	VC
28	looking	look	VBG	_	27	ADV
29	at	at	IN	_	28	ADV
30	the	the	DT	_	32	NMOD
31	expression	expression	NN	_	32	NMOD
32	levels	level	NNS	_	29	PMOD
33	of	of	IN	_	32	NMOD
34	Abcg5	abcg0	NN	_	56	NMOD
35	,	,	,	_	34	P
36	Abcg8	abcg0	NN	_	34	CONJ
37	,	,	,	_	36	P
38	Hmgr	hmgr	NN	_	36	CONJ
39	,	,	,	_	38	P
40	Cyp7a1	cyp0a0	NN	_	38	CONJ
41	,	,	,	_	40	P
42	Abca1	abca0	NN	_	40	CONJ
43	,	,	,	_	42	P
44	Mdr2	mdr0	NN	_	42	CONJ
45	,	,	,	_	44	P
46	Lxr	lxr	NN	_	44	CONJ
47	,	,	,	_	46	P
48	Srebp	srebp	NN	_	50	NMOD
49	-	-	HYPH	_	48	P
50	1c	0c	NN	_	46	CONJ
51	,	,	,	_	50	P
52	and	and	CC	_	50	COORD
53	Srebp	srebp	NN	_	52	CONJ
54	-	-	HYPH	_	53	P
55	2	0	CD	_	53	NMOD
56	mRNA	mrna	NN	_	33	PMOD
57	in	in	IN	_	32	LOC
58	the	the	DT	_	59	NMOD
59	livers	liver	NNS	_	57	PMOD
60	of	of	IN	_	59	NMOD
61	mice	mouse	NNS	_	60	PMOD
62	fed	feed	VBN	_	61	NMOD
63	a	a	DT	_	66	NMOD
64	regular	regular	JJ	_	66	NMOD
65	chow	chow	NN	_	66	NMOD
66	diet	diet	NN	_	62	OBJ
67	(	(	-LRB-	_	69	P
68	Figure	figure	NN	_	69	NMOD
69	4a	0a	NN	_	27	PRN
70	)	)	-RRB-	_	69	P
71	.	.	.	_	26	P

1	As	as	IN	_	8	ADV
2	expected	expect	VBN	_	1	SUB
3	,	,	,	_	8	P
4	Abcg8	abcg0	NN	_	5	NMOD
5	mRNA	mrna	NN	_	7	NMOD
6	expression	expression	NN	_	7	NMOD
7	levels	level	NNS	_	8	SBJ
8	were	be	VBD	_	0	ROOT
9	undetectable	undetectable	JJ	_	8	PRD
10	in	in	IN	_	8	LOC
11	the	the	DT	_	16	NMOD
12	Abcg8	abcg0	NN	_	16	NMOD
13	-	-	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	-	-	SYM	_	12	P
16	mice	mouse	NNS	_	10	PMOD
17	and	and	CC	_	8	COORD
18	were	be	VBD	_	17	CONJ
19	reduced	reduce	VBN	_	18	VC
20	by	by	IN	_	19	EXT
21	~	~	SYM	_	22	P
22	50	0	CD	_	23	NMOD
23	%	%	NN	_	20	PMOD
24	in	in	IN	_	19	LOC
25	the	the	DT	_	27	NMOD
26	heterozygous	heterozygous	JJ	_	27	NMOD
27	mice	mouse	NNS	_	24	PMOD
28	,	,	,	_	19	P
29	relative	relative	JJ	_	19	ADV
30	to	to	IN	_	29	AMOD
31	wild	wild	JJ	_	33	NMOD
32	-	-	HYPH	_	31	P
33	type	type	NN	_	34	NMOD
34	mice	mouse	NNS	_	30	PMOD
35	.	.	.	_	8	P

1	Interestingly	interestingly	RB	_	20	ADV
2	,	,	,	_	20	P
3	by	by	IN	_	20	MNR
4	quantitative	quantitative	JJ	_	7	NMOD
5	RT	rt	NN	_	7	NMOD
6	-	-	HYPH	_	5	P
7	PCR	pcr	NN	_	3	PMOD
8	,	,	,	_	20	P
9	the	the	DT	_	11	NMOD
10	mRNA	mrna	NN	_	11	NMOD
11	expression	expression	NN	_	20	SBJ
12	of	of	IN	_	11	NMOD
13	Abcg5	abcg0	NN	_	12	PMOD
14	in	in	IN	_	11	LOC
15	the	the	DT	_	19	NMOD
16	knock	knock	VB	_	19	NMOD
17	-	-	HYPH	_	16	P
18	out	out	RP	_	16	AMOD
19	mice	mouse	NNS	_	14	PMOD
20	was	be	VBD	_	0	ROOT
21	also	also	RB	_	20	ADV
22	reduced	reduce	VBN	_	20	VC
23	by	by	IN	_	22	EXT
24	more	more	JJR	_	27	NMOD
25	than	than	IN	_	24	QMOD
26	60	0	CD	_	24	QMOD
27	%	%	NN	_	23	PMOD
28	compared	compare	VBN	_	22	ADV
29	to	to	IN	_	28	PMOD
30	the	the	DT	_	34	NMOD
31	wild	wild	JJ	_	33	NMOD
32	-	-	HYPH	_	31	P
33	type	type	NN	_	34	NMOD
34	mice	mouse	NNS	_	29	PMOD
35	,	,	,	_	22	P
36	although	although	IN	_	22	ADV
37	no	no	DT	_	38	NMOD
38	changes	change	NNS	_	39	SBJ
39	were	be	VBD	_	36	SUB
40	noted	note	VBN	_	39	VC
41	in	in	IN	_	40	LOC
42	the	the	DT	_	44	NMOD
43	heterozygous	heterozygous	JJ	_	44	NMOD
44	mice	mouse	NNS	_	41	PMOD
45	.	.	.	_	20	P

1	Expression	expression	NN	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	HMG	hmg	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	CoA	coa	NN	_	6	NMOD
6	reductase	reductase	NN	_	7	NMOD
7	mRNA	mrna	NN	_	2	PMOD
8	was	be	VBD	_	0	ROOT
9	decreased	decrease	VBN	_	8	VC
10	by	by	IN	_	9	EXT
11	~	~	SYM	_	12	P
12	50	0	CD	_	13	NMOD
13	%	%	NN	_	10	PMOD
14	and	and	CC	_	13	COORD
15	~	~	SYM	_	16	P
16	80	0	CD	_	17	NMOD
17	%	%	NN	_	14	CONJ
18	in	in	IN	_	9	LOC
19	the	the	DT	_	23	NMOD
20	heterozygote	heterozygote	NN	_	23	NMOD
21	and	and	CC	_	20	COORD
22	knockout	knockout	NN	_	21	CONJ
23	mice	mouse	NNS	_	18	PMOD
24	respectively	respectively	RB	_	9	ADV
25	,	,	,	_	9	P
26	in	in	IN	_	9	ADV
27	keeping	keep	VBG	_	26	PMOD
28	with	with	IN	_	27	NMOD
29	limited	limited	JJ	_	30	NMOD
30	observations	observation	NNS	_	28	PMOD
31	in	in	IN	_	30	LOC
32	human	human	JJ	_	33	NMOD
33	patients	patient	NNS	_	31	PMOD
34	with	with	IN	_	33	NMOD
35	this	this	DT	_	36	NMOD
36	disorder	disorder	NN	_	34	PMOD
37	[	[	-LRB-	_	38	P
38	7	0	CD	_	9	PRN
39	]	]	-RRB-	_	38	P
40	.	.	.	_	8	P

1	To	to	TO	_	18	PRP
2	verify	verify	VB	_	1	IM
3	whether	whether	IN	_	2	OBJ
4	the	the	DT	_	6	NMOD
5	mRNA	mrna	NN	_	6	NMOD
6	changes	change	NNS	_	7	SBJ
7	resulted	result	VBD	_	3	SUB
8	in	in	IN	_	7	ADV
9	alteration	alteration	NN	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	14	NMOD
12	enzyme	enzyme	NN	_	13	NMOD
13	activity	activity	NN	_	14	NMOD
14	changes	change	NNS	_	10	PMOD
15	,	,	,	_	18	P
16	liver	liver	NN	_	17	NMOD
17	samples	sample	NNS	_	18	SBJ
18	were	be	VBD	_	0	ROOT
19	analyzed	analyze	VBN	_	18	VC
20	for	for	IN	_	19	ADV
21	HMG	hmg	NN	_	23	NMOD
22	-	-	HYPH	_	21	P
23	CoA	coa	NN	_	24	NMOD
24	reductase	reductase	NN	_	25	NMOD
25	activity	activity	NN	_	20	PMOD
26	and	and	CC	_	25	COORD
27	Cyp7a1	cyp0a0	NN	_	28	NMOD
28	activity	activity	NN	_	26	CONJ
29	(	(	-LRB-	_	31	P
30	Figure	figure	NN	_	31	NMOD
31	4b	0b	NN	_	19	PRN
32	)	)	-RRB-	_	31	P
33	.	.	.	_	18	P

1	HMG	hmg	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	CoA	coa	NN	_	4	NMOD
4	reductase	reductase	NN	_	5	NMOD
5	activity	activity	NN	_	6	SBJ
6	was	be	VBD	_	0	ROOT
7	reduced	reduce	VBN	_	6	VC
8	by	by	IN	_	7	EXT
9	30	0	CD	_	10	NMOD
10	%	%	NN	_	8	PMOD
11	and	and	CC	_	10	COORD
12	60	0	CD	_	13	NMOD
13	%	%	NN	_	11	CONJ
14	in	in	IN	_	7	LOC
15	the	the	DT	_	25	NMOD
16	Abcg8	abcg0	NN	_	25	NMOD
17	+	+	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	-	-	SYM	_	16	P
20	and	and	CC	_	16	COORD
21	Abcg8	abcg0	NN	_	20	CONJ
22	-	-	SYM	_	21	P
23	/	/	HYPH	_	21	P
24	-	-	SYM	_	21	P
25	mice	mouse	NNS	_	14	PMOD
26	,	,	,	_	7	P
27	respectively	respectively	RB	_	7	ADV
28	(	(	-LRB-	_	30	P
29	Figure	figure	NN	_	30	NMOD
30	4b	0b	NN	_	7	PRN
31	)	)	-RRB-	_	30	P
32	,	,	,	_	6	P
33	and	and	CC	_	6	COORD
34	thus	thus	RB	_	35	ADV
35	reflected	reflect	VBD	_	33	CONJ
36	the	the	DT	_	37	NMOD
37	changes	change	NNS	_	35	OBJ
38	in	in	IN	_	37	NMOD
39	mRNA	mrna	NN	_	40	NMOD
40	expression	expression	NN	_	38	PMOD
41	.	.	.	_	6	P

1	In	in	IN	_	20	ADV
2	contrast	contrast	NN	_	1	PMOD
3	,	,	,	_	20	P
4	although	although	IN	_	20	ADV
5	the	the	DT	_	9	NMOD
6	Cyp7a1	cyp0a0	NN	_	7	NMOD
7	mRNA	mrna	NN	_	9	NMOD
8	expression	expression	NN	_	9	NMOD
9	levels	level	NNS	_	10	SBJ
10	were	be	VBD	_	4	SUB
11	essentially	essentially	RB	_	12	AMOD
12	unchanged	unchanged	JJ	_	10	PRD
13	in	in	IN	_	10	LOC
14	the	the	DT	_	16	NMOD
15	knockout	knockout	NN	_	16	NMOD
16	mouse	mouse	NN	_	13	PMOD
17	,	,	,	_	20	P
18	Cyp7a1	cyp0a0	NN	_	19	NMOD
19	activity	activity	NN	_	20	SBJ
20	was	be	VBD	_	0	ROOT
21	significantly	significantly	RB	_	20	ADV
22	decreased	decrease	VBN	_	20	VC
23	by	by	IN	_	22	EXT
24	37	0	CD	_	25	NMOD
25	%	%	NN	_	23	PMOD
26	(	(	-LRB-	_	29	P
27	P	p	NN	_	29	SBJ
28	<	<	SYM	_	29	P
29	0.01	0	CD	_	22	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	20	P

1	In	in	IN	_	13	LOC
2	the	the	DT	_	4	NMOD
3	heterozygous	heterozygous	JJ	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	,	,	,	_	13	P
6	both	both	CC	_	8	COORD
7	the	the	DT	_	8	NMOD
8	mRNA	mrna	NN	_	13	SBJ
9	and	and	CC	_	8	COORD
10	activity	activity	NN	_	9	CONJ
11	of	of	IN	_	10	NMOD
12	Cyp7a1	cyp0a0	NN	_	11	PMOD
13	were	be	VBD	_	0	ROOT
14	decreased	decrease	VBN	_	13	VC
15	.	.	.	_	13	P

1	Sitosterol	sitosterol	NN	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	known	know	VBN	_	2	VC
4	to	to	TO	_	3	OPRD
5	be	be	VB	_	4	IM
6	a	a	DT	_	9	NMOD
7	direct	direct	JJ	_	9	NMOD
8	competitive	competitive	JJ	_	9	NMOD
9	inhibitor	inhibitor	NN	_	5	PRD
10	of	of	IN	_	9	NMOD
11	Cyp7a1	cyp0a0	NN	_	10	PMOD
12	and	and	CC	_	2	COORD
13	it	it	PRP	_	14	SBJ
14	is	be	VBZ	_	12	CONJ
15	likely	likely	JJ	_	14	PRD
16	that	that	IN	_	14	OBJ
17	the	the	DT	_	20	NMOD
18	elevated	elevated	JJ	_	20	NMOD
19	plant	plant	NN	_	20	NMOD
20	sterols	sterol	NNS	_	24	SBJ
21	in	in	IN	_	20	LOC
22	the	the	DT	_	23	NMOD
23	liver	liver	NN	_	21	PMOD
24	are	be	VBP	_	16	SUB
25	responsible	responsible	JJ	_	24	PRD
26	for	for	IN	_	25	AMOD
27	the	the	DT	_	28	NMOD
28	inhibition	inhibition	NN	_	26	PMOD
29	in	in	IN	_	28	LOC
30	the	the	DT	_	32	NMOD
31	knockout	knockout	NN	_	32	NMOD
32	mouse	mouse	NN	_	29	PMOD
33	[	[	-LRB-	_	34	P
34	39	0	CD	_	2	PRN
35	]	]	-RRB-	_	34	P
36	.	.	.	_	2	P

1	Localization	localization	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	Abcg5	abcg0	NN	_	4	NMOD
4	protein	protein	NN	_	2	PMOD
5	in	in	IN	_	1	LOC
6	Abcg8	abcg0	NN	_	10	NMOD
7	-	-	SYM	_	6	P
8	/	/	HYPH	_	6	P
9	-	-	SYM	_	6	P
10	knockout	knockout	NN	_	11	NMOD
11	mice	mouse	NNS	_	5	PMOD

1	Does	do	VBZ	_	0	ROOT
2	the	the	DT	_	3	NMOD
3	loss	loss	NN	_	1	SBJ
4	of	of	IN	_	3	NMOD
5	Abcg8	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	4	PMOD
8	-	-	HYPH	_	7	P
9	2	0	CD	_	7	NMOD
10	result	result	VB	_	1	VC
11	in	in	IN	_	10	ADV
12	loss	loss	NN	_	11	PMOD
13	of	of	IN	_	12	NMOD
14	Abcg5	abcg0	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	sterolin	sterolin	NN	_	19	NMOD
17	-	-	HYPH	_	16	P
18	1	0	CD	_	16	NMOD
19	expression	expression	NN	_	13	PMOD
20	,	,	,	_	10	P
21	as	as	IN	_	10	ADV
22	might	might	MD	_	21	SUB
23	be	be	VB	_	22	VC
24	predicted	predict	VBN	_	23	VC
25	from	from	IN	_	24	ADV
26	the	the	DT	_	28	NMOD
27	genetic	genetic	JJ	_	28	NMOD
28	studies	study	NNS	_	25	PMOD
29	and	and	CC	_	25	COORD
30	more	more	RBR	_	31	AMOD
31	recently	recently	RB	_	32	TMP
32	from	from	IN	_	29	CONJ
33	the	the	DT	_	40	NMOD
34	in	in	FW	_	35	AMOD
35	vitro	vitro	FW	_	40	NMOD
36	and	and	CC	_	35	COORD
37	in	in	FW	_	38	AMOD
38	vivo	vivo	FW	_	36	CONJ
39	expression	expression	NN	_	40	NMOD
40	studies	study	NNS	_	32	PMOD
41	?	?	.	_	1	P

1	A	a	DT	_	3	NMOD
2	robust	robust	JJ	_	3	NMOD
3	antibody	antibody	NN	_	11	SBJ
4	to	to	IN	_	3	NMOD
5	mouse	mouse	NN	_	8	NMOD
6	Abcg8	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	4	PMOD
9	-	-	HYPH	_	8	P
10	2	0	CD	_	8	NMOD
11	is	be	VBZ	_	0	ROOT
12	not	not	RB	_	11	ADV
13	currently	currently	RB	_	11	TMP
14	available	available	JJ	_	11	PRD
15	.	.	.	_	11	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	three	three	CD	_	5	NMOD
4	separate	separate	JJ	_	5	NMOD
5	groups	group	NNS	_	6	SBJ
6	have	have	VBP	_	0	ROOT
7	developed	develop	VBN	_	6	VC
8	rabbit	rabbit	NN	_	10	NMOD
9	polyclonal	polyclonal	JJ	_	10	NMOD
10	antibody	antibody	NN	_	7	OBJ
11	to	to	IN	_	10	NMOD
12	mouse	mouse	NN	_	15	NMOD
13	Abcg5	abcg0	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	sterolin	sterolin	NN	_	11	PMOD
16	-	-	HYPH	_	15	P
17	1	0	CD	_	15	NMOD
18	.	.	.	_	6	P

1	These	these	DT	_	3	NMOD
2	three	three	CD	_	3	NMOD
3	antibodies	antibody	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	used	use	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	Western	western	NNP	_	8	NMOD
8	blotting	blotting	NN	_	6	PMOD
9	and	and	CC	_	8	COORD
10	immunohistochemistry	immunohistochemistry	NN	_	11	NMOD
11	experiments	experiment	NNS	_	9	CONJ
12	on	on	IN	_	5	ADV
13	the	the	DT	_	14	NMOD
14	liver	liver	NN	_	12	PMOD
15	and	and	CC	_	14	COORD
16	intestine	intestine	NN	_	15	CONJ
17	of	of	IN	_	14	NMOD
18	Abcg8	abcg0	NN	_	22	NMOD
19	-	-	SYM	_	18	P
20	/	/	HYPH	_	18	P
21	-	-	SYM	_	18	P
22	mice	mouse	NNS	_	17	PMOD
23	.	.	.	_	4	P

1	Western	western	NNP	_	2	NMOD
2	blotting	blotting	NN	_	20	SBJ
3	of	of	IN	_	2	NMOD
4	liver	liver	NN	_	7	NMOD
5	total	total	JJ	_	6	NMOD
6	membrane	membrane	NN	_	7	NMOD
7	preparations	preparation	NNS	_	3	PMOD
8	using	use	VBG	_	2	NMOD
9	the	the	DT	_	19	NMOD
10	three	three	CD	_	19	NMOD
11	separately	separately	RB	_	13	AMOD
12	-	-	HYPH	_	11	P
13	developed	develop	VBN	_	19	NMOD
14	anti-Abcg5	anti-abcg0	NN	_	16	AMOD
15	/	/	HYPH	_	14	P
16	sterolin	sterolin	NN	_	19	NMOD
17	-	-	HYPH	_	16	P
18	1	0	CD	_	16	AMOD
19	antibodies	antibody	NNS	_	8	OBJ
20	showed	show	VBD	_	0	ROOT
21	different	different	JJ	_	22	NMOD
22	results	result	NNS	_	20	OBJ
23	.	.	.	_	20	P

1	As	as	IN	_	12	ADV
2	has	have	VBZ	_	1	SUB
3	been	be	VBN	_	2	VC
4	previously	previously	RB	_	3	ADV
5	published	publish	VBN	_	3	VC
6	,	,	,	_	12	P
7	Abcg5	abcg0	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	sterolin	sterolin	NN	_	12	SBJ
10	-	-	HYPH	_	9	P
11	1	0	CD	_	9	NMOD
12	exists	exist	VBZ	_	0	ROOT
13	in	in	IN	_	12	ADV
14	two	two	CD	_	16	NMOD
15	separate	separate	JJ	_	16	NMOD
16	forms	form	NNS	_	13	PMOD
17	,	,	,	_	16	P
18	the	the	DT	_	24	NMOD
19	'	'	``	_	24	P
20	immature	immature	NN	_	24	NMOD
21	'	'	''	_	24	P
22	75	0	CD	_	23	NMOD
23	kDa	kda	NN	_	24	NMOD
24	protein	protein	NN	_	16	APPO
25	and	and	CC	_	24	COORD
26	a	a	DT	_	34	NMOD
27	fully	fully	RB	_	28	AMOD
28	glycosylated	glycosylated	VBN	_	34	NMOD
29	'	'	``	_	34	P
30	mature	mature	NN	_	34	NMOD
31	'	'	''	_	34	P
32	93	0	CD	_	33	NMOD
33	kDa	kda	NN	_	34	NMOD
34	protein	protein	NN	_	25	CONJ
35	[	[	-LRB-	_	38	P
36	18	0	CD	_	38	NMOD
37	,	,	,	_	38	P
38	30	0	CD	_	12	PRN
39	]	]	-RRB-	_	38	P
40	.	.	.	_	12	P

1	Using	use	VBG	_	16	MNR
2	the	the	DT	_	10	NMOD
3	SC	sc	NN	_	9	NMOD
4	anti-Abcg5	anti-abcg0	NN	_	6	AMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	9	NMOD
7	-	-	HYPH	_	6	P
8	1	0	CD	_	6	AMOD
9	peptide	peptide	NN	_	10	NMOD
10	antibody	antibody	NN	_	1	OBJ
11	,	,	,	_	16	P
12	a	a	DT	_	15	NMOD
13	75	0	CD	_	14	NMOD
14	kDa	kda	NN	_	15	NMOD
15	band	band	NN	_	16	SBJ
16	is	be	VBZ	_	0	ROOT
17	detected	detect	VBN	_	16	VC
18	(	(	-LRB-	_	20	P
19	Figure	figure	NN	_	20	NMOD
20	5a	0a	NN	_	17	PRN
21	)	)	-RRB-	_	20	P
22	.	.	.	_	16	P

1	This	this	DT	_	2	NMOD
2	antibody	antibody	NN	_	3	SBJ
3	does	do	VBZ	_	22	DEP
4	not	not	RB	_	3	ADV
5	detect	detect	VB	_	3	VC
6	a	a	DT	_	12	NMOD
7	'	'	``	_	12	P
8	mature	mature	JJ	_	12	NMOD
9	'	'	''	_	12	P
10	93	0	CD	_	11	NMOD
11	kDa	kda	NN	_	12	NMOD
12	band	band	NN	_	5	OBJ
13	in	in	IN	_	5	LOC
14	either	either	CC	_	20	COORD
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	20	NMOD
18	or	or	CC	_	17	COORD
19	knockout	knockout	NN	_	18	CONJ
20	animals	animal	NNS	_	13	PMOD
21	nor	nor	CC	_	22	COORD
22	is	be	VBZ	_	0	ROOT
23	the	the	DT	_	26	NMOD
24	75	0	CD	_	25	NMOD
25	kDa	kda	NN	_	26	NMOD
26	band	band	NN	_	22	SBJ
27	sensitive	sensitive	JJ	_	22	PRD
28	to	to	IN	_	27	AMOD
29	either	either	CC	_	32	COORD
30	Endo	endo	NN	_	32	NMOD
31	-	-	HYPH	_	30	P
32	H	h	NN	_	28	PMOD
33	or	or	CC	_	32	COORD
34	PNGaseF	pngasef	NN	_	33	CONJ
35	(	(	-LRB-	_	38	P
36	lower	low	JJ	_	37	NMOD
37	panel	panel	NN	_	38	SBJ
38	shows	show	VBZ	_	22	PRN
39	same	same	JJ	_	40	NMOD
40	aliquots	aliquot	NNS	_	38	OBJ
41	probed	probe	VBN	_	40	NMOD
42	with	with	IN	_	41	MNR
43	anti-transferrin	anti-transferrin	NN	_	42	PMOD
44	)	)	-RRB-	_	38	P
45	.	.	.	_	22	P

1	The	the	DT	_	3	NMOD
2	AMC	amc	NN	_	3	NMOD
3	antibody	antibody	NN	_	4	SBJ
4	detects	detect	VBZ	_	0	ROOT
5	the	the	DT	_	9	NMOD
6	'	'	``	_	9	P
7	mature	mature	NN	_	9	NMOD
8	'	'	''	_	9	P
9	form	form	NN	_	4	OBJ
10	of	of	IN	_	9	NMOD
11	Abcg5	abcg0	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	sterolin	sterolin	NN	_	10	PMOD
14	-	-	HYPH	_	13	P
15	1	0	CD	_	13	NMOD
16	in	in	IN	_	9	LOC
17	wild	wild	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	type	type	NN	_	20	NMOD
20	animals	animal	NNS	_	16	PMOD
21	but	but	CC	_	20	COORD
22	not	not	RB	_	21	ADV
23	the	the	DT	_	24	NMOD
24	knockouts	knockout	NNS	_	21	CONJ
25	.	.	.	_	4	P

1	Interestingly	interestingly	RB	_	10	ADV
2	,	,	,	_	10	P
3	the	the	DT	_	9	NMOD
4	'	'	``	_	9	P
5	immature	immature	JJ	_	9	NMOD
6	'	'	''	_	9	P
7	75	0	CD	_	8	NMOD
8	kDa	kda	NN	_	9	NMOD
9	band	band	NN	_	10	SBJ
10	is	be	VBZ	_	0	ROOT
11	detected	detect	VBN	_	10	VC
12	by	by	IN	_	11	MNR
13	this	this	DT	_	14	NMOD
14	antibody	antibody	NN	_	12	PMOD
15	but	but	CC	_	10	COORD
16	the	the	DT	_	17	NMOD
17	band	band	NN	_	18	SBJ
18	shifts	shift	VBZ	_	15	CONJ
19	with	with	IN	_	18	ADV
20	Endo	endo	NN	_	22	NMOD
21	-	-	HYPH	_	20	P
22	H	h	NN	_	26	NMOD
23	and	and	CC	_	22	COORD
24	PNGase	pngase	NN	_	25	NMOD
25	F	f	NN	_	23	CONJ
26	treatment	treatment	NN	_	19	PMOD
27	(	(	-LRB-	_	29	P
28	Figure	figure	NN	_	29	NMOD
29	5b	0b	NN	_	10	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	10	P

1	The	the	DT	_	3	NMOD
2	UTSW	utsw	NN	_	3	NMOD
3	antibody	antibody	NN	_	4	SBJ
4	detects	detect	VBZ	_	0	ROOT
5	the	the	DT	_	13	NMOD
6	'	'	``	_	13	P
7	mature	mature	JJ	_	13	NMOD
8	'	'	''	_	7	P
9	and	and	CC	_	7	COORD
10	'	'	``	_	11	P
11	immature	immature	JJ	_	9	CONJ
12	'	'	''	_	13	P
13	forms	form	NNS	_	4	OBJ
14	of	of	IN	_	13	NMOD
15	Abcg5	abcg0	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	sterolin	sterolin	NN	_	14	PMOD
18	-	-	HYPH	_	17	P
19	1	0	CD	_	17	NMOD
20	in	in	IN	_	4	LOC
21	wild	wild	JJ	_	23	NMOD
22	-	-	HYPH	_	21	P
23	type	type	NN	_	24	NMOD
24	animals	animal	NNS	_	20	PMOD
25	but	but	CC	_	4	COORD
26	detects	detect	VBZ	_	25	CONJ
27	no	no	DT	_	28	NMOD
28	forms	form	NNS	_	26	OBJ
29	in	in	IN	_	26	LOC
30	the	the	DT	_	32	NMOD
31	knockout	knockout	NN	_	32	NMOD
32	mouse	mouse	NN	_	29	PMOD
33	(	(	-LRB-	_	35	P
34	Figure	figure	NN	_	35	NMOD
35	5c	0c	NN	_	4	PRN
36	)	)	-RRB-	_	35	P
37	.	.	.	_	4	P

1	What	what	WP	_	2	SBJ
2	does	do	VBZ	_	15	SBJ
3	hold	hold	VB	_	2	VC
4	true	true	JJ	_	3	PRD
5	for	for	IN	_	3	ADV
6	all	all	DT	_	7	NMOD
7	antibodies	antibody	NNS	_	5	PMOD
8	used	use	VBN	_	7	NMOD
9	against	against	IN	_	8	ADV
10	Abcg5	abcg0	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	9	PMOD
13	-	-	HYPH	_	12	P
14	1	0	CD	_	12	NMOD
15	is	be	VBZ	_	0	ROOT
16	the	the	DT	_	17	NMOD
17	detection	detection	NN	_	15	PRD
18	of	of	IN	_	17	NMOD
19	a	a	DT	_	22	NMOD
20	75	0	CD	_	21	NMOD
21	kDa	kda	NN	_	22	NMOD
22	band	band	NN	_	18	PMOD
23	.	.	.	_	15	P

1	Immunohistochemistry	immunohistochemistry	NN	_	2	NMOD
2	experiments	experiment	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	carried	carry	VBN	_	3	VC
5	out	out	RP	_	4	PRT
6	using	use	VBG	_	4	MNR
7	all	all	DT	_	9	NMOD
8	three	three	CD	_	9	NMOD
9	antibodies	antibody	NNS	_	6	OBJ
10	.	.	.	_	3	P

1	In	in	IN	_	9	LOC
2	acute	acute	JJ	_	4	NMOD
3	transfection	transfection	NN	_	4	NMOD
4	studies	study	NNS	_	1	PMOD
5	,	,	,	_	9	P
6	the	the	DT	_	8	NMOD
7	SC	sc	NN	_	8	NMOD
8	antibody	antibody	NN	_	9	SBJ
9	recognized	recognize	VBD	_	0	ROOT
10	over-expressed	over-expressed	VBN	_	14	NMOD
11	mouse	mouse	NN	_	14	NMOD
12	Abcg5	abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	9	OBJ
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	NMOD
17	in	in	IN	_	14	LOC
18	COS	co	NN	_	21	NMOD
19	-	-	HYPH	_	18	P
20	1	0	CD	_	18	NMOD
21	cells	cell	NNS	_	17	PMOD
22	,	,	,	_	14	P
23	but	but	CC	_	14	COORD
24	not	not	RB	_	23	ADV
25	mouse	mouse	NN	_	28	NMOD
26	Abcg8	abcg0	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	sterolin	sterolin	NN	_	23	CONJ
29	-	-	HYPH	_	28	P
30	2	0	CD	_	28	NMOD
31	(	(	-LRB-	_	35	P
32	Figure	figure	NN	_	35	NMOD
33	6b	0b	NN	_	35	NMOD
34	,	,	,	_	35	P
35	6c	0c	NN	_	9	PRN
36	)	)	-RRB-	_	35	P
37	.	.	.	_	9	P

1	Co-transfection	co-transfection	NN	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	COS	co	NN	_	6	NMOD
4	-	-	HYPH	_	3	P
5	1	0	CD	_	3	NMOD
6	cells	cell	NNS	_	2	PMOD
7	with	with	IN	_	1	NMOD
8	both	both	CC	_	9	COORD
9	Abcg5	abcg0	NN	_	12	NMOD
10	and	and	CC	_	9	COORD
11	Abcg8	abcg0	NN	_	10	CONJ
12	cDNAs	cdna	NNS	_	7	PMOD
13	did	do	VBD	_	0	ROOT
14	not	not	RB	_	13	ADV
15	alter	alter	VB	_	13	VC
16	the	the	DT	_	17	NMOD
17	pattern	pattern	NN	_	15	OBJ
18	of	of	IN	_	17	NMOD
19	immunofluorescence	immunofluorescence	NN	_	18	PMOD
20	,	,	,	_	15	P
21	although	although	IN	_	15	ADV
22	we	we	PRP	_	23	SBJ
23	are	be	VBP	_	21	SUB
24	not	not	RB	_	23	ADV
25	able	able	JJ	_	23	PRD
26	to	to	TO	_	25	AMOD
27	confirm	confirm	VB	_	26	IM
28	simultaneous	simultaneous	JJ	_	29	NMOD
29	expression	expression	NN	_	27	OBJ
30	of	of	IN	_	29	NMOD
31	Abcg8	abcg0	NN	_	30	PMOD
32	in	in	IN	_	29	LOC
33	cells	cell	NNS	_	32	PMOD
34	expressing	express	VBG	_	33	NMOD
35	Abcg5	abcg0	NN	_	37	NMOD
36	/	/	HYPH	_	35	P
37	sterolin	sterolin	NN	_	34	OBJ
38	-	-	HYPH	_	37	P
39	1	0	CD	_	37	NMOD
40	,	,	,	_	23	P
41	as	as	IN	_	23	ADV
42	we	we	PRP	_	43	SBJ
43	have	have	VBP	_	41	SUB
44	no	no	DT	_	46	NMOD
45	suitable	suitable	JJ	_	46	NMOD
46	antibody	antibody	NN	_	43	OBJ
47	for	for	IN	_	46	NMOD
48	Abcg8	abcg0	NN	_	50	NMOD
49	/	/	HYPH	_	48	P
50	sterolin	sterolin	NN	_	47	PMOD
51	-	-	HYPH	_	50	P
52	2	0	CD	_	50	NMOD
53	(	(	-LRB-	_	55	P
54	Figure	figure	NN	_	55	NMOD
55	6d	0d	NN	_	15	PRN
56	)	)	-RRB-	_	55	P
57	.	.	.	_	13	P

1	Nevertheless	nevertheless	RB	_	5	ADV
2	,	,	,	_	5	P
3	this	this	DT	_	4	NMOD
4	experiment	experiment	NN	_	5	SBJ
5	indicates	indicate	VBZ	_	0	ROOT
6	that	that	IN	_	5	OBJ
7	the	the	DT	_	9	NMOD
8	SC	sc	NN	_	9	NMOD
9	antibody	antibody	NN	_	10	SBJ
10	can	can	MD	_	6	SUB
11	recognize	recognize	VB	_	10	VC
12	Abcg5	abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	11	OBJ
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	NMOD
17	but	but	CC	_	10	COORD
18	does	do	VBZ	_	17	CONJ
19	not	not	RB	_	18	ADV
20	cross-react	cross-react	VB	_	18	VC
21	with	with	IN	_	20	ADV
22	Abcg8	abcg0	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	sterolin	sterolin	NN	_	21	PMOD
25	-	-	HYPH	_	24	P
26	2	0	CD	_	24	NMOD
27	.	.	.	_	5	P

1	Serial	serial	JJ	_	2	NMOD
2	sections	section	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	intestinal	intestinal	JJ	_	5	NMOD
5	tissue	tissue	NN	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	incubated	incubate	VBN	_	6	VC
8	with	with	IN	_	7	MNR
9	anti-Abcg5	anti-abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	8	PMOD
12	-	-	HYPH	_	11	P
13	1	0	CD	_	11	NMOD
14	to	to	TO	_	7	PRP
15	determine	determine	VB	_	14	IM
16	the	the	DT	_	18	NMOD
17	cellular	cellular	JJ	_	18	NMOD
18	location	location	NN	_	15	OBJ
19	of	of	IN	_	18	NMOD
20	Abcg5	abcg0	NN	_	22	NMOD
21	/	/	HYPH	_	20	P
22	sterolin	sterolin	NN	_	19	PMOD
23	-	-	HYPH	_	22	P
24	1	0	CD	_	22	NMOD
25	.	.	.	_	6	P

1	The	the	DT	_	2	NMOD
2	pattern	pattern	NN	_	15	SBJ
3	of	of	IN	_	2	NMOD
4	staining	staining	NN	_	3	PMOD
5	of	of	IN	_	2	NMOD
6	Abcg5	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	5	PMOD
9	-	-	HYPH	_	8	P
10	1	0	CD	_	8	NMOD
11	in	in	IN	_	2	LOC
12	the	the	DT	_	14	NMOD
13	intestinal	intestinal	JJ	_	14	NMOD
14	sections	section	NNS	_	11	PMOD
15	is	be	VBZ	_	0	ROOT
16	clearly	clearly	RB	_	17	AMOD
17	apical	apical	JJ	_	15	PRD
18	and	and	CC	_	17	COORD
19	localized	localized	JJ	_	18	CONJ
20	to	to	IN	_	19	AMOD
21	the	the	DT	_	22	NMOD
22	villi	villus	NNS	_	20	PMOD
23	of	of	IN	_	22	NMOD
24	the	the	DT	_	25	NMOD
25	enterocytes	enterocytes	NNS	_	23	PMOD
26	(	(	-LRB-	_	32	P
27	Figure	figure	NN	_	32	NMOD
28	6g	0g	NN	_	32	NMOD
29	,	,	,	_	32	P
30	6h	0h	NN	_	32	NMOD
31	,	,	,	_	32	P
32	6i	0i	NN	_	15	PRN
33	)	)	-RRB-	_	32	P
34	.	.	.	_	15	P

1	Loss	loss	NN	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	Abcg8	abcg0	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	sterolin	sterolin	NN	_	2	PMOD
6	-	-	HYPH	_	5	P
7	2	0	CD	_	5	NMOD
8	does	do	VBZ	_	0	ROOT
9	not	not	RB	_	8	ADV
10	seem	seem	VB	_	8	VC
11	to	to	TO	_	10	OPRD
12	affect	affect	VB	_	11	IM
13	this	this	DT	_	14	NMOD
14	pattern	pattern	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	staining	staining	NN	_	15	PMOD
17	.	.	.	_	8	P

1	To	to	TO	_	17	PRP
2	further	far	RB	_	1	ADV
3	confirm	confirm	VB	_	1	IM
4	that	that	IN	_	3	OBJ
5	the	the	DT	_	6	NMOD
6	antibody	antibody	NN	_	8	SBJ
7	used	use	VBN	_	6	NMOD
8	recognizes	recognize	VBZ	_	4	SUB
9	Abcg5	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	8	OBJ
12	-	-	HYPH	_	11	P
13	1	0	CD	_	11	NMOD
14	;	;	:	_	17	P
15	this	this	DT	_	16	NMOD
16	pattern	pattern	NN	_	17	SBJ
17	is	be	VBZ	_	0	ROOT
18	blocked	block	VBN	_	17	VC
19	if	if	IN	_	18	ADV
20	the	the	DT	_	21	NMOD
21	antibody	antibody	NN	_	22	SBJ
22	is	be	VBZ	_	19	SUB
23	pre-incubated	pre-incubated	VBN	_	22	VC
24	with	with	IN	_	23	MNR
25	the	the	DT	_	26	NMOD
26	peptide	peptide	NN	_	24	PMOD
27	to	to	IN	_	31	ADV
28	which	which	WDT	_	27	PMOD
29	it	it	PRP	_	30	SBJ
30	was	be	VBD	_	26	NMOD
31	raised	raise	VBN	_	30	VC
32	(	(	-LRB-	_	34	P
33	Figure	figure	NN	_	34	NMOD
34	6f	0f	NN	_	18	PRN
35	)	)	-RRB-	_	34	P
36	.	.	.	_	17	P

1	To	to	TO	_	19	PRP
2	further	far	RB	_	1	ADV
3	confirm	confirm	VB	_	1	IM
4	that	that	IN	_	3	OBJ
5	Abcg5	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	10	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	expression	expression	NN	_	11	SBJ
11	is	be	VBZ	_	4	SUB
12	preserved	preserve	VBN	_	11	VC
13	and	and	CC	_	11	COORD
14	may	may	MD	_	13	CONJ
15	be	be	VB	_	14	VC
16	apical	apical	JJ	_	15	PRD
17	,	,	,	_	19	P
18	immunohistochemistry	immunohistochemistry	NN	_	19	SBJ
19	was	be	VBD	_	0	ROOT
20	performed	perform	VBN	_	19	VC
21	in	in	IN	_	20	LOC
22	Amsterdam	amsterdam	NN	_	21	PMOD
23	using	use	VBG	_	20	MNR
24	the	the	DT	_	26	NMOD
25	AMC	amc	NN	_	26	NMOD
26	antibody	antibody	NN	_	23	OBJ
27	to	to	TO	_	23	PRP
28	stain	stain	VB	_	27	IM
29	liver	liver	NN	_	30	NMOD
30	sections	section	NNS	_	28	OBJ
31	from	from	IN	_	30	NMOD
32	wild	wild	JJ	_	34	NMOD
33	-	-	HYPH	_	32	P
34	type	type	NN	_	37	NMOD
35	and	and	CC	_	34	COORD
36	knockout	knockout	NN	_	35	CONJ
37	mice	mouse	NNS	_	31	PMOD
38	[	[	-LRB-	_	39	P
39	30	0	CD	_	20	PRN
40	]	]	-RRB-	_	39	P
41	.	.	.	_	19	P

1	As	as	IN	_	24	ADV
2	a	a	DT	_	3	NMOD
3	control	control	NN	_	1	PMOD
4	,	,	,	_	24	P
5	the	the	DT	_	6	NMOD
6	expression	expression	NN	_	24	SBJ
7	of	of	IN	_	6	NMOD
8	Abcb11	abcb0	NN	_	7	PMOD
9	,	,	,	_	8	P
10	an	an	DT	_	12	NMOD
11	ABC	abc	NN	_	12	NMOD
12	transporter	transporter	NN	_	8	APPO
13	known	know	VBN	_	12	NMOD
14	to	to	TO	_	13	OPRD
15	be	be	VB	_	14	IM
16	responsible	responsible	JJ	_	15	PRD
17	for	for	IN	_	16	AMOD
18	the	the	DT	_	19	NMOD
19	export	export	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	bile	bile	NN	_	22	NMOD
22	salts	salt	NNS	_	20	PMOD
23	,	,	,	_	24	P
24	was	be	VBD	_	0	ROOT
25	compared	compare	VBN	_	24	VC
26	to	to	IN	_	25	ADV
27	that	that	DT	_	26	PMOD
28	of	of	IN	_	27	NMOD
29	Abcg5	abcg0	NN	_	31	NMOD
30	/	/	HYPH	_	29	P
31	sterolin	sterolin	NN	_	28	PMOD
32	-	-	HYPH	_	31	P
33	1	0	CD	_	31	NMOD
34	(	(	-LRB-	_	38	P
35	Figure	figure	NN	_	38	NMOD
36	6j	0j	NN	_	38	NMOD
37	,	,	,	_	38	P
38	6k	0k	NN	_	25	PRN
39	)	)	-RRB-	_	38	P
40	.	.	.	_	24	P

1	Again	again	RB	_	5	ADV
2	,	,	,	_	5	P
3	both	both	DT	_	4	NMOD
4	proteins	protein	NNS	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	apically	apically	RB	_	5	ADV
7	localized	localize	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	liver	liver	NN	_	10	NMOD
10	sections	section	NNS	_	8	PMOD
11	from	from	IN	_	10	NMOD
12	wild	wild	JJ	_	14	NMOD
13	-	-	HYPH	_	12	P
14	type	type	NN	_	15	NMOD
15	mice	mouse	NNS	_	11	PMOD
16	and	and	CC	_	5	COORD
17	this	this	DT	_	18	NMOD
18	pattern	pattern	NN	_	19	SBJ
19	is	be	VBZ	_	16	CONJ
20	essentially	essentially	RB	_	21	AMOD
21	unperturbed	unperturbed	JJ	_	19	PRD
22	in	in	IN	_	19	LOC
23	liver	liver	NN	_	22	PMOD
24	from	from	IN	_	23	NMOD
25	knockout	knockout	NN	_	26	NMOD
26	mice	mouse	NNS	_	24	PMOD
27	,	,	,	_	19	P
28	although	although	IN	_	19	ADV
29	the	the	DT	_	31	NMOD
30	expression	expression	NN	_	31	NMOD
31	level	level	NN	_	38	SBJ
32	of	of	IN	_	31	NMOD
33	Abcg5	abcg0	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	sterolin	sterolin	NN	_	32	PMOD
36	-	-	HYPH	_	35	P
37	1	0	CD	_	35	NMOD
38	seems	seem	VBZ	_	28	SUB
39	to	to	TO	_	38	OPRD
40	be	be	VB	_	39	IM
41	less	less	RBR	_	42	AMOD
42	robust	robust	JJ	_	40	PRD
43	qualitatively	qualitatively	RB	_	40	ADV
44	(	(	-LRB-	_	48	P
45	Figure	figure	NN	_	48	NMOD
46	6l	0l	NN	_	48	NMOD
47	,	,	,	_	48	P
48	6m	0m	NN	_	5	PRN
49	)	)	-RRB-	_	48	P
50	.	.	.	_	5	P

1	To	to	TO	_	21	PRP
2	further	far	RB	_	1	ADV
3	confirm	confirm	VB	_	1	IM
4	the	the	DT	_	6	NMOD
5	apical	apical	JJ	_	6	NMOD
6	expression	expression	NN	_	3	OBJ
7	of	of	IN	_	6	NMOD
8	Abcg5	abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	sterolin	sterolin	NN	_	7	PMOD
11	-	-	HYPH	_	10	P
12	1	0	CD	_	10	NMOD
13	in	in	IN	_	6	LOC
14	the	the	DT	_	16	NMOD
15	knockout	knockout	NN	_	16	NMOD
16	mice	mouse	NNS	_	13	PMOD
17	,	,	,	_	21	P
18	the	the	DT	_	20	NMOD
19	UTSW	utsw	NN	_	20	NMOD
20	antibody	antibody	NN	_	21	SBJ
21	was	be	VBD	_	0	ROOT
22	used	use	VBN	_	21	VC
23	to	to	TO	_	22	PRP
24	stain	stain	VB	_	23	IM
25	liver	liver	NN	_	26	NMOD
26	sections	section	NNS	_	24	OBJ
27	of	of	IN	_	26	NMOD
28	wild	wild	JJ	_	30	NMOD
29	-	-	HYPH	_	28	P
30	type	type	NN	_	33	NMOD
31	and	and	CC	_	30	COORD
32	knockout	knockout	NN	_	31	CONJ
33	mice	mouse	NNS	_	27	PMOD
34	.	.	.	_	21	P

1	Again	again	RB	_	4	ADV
2	,	,	,	_	4	P
3	there	there	EX	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	apical	apical	JJ	_	6	NMOD
6	expression	expression	NN	_	4	PRD
7	of	of	IN	_	6	NMOD
8	Abcg5	abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	sterolin	sterolin	NN	_	7	PMOD
11	-	-	HYPH	_	10	P
12	1	0	CD	_	10	NMOD
13	in	in	IN	_	4	LOC
14	both	both	CC	_	17	COORD
15	wild	wild	JJ	_	17	NMOD
16	-	-	HYPH	_	15	P
17	type	type	NN	_	20	NMOD
18	and	and	CC	_	17	COORD
19	knockout	knockout	NN	_	18	CONJ
20	livers	liver	NNS	_	13	PMOD
21	(	(	-LRB-	_	25	P
22	Figure	figure	NN	_	25	NMOD
23	7a	0a	NN	_	25	NMOD
24	,	,	,	_	25	P
25	7b	0b	NN	_	4	PRN
26	)	)	-RRB-	_	25	P
27	.	.	.	_	4	P

1	Biliary	biliary	JJ	_	2	NMOD
2	secretion	secretion	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	bile	bile	NN	_	5	NMOD
5	salts	salt	NNS	_	3	PMOD
6	,	,	,	_	5	P
7	sterol	sterol	NN	_	5	CONJ
8	and	and	CC	_	7	COORD
9	phospholipids	phospholipid	NNS	_	8	CONJ
10	in	in	IN	_	2	LOC
11	Abcg8	abcg0	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	sterolin	sterolin	NN	_	16	AMOD
14	-	-	HYPH	_	13	P
15	2	0	CD	_	13	NMOD
16	deficient	deficient	JJ	_	17	NMOD
17	mice	mouse	NNS	_	10	PMOD

1	Sitosterolemic	sitosterolemic	JJ	_	2	NMOD
2	individuals	individual	NNS	_	3	SBJ
3	have	have	VBP	_	0	ROOT
4	an	an	DT	_	6	NMOD
5	impaired	impaired	JJ	_	6	NMOD
6	ability	ability	NN	_	3	OBJ
7	to	to	TO	_	6	NMOD
8	secrete	secrete	VB	_	7	IM
9	cholesterol	cholesterol	NN	_	8	OBJ
10	and	and	CC	_	9	COORD
11	plant	plant	NN	_	12	NMOD
12	sterols	sterol	NNS	_	10	CONJ
13	into	into	IN	_	8	DIR
14	bile	bile	NN	_	13	PMOD
15	[	[	-LRB-	_	18	P
16	40	0	CD	_	18	NMOD
17	,	,	,	_	18	P
18	41	0	CD	_	3	PRN
19	]	]	-RRB-	_	18	P
20	.	.	.	_	3	P

1	We	we	PRP	_	2	SBJ
2	analyzed	analyze	VBD	_	0	ROOT
3	the	the	DT	_	5	NMOD
4	knockout	knockout	NN	_	5	NMOD
5	mice	mouse	NNS	_	2	OBJ
6	for	for	IN	_	2	ADV
7	any	any	DT	_	8	NMOD
8	alterations	alteration	NNS	_	6	PMOD
9	in	in	IN	_	8	NMOD
10	biliary	biliary	JJ	_	11	NMOD
11	sterol	sterol	NN	_	12	NMOD
12	handling	handling	NN	_	9	PMOD
13	.	.	.	_	2	P

1	Analyses	analysis	NNS	_	8	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	7	NMOD
4	initial	initial	JJ	_	7	NMOD
5	basal	basal	JJ	_	7	NMOD
6	bile	bile	NN	_	7	NMOD
7	secretion	secretion	NN	_	2	PMOD
8	showed	show	VBD	_	0	ROOT
9	that	that	IN	_	8	OBJ
10	the	the	DT	_	14	NMOD
11	sterol	sterol	NN	_	14	NMOD
12	and	and	CC	_	11	COORD
13	phospholipid	phospholipid	NN	_	12	CONJ
14	contents	content	NNS	_	21	SBJ
15	in	in	IN	_	14	LOC
16	Abcg8	abcg0	NN	_	20	NMOD
17	-	-	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	-	-	SYM	_	16	P
20	mice	mouse	NNS	_	15	PMOD
21	were	be	VBD	_	9	SUB
22	reduced	reduce	VBN	_	21	VC
23	as	as	IN	_	22	ADV
24	compared	compare	VBN	_	23	SUB
25	to	to	IN	_	24	ADV
26	wild	wild	JJ	_	28	NMOD
27	-	-	HYPH	_	26	P
28	type	type	NN	_	29	NMOD
29	mice	mouse	NNS	_	25	PMOD
30	,	,	,	_	8	P
31	(	(	-LRB-	_	51	P
32	Figure	figure	NN	_	37	NMOD
33	8a	0a	NN	_	37	NMOD
34	,	,	,	_	37	P
35	8b	0b	NN	_	37	NMOD
36	,	,	,	_	37	P
37	8c	0c	NN	_	51	DEP
38	,	,	,	_	51	P
39	bile	bile	NN	_	40	NMOD
40	salt	salt	NN	_	41	NMOD
41	secretion	secretion	NN	_	51	DEP
42	not	not	RB	_	44	AMOD
43	statistically	statistically	RB	_	44	AMOD
44	significant	significant	JJ	_	41	OPRD
45	,	,	,	_	51	P
46	for	for	IN	_	51	ADV
47	sterol	sterol	NN	_	48	NMOD
48	secretion	secretion	NN	_	46	PMOD
49	P	p	NN	_	51	SBJ
50	=	=	SYM	_	51	P
51	0.01	0	CD	_	8	PRN
52	and	and	CC	_	51	COORD
53	for	for	IN	_	58	ADV
54	phospholipid	phospholipid	NN	_	55	NMOD
55	secretion	secretion	NN	_	53	PMOD
56	P	p	NN	_	58	SBJ
57	=	=	SYM	_	58	P
58	0.03	0	CD	_	52	CONJ
59	)	)	-RRB-	_	51	P
60	.	.	.	_	8	P

1	To	to	TO	_	23	PRP
2	investigate	investigate	VB	_	1	IM
3	whether	whether	IN	_	2	OBJ
4	the	the	DT	_	5	NMOD
5	defect	defect	NN	_	10	SBJ
6	in	in	IN	_	5	NMOD
7	biliary	biliary	JJ	_	9	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	secretion	secretion	NN	_	6	PMOD
10	could	could	MD	_	3	SUB
11	be	be	VB	_	10	VC
12	(	(	-LRB-	_	11	P
13	partly	partly	RB	_	11	ADV
14	)	)	-RRB-	_	11	P
15	restored	restore	VBN	_	11	VC
16	by	by	IN	_	15	MNR
17	forced	force	VBN	_	20	NMOD
18	biliary	biliary	JJ	_	19	NMOD
19	sterol	sterol	NN	_	20	NMOD
20	secretion	secretion	NN	_	16	PMOD
21	,	,	,	_	23	P
22	we	we	PRP	_	23	SBJ
23	infused	infuse	VBD	_	0	ROOT
24	mice	mouse	NNS	_	23	OBJ
25	with	with	IN	_	23	MNR
26	stepwise	stepwise	JJ	_	27	AMOD
27	increasing	increase	VBG	_	28	NMOD
28	doses	dose	NNS	_	25	PMOD
29	of	of	IN	_	28	NMOD
30	tauroursodeoxycholic	tauroursodeoxycholic	JJ	_	31	NMOD
31	acid	acid	NN	_	33	NMOD
32	(	(	-LRB-	_	33	P
33	TUDC	tudc	NN	_	29	PMOD
34	)	)	-RRB-	_	23	P
35	.	.	.	_	23	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	first	$#ORD#$	RB	_	2	TMP
4	depleted	deplete	VBN	_	2	VC
5	of	of	IN	_	4	ADV
6	their	their	PRP$	_	10	NMOD
7	endogenous	endogenous	JJ	_	10	NMOD
8	bile	bile	NN	_	9	NMOD
9	salt	salt	NN	_	10	NMOD
10	pools	pool	NNS	_	5	PMOD
11	for	for	IN	_	4	TMP
12	90	0	CD	_	13	NMOD
13	min	min	NN	_	11	PMOD
14	and	and	CC	_	2	COORD
15	subsequently	subsequently	RB	_	16	TMP
16	infused	infuse	VBN	_	14	CONJ
17	via	via	IN	_	16	LOC
18	the	the	DT	_	20	NMOD
19	jugular	jugular	JJ	_	20	NMOD
20	vein	vein	NN	_	17	PMOD
21	with	with	IN	_	16	MNR
22	increasing	increase	VBG	_	23	NMOD
23	doses	dose	NNS	_	21	PMOD
24	of	of	IN	_	23	NMOD
25	TUDC	tudc	NN	_	24	PMOD
26	.	.	.	_	2	P

1	As	as	IN	_	10	ADV
2	shown	show	VBN	_	1	SUB
3	in	in	IN	_	2	LOC
4	Figure	figure	NN	_	5	NMOD
5	8d	0d	NN	_	3	PMOD
6	,	,	,	_	10	P
7	bile	bile	NN	_	8	NMOD
8	salt	salt	NN	_	9	NMOD
9	secretion	secretion	NN	_	10	SBJ
10	was	be	VBD	_	0	ROOT
11	no	no	RB	_	12	AMOD
12	different	different	JJ	_	10	PRD
13	between	between	IN	_	10	ADV
14	the	the	DT	_	16	NMOD
15	different	different	JJ	_	16	NMOD
16	genotypes	genotype	NNS	_	13	PMOD
17	during	during	IN	_	10	TMP
18	the	the	DT	_	19	NMOD
19	depletion	depletion	NN	_	17	PMOD
20	or	or	CC	_	19	COORD
21	the	the	DT	_	23	NMOD
22	TUDC	tudc	NN	_	23	NMOD
23	infusion	infusion	NN	_	20	CONJ
24	phases	phase	NNS	_	23	NMOD
25	of	of	IN	_	24	NMOD
26	the	the	DT	_	27	NMOD
27	experiment	experiment	NN	_	25	PMOD
28	.	.	.	_	10	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	a	a	DT	_	5	NMOD
4	different	different	JJ	_	5	NMOD
5	pattern	pattern	NN	_	6	SBJ
6	emerged	emerge	VBD	_	0	ROOT
7	for	for	IN	_	6	ADV
8	the	the	DT	_	9	NMOD
9	secretion	secretion	NN	_	7	PMOD
10	of	of	IN	_	9	NMOD
11	phospholipid	phospholipid	NN	_	10	PMOD
12	(	(	-LRB-	_	14	P
13	Figure	figure	NN	_	14	NMOD
14	8f	0f	NN	_	6	PRN
15	)	)	-RRB-	_	14	P
16	.	.	.	_	6	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	4	NMOD
4	difference	difference	NN	_	2	PRD
5	between	between	IN	_	4	NMOD
6	wild	wild	JJ	_	8	NMOD
7	-	-	HYPH	_	6	P
8	type	type	NN	_	11	NMOD
9	and	and	CC	_	8	COORD
10	heterozygous	heterozygous	JJ	_	9	CONJ
11	mice	mouse	NNS	_	5	PMOD
12	,	,	,	_	2	P
13	but	but	CC	_	2	COORD
14	knockout	knockout	NN	_	15	NMOD
15	mice	mouse	NNS	_	16	SBJ
16	showed	show	VBD	_	13	CONJ
17	a	a	DT	_	18	NMOD
18	trend	trend	NN	_	16	OBJ
19	of	of	IN	_	18	NMOD
20	lower	low	JJR	_	22	NMOD
21	phospholipid	phospholipid	NN	_	22	NMOD
22	secretion	secretion	NN	_	19	PMOD
23	during	during	IN	_	16	TMP
24	both	both	CC	_	29	COORD
25	the	the	DT	_	29	NMOD
26	depletion	depletion	NN	_	29	NMOD
27	and	and	CC	_	26	COORD
28	infusion	infusion	NN	_	27	CONJ
29	phase	phase	NN	_	23	PMOD
30	.	.	.	_	2	P

1	Even	even	RB	_	3	AMOD
2	more	more	RBR	_	1	AMOD
3	dramatic	dramatic	JJ	_	4	PRD
4	was	be	VBD	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	effect	effect	NN	_	4	SBJ
7	on	on	IN	_	6	NMOD
8	biliary	biliary	JJ	_	9	NMOD
9	sterol	sterol	NN	_	10	NMOD
10	secretion	secretion	NN	_	7	PMOD
11	although	although	IN	_	4	ADV
12	the	the	DT	_	14	NMOD
13	sterol	sterol	NN	_	14	NMOD
14	contents	content	NNS	_	15	SBJ
15	were	be	VBD	_	11	SUB
16	determined	determine	VBN	_	15	VC
17	enzymatically	enzymatically	RB	_	16	MNR
18	and	and	CC	_	15	COORD
19	no	no	DT	_	20	NMOD
20	distinction	distinction	NN	_	21	SBJ
21	is	be	VBZ	_	18	CONJ
22	made	make	VBN	_	21	VC
23	as	as	IN	_	20	NMOD
24	to	to	IN	_	23	PMOD
25	whether	whether	IN	_	24	PMOD
26	this	this	DT	_	27	SBJ
27	is	be	VBZ	_	25	SUB
28	sitosterol	sitosterol	NN	_	27	PRD
29	or	or	CC	_	28	COORD
30	cholesterol	cholesterol	NN	_	29	CONJ
31	(	(	-LRB-	_	33	P
32	Figure	figure	NN	_	33	NMOD
33	8e	0e	NN	_	4	PRN
34	,	,	,	_	33	P
35	but	but	CC	_	33	COORD
36	see	see	VB	_	35	CONJ
37	below	below	RB	_	36	ADV
38	)	)	-RRB-	_	33	P
39	.	.	.	_	4	P

1	In	in	IN	_	11	LOC
2	the	the	DT	_	4	NMOD
3	knockout	knockout	NN	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	,	,	,	_	11	P
6	almost	almost	RB	_	10	NMOD
7	no	no	DT	_	10	NMOD
8	stimulated	stimulate	VBN	_	10	NMOD
9	sterol	sterol	NN	_	10	NMOD
10	secretion	secretion	NN	_	11	SBJ
11	was	be	VBD	_	0	ROOT
12	noted	note	VBN	_	11	VC
13	,	,	,	_	12	P
14	with	with	IN	_	12	ADV
15	an	an	DT	_	17	NMOD
16	intermediate	intermediate	JJ	_	17	NMOD
17	phenotype	phenotype	NN	_	14	PMOD
18	in	in	IN	_	17	LOC
19	the	the	DT	_	21	NMOD
20	heterozygous	heterozygous	JJ	_	21	NMOD
21	mice	mouse	NNS	_	18	PMOD
22	.	.	.	_	11	P

1	In	in	IN	_	8	LOC
2	the	the	DT	_	4	NMOD
3	heterozygous	heterozygous	JJ	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	,	,	,	_	8	P
6	sterol	sterol	NN	_	7	NMOD
7	secretion	secretion	NN	_	8	SBJ
8	increased	increase	VBD	_	0	ROOT
9	to	to	TO	_	8	PRP
10	reach	reach	VB	_	9	IM
11	a	a	DT	_	13	NMOD
12	maximal	maximal	JJ	_	13	NMOD
13	level	level	NN	_	10	OBJ
14	of	of	IN	_	13	NMOD
15	about	about	IN	_	16	QMOD
16	50	0	CD	_	17	NMOD
17	%	%	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	the	the	DT	_	21	NMOD
20	wild	wild	JJ	_	21	NMOD
21	type	type	NN	_	18	PMOD
22	suggesting	suggest	VBG	_	8	ADV
23	that	that	IN	_	22	OBJ
24	Abcg8	abcg0	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	sterolin	sterolin	NN	_	29	SBJ
27	-	-	HYPH	_	26	P
28	2	0	CD	_	26	NMOD
29	is	be	VBZ	_	23	SUB
30	a	a	DT	_	34	NMOD
31	rate	rate	NN	_	33	AMOD
32	-	-	HYPH	_	31	P
33	limiting	limit	VBG	_	34	NMOD
34	step	step	NN	_	29	PRD
35	for	for	IN	_	34	NMOD
36	biliary	biliary	JJ	_	40	NMOD
37	'	'	``	_	40	P
38	cholesterol	cholesterol	NN	_	40	NMOD
39	'	'	''	_	40	P
40	secretion	secretion	NN	_	35	PMOD
41	.	.	.	_	8	P

1	In	in	IN	_	8	LOC
2	the	the	DT	_	4	NMOD
3	knockout	knockout	NN	_	4	NMOD
4	mice	mouse	NNS	_	1	PMOD
5	,	,	,	_	8	P
6	sterol	sterol	NN	_	7	NMOD
7	secretion	secretion	NN	_	8	SBJ
8	remained	remain	VBD	_	0	ROOT
9	at	at	IN	_	8	OPRD
10	a	a	DT	_	12	NMOD
11	constant	constant	JJ	_	12	NMOD
12	level	level	NN	_	9	PMOD
13	during	during	IN	_	8	TMP
14	the	the	DT	_	16	NMOD
15	depletion	depletion	NN	_	16	NMOD
16	phase	phase	NN	_	13	PMOD
17	and	and	CC	_	8	COORD
18	increased	increase	VBN	_	17	CONJ
19	minimally	minimally	RB	_	18	ADV
20	upon	upon	IN	_	18	TMP
21	infusion	infusion	NN	_	20	PMOD
22	of	of	IN	_	21	NMOD
23	TUDC	tudc	NN	_	22	PMOD
24	.	.	.	_	8	P

1	Since	since	IN	_	13	PRP
2	the	the	DT	_	7	NMOD
3	Abcg8	abcg0	NN	_	7	NMOD
4	-	-	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	-	-	SYM	_	3	P
7	mice	mouse	NNS	_	9	SBJ
8	still	still	RB	_	9	TMP
9	secreted	secrete	VBD	_	1	SUB
10	some	some	DT	_	11	NMOD
11	sterols	sterol	NNS	_	9	OBJ
12	we	we	PRP	_	13	SBJ
13	were	be	VBD	_	0	ROOT
14	interested	interested	JJ	_	13	PRD
15	in	in	IN	_	14	AMOD
16	which	which	WDT	_	19	NMOD
17	biliary	biliary	JJ	_	18	NMOD
18	sterol	sterol	NN	_	19	NMOD
19	species	specie	NNS	_	20	SBJ
20	were	be	VBD	_	15	PMOD
21	being	be	VBG	_	20	VC
22	secreted	secrete	VBN	_	21	VC
23	.	.	.	_	13	P

1	Therefore	therefore	RB	_	3	ADV
2	bile	bile	NN	_	3	SBJ
3	was	be	VBD	_	0	ROOT
4	collected	collect	VBN	_	3	VC
5	from	from	IN	_	4	ADV
6	mice	mouse	NNS	_	5	PMOD
7	during	during	IN	_	4	TMP
8	a	a	DT	_	10	NMOD
9	constant	constant	JJ	_	10	NMOD
10	infusion	infusion	NN	_	7	PMOD
11	of	of	IN	_	10	NMOD
12	TUDC	tudc	NN	_	11	PMOD
13	and	and	CC	_	4	COORD
14	analyzed	analyze	VBN	_	13	CONJ
15	by	by	IN	_	14	MNR
16	GC	gc	NN	_	15	PMOD
17	.	.	.	_	3	P

1	Mice	mouse	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	first	$#ORD#$	RB	_	4	TMP
4	depleted	deplete	VBN	_	2	VC
5	of	of	IN	_	4	ADV
6	their	their	PRP$	_	10	NMOD
7	endogenous	endogenous	JJ	_	10	NMOD
8	bile	bile	NN	_	9	NMOD
9	acid	acid	NN	_	10	NMOD
10	pools	pool	NNS	_	5	PMOD
11	for	for	IN	_	4	TMP
12	30	0	CD	_	13	NMOD
13	minutes	minute	NNS	_	11	PMOD
14	then	then	RB	_	15	TMP
15	infused	infuse	VBN	_	4	VC
16	with	with	IN	_	15	MNR
17	a	a	DT	_	19	NMOD
18	continuous	continuous	JJ	_	19	NMOD
19	dose	dose	NN	_	16	PMOD
20	of	of	IN	_	19	NMOD
21	TUDC	tudc	NN	_	20	PMOD
22	(	(	-LRB-	_	24	P
23	1,200	0	CD	_	24	NMOD
24	nmol	nmol	NN	_	4	PRN
25	/	/	SYM	_	26	P
26	min	min	NN	_	24	NMOD
27	/	/	SYM	_	31	P
28	100	0	NN	_	29	NMOD
29	g	g	NN	_	31	NMOD
30	body	body	NN	_	31	NMOD
31	weight	weight	NN	_	24	NMOD
32	)	)	-RRB-	_	24	P
33	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	knockout	knockout	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	showed	show	VBD	_	0	ROOT
5	a	a	DT	_	8	NMOD
6	significantly	significantly	RB	_	7	AMOD
7	diminished	diminish	VBN	_	8	NMOD
8	ability	ability	NN	_	4	OBJ
9	to	to	TO	_	8	NMOD
10	secrete	secrete	VB	_	9	IM
11	cholesterol	cholesterol	NN	_	10	OBJ
12	,	,	,	_	4	P
13	yet	yet	CC	_	4	COORD
14	still	still	RB	_	15	ADV
15	maintained	maintain	VBD	_	13	CONJ
16	the	the	DT	_	17	NMOD
17	ability	ability	NN	_	15	OBJ
18	to	to	TO	_	17	NMOD
19	secrete	secrete	VB	_	18	IM
20	sitosterol	sitosterol	NN	_	19	OBJ
21	and	and	CC	_	20	COORD
22	campesterol	campesterol	NN	_	21	CONJ
23	compared	compare	VBN	_	4	ADV
24	to	to	IN	_	23	PMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	28	NMOD
28	mice	mouse	NNS	_	24	PMOD
29	(	(	-LRB-	_	30	P
30	Figure	figure	NN	_	4	PRN
31	9	0	CD	_	30	NMOD
32	)	)	-RRB-	_	30	P
33	.	.	.	_	4	P

1	Surprisingly	surprisingly	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	8	NMOD
4	Abcg8	abcg0	NN	_	8	NMOD
5	+	+	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	-	-	SYM	_	4	P
8	mice	mouse	NNS	_	9	SBJ
9	tended	tend	VBD	_	0	ROOT
10	to	to	TO	_	9	OPRD
11	show	show	VB	_	10	IM
12	an	an	DT	_	14	NMOD
13	increased	increase	VBN	_	14	NMOD
14	ability	ability	NN	_	11	OBJ
15	to	to	TO	_	14	NMOD
16	secrete	secrete	VB	_	15	IM
17	all	all	DT	_	18	NMOD
18	sterols	sterol	NNS	_	16	OBJ
19	above	above	IN	_	16	ADV
20	the	the	DT	_	21	NMOD
21	levels	level	NNS	_	19	PMOD
22	seen	see	VBN	_	21	NMOD
23	in	in	IN	_	22	LOC
24	the	the	DT	_	28	NMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	28	NMOD
28	mice	mouse	NNS	_	23	PMOD
29	,	,	,	_	9	P
30	although	although	IN	_	9	ADV
31	this	this	DT	_	32	SBJ
32	was	be	VBD	_	30	SUB
33	not	not	RB	_	32	ADV
34	statistically	statistically	RB	_	35	AMOD
35	significant	significant	JJ	_	32	PRD
36	.	.	.	_	9	P

1	Discussion	discussion	NN	_	0	ROOT

1	The	the	DT	_	2	NMOD
2	mechanism	mechanism	NN	_	30	SBJ
3	by	by	IN	_	7	MNR
4	which	which	WDT	_	3	PMOD
5	dietary	dietary	JJ	_	6	NMOD
6	cholesterol	cholesterol	NN	_	7	SBJ
7	is	be	VBZ	_	2	NMOD
8	specifically	specifically	RB	_	7	ADV
9	absorbed	absorb	VBN	_	7	VC
10	and	and	CC	_	7	COORD
11	dietary	dietary	JJ	_	13	NMOD
12	non-cholesterol	non-cholesterol	NN	_	13	NMOD
13	sterols	sterol	NNS	_	15	SBJ
14	primarily	primarily	RB	_	15	ADV
15	excluded	exclude	VBD	_	10	CONJ
16	or	or	CC	_	2	COORD
17	the	the	DT	_	18	NMOD
18	mechanism	mechanism	NN	_	16	CONJ
19	(	(	-LRB-	_	18	P
20	s	s	AFX	_	18	NMOD
21	)	)	-RRB-	_	18	P
22	by	by	IN	_	28	MNR
23	which	which	WDT	_	22	PMOD
24	the	the	DT	_	25	NMOD
25	liver	liver	NN	_	26	SBJ
26	can	can	MD	_	18	NMOD
27	selectively	selectively	RB	_	26	ADV
28	secrete	secrete	VB	_	26	VC
29	sterols	sterol	NNS	_	28	OBJ
30	has	have	VBZ	_	0	ROOT
31	not	not	RB	_	30	ADV
32	been	be	VBN	_	30	VC
33	elucidated	elucidate	VBN	_	32	VC
34	.	.	.	_	30	P

1	Identification	identification	NN	_	24	SBJ
2	of	of	IN	_	1	NMOD
3	the	the	DT	_	5	NMOD
4	genetic	genetic	JJ	_	5	NMOD
5	defect	defect	NN	_	2	PMOD
6	(	(	-LRB-	_	5	P
7	s	s	AFX	_	5	NMOD
8	)	)	-RRB-	_	5	P
9	in	in	IN	_	5	LOC
10	a	a	DT	_	13	NMOD
11	rare	rare	JJ	_	13	NMOD
12	human	human	JJ	_	13	NMOD
13	disorder	disorder	NN	_	9	PMOD
14	,	,	,	_	13	P
15	sitosterolemia	sitosterolemia	NN	_	13	APPO
16	,	,	,	_	13	P
17	where	where	WRB	_	22	LOC
18	these	these	DT	_	19	NMOD
19	processes	process	NNS	_	20	SBJ
20	are	be	VBP	_	13	NMOD
21	specifically	specifically	RB	_	20	ADV
22	disrupted	disrupt	VBN	_	20	VC
23	,	,	,	_	24	P
24	may	may	MD	_	0	ROOT
25	finally	finally	RB	_	24	TMP
26	have	have	VB	_	24	VC
27	led	lead	VBN	_	26	VC
28	to	to	IN	_	27	ADV
29	the	the	DT	_	30	NMOD
30	identification	identification	NN	_	28	PMOD
31	of	of	IN	_	30	NMOD
32	the	the	DT	_	34	NMOD
33	'	'	``	_	34	P
34	transporters	transporter	NNS	_	31	PMOD
35	'	'	''	_	34	P
36	responsible	responsible	JJ	_	34	NMOD
37	for	for	IN	_	36	AMOD
38	these	these	DT	_	39	NMOD
39	processes	process	NNS	_	37	PMOD
40	.	.	.	_	24	P

1	Complete	complete	JJ	_	2	NMOD
2	defects	defect	NNS	_	28	SBJ
3	in	in	IN	_	2	NMOD
4	one	one	CD	_	7	NMOD
5	of	of	IN	_	4	QMOD
6	two	two	CD	_	4	QMOD
7	genes	gene	NNS	_	3	PMOD
8	(	(	-LRB-	_	7	P
9	but	but	CC	_	7	COORD
10	not	not	RB	_	9	ADV
11	both	both	DT	_	9	CONJ
12	)	)	-RRB-	_	2	P
13	,	,	,	_	2	P
14	organized	organize	VBN	_	2	NMOD
15	in	in	IN	_	14	MNR
16	a	a	DT	_	22	NMOD
17	head	head	NN	_	22	NMOD
18	-	-	HYPH	_	17	P
19	to	to	IN	_	17	NMOD
20	-	-	HYPH	_	19	P
21	head	head	NN	_	19	PMOD
22	configuration	configuration	NN	_	15	PMOD
23	at	at	IN	_	14	LOC
24	the	the	DT	_	26	NMOD
25	STSL	stsl	NN	_	26	NMOD
26	locus	locus	NN	_	23	PMOD
27	,	,	,	_	28	P
28	causes	cause	VBZ	_	0	ROOT
29	sitosterolemia	sitosterolemia	NN	_	28	OBJ
30	.	.	.	_	28	P

1	We	we	PRP	_	2	SBJ
2	report	report	VBP	_	0	ROOT
3	a	a	DT	_	5	NMOD
4	mouse	mouse	NN	_	5	NMOD
5	model	model	NN	_	2	OBJ
6	of	of	IN	_	5	NMOD
7	sitosterolemia	sitosterolemia	NN	_	6	PMOD
8	,	,	,	_	5	P
9	with	with	IN	_	5	NMOD
10	a	a	DT	_	16	NMOD
11	selective	selective	JJ	_	16	NMOD
12	,	,	,	_	11	P
13	but	but	CC	_	11	COORD
14	complete	complete	JJ	_	13	CONJ
15	,	,	,	_	16	P
16	defect	defect	NN	_	9	PMOD
17	in	in	IN	_	16	LOC
18	one	one	CD	_	17	PMOD
19	of	of	IN	_	18	NMOD
20	these	these	DT	_	21	NMOD
21	genes	gene	NNS	_	19	PMOD
22	,	,	,	_	18	P
23	Abcg8	abcg0	NN	_	18	APPO
24	.	.	.	_	2	P

1	This	this	DT	_	2	NMOD
2	mouse	mouse	NN	_	3	SBJ
3	reflects	reflect	VBZ	_	0	ROOT
4	the	the	DT	_	6	NMOD
5	known	known	JJ	_	6	NMOD
6	defects	defect	NNS	_	3	OBJ
7	described	describe	VBN	_	6	NMOD
8	in	in	IN	_	7	LOC
9	human	human	JJ	_	10	NMOD
10	sitosterolemia	sitosterolemia	NN	_	8	PMOD
11	[	[	-LRB-	_	16	P
12	5	0	CD	_	16	NMOD
13	,	,	,	_	16	P
14	7	0	CD	_	16	NMOD
15	,	,	,	_	16	P
16	42	0	CD	_	3	PRN
17	]	]	-RRB-	_	16	P
18	.	.	.	_	3	P

1	Plasma	plasma	NN	_	11	SBJ
2	and	and	CC	_	1	COORD
3	all	all	DT	_	4	NMOD
4	tissues	tissue	NNS	_	2	CONJ
5	,	,	,	_	4	P
6	apart	apart	RB	_	4	NMOD
7	from	from	IN	_	6	AMOD
8	the	the	DT	_	9	NMOD
9	brain	brain	NN	_	7	PMOD
10	,	,	,	_	11	P
11	have	have	VBP	_	0	ROOT
12	significantly	significantly	RB	_	13	AMOD
13	elevated	elevate	VBN	_	15	NMOD
14	sitosterol	sitosterol	NN	_	15	NMOD
15	levels	level	NNS	_	11	OBJ
16	.	.	.	_	11	P

1	Homozygous	homozygous	JJ	_	3	NMOD
2	knockout	knockout	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	viable	viable	JJ	_	4	PRD
6	,	,	,	_	5	P
7	fertile	fertile	JJ	_	5	CONJ
8	and	and	CC	_	7	COORD
9	sitosterolemic	sitosterolemic	JJ	_	8	CONJ
10	.	.	.	_	4	P

1	However	however	RB	_	4	ADV
2	,	,	,	_	4	P
3	fertility	fertility	NN	_	4	SBJ
4	seems	seem	VBZ	_	0	ROOT
5	to	to	TO	_	4	OPRD
6	be	be	VB	_	5	IM
7	reduced	reduce	VBN	_	6	VC
8	when	when	WRB	_	12	TMP
9	homozygous	homozygous	JJ	_	10	NMOD
10	mice	mouse	NNS	_	11	SBJ
11	are	be	VBP	_	7	TMP
12	bred	breed	VBN	_	11	VC
13	together	together	RB	_	12	ADV
14	(	(	-LRB-	_	15	P
15	S	s	NNP	_	7	CIT
16	Patel	patel	NNP	_	15	DEP
17	and	and	CC	_	16	COORD
18	J	j	NNP	_	17	CONJ
19	Oatis	oatis	NNP	_	15	DEP
20	,	,	,	_	15	P
21	unpublished	unpublished	JJ	_	15	DEP
22	observation	observation	NN	_	15	DEP
23	)	)	-RRB-	_	15	P
24	.	.	.	_	4	P

1	This	this	DT	_	2	NMOD
2	model	model	NN	_	3	SBJ
3	reflects	reflect	VBZ	_	0	ROOT
4	many	many	JJ	_	7	NMOD
5	other	other	JJ	_	7	NMOD
6	observed	observe	VBN	_	7	NMOD
7	changes	change	NNS	_	3	OBJ
8	described	describe	VBN	_	7	NMOD
9	in	in	IN	_	8	LOC
10	limited	limited	JJ	_	11	NMOD
11	studies	study	NNS	_	9	PMOD
12	in	in	IN	_	11	LOC
13	humans	human	NNS	_	12	PMOD
14	.	.	.	_	3	P

1	For	for	IN	_	16	ADV
2	example	example	NN	_	1	PMOD
3	,	,	,	_	16	P
4	in	in	IN	_	16	LOC
5	humans	human	NNS	_	4	PMOD
6	,	,	,	_	16	P
7	the	the	DT	_	8	NMOD
8	activity	activity	NN	_	16	SBJ
9	of	of	IN	_	8	NMOD
10	HMG	hmg	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	CoA	coa	NN	_	13	NMOD
13	reductase	reductase	NN	_	9	PMOD
14	and	and	CC	_	13	COORD
15	CYP7a1	cyp0a0	NN	_	14	CONJ
16	have	have	VBP	_	0	ROOT
17	been	be	VBN	_	16	VC
18	reported	report	VBN	_	17	VC
19	to	to	TO	_	18	OPRD
20	be	be	VB	_	19	IM
21	low	low	JJ	_	20	PRD
22	[	[	-LRB-	_	25	P
23	7	0	CD	_	25	NMOD
24	,	,	,	_	25	P
25	39	0	CD	_	18	PRN
26	]	]	-RRB-	_	25	P
27	.	.	.	_	16	P

1	In	in	IN	_	6	LOC
2	this	this	DT	_	3	NMOD
3	study	study	NN	_	1	PMOD
4	,	,	,	_	6	P
5	we	we	PRP	_	6	SBJ
6	show	show	VBP	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	the	the	DT	_	9	NMOD
9	mRNA	mrna	NN	_	19	SBJ
10	and	and	CC	_	9	COORD
11	enzyme	enzyme	NN	_	12	NMOD
12	activities	activity	NNS	_	10	CONJ
13	in	in	IN	_	9	LOC
14	the	the	DT	_	15	NMOD
15	livers	liver	NNS	_	13	PMOD
16	from	from	IN	_	15	NMOD
17	knockout	knockout	NN	_	18	NMOD
18	animals	animal	NNS	_	16	PMOD
19	are	be	VBP	_	7	SUB
20	also	also	RB	_	19	ADV
21	significantly	significantly	RB	_	19	ADV
22	reduced	reduce	VBN	_	19	VC
23	.	.	.	_	6	P

1	Additionally	additionally	RB	_	18	ADV
2	,	,	,	_	18	P
3	the	the	DT	_	4	NMOD
4	activity	activity	NN	_	18	SBJ
5	of	of	IN	_	4	NMOD
6	the	the	DT	_	10	NMOD
7	rate	rate	NN	_	9	AMOD
8	-	-	HYPH	_	7	P
9	limiting	limit	VBG	_	10	NMOD
10	enzyme	enzyme	NN	_	5	PMOD
11	for	for	IN	_	10	NMOD
12	bile	bile	NN	_	13	NMOD
13	acid	acid	NN	_	14	NMOD
14	synthesis	synthesis	NN	_	11	PMOD
15	,	,	,	_	10	P
16	CYP7a1	cyp0a0	NN	_	10	APPO
17	,	,	,	_	18	P
18	is	be	VBZ	_	0	ROOT
19	reduced	reduce	VBN	_	18	VC
20	,	,	,	_	19	P
21	although	although	IN	_	19	ADV
22	no	no	DT	_	23	NMOD
23	changes	change	NNS	_	28	SBJ
24	at	at	IN	_	23	LOC
25	the	the	DT	_	27	NMOD
26	mRNA	mrna	NN	_	27	NMOD
27	level	level	NN	_	24	PMOD
28	are	be	VBP	_	21	SUB
29	noted	note	VBN	_	28	VC
30	.	.	.	_	18	P

1	This	this	DT	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	also	also	RB	_	2	ADV
4	in	in	IN	_	2	PRD
5	keeping	keep	VBG	_	4	PMOD
6	with	with	IN	_	5	NMOD
7	previous	previous	JJ	_	8	NMOD
8	studies	study	NNS	_	6	PMOD
9	that	that	WDT	_	10	SBJ
10	show	show	VBP	_	8	NMOD
11	that	that	IN	_	10	OBJ
12	sitosterol	sitosterol	NN	_	13	SBJ
13	is	be	VBZ	_	11	SUB
14	a	a	DT	_	16	NMOD
15	direct	direct	JJ	_	16	NMOD
16	inhibitor	inhibitor	NN	_	13	PRD
17	of	of	IN	_	16	NMOD
18	this	this	DT	_	19	NMOD
19	enzyme	enzyme	NN	_	17	PMOD
20	in	in	FW	_	21	AMOD
21	vitro	vitro	FW	_	13	ADV
22	[	[	-LRB-	_	23	P
23	39	0	CD	_	2	PRN
24	]	]	-RRB-	_	23	P
25	.	.	.	_	2	P

1	Biliary	biliary	JJ	_	2	NMOD
2	sterols	sterol	NNS	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	Abcg8	abcg0	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	deficient	deficient	JJ	_	7	NMOD
7	mice	mouse	NNS	_	3	PMOD
8	were	be	VBD	_	0	ROOT
9	dramatically	dramatically	RB	_	10	AMOD
10	different	different	JJ	_	8	PRD
11	compared	compare	VBN	_	8	ADV
12	to	to	IN	_	11	PMOD
13	wild	wild	JJ	_	15	NMOD
14	-	-	HYPH	_	13	P
15	type	type	NN	_	16	NMOD
16	mice	mouse	NNS	_	12	PMOD
17	.	.	.	_	8	P

1	Measurement	measurement	NN	_	13	SBJ
2	of	of	IN	_	1	NMOD
3	biliary	biliary	JJ	_	4	NMOD
4	sterol	sterol	NN	_	6	NMOD
5	secretion	secretion	NN	_	6	NMOD
6	rates	rate	NNS	_	2	PMOD
7	in	in	IN	_	6	LOC
8	Abcg8	abcg0	NN	_	12	NMOD
9	-	-	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	-	-	SYM	_	8	P
12	mice	mouse	NNS	_	7	PMOD
13	demonstrated	demonstrate	VBD	_	0	ROOT
14	a	a	DT	_	15	NMOD
15	failure	failure	NN	_	13	OBJ
16	to	to	TO	_	15	NMOD
17	increase	increase	VB	_	16	IM
18	sterol	sterol	NN	_	19	NMOD
19	secretion	secretion	NN	_	17	OBJ
20	into	into	IN	_	19	NMOD
21	bile	bile	NN	_	20	PMOD
22	despite	despite	IN	_	15	NMOD
23	exogenous	exogenous	JJ	_	24	NMOD
24	infusion	infusion	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	bile	bile	NN	_	27	NMOD
27	acids	acid	NNS	_	25	PMOD
28	.	.	.	_	13	P

1	Furthermore	furthermore	RB	_	11	ADV
2	,	,	,	_	11	P
3	complete	complete	JJ	_	4	NMOD
4	loss	loss	NN	_	11	SBJ
5	of	of	IN	_	4	NMOD
6	Abcg8	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	5	PMOD
9	-	-	HYPH	_	8	P
10	2	0	CD	_	8	NMOD
11	results	result	VBZ	_	0	ROOT
12	in	in	IN	_	11	ADV
13	an	an	DT	_	14	NMOD
14	inability	inability	NN	_	12	PMOD
15	to	to	TO	_	14	NMOD
16	secrete	secrete	VB	_	15	IM
17	cholesterol	cholesterol	NN	_	16	OBJ
18	into	into	IN	_	16	DIR
19	bile	bile	NN	_	18	PMOD
20	,	,	,	_	11	P
21	although	although	IN	_	11	ADV
22	secretion	secretion	NN	_	25	SBJ
23	of	of	IN	_	22	NMOD
24	sitosterol	sitosterol	NN	_	23	PMOD
25	seemed	seem	VBD	_	21	SUB
26	to	to	TO	_	25	OPRD
27	be	be	VB	_	26	IM
28	preserved	preserve	VBN	_	27	VC
29	.	.	.	_	11	P

1	Arguably	arguably	RB	_	25	ADV
2	,	,	,	_	25	P
3	since	since	IN	_	25	PRP
4	the	the	DT	_	6	NMOD
5	body	body	NN	_	6	NMOD
6	pools	pool	NNS	_	15	SBJ
7	and	and	CC	_	6	COORD
8	plasma	plasma	NN	_	9	NMOD
9	sitosterol	sitosterol	NN	_	10	NMOD
10	levels	level	NNS	_	7	CONJ
11	in	in	IN	_	6	LOC
12	the	the	DT	_	14	NMOD
13	knockout	knockout	NN	_	14	NMOD
14	mice	mouse	NNS	_	11	PMOD
15	are	be	VBP	_	3	SUB
16	so	so	RB	_	17	AMOD
17	considerably	considerably	RB	_	15	ADV
18	elevated	elevated	JJ	_	15	PRD
19	,	,	,	_	25	P
20	perhaps	perhaps	RB	_	25	ADV
21	the	the	DT	_	24	NMOD
22	biliary	biliary	JJ	_	23	NMOD
23	sitosterol	sitosterol	NN	_	24	NMOD
24	levels	level	NNS	_	25	SBJ
25	could	could	MD	_	0	ROOT
26	be	be	VB	_	25	VC
27	considered	consider	VBN	_	26	VC
28	to	to	TO	_	27	OPRD
29	be	be	VB	_	28	IM
30	inappropriately	inappropriately	RB	_	31	AMOD
31	low	low	JJ	_	29	PRD
32	.	.	.	_	25	P

1	Despite	despite	IN	_	14	ADV
2	this	this	DT	_	3	NMOD
3	reservation	reservation	NN	_	1	PMOD
4	,	,	,	_	14	P
5	the	the	DT	_	6	NMOD
6	finding	finding	NN	_	14	SBJ
7	that	that	IN	_	6	NMOD
8	sitosterol	sitosterol	NN	_	9	SBJ
9	is	be	VBZ	_	7	SUB
10	present	present	JJ	_	9	PRD
11	in	in	IN	_	10	LOC
12	the	the	DT	_	13	NMOD
13	bile	bile	NN	_	11	PMOD
14	suggests	suggest	VBZ	_	0	ROOT
15	that	that	IN	_	14	OBJ
16	plant	plant	NN	_	17	NMOD
17	sterols	sterol	NNS	_	18	SBJ
18	may	may	MD	_	15	SUB
19	be	be	VB	_	18	VC
20	secreted	secrete	VBN	_	19	VC
21	independent	independent	RB	_	20	ADV
22	of	of	IN	_	21	AMOD
23	Abcg8	abcg0	NN	_	25	NMOD
24	/	/	HYPH	_	23	P
25	sterolin	sterolin	NN	_	22	PMOD
26	-	-	HYPH	_	25	P
27	2	0	CD	_	25	NMOD
28	.	.	.	_	14	P

1	The	the	DT	_	2	NMOD
2	ability	ability	NN	_	24	SBJ
3	of	of	IN	_	2	NMOD
4	Abcg8	abcg0	NN	_	8	NMOD
5	-	-	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	-	-	SYM	_	4	P
8	mice	mouse	NNS	_	3	PMOD
9	to	to	TO	_	2	NMOD
10	secrete	secrete	VB	_	9	IM
11	bile	bile	NN	_	12	NMOD
12	salt	salt	NN	_	10	OBJ
13	and	and	CC	_	12	COORD
14	phospholipid	phospholipid	NN	_	13	CONJ
15	into	into	IN	_	10	DIR
16	bile	bile	NN	_	15	PMOD
17	as	as	IN	_	10	ADV
18	compared	compare	VBN	_	17	SUB
19	to	to	IN	_	18	ADV
20	wild	wild	JJ	_	22	NMOD
21	-	-	HYPH	_	20	P
22	type	type	NN	_	23	NMOD
23	mice	mouse	NNS	_	19	PMOD
24	was	be	VBD	_	0	ROOT
25	not	not	RB	_	24	ADV
26	significantly	significantly	RB	_	24	ADV
27	impaired	impair	VBN	_	24	VC
28	.	.	.	_	24	P

1	Collectively	collectively	RB	_	4	ADV
2	these	these	DT	_	3	NMOD
3	data	datum	NNS	_	4	SBJ
4	suggest	suggest	VBP	_	0	ROOT
5	that	that	IN	_	4	OBJ
6	Abcg8	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	11	SBJ
9	-	-	HYPH	_	8	P
10	2	0	CD	_	8	NMOD
11	is	be	VBZ	_	5	SUB
12	necessary	necessary	JJ	_	11	PRD
13	for	for	IN	_	12	AMOD
14	hepatobiliary	hepatobiliary	JJ	_	16	NMOD
15	cholesterol	cholesterol	NN	_	16	NMOD
16	secretion	secretion	NN	_	13	PMOD
17	in	in	IN	_	16	LOC
18	mice	mouse	NNS	_	17	PMOD
19	.	.	.	_	4	P

1	Abcg8	abcg0	NN	_	5	NMOD
2	-	-	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	-	-	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	appeared	appear	VBD	_	0	ROOT
7	normal	normal	JJ	_	6	OPRD
8	and	and	CC	_	7	COORD
9	healthy	healthy	JJ	_	8	CONJ
10	maintained	maintain	VBN	_	6	ADV
11	on	on	IN	_	10	ADV
12	a	a	DT	_	16	NMOD
13	regular	regular	JJ	_	16	NMOD
14	rodent	rodent	NN	_	15	NMOD
15	chow	chow	NN	_	16	NMOD
16	diet	diet	NN	_	11	PMOD
17	.	.	.	_	6	P

1	Their	their	PRP$	_	3	NMOD
2	phenotypic	phenotypic	JJ	_	3	NMOD
3	features	feature	NNS	_	4	SBJ
4	are	be	VBP	_	0	ROOT
5	very	very	RB	_	6	AMOD
6	similar	similar	JJ	_	4	PRD
7	to	to	IN	_	6	AMOD
8	those	those	DT	_	7	PMOD
9	recently	recently	RB	_	10	TMP
10	reported	report	VBN	_	8	NMOD
11	for	for	IN	_	10	ADV
12	a	a	DT	_	13	NMOD
13	mouse	mouse	NN	_	11	PMOD
14	deficient	deficient	JJ	_	13	NMOD
15	in	in	IN	_	14	AMOD
16	both	both	DT	_	17	NMOD
17	sterolins	sterolins	NNS	_	15	PMOD
18	simultaneously	simultaneously	RB	_	17	TMP
19	[	[	-LRB-	_	22	P
20	7	0	CD	_	22	NMOD
21	,	,	,	_	22	P
22	20	0	CD	_	4	PRN
23	]	]	-RRB-	_	22	P
24	.	.	.	_	4	P

1	Plasma	plasma	NN	_	6	NMOD
2	and	and	CC	_	1	COORD
3	hepatic	hepatic	JJ	_	2	CONJ
4	plant	plant	NN	_	5	NMOD
5	sterol	sterol	NN	_	6	NMOD
6	levels	level	NNS	_	17	SBJ
7	in	in	IN	_	6	LOC
8	Abcg8	abcg0	NN	_	7	PMOD
9	-	-	SYM	_	8	P
10	/	/	HYPH	_	8	P
11	-	-	SYM	_	8	P
12	and	and	CC	_	8	COORD
13	Abcg5	abcg0	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	Abcg8	abcg0	NN	_	16	NMOD
16	knockout	knockout	NN	_	12	CONJ
17	are	be	VBP	_	0	ROOT
18	increased	increase	VBN	_	17	VC
19	similarly	similarly	RB	_	18	ADV
20	with	with	IN	_	18	ADV
21	marked	marked	JJ	_	22	NMOD
22	decreases	decrease	NNS	_	20	PMOD
23	in	in	IN	_	22	NMOD
24	cholesterol	cholesterol	NN	_	25	NMOD
25	levels	level	NNS	_	23	PMOD
26	.	.	.	_	17	P

1	Interestingly	interestingly	RB	_	13	ADV
2	,	,	,	_	13	P
3	plasma	plasma	NN	_	4	NMOD
4	triglyceride	triglyceride	NN	_	5	NMOD
5	levels	level	NNS	_	13	SBJ
6	of	of	IN	_	5	NMOD
7	the	the	DT	_	12	NMOD
8	Abcg8	abcg0	NN	_	11	NMOD
9	-	-	SYM	_	11	P
10	/	/	HYPH	_	11	P
11	-	-	SYM	_	12	NMOD
12	mice	mouse	NNS	_	6	PMOD
13	were	be	VBD	_	0	ROOT
14	slightly	slightly	RB	_	15	AMOD
15	higher	high	JJR	_	13	PRD
16	than	than	IN	_	15	AMOD
17	wild	wild	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	type	type	NN	_	20	NMOD
20	animals	animal	NNS	_	16	PMOD
21	and	and	CC	_	13	COORD
22	this	this	DT	_	24	NMOD
23	increased	increase	VBN	_	24	NMOD
24	triglyceride	triglyceride	NN	_	25	SBJ
25	is	be	VBZ	_	21	CONJ
26	carried	carry	VBN	_	25	VC
27	in	in	IN	_	26	LOC
28	the	the	DT	_	31	NMOD
29	LDL	ldl	NN	_	30	NMOD
30	fraction	fraction	NN	_	31	NMOD
31	range	range	NN	_	27	PMOD
32	,	,	,	_	26	P
33	as	as	IN	_	26	ADV
34	measured	measure	VBN	_	33	SUB
35	by	by	IN	_	34	MNR
36	FPLC	fplc	NN	_	35	PMOD
37	.	.	.	_	13	P

1	The	the	DT	_	2	NMOD
2	significance	significance	NN	_	5	SBJ
3	of	of	IN	_	2	NMOD
4	this	this	DT	_	3	PMOD
5	is	be	VBZ	_	0	ROOT
6	not	not	RB	_	5	ADV
7	clear	clear	JJ	_	5	PRD
8	,	,	,	_	5	P
9	although	although	IN	_	5	ADV
10	preliminary	preliminary	JJ	_	14	NMOD
11	SDS	sd	NN	_	13	NMOD
12	-	-	HYPH	_	11	P
13	PAGE	page	NN	_	14	NMOD
14	analyses	analysis	NNS	_	19	SBJ
15	of	of	IN	_	14	NMOD
16	all	all	PDT	_	18	NMOD
17	the	the	DT	_	18	NMOD
18	fractions	fraction	NNS	_	15	PMOD
19	failed	fail	VBD	_	9	SUB
20	to	to	TO	_	19	OPRD
21	reveal	reveal	VB	_	20	IM
22	any	any	DT	_	23	NMOD
23	differences	difference	NNS	_	21	OBJ
24	between	between	IN	_	23	NMOD
25	wild	wild	JJ	_	27	NMOD
26	-	-	HYPH	_	25	P
27	type	type	NN	_	30	NMOD
28	and	and	CC	_	27	COORD
29	knockout	knockout	NN	_	28	CONJ
30	samples	sample	NNS	_	24	PMOD
31	.	.	.	_	5	P

1	Hepatic	hepatic	JJ	_	2	NMOD
2	levels	level	NNS	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	GC	gc	NN	_	6	AMOD
5	-	-	HYPH	_	4	P
6	measured	measure	VBN	_	7	NMOD
7	cholesterol	cholesterol	NN	_	3	PMOD
8	were	be	VBD	_	0	ROOT
9	greatly	greatly	RB	_	8	ADV
10	reduced	reduce	VBN	_	8	VC
11	in	in	IN	_	10	LOC
12	Abcg8	abcg0	NN	_	15	NMOD
13	-	-	SYM	_	15	P
14	/	/	HYPH	_	15	P
15	-	-	SYM	_	16	NMOD
16	mice	mouse	NNS	_	11	PMOD
17	compared	compare	VBN	_	10	ADV
18	to	to	IN	_	17	PMOD
19	wild	wild	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	type	type	NN	_	22	NMOD
22	mice	mouse	NNS	_	18	PMOD
23	,	,	,	_	8	P
24	yet	yet	CC	_	8	COORD
25	mRNA	mrna	NN	_	26	NMOD
26	levels	level	NNS	_	35	SBJ
27	of	of	IN	_	26	NMOD
28	HMG	hmg	NN	_	30	NMOD
29	-	-	HYPH	_	28	P
30	CoA	coa	NN	_	31	NMOD
31	reductase	reductase	NN	_	27	PMOD
32	and	and	CC	_	26	COORD
33	enzyme	enzyme	NN	_	34	NMOD
34	activity	activity	NN	_	32	CONJ
35	are	be	VBP	_	24	CONJ
36	also	also	RB	_	35	ADV
37	reduced	reduce	VBN	_	35	VC
38	without	without	IN	_	37	ADV
39	any	any	DT	_	41	NMOD
40	significant	significant	JJ	_	41	NMOD
41	change	change	NN	_	38	PMOD
42	in	in	IN	_	41	NMOD
43	mRNA	mrna	NN	_	42	PMOD
44	of	of	IN	_	43	NMOD
45	the	the	DT	_	46	NMOD
46	Srebps	srebps	NNS	_	44	PMOD
47	.	.	.	_	8	P

1	The	the	DT	_	2	NMOD
2	basis	base	NN	_	5	SBJ
3	for	for	IN	_	2	NMOD
4	this	this	DT	_	3	PMOD
5	is	be	VBZ	_	0	ROOT
6	not	not	RB	_	5	ADV
7	clear	clear	JJ	_	5	PRD
8	at	at	IN	_	5	TMP
9	present	present	JJ	_	8	PMOD
10	,	,	,	_	5	P
11	unless	unless	IN	_	5	ADV
12	the	the	DT	_	13	NMOD
13	increase	increase	NN	_	17	SBJ
14	in	in	IN	_	13	NMOD
15	non-plant	non-plant	JJ	_	16	NMOD
16	sterols	sterol	NNS	_	14	PMOD
17	leads	lead	VBZ	_	11	SUB
18	to	to	IN	_	17	ADV
19	a	a	DT	_	20	NMOD
20	suppression	suppression	NN	_	18	PMOD
21	of	of	IN	_	20	NMOD
22	SREBP	srebp	NN	_	23	NMOD
23	activation	activation	NN	_	21	PMOD
24	.	.	.	_	5	P

1	Sitosterol	sitosterol	NN	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	shown	show	VBN	_	3	VC
5	to	to	TO	_	4	OPRD
6	directly	directly	RB	_	5	ADV
7	inhibit	inhibit	VB	_	5	IM
8	Cyp7a1	cyp0a0	NN	_	9	NMOD
9	activity	activity	NN	_	7	OBJ
10	in	in	FW	_	11	AMOD
11	vitro	vitro	FW	_	7	LOC
12	and	and	CC	_	2	COORD
13	we	we	PRP	_	14	SBJ
14	presume	presume	VBP	_	12	CONJ
15	this	this	DT	_	16	SBJ
16	may	may	MD	_	14	OBJ
17	account	account	VB	_	16	VC
18	for	for	IN	_	17	ADV
19	the	the	DT	_	22	NMOD
20	reduced	reduce	VBN	_	22	NMOD
21	enzyme	enzyme	NN	_	22	NMOD
22	activity	activity	NN	_	18	PMOD
23	[	[	-LRB-	_	24	P
24	39	0	CD	_	2	PRN
25	]	]	-RRB-	_	24	P
26	.	.	.	_	2	P

1	In	in	IN	_	28	LOC
2	preliminary	preliminary	JJ	_	3	NMOD
3	studies	study	NNS	_	1	PMOD
4	,	,	,	_	28	P
5	when	when	WRB	_	9	TMP
6	knockout	knockout	NN	_	7	NMOD
7	mice	mouse	NNS	_	8	SBJ
8	are	be	VBP	_	28	TMP
9	placed	place	VBN	_	8	VC
10	on	on	IN	_	9	ADV
11	a	a	DT	_	14	NMOD
12	low	low	JJ	_	13	NMOD
13	sitosterol	sitosterol	NN	_	14	NMOD
14	diet	diet	NN	_	10	PMOD
15	,	,	,	_	28	P
16	the	the	DT	_	17	NMOD
17	activity	activity	NN	_	28	SBJ
18	of	of	IN	_	17	NMOD
19	this	this	DT	_	20	NMOD
20	enzyme	enzyme	NN	_	18	PMOD
21	,	,	,	_	17	P
22	as	as	RB	_	24	ADV
23	well	well	RB	_	24	ADV
24	as	as	IN	_	17	COORD
25	the	the	DT	_	27	NMOD
26	mRNA	mrna	NN	_	27	NMOD
27	levels	level	NNS	_	24	CONJ
28	are	be	VBP	_	0	ROOT
29	increased	increase	VBN	_	28	VC
30	(	(	-LRB-	_	31	P
31	E	e	NNP	_	29	CIT
32	Klett	klett	NNP	_	31	DEP
33	and	and	CC	_	32	COORD
34	S	s	NNP	_	33	CONJ
35	Patel	patel	NNP	_	31	DEP
36	,	,	,	_	31	P
37	unpublished	unpublished	JJ	_	31	DEP
38	observations	observation	NNS	_	31	DEP
39	)	)	-RRB-	_	31	P
40	.	.	.	_	28	P

1	Another	another	DT	_	2	NMOD
2	prediction	prediction	NN	_	15	SBJ
3	,	,	,	_	2	P
4	based	base	VBN	_	2	NMOD
5	upon	upon	IN	_	4	PMOD
6	the	the	DT	_	10	NMOD
7	enzyme	enzyme	NN	_	10	NMOD
8	and	and	CC	_	7	COORD
9	mRNA	mrna	NN	_	8	CONJ
10	levels	level	NNS	_	5	PMOD
11	in	in	IN	_	10	LOC
12	knockout	knockout	NN	_	13	NMOD
13	mice	mouse	NNS	_	11	PMOD
14	,	,	,	_	15	P
15	is	be	VBZ	_	0	ROOT
16	that	that	IN	_	15	PRD
17	if	if	IN	_	32	ADV
18	these	these	DT	_	19	NMOD
19	mice	mouse	NNS	_	20	SBJ
20	are	be	VBP	_	17	SUB
21	placed	place	VBN	_	20	VC
22	on	on	IN	_	21	ADV
23	a	a	DT	_	29	NMOD
24	high	high	JJ	_	25	NMOD
25	cholesterol	cholesterol	NN	_	28	NMOD
26	/	/	HYPH	_	25	P
27	high	high	JJ	_	28	NMOD
28	sitosterol	sitosterol	NN	_	29	NMOD
29	diet	diet	NN	_	22	PMOD
30	,	,	,	_	32	P
31	they	they	PRP	_	32	SBJ
32	may	may	MD	_	16	SUB
33	show	show	VB	_	32	VC
34	significant	significant	JJ	_	35	NMOD
35	accumulation	accumulation	NN	_	33	OBJ
36	of	of	IN	_	35	NMOD
37	both	both	DT	_	38	NMOD
38	sterols	sterol	NNS	_	36	PMOD
39	in	in	IN	_	35	LOC
40	the	the	DT	_	41	NMOD
41	body	body	NN	_	39	PMOD
42	.	.	.	_	15	P

1	This	this	DT	_	2	SBJ
2	may	may	MD	_	0	ROOT
3	also	also	RB	_	2	ADV
4	be	be	VB	_	2	VC
5	relevant	relevant	JJ	_	4	PRD
6	to	to	IN	_	5	AMOD
7	the	the	DT	_	9	NMOD
8	human	human	JJ	_	9	NMOD
9	disorder	disorder	NN	_	6	PMOD
10	where	where	WRB	_	19	LOC
11	some	some	DT	_	17	NMOD
12	,	,	,	_	13	P
13	although	although	IN	_	17	PRN
14	not	not	RB	_	15	ADV
15	all	all	DT	_	13	SUB
16	affected	affect	VBN	_	17	NMOD
17	individuals	individual	NNS	_	19	SBJ
18	,	,	,	_	19	P
19	manifest	manifest	VBP	_	9	NMOD
20	premature	premature	JJ	_	23	NMOD
21	coronary	coronary	JJ	_	22	NMOD
22	artery	artery	NN	_	23	NMOD
23	disease	disease	NN	_	19	OBJ
24	.	.	.	_	2	P

1	Abcg8	abcg0	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	sterolin	sterolin	NN	_	6	AMOD
4	-	-	HYPH	_	3	P
5	2	0	CD	_	3	NMOD
6	deficient	deficient	JJ	_	7	NMOD
7	mice	mouse	NNS	_	9	SBJ
8	also	also	RB	_	9	ADV
9	allow	allow	VBP	_	0	ROOT
10	us	us	PRP	_	11	SBJ
11	to	to	TO	_	9	OPRD
12	examine	examine	VB	_	11	IM
13	the	the	DT	_	14	NMOD
14	role	role	NN	_	12	OBJ
15	of	of	IN	_	14	NMOD
16	this	this	DT	_	17	NMOD
17	protein	protein	NN	_	15	PMOD
18	in	in	IN	_	14	NMOD
19	biliary	biliary	JJ	_	20	NMOD
20	sterol	sterol	NN	_	21	NMOD
21	secretion	secretion	NN	_	18	PMOD
22	.	.	.	_	9	P

1	The	the	DT	_	2	NMOD
2	bile	bile	NN	_	3	SBJ
3	is	be	VBZ	_	0	ROOT
4	sterol	sterol	NN	_	5	AMOD
5	poor	poor	JJ	_	3	PRD
6	and	and	CC	_	3	COORD
7	upon	upon	IN	_	22	TMP
8	stimulation	stimulation	NN	_	7	PMOD
9	by	by	IN	_	8	NMOD
10	increasing	increase	VBG	_	9	PMOD
11	bile	bile	NN	_	12	NMOD
12	salt	salt	NN	_	13	NMOD
13	excretion	excretion	NN	_	10	OBJ
14	,	,	,	_	22	P
15	Abcg8	abcg0	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	sterolin	sterolin	NN	_	20	AMOD
18	-	-	HYPH	_	17	P
19	2	0	CD	_	17	NMOD
20	deficient	deficient	JJ	_	21	NMOD
21	mice	mouse	NNS	_	22	SBJ
22	can	can	MD	_	6	CONJ
23	not	not	RB	_	22	ADV
24	respond	respond	VB	_	22	VC
25	,	,	,	_	24	P
26	in	in	IN	_	24	ADV
27	contrast	contrast	NN	_	26	PMOD
28	to	to	IN	_	27	NMOD
29	the	the	DT	_	33	NMOD
30	wild	wild	JJ	_	32	NMOD
31	-	-	HYPH	_	30	P
32	type	type	NN	_	33	NMOD
33	mice	mouse	NNS	_	28	PMOD
34	.	.	.	_	3	P

1	Thus	thus	RB	_	8	ADV
2	,	,	,	_	8	P
3	Abcg8	abcg0	NN	_	5	NMOD
4	/	/	HYPH	_	3	P
5	sterolin	sterolin	NN	_	8	SBJ
6	-	-	HYPH	_	5	P
7	2	0	CD	_	5	NMOD
8	is	be	VBZ	_	0	ROOT
9	necessary	necessary	JJ	_	8	PRD
10	for	for	IN	_	9	AMOD
11	cholesterol	cholesterol	NN	_	12	NMOD
12	secretion	secretion	NN	_	10	PMOD
13	but	but	CC	_	9	COORD
14	not	not	RB	_	13	ADV
15	necessary	necessary	JJ	_	13	CONJ
16	for	for	IN	_	15	AMOD
17	plant	plant	NN	_	18	NMOD
18	sterol	sterol	NN	_	19	NMOD
19	secretion	secretion	NN	_	16	PMOD
20	.	.	.	_	8	P

1	It	it	PRP	_	2	SBJ
2	could	could	MD	_	0	ROOT
3	be	be	VB	_	2	VC
4	argued	argue	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	although	although	IN	_	21	ADV
7	the	the	DT	_	10	NMOD
8	biliary	biliary	JJ	_	9	NMOD
9	sterol	sterol	NN	_	10	NMOD
10	output	output	NN	_	11	SBJ
11	is	be	VBZ	_	6	SUB
12	comparable	comparable	JJ	_	11	PRD
13	to	to	IN	_	12	AMOD
14	that	that	DT	_	13	PMOD
15	seen	see	VBN	_	14	NMOD
16	in	in	IN	_	15	LOC
17	wild	wild	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	type	type	NN	_	20	NMOD
20	mice	mouse	NNS	_	16	PMOD
21	that	that	IN	_	5	ADV
22	this	this	DT	_	23	SBJ
23	is	be	VBZ	_	21	SUB
24	inappropriately	inappropriately	RB	_	25	AMOD
25	low	low	JJ	_	23	PRD
26	,	,	,	_	4	P
27	since	since	IN	_	4	PRP
28	the	the	DT	_	32	NMOD
29	tissue	tissue	NN	_	32	NMOD
30	and	and	CC	_	29	COORD
31	plasma	plasma	NN	_	30	CONJ
32	pools	pool	NNS	_	35	SBJ
33	of	of	IN	_	32	NMOD
34	sitosterol	sitosterol	NN	_	33	PMOD
35	are	be	VBP	_	27	SUB
36	so	so	RB	_	37	AMOD
37	elevated	elevated	JJ	_	35	PRD
38	in	in	IN	_	35	LOC
39	the	the	DT	_	41	NMOD
40	knockout	knockout	NN	_	41	NMOD
41	mice	mouse	NNS	_	38	PMOD
42	.	.	.	_	2	P

1	Despite	despite	IN	_	15	ADV
2	this	this	DT	_	3	NMOD
3	caveat	caveat	NN	_	1	PMOD
4	,	,	,	_	15	P
5	the	the	DT	_	6	NMOD
6	findings	finding	NNS	_	15	SBJ
7	of	of	IN	_	6	NMOD
8	sitosterol	sitosterol	NN	_	7	PMOD
9	in	in	IN	_	8	NMOD
10	significant	significant	JJ	_	11	NMOD
11	quantities	quantity	NNS	_	9	PMOD
12	in	in	IN	_	8	LOC
13	the	the	DT	_	14	NMOD
14	bile	bile	NN	_	12	PMOD
15	suggests	suggest	VBZ	_	0	ROOT
16	that	that	IN	_	15	OBJ
17	mechanisms	mechanism	NNS	_	23	SBJ
18	other	other	JJ	_	17	NMOD
19	than	than	IN	_	18	AMOD
20	via	via	IN	_	19	PMOD
21	the	the	DT	_	22	NMOD
22	sterolins	sterolins	NNS	_	20	PMOD
23	can	can	MD	_	16	SUB
24	'	'	``	_	23	P
25	export	export	VB	_	23	VC
26	'	'	''	_	25	P
27	some	some	DT	_	25	OBJ
28	of	of	IN	_	27	NMOD
29	these	these	DT	_	30	NMOD
30	sterols	sterol	NNS	_	28	PMOD
31	.	.	.	_	15	P

1	Interestingly	interestingly	RB	_	31	ADV
2	,	,	,	_	31	P
3	although	although	IN	_	31	ADV
4	humans	human	NNS	_	16	SBJ
5	who	who	WP	_	6	SBJ
6	are	be	VBP	_	4	NMOD
7	heterozygous	heterozygous	JJ	_	6	PRD
8	for	for	IN	_	7	AMOD
9	genetic	genetic	JJ	_	10	NMOD
10	defects	defect	NNS	_	8	PMOD
11	in	in	IN	_	10	LOC
12	either	either	CC	_	13	COORD
13	ABCG5	abcg0	NN	_	11	PMOD
14	or	or	CC	_	13	COORD
15	ABCG8	abcg0	NN	_	14	CONJ
16	seem	seem	VBP	_	3	SUB
17	to	to	TO	_	16	OPRD
18	be	be	VB	_	17	IM
19	phenotypically	phenotypically	RB	_	20	AMOD
20	normal	normal	JJ	_	18	PRD
21	,	,	,	_	31	P
22	mice	mouse	NNS	_	31	SBJ
23	heterozygous	heterozygous	JJ	_	22	NMOD
24	for	for	IN	_	23	AMOD
25	Abcg8	abcg0	NN	_	27	NMOD
26	/	/	HYPH	_	25	P
27	sterolin	sterolin	NN	_	30	NMOD
28	-	-	HYPH	_	27	P
29	2	0	CD	_	27	NMOD
30	deficiency	deficiency	NN	_	24	PMOD
31	show	show	VBP	_	0	ROOT
32	that	that	IN	_	31	OBJ
33	sterol	sterol	NN	_	34	NMOD
34	secretion	secretion	NN	_	35	SBJ
35	is	be	VBZ	_	32	SUB
36	impaired	impaired	JJ	_	35	PRD
37	,	,	,	_	36	P
38	but	but	CC	_	36	COORD
39	not	not	RB	_	38	ADV
40	absent	absent	JJ	_	38	CONJ
41	.	.	.	_	31	P

1	Note	note	VB	_	0	ROOT
2	that	that	IN	_	1	OBJ
3	under	under	IN	_	16	ADV
4	steady	steady	JJ	_	6	NMOD
5	-	-	HYPH	_	4	P
6	state	state	NN	_	7	NMOD
7	conditions	condition	NNS	_	3	PMOD
8	on	on	IN	_	16	ADV
9	a	a	DT	_	12	NMOD
10	rodent	rodent	NN	_	11	NMOD
11	chow	chow	NN	_	12	NMOD
12	diet	diet	NN	_	8	PMOD
13	,	,	,	_	16	P
14	heterozygous	heterozygous	JJ	_	15	NMOD
15	animals	animal	NNS	_	16	SBJ
16	show	show	VBP	_	2	SUB
17	no	no	DT	_	19	NMOD
18	significant	significant	JJ	_	19	NMOD
19	elevations	elevation	NNS	_	16	OBJ
20	in	in	IN	_	19	NMOD
21	plasma	plasma	NN	_	24	NMOD
22	or	or	CC	_	21	COORD
23	tissue	tissue	NN	_	22	CONJ
24	sitosterol	sitosterol	NN	_	25	NMOD
25	levels	level	NNS	_	20	PMOD
26	,	,	,	_	16	P
27	suggesting	suggest	VBG	_	16	ADV
28	that	that	IN	_	27	OBJ
29	the	the	DT	_	30	NMOD
30	activity	activity	NN	_	34	SBJ
31	of	of	IN	_	30	NMOD
32	these	these	DT	_	33	NMOD
33	proteins	protein	NNS	_	31	PMOD
34	may	may	MD	_	28	SUB
35	not	not	RB	_	34	ADV
36	be	be	VB	_	34	VC
37	rate	rate	NN	_	38	AMOD
38	limiting	limit	VBG	_	36	PRD
39	.	.	.	_	1	P

1	Furthermore	furthermore	RB	_	10	ADV
2	,	,	,	_	10	P
3	the	the	DT	_	9	NMOD
4	heterozygous	heterozygous	JJ	_	9	NMOD
5	Abcg8	abcg0	NN	_	9	NMOD
6	+	+	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	-	-	SYM	_	5	P
9	mice	mouse	NNS	_	10	SBJ
10	showed	show	VBD	_	0	ROOT
11	higher	high	JJR	_	12	NMOD
12	levels	level	NNS	_	10	OBJ
13	of	of	IN	_	12	NMOD
14	biliary	biliary	JJ	_	15	NMOD
15	sitosterol	sitosterol	NN	_	13	PMOD
16	relative	relative	JJ	_	12	NMOD
17	to	to	IN	_	16	AMOD
18	the	the	DT	_	22	NMOD
19	wild	wild	JJ	_	21	NMOD
20	-	-	HYPH	_	19	P
21	type	type	NN	_	22	NMOD
22	mice	mouse	NNS	_	17	PMOD
23	.	.	.	_	10	P

1	While	while	IN	_	32	ADV
2	the	the	DT	_	3	NMOD
3	rate	rate	NN	_	9	SBJ
4	of	of	IN	_	3	NMOD
5	total	total	JJ	_	8	NMOD
6	biliary	biliary	JJ	_	7	NMOD
7	sterol	sterol	NN	_	8	NMOD
8	secretion	secretion	NN	_	4	PMOD
9	is	be	VBZ	_	1	SUB
10	reduced	reduce	VBN	_	9	VC
11	compared	compare	VBN	_	10	ADV
12	to	to	IN	_	11	PMOD
13	wild	wild	JJ	_	15	NMOD
14	-	-	HYPH	_	13	P
15	type	type	NN	_	16	NMOD
16	mice	mouse	NNS	_	12	PMOD
17	,	,	,	_	10	P
18	since	since	IN	_	10	PRP
19	the	the	DT	_	21	NMOD
20	heterozygous	heterozygous	JJ	_	21	NMOD
21	mice	mouse	NNS	_	22	SBJ
22	are	be	VBP	_	18	SUB
23	not	not	RB	_	22	ADV
24	sitosterolemic	sitosterolemic	JJ	_	22	PRD
25	,	,	,	_	32	P
26	either	either	CC	_	32	COORD
27	the	the	DT	_	28	NMOD
28	activity	activity	NN	_	32	SBJ
29	of	of	IN	_	28	NMOD
30	these	these	DT	_	31	NMOD
31	proteins	protein	NNS	_	29	PMOD
32	is	be	VBZ	_	0	ROOT
33	not	not	RB	_	32	ADV
34	rate	rate	NN	_	35	AMOD
35	limiting	limit	VBG	_	32	PRD
36	or	or	CC	_	32	COORD
37	other	other	JJ	_	38	NMOD
38	mechanisms	mechanism	NNS	_	39	SBJ
39	can	can	MD	_	36	CONJ
40	compensate	compensate	VB	_	39	VC
41	for	for	IN	_	40	ADV
42	a	a	DT	_	45	NMOD
43	50	0	CD	_	44	NMOD
44	%	%	NN	_	45	NMOD
45	loss	loss	NN	_	41	PMOD
46	of	of	IN	_	45	NMOD
47	activity	activity	NN	_	46	PMOD
48	.	.	.	_	32	P

1	On	on	IN	_	20	ADV
2	the	the	DT	_	4	NMOD
3	other	other	JJ	_	4	NMOD
4	hand	hand	NN	_	1	PMOD
5	,	,	,	_	20	P
6	since	since	IN	_	20	PRP
7	feeding	feeding	NN	_	8	SBJ
8	is	be	VBZ	_	6	SUB
9	intermittent	intermittent	JJ	_	8	PRD
10	,	,	,	_	20	P
11	a	a	DT	_	16	NMOD
12	slow	slow	JJ	_	16	NMOD
13	,	,	,	_	12	P
14	but	but	CC	_	12	COORD
15	continuous	continuous	JJ	_	14	CONJ
16	secretion	secretion	NN	_	20	SBJ
17	during	during	IN	_	16	TMP
18	post-prandial	post-prandial	JJ	_	19	NMOD
19	periods	period	NNS	_	17	PMOD
20	could	could	MD	_	0	ROOT
21	easily	easily	RB	_	20	ADV
22	negate	negate	VB	_	20	VC
23	any	any	DT	_	26	NMOD
24	mild	mild	JJ	_	26	NMOD
25	temporary	temporary	JJ	_	26	NMOD
26	increase	increase	NN	_	22	OBJ
27	in	in	IN	_	26	NMOD
28	tissue	tissue	NN	_	33	NMOD
29	and	and	CC	_	28	COORD
30	plasma	plasma	NN	_	29	CONJ
31	plant	plant	NN	_	32	NMOD
32	sterol	sterol	NN	_	33	NMOD
33	levels	level	NNS	_	27	PMOD
34	in	in	IN	_	26	LOC
35	heterozygous	heterozygous	JJ	_	36	NMOD
36	animals	animal	NNS	_	34	PMOD
37	.	.	.	_	20	P

1	This	this	DT	_	2	SBJ
2	may	may	MD	_	0	ROOT
3	be	be	VB	_	2	VC
4	amenable	amenable	JJ	_	3	PRD
5	to	to	IN	_	4	AMOD
6	testing	test	VBG	_	5	PMOD
7	by	by	IN	_	6	MNR
8	placing	place	VBG	_	7	PMOD
9	these	these	DT	_	10	NMOD
10	animals	animal	NNS	_	8	OBJ
11	on	on	IN	_	8	ADV
12	a	a	DT	_	16	NMOD
13	high	high	JJ	_	15	NMOD
14	plant	plant	NN	_	15	NMOD
15	sterol	sterol	NN	_	16	NMOD
16	diet	diet	NN	_	11	PMOD
17	and	and	CC	_	8	COORD
18	measuring	measure	VBG	_	17	CONJ
19	the	the	DT	_	22	NMOD
20	plasma	plasma	NN	_	21	NMOD
21	sterol	sterol	NN	_	22	NMOD
22	levels	level	NNS	_	18	OBJ
23	.	.	.	_	2	P

1	Recently	recently	RB	_	6	TMP
2	,	,	,	_	6	P
3	Kosters	kosters	NNP	_	6	SBJ
4	et	et	FW	_	5	AMOD
5	al.	al.	FW	_	3	NMOD
6	reported	report	VBD	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	Abcg5	abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	Abcg8	abcg0	NN	_	11	NMOD
11	mRNA	mrna	NN	_	12	NMOD
12	expression	expression	NN	_	20	SBJ
13	in	in	IN	_	12	LOC
14	a	a	DT	_	15	NMOD
15	variety	variety	NN	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	different	different	JJ	_	19	NMOD
18	mouse	mouse	NN	_	19	NMOD
19	strains	strain	NNS	_	16	PMOD
20	correlated	correlate	VBD	_	7	SUB
21	with	with	IN	_	20	ADV
22	biliary	biliary	JJ	_	23	NMOD
23	cholesterol	cholesterol	NN	_	24	NMOD
24	secretion	secretion	NN	_	25	NMOD
25	rates	rate	NNS	_	21	PMOD
26	[	[	-LRB-	_	27	P
27	30	0	CD	_	6	PRN
28	]	]	-RRB-	_	27	P
29	.	.	.	_	6	P

1	In	in	IN	_	25	LOC
2	their	their	PRP$	_	3	NMOD
3	studies	study	NNS	_	1	PMOD
4	,	,	,	_	25	P
5	although	although	IN	_	25	ADV
6	diosgenin	diosgenin	NN	_	8	AMOD
7	-	-	HYPH	_	6	P
8	fed	feed	VBN	_	9	NMOD
9	mice	mouse	NNS	_	10	SBJ
10	showed	show	VBD	_	5	SUB
11	a	a	DT	_	13	NMOD
12	marked	marked	JJ	_	13	NMOD
13	increase	increase	NN	_	10	OBJ
14	in	in	IN	_	13	NMOD
15	biliary	biliary	JJ	_	17	NMOD
16	cholesterol	cholesterol	NN	_	17	NMOD
17	output	output	NN	_	14	PMOD
18	,	,	,	_	25	P
19	mRNA	mrna	NN	_	20	NMOD
20	levels	level	NNS	_	25	SBJ
21	of	of	IN	_	20	NMOD
22	Abcg5	abcg0	NN	_	21	PMOD
23	and	and	CC	_	22	COORD
24	Abcg8	abcg0	NN	_	23	CONJ
25	were	be	VBD	_	0	ROOT
26	not	not	RB	_	25	ADV
27	altered	alter	VBN	_	25	VC
28	.	.	.	_	25	P

1	Using	use	VBG	_	11	MNR
2	Western	western	NNP	_	3	NMOD
3	blot	blot	NN	_	4	NMOD
4	analyses	analysis	NNS	_	1	OBJ
5	,	,	,	_	11	P
6	the	the	DT	_	8	NMOD
7	protein	protein	NN	_	8	NMOD
8	level	level	NN	_	11	SBJ
9	of	of	IN	_	8	NMOD
10	Abcg5	abcg0	NN	_	9	PMOD
11	was	be	VBD	_	0	ROOT
12	also	also	RB	_	11	ADV
13	not	not	RB	_	11	ADV
14	altered	alter	VBN	_	11	VC
15	by	by	IN	_	14	MNR
16	diosgenin	diosgenin	NN	_	15	PMOD
17	,	,	,	_	14	P
18	although	although	IN	_	14	ADV
19	Abcg8	abcg0	NN	_	20	SBJ
20	was	be	VBD	_	18	SUB
21	not	not	RB	_	22	ADV
22	measured	measure	VBN	_	20	VC
23	.	.	.	_	11	P

1	They	they	PRP	_	2	SBJ
2	concluded	conclude	VBD	_	0	ROOT
3	that	that	IN	_	2	OBJ
4	a	a	DT	_	6	NMOD
5	parallel	parallel	JJ	_	6	NMOD
6	route	route	NN	_	11	SBJ
7	for	for	IN	_	6	NMOD
8	biliary	biliary	JJ	_	9	NMOD
9	cholesterol	cholesterol	NN	_	10	NMOD
10	secretion	secretion	NN	_	7	PMOD
11	might	might	MD	_	3	SUB
12	be	be	VB	_	11	VC
13	operational	operational	JJ	_	12	PRD
14	,	,	,	_	12	P
15	independent	independent	JJ	_	12	ADV
16	of	of	IN	_	15	AMOD
17	the	the	DT	_	18	NMOD
18	sterolins	sterolins	NNS	_	16	PMOD
19	.	.	.	_	2	P

1	While	while	IN	_	16	ADV
2	biliary	biliary	JJ	_	3	NMOD
3	cholesterol	cholesterol	NN	_	4	NMOD
4	secretion	secretion	NN	_	5	SBJ
5	is	be	VBZ	_	1	SUB
6	not	not	RB	_	5	ADV
7	completely	completely	RB	_	8	AMOD
8	absent	absent	JJ	_	5	PRD
9	in	in	IN	_	5	LOC
10	the	the	DT	_	14	NMOD
11	Abcg8	abcg0	NN	_	13	AMOD
12	-	-	HYPH	_	11	P
13	deficient	deficient	JJ	_	14	NMOD
14	mice	mouse	NNS	_	9	PMOD
15	it	it	PRP	_	16	SBJ
16	would	would	MD	_	0	ROOT
17	appear	appear	VB	_	16	VC
18	that	that	IN	_	17	OBJ
19	sterolin	sterolin	NN	_	22	SBJ
20	-	-	HYPH	_	19	P
21	2	0	CD	_	19	NMOD
22	plays	play	VBZ	_	18	SUB
23	a	a	DT	_	25	NMOD
24	major	major	JJ	_	25	NMOD
25	role	role	NN	_	22	OBJ
26	in	in	IN	_	22	ADV
27	this	this	DT	_	28	NMOD
28	process	process	NN	_	26	PMOD
29	.	.	.	_	16	P

1	In	in	IN	_	14	ADV
2	a	a	DT	_	4	NMOD
3	genetic	genetic	JJ	_	4	NMOD
4	screen	screen	NN	_	1	PMOD
5	of	of	IN	_	4	NMOD
6	plasma	plasma	NN	_	9	NMOD
7	plant	plant	NN	_	8	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	levels	level	NNS	_	5	PMOD
10	,	,	,	_	14	P
11	Sehayek	sehayek	NNP	_	14	SBJ
12	et	et	FW	_	13	AMOD
13	al.	al.	FW	_	11	NMOD
14	identified	identify	VBD	_	0	ROOT
15	three	three	CD	_	16	NMOD
16	loci	locus	NNS	_	14	OBJ
17	that	that	WDT	_	18	SBJ
18	may	may	MD	_	16	NMOD
19	be	be	VB	_	18	VC
20	responsible	responsible	JJ	_	19	PRD
21	for	for	IN	_	20	AMOD
22	controlling	control	VBG	_	21	PMOD
23	plasma	plasma	NN	_	26	NMOD
24	plant	plant	NN	_	25	NMOD
25	sterol	sterol	NN	_	26	NMOD
26	levels	level	NNS	_	22	OBJ
27	and	and	CC	_	14	COORD
28	not	not	RB	_	29	NMOD
29	one	one	CD	_	33	SBJ
30	of	of	IN	_	29	NMOD
31	these	these	DT	_	32	NMOD
32	loci	locus	NNS	_	30	PMOD
33	mapped	map	VBN	_	27	CONJ
34	to	to	IN	_	33	ADV
35	the	the	DT	_	38	NMOD
36	murine	murine	JJ	_	38	NMOD
37	STSL	stsl	NN	_	38	NMOD
38	region	region	NN	_	34	PMOD
39	[	[	-LRB-	_	40	P
40	43	0	CD	_	14	PRN
41	]	]	-RRB-	_	40	P
42	.	.	.	_	14	P

1	Thus	thus	RB	_	4	ADV
2	,	,	,	_	4	P
3	there	there	EX	_	4	SBJ
4	is	be	VBZ	_	0	ROOT
5	support	support	NN	_	4	PRD
6	for	for	IN	_	5	NMOD
7	at	at	RB	_	8	QMOD
8	least	least	RBS	_	10	NMOD
9	four	four	CD	_	8	QMOD
10	loci	locus	NNS	_	6	PMOD
11	that	that	WDT	_	12	SBJ
12	may	may	MD	_	10	NMOD
13	be	be	VB	_	12	VC
14	involved	involve	VBN	_	13	VC
15	in	in	IN	_	14	ADV
16	regulating	regulate	VBG	_	15	PMOD
17	plasma	plasma	NN	_	20	NMOD
18	plant	plant	NN	_	19	NMOD
19	sterol	sterol	NN	_	20	NMOD
20	levels	level	NNS	_	16	OBJ
21	.	.	.	_	4	P

1	To	to	IN	_	6	TMP
2	date	date	NN	_	1	PMOD
3	the	the	DT	_	5	NMOD
4	STSL	stsl	NN	_	5	NMOD
5	locus	locus	NN	_	6	SBJ
6	is	be	VBZ	_	0	ROOT
7	the	the	DT	_	9	NMOD
8	only	only	JJ	_	9	NMOD
9	one	one	CD	_	6	PRD
10	proven	prove	VBN	_	9	NMOD
11	to	to	TO	_	10	OPRD
12	be	be	VB	_	11	IM
13	involved	involve	VBN	_	12	VC
14	in	in	IN	_	13	ADV
15	dietary	dietary	JJ	_	16	NMOD
16	sterol	sterol	NN	_	17	NMOD
17	trafficking	trafficking	NN	_	14	PMOD
18	and	and	CC	_	6	COORD
19	the	the	DT	_	20	NMOD
20	identity	identity	NN	_	24	SBJ
21	of	of	IN	_	20	NMOD
22	the	the	DT	_	23	NMOD
23	others	others	NNS	_	21	PMOD
24	remains	remain	VBZ	_	18	CONJ
25	to	to	TO	_	24	OPRD
26	be	be	VB	_	25	IM
27	elucidated	elucidate	VBN	_	26	VC
28	.	.	.	_	6	P

1	We	we	PRP	_	8	SBJ
2	,	,	,	_	1	P
3	as	as	RB	_	5	ADV
4	well	well	RB	_	5	ADV
5	as	as	IN	_	1	COORD
6	others	others	NNS	_	5	CONJ
7	,	,	,	_	8	P
8	have	have	VBP	_	0	ROOT
9	proposed	propose	VBN	_	8	VC
10	Abcg5	abcg0	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	9	OBJ
13	-	-	HYPH	_	12	P
14	1	0	CD	_	12	NMOD
15	and	and	CC	_	12	COORD
16	Abcg8	abcg0	NN	_	18	NMOD
17	/	/	HYPH	_	16	P
18	sterolin	sterolin	NN	_	15	CONJ
19	-	-	HYPH	_	18	P
20	2	0	CD	_	18	NMOD
21	to	to	TO	_	9	OPRD
22	function	function	VB	_	21	IM
23	as	as	IN	_	22	ADV
24	obligate	obligate	JJ	_	25	NMOD
25	heterodimers	heterodimers	NNS	_	23	PMOD
26	.	.	.	_	8	P

1	Thus	thus	RB	_	10	ADV
2	knocking	knock	VBG	_	10	SBJ
3	out	out	RP	_	2	PRT
4	Abcg8	abcg0	NN	_	6	NMOD
5	/	/	HYPH	_	4	P
6	sterolin	sterolin	NN	_	2	OBJ
7	-	-	HYPH	_	6	P
8	2	0	CD	_	6	NMOD
9	alone	alone	RB	_	6	NMOD
10	is	be	VBZ	_	0	ROOT
11	equivalent	equivalent	JJ	_	10	PRD
12	to	to	IN	_	11	AMOD
13	a	a	DT	_	15	NMOD
14	functional	functional	JJ	_	15	NMOD
15	loss	loss	NN	_	12	PMOD
16	of	of	IN	_	15	NMOD
17	both	both	DT	_	18	NMOD
18	sterolins	sterolins	NNS	_	16	PMOD
19	.	.	.	_	10	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	shown	show	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	Abcg8	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	11	NMOD
9	-	-	HYPH	_	8	P
10	2	0	CD	_	8	NMOD
11	expression	expression	NN	_	12	SBJ
12	is	be	VBZ	_	5	SUB
13	required	require	VBN	_	12	VC
14	for	for	IN	_	13	PRP
15	correct	correct	JJ	_	17	NMOD
16	apical	apical	JJ	_	17	NMOD
17	trafficking	trafficking	NN	_	14	PMOD
18	of	of	IN	_	17	NMOD
19	Abcg5	abcg0	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	sterolin	sterolin	NN	_	18	PMOD
22	-	-	HYPH	_	21	P
23	1	0	CD	_	21	NMOD
24	to	to	IN	_	17	NMOD
25	the	the	DT	_	27	NMOD
26	apical	apical	JJ	_	27	NMOD
27	surface	surface	NN	_	24	PMOD
28	in	in	IN	_	17	NMOD
29	a	a	DT	_	32	NMOD
30	polarized	polarize	VBN	_	31	NMOD
31	cell	cell	NN	_	32	NMOD
32	line	line	NN	_	28	PMOD
33	and	and	CC	_	28	COORD
34	more	more	RBR	_	35	AMOD
35	recently	recently	RB	_	33	CONJ
36	in	in	FW	_	35	AMOD
37	vivo	vivo	FW	_	35	AMOD
38	by	by	IN	_	17	NMOD
39	over-expression	over-expression	NN	_	40	NMOD
40	experiments	experiment	NNS	_	38	PMOD
41	[	[	-LRB-	_	44	P
42	18	0	CD	_	44	NMOD
43	,	,	,	_	44	P
44	19	0	CD	_	4	PRN
45	]	]	-RRB-	_	44	P
46	.	.	.	_	2	P

1	In	in	IN	_	18	ADV
2	experiments	experiment	NNS	_	1	PMOD
3	shown	show	VBN	_	2	NMOD
4	here	here	RB	_	3	LOC
5	,	,	,	_	18	P
6	using	use	VBG	_	18	MNR
7	three	three	CD	_	15	NMOD
8	separately	separately	RB	_	9	AMOD
9	developed	develop	VBN	_	15	NMOD
10	anti-Abcg5	anti-abcg0	NN	_	12	AMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	15	NMOD
13	-	-	HYPH	_	12	P
14	1	0	CD	_	12	AMOD
15	antibodies	antibody	NNS	_	6	OBJ
16	,	,	,	_	18	P
17	we	we	PRP	_	18	SBJ
18	have	have	VBP	_	0	ROOT
19	obtained	obtain	VBN	_	18	VC
20	inconsistent	inconsistent	JJ	_	21	NMOD
21	data	datum	NNS	_	19	OBJ
22	regarding	regard	VBG	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	trafficking	trafficking	NN	_	22	PMOD
25	of	of	IN	_	24	NMOD
26	Abcg5	abcg0	NN	_	28	NMOD
27	/	/	HYPH	_	26	P
28	sterolin	sterolin	NN	_	25	PMOD
29	-	-	HYPH	_	28	P
30	1	0	CD	_	28	NMOD
31	in	in	IN	_	24	LOC
32	Abcg8	abcg0	NN	_	36	NMOD
33	-	-	SYM	_	32	P
34	/	/	HYPH	_	32	P
35	-	-	SYM	_	32	P
36	mice	mouse	NNS	_	31	PMOD
37	.	.	.	_	18	P

1	Based	base	VBN	_	9	PRP
2	upon	upon	IN	_	1	PMOD
3	classical	classical	JJ	_	7	NMOD
4	N	n	NN	_	6	NMOD
5	-	-	HYPH	_	4	P
6	glycosylation	glycosylation	NN	_	7	NMOD
7	maturation	maturation	NN	_	2	PMOD
8	it	it	PRP	_	9	SBJ
9	would	would	MD	_	0	ROOT
10	appear	appear	VB	_	9	VC
11	that	that	IN	_	10	OBJ
12	Abcg5	abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	26	SBJ
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	NMOD
17	,	,	,	_	14	P
18	in	in	IN	_	14	LOC
19	the	the	DT	_	24	NMOD
20	Abcg8	abcg0	NN	_	23	NMOD
21	-	-	SYM	_	23	P
22	/	/	HYPH	_	23	P
23	-	-	SYM	_	24	NMOD
24	mice	mouse	NNS	_	18	PMOD
25	,	,	,	_	26	P
26	does	do	VBZ	_	11	SUB
27	not	not	RB	_	26	ADV
28	exit	exit	VB	_	26	VC
29	the	the	DT	_	31	NMOD
30	endoplasmic	endoplasmic	JJ	_	31	NMOD
31	reticulum	reticulum	NN	_	28	OBJ
32	.	.	.	_	9	P

1	However	however	RB	_	6	ADV
2	,	,	,	_	6	P
3	by	by	IN	_	6	MNR
4	immunohistochemistry	immunohistochemistry	NN	_	3	PMOD
5	it	it	PRP	_	6	SBJ
6	appears	appear	VBZ	_	0	ROOT
7	that	that	IN	_	6	OBJ
8	Abcg5	abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	sterolin	sterolin	NN	_	13	SBJ
11	-	-	HYPH	_	10	P
12	1	0	CD	_	10	NMOD
13	is	be	VBZ	_	7	SUB
14	apically	apically	RB	_	13	ADV
15	expressed	express	VBN	_	13	VC
16	in	in	IN	_	15	LOC
17	the	the	DT	_	21	NMOD
18	Abcg8	abcg0	NN	_	20	AMOD
19	-	-	HYPH	_	18	P
20	deficient	deficient	JJ	_	21	NMOD
21	mice	mouse	NNS	_	16	PMOD
22	regardless	regardless	RB	_	15	ADV
23	of	of	IN	_	22	AMOD
24	the	the	DT	_	30	NMOD
25	anti-Abcg5	anti-abcg0	NN	_	27	AMOD
26	/	/	HYPH	_	25	P
27	sterolin	sterolin	NN	_	30	NMOD
28	-	-	HYPH	_	27	P
29	1	0	CD	_	27	AMOD
30	antibody	antibody	NN	_	23	PMOD
31	used	use	VBN	_	30	NMOD
32	.	.	.	_	6	P

1	Interestingly	interestingly	RB	_	20	ADV
2	,	,	,	_	20	P
3	in	in	IN	_	20	LOC
4	a	a	DT	_	5	NMOD
5	report	report	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	Abcg5	abcg0	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	Abcg8	abcg0	NN	_	10	NMOD
10	localization	localization	NN	_	6	PMOD
11	in	in	IN	_	10	LOC
12	canine	canine	JJ	_	13	NMOD
13	gallbladder	gallbladder	NN	_	15	NMOD
14	epithelial	epithelial	JJ	_	15	NMOD
15	cells	cell	NNS	_	11	PMOD
16	,	,	,	_	20	P
17	these	these	DT	_	19	NMOD
18	two	two	CD	_	19	NMOD
19	proteins	protein	NNS	_	20	SBJ
20	were	be	VBD	_	0	ROOT
21	found	find	VBN	_	20	VC
22	intracellularly	intracellularly	RB	_	21	ADV
23	under	under	IN	_	21	ADV
24	baseline	baseline	NN	_	25	NMOD
25	conditions	condition	NNS	_	23	PMOD
26	[	[	-LRB-	_	27	P
27	44	0	CD	_	21	PRN
28	]	]	-RRB-	_	27	P
29	.	.	.	_	20	P

1	But	but	CC	_	24	COORD
2	when	when	WRB	_	3	TMP
3	given	give	VBN	_	24	TMP
4	liver	liver	NN	_	7	NMOD
5	X	x	NN	_	7	NMOD
6	receptor	receptor	NN	_	7	NMOD
7	alpha	alpha	NN	_	9	NMOD
8	(	(	-LRB-	_	9	P
9	LXRα	lxrα	NN	_	11	NMOD
10	)	)	-RRB-	_	11	P
11	agonist	agonist	NN	_	3	OBJ
12	,	,	,	_	24	P
13	Abcg5	abcg0	NN	_	15	NMOD
14	/	/	HYPH	_	13	P
15	sterolin	sterolin	NN	_	24	SBJ
16	-	-	HYPH	_	15	P
17	1	0	CD	_	15	NMOD
18	and	and	CC	_	15	COORD
19	Abcg8	abcg0	NN	_	21	NMOD
20	/	/	HYPH	_	19	P
21	sterolin	sterolin	NN	_	18	CONJ
22	-	-	HYPH	_	21	P
23	2	0	CD	_	21	NMOD
24	appeared	appear	VBD	_	0	ROOT
25	to	to	TO	_	24	OPRD
26	be	be	VB	_	25	IM
27	expressed	express	VBN	_	26	VC
28	at	at	IN	_	27	LOC
29	the	the	DT	_	31	NMOD
30	apical	apical	JJ	_	31	NMOD
31	surface	surface	NN	_	28	PMOD
32	.	.	.	_	24	P

1	In	in	IN	_	12	LOC
2	these	these	DT	_	3	NMOD
3	studies	study	NNS	_	1	PMOD
4	the	the	DT	_	11	NMOD
5	UTSW	utsw	NN	_	11	NMOD
6	anti-Abcg5	anti-abcg0	NN	_	8	AMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	11	NMOD
9	-	-	HYPH	_	8	P
10	1	0	CD	_	8	AMOD
11	antibody	antibody	NN	_	12	SBJ
12	was	be	VBD	_	0	ROOT
13	used	use	VBN	_	12	VC
14	.	.	.	_	12	P

1	It	it	PRP	_	2	SBJ
2	is	be	VBZ	_	0	ROOT
3	apparent	apparent	JJ	_	2	PRD
4	with	with	IN	_	2	ADV
5	these	these	DT	_	7	NMOD
6	conflicting	conflict	VBG	_	7	NMOD
7	data	datum	NNS	_	4	PMOD
8	that	that	IN	_	2	OBJ
9	the	the	DT	_	10	NMOD
10	trafficking	trafficking	NN	_	14	SBJ
11	of	of	IN	_	10	NMOD
12	these	these	DT	_	13	NMOD
13	transporters	transporter	NNS	_	11	PMOD
14	is	be	VBZ	_	8	SUB
15	not	not	RB	_	14	ADV
16	as	as	RB	_	19	AMOD
17	clear	clear	JJ	_	19	AMOD
18	-	-	HYPH	_	17	P
19	cut	cut	JJ	_	14	PRD
20	.	.	.	_	2	P

1	In	in	IN	_	9	LOC
2	a	a	DT	_	4	NMOD
3	recent	recent	JJ	_	4	NMOD
4	paper	paper	NN	_	1	PMOD
5	,	,	,	_	9	P
6	Mangrivite	mangrivite	NNP	_	9	SBJ
7	et	et	FW	_	8	AMOD
8	al.	al.	FW	_	6	NMOD
9	showed	show	VBD	_	0	ROOT
10	that	that	IN	_	9	OBJ
11	the	the	DT	_	13	NMOD
12	apical	apical	JJ	_	13	NMOD
13	sorting	sorting	NN	_	22	SBJ
14	of	of	IN	_	13	NMOD
15	rat	rat	NN	_	16	NMOD
16	SPNT	spnt	NN	_	14	PMOD
17	in	in	IN	_	13	LOC
18	polarized	polarize	VBN	_	21	NMOD
19	renal	renal	JJ	_	21	NMOD
20	epithelial	epithelial	JJ	_	21	NMOD
21	cells	cell	NNS	_	17	PMOD
22	was	be	VBD	_	10	SUB
23	independent	independent	JJ	_	22	PRD
24	of	of	IN	_	23	AMOD
25	N	n	NN	_	27	NMOD
26	-	-	HYPH	_	25	P
27	glycosylation	glycosylation	NN	_	24	PMOD
28	[	[	-LRB-	_	29	P
29	45	0	CD	_	9	PRN
30	]	]	-RRB-	_	29	P
31	.	.	.	_	9	P

1	Therefore	therefore	RB	_	8	ADV
2	,	,	,	_	8	P
3	at	at	IN	_	8	TMP
4	this	this	DT	_	5	NMOD
5	time	time	NN	_	3	PMOD
6	,	,	,	_	8	P
7	we	we	PRP	_	8	SBJ
8	can	can	MD	_	0	ROOT
9	neither	neither	RB	_	8	ADV
10	exclude	exclude	VB	_	8	VC
11	the	the	DT	_	12	NMOD
12	possibility	possibility	NN	_	10	OBJ
13	that	that	IN	_	12	NMOD
14	Abcg5	abcg0	NN	_	16	NMOD
15	/	/	HYPH	_	14	P
16	sterolin	sterolin	NN	_	19	NMOD
17	-	-	HYPH	_	16	P
18	1	0	CD	_	16	NMOD
19	expression	expression	NN	_	20	SBJ
20	is	be	VBZ	_	13	SUB
21	functional	functional	JJ	_	20	PRD
22	in	in	IN	_	20	LOC
23	our	our	PRP$	_	30	NMOD
24	Abcg8	abcg0	NN	_	26	NMOD
25	/	/	HYPH	_	24	P
26	sterolin	sterolin	NN	_	29	AMOD
27	-	-	HYPH	_	26	P
28	2	0	CD	_	26	NMOD
29	deficient	deficient	JJ	_	30	NMOD
30	mice	mouse	NNS	_	22	PMOD
31	nor	nor	CC	_	8	COORD
32	can	can	MD	_	31	CONJ
33	we	we	PRP	_	32	SBJ
34	rule	rule	VB	_	32	VC
35	it	it	PRP	_	34	OBJ
36	out	out	RP	_	34	PRT
37	.	.	.	_	8	P

1	We	we	PRP	_	2	SBJ
2	have	have	VBP	_	0	ROOT
3	no	no	DT	_	5	NMOD
4	functional	functional	JJ	_	5	NMOD
5	assay	assay	NN	_	2	OBJ
6	for	for	IN	_	5	NMOD
7	these	these	DT	_	8	NMOD
8	proteins	protein	NNS	_	6	PMOD
9	at	at	IN	_	2	TMP
10	present	present	JJ	_	9	PMOD
11	.	.	.	_	2	P

1	More	more	RBR	_	2	AMOD
2	extensive	extensive	JJ	_	4	NMOD
3	fractionation	fractionation	NN	_	4	NMOD
4	experiments	experiment	NNS	_	5	SBJ
5	are	be	VBP	_	0	ROOT
6	underway	underway	JJ	_	5	PRD
7	to	to	TO	_	4	NMOD
8	better	well	RBR	_	7	ADV
9	determine	determine	VB	_	7	IM
10	the	the	DT	_	13	NMOD
11	exact	exact	JJ	_	13	NMOD
12	compartmental	compartmental	JJ	_	13	NMOD
13	location	location	NN	_	9	OBJ
14	of	of	IN	_	13	NMOD
15	Abcg5	abcg0	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	sterolin	sterolin	NN	_	14	PMOD
18	-	-	HYPH	_	17	P
19	1	0	CD	_	17	NMOD
20	in	in	IN	_	13	LOC
21	the	the	DT	_	26	NMOD
22	Abcg8	abcg0	NN	_	26	NMOD
23	-	-	SYM	_	22	P
24	/	/	HYPH	_	22	P
25	-	-	SYM	_	22	P
26	mice	mouse	NNS	_	20	PMOD
27	.	.	.	_	5	P

1	In	in	IN	_	8	ADV
2	this	this	DT	_	3	NMOD
3	context	context	NN	_	1	PMOD
4	,	,	,	_	8	P
5	Plösch	plösch	NNP	_	8	SBJ
6	et	et	FW	_	7	AMOD
7	al.	al.	FW	_	5	NMOD
8	have	have	VBP	_	0	ROOT
9	described	describe	VBN	_	8	VC
10	an	an	DT	_	17	NMOD
11	Abcg5	abcg0	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	sterolin	sterolin	NN	_	16	AMOD
14	-	-	HYPH	_	13	P
15	1	0	CD	_	13	NMOD
16	deficient	deficient	JJ	_	17	NMOD
17	mouse	mouse	NN	_	9	OBJ
18	that	that	WDT	_	19	SBJ
19	maintains	maintain	VBZ	_	17	NMOD
20	the	the	DT	_	21	NMOD
21	ability	ability	NN	_	19	OBJ
22	to	to	TO	_	21	NMOD
23	secrete	secrete	VB	_	22	IM
24	biliary	biliary	JJ	_	25	NMOD
25	cholesterol	cholesterol	NN	_	23	OBJ
26	to	to	IN	_	23	ADV
27	the	the	DT	_	29	NMOD
28	same	same	JJ	_	29	NMOD
29	extent	extent	NN	_	26	PMOD
30	as	as	IN	_	29	NMOD
31	the	the	DT	_	35	NMOD
32	wild	wild	JJ	_	34	NMOD
33	-	-	HYPH	_	32	P
34	type	type	NN	_	35	NMOD
35	mice	mouse	NNS	_	30	PMOD
36	and	and	CC	_	19	COORD
37	,	,	,	_	36	P
38	when	when	WRB	_	39	TMP
39	fed	feed	VBN	_	44	TMP
40	a	a	DT	_	42	NMOD
41	LXR	lxr	NN	_	42	NMOD
42	agonist	agonist	NN	_	39	OBJ
43	,	,	,	_	44	P
44	had	have	VBD	_	36	CONJ
45	higher	high	JJR	_	48	NMOD
46	Abcg8	abcg0	NN	_	47	NMOD
47	mRNA	mrna	NN	_	48	NMOD
48	expression	expression	NN	_	44	OBJ
49	and	and	CC	_	44	COORD
50	tended	tend	VBD	_	49	CONJ
51	to	to	TO	_	50	OPRD
52	secrete	secrete	VB	_	51	IM
53	more	more	JJR	_	55	NMOD
54	biliary	biliary	JJ	_	55	NMOD
55	cholesterol	cholesterol	NN	_	52	OBJ
56	than	than	IN	_	55	NMOD
57	wild	wild	JJ	_	59	NMOD
58	-	-	HYPH	_	57	P
59	type	type	NN	_	60	NMOD
60	mice	mouse	NNS	_	56	PMOD
61	[	[	-LRB-	_	62	P
62	46	0	CD	_	9	PRN
63	]	]	-RRB-	_	62	P
64	.	.	.	_	8	P

1	It	it	PRP	_	2	SBJ
2	has	have	VBZ	_	0	ROOT
3	been	be	VBN	_	2	VC
4	argued	argue	VBN	_	3	VC
5	that	that	IN	_	4	OBJ
6	Abcg5	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	17	SBJ
9	-	-	HYPH	_	8	P
10	1	0	CD	_	8	NMOD
11	and	and	CC	_	8	COORD
12	Abcg8	abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	11	CONJ
15	-	-	HYPH	_	14	P
16	2	0	CD	_	14	NMOD
17	are	be	VBP	_	5	SUB
18	dependent	dependent	JJ	_	17	PRD
19	upon	upon	IN	_	18	AMOD
20	each	each	DT	_	21	NMOD
21	other	other	JJ	_	19	PMOD
22	for	for	IN	_	17	ADV
23	secretion	secretion	NN	_	22	PMOD
24	of	of	IN	_	23	NMOD
25	hepatic	hepatic	JJ	_	26	NMOD
26	sterols	sterol	NNS	_	24	PMOD
27	into	into	IN	_	23	NMOD
28	bile	bile	NN	_	27	PMOD
29	[	[	-LRB-	_	30	P
30	19	0	CD	_	4	PRN
31	]	]	-RRB-	_	30	P
32	.	.	.	_	2	P

1	Given	give	VBN	_	14	ADV
2	the	the	DT	_	3	NMOD
3	data	datum	NNS	_	1	PMOD
4	presented	present	VBN	_	3	NMOD
5	here	here	RB	_	4	LOC
6	and	and	CC	_	1	COORD
7	from	from	IN	_	6	CONJ
8	the	the	DT	_	12	NMOD
9	Abcg5	abcg0	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	deficient	deficient	JJ	_	12	NMOD
12	mouse	mouse	NN	_	7	PMOD
13	this	this	DT	_	14	SBJ
14	does	do	VBZ	_	0	ROOT
15	not	not	RB	_	14	ADV
16	appear	appear	VB	_	14	VC
17	to	to	TO	_	16	OPRD
18	be	be	VB	_	17	IM
19	the	the	DT	_	20	NMOD
20	case	case	NN	_	18	PRD
21	.	.	.	_	14	P

1	Perhaps	perhaps	RB	_	10	ADV
2	in	in	IN	_	10	LOC
3	the	the	DT	_	6	NMOD
4	previously	previously	RB	_	5	AMOD
5	published	publish	VBN	_	6	NMOD
6	model	model	NN	_	2	PMOD
7	a	a	DT	_	9	NMOD
8	non-physiologic	non-physiologic	JJ	_	9	NMOD
9	state	state	NN	_	10	SBJ
10	has	have	VBZ	_	0	ROOT
11	been	be	VBN	_	10	VC
12	made	make	VBN	_	11	VC
13	that	that	WDT	_	14	SBJ
14	generates	generate	VBZ	_	9	NMOD
15	these	these	DT	_	16	NMOD
16	data	datum	NNS	_	14	OBJ
17	.	.	.	_	10	P

1	Taken	take	VBN	_	7	DEP
2	together	together	RB	_	1	ADV
3	,	,	,	_	7	P
4	these	these	DT	_	6	NMOD
5	animal	animal	NN	_	6	NMOD
6	models	model	NNS	_	7	SBJ
7	suggest	suggest	VBP	_	0	ROOT
8	that	that	IN	_	7	OBJ
9	Abcg5	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	20	SBJ
12	-	-	HYPH	_	11	P
13	1	0	CD	_	11	NMOD
14	and	and	CC	_	11	COORD
15	Abcg8	abcg0	NN	_	17	NMOD
16	/	/	HYPH	_	15	P
17	sterolin	sterolin	NN	_	14	CONJ
18	-	-	HYPH	_	17	P
19	2	0	CD	_	17	NMOD
20	have	have	VBP	_	8	SUB
21	independent	independent	JJ	_	22	NMOD
22	function	function	NN	_	20	OBJ
23	in	in	FW	_	24	AMOD
24	vivo	vivo	FW	_	20	ADV
25	or	or	CC	_	8	COORD
26	that	that	IN	_	25	CONJ
27	there	there	EX	_	28	SBJ
28	are	be	VBP	_	26	SUB
29	proteins	protein	NNS	_	28	PRD
30	other	other	JJ	_	29	NMOD
31	than	than	IN	_	30	AMOD
32	the	the	DT	_	33	NMOD
33	sterolins	sterolins	NNS	_	31	PMOD
34	that	that	WDT	_	35	SBJ
35	can	can	MD	_	29	NMOD
36	secrete	secrete	VB	_	35	VC
37	biliary	biliary	JJ	_	38	NMOD
38	sterols	sterol	NNS	_	36	OBJ
39	.	.	.	_	7	P

1	Conclusions	conclusion	NNS	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	major	major	JJ	_	3	NMOD
3	findings	finding	NNS	_	7	SBJ
4	in	in	IN	_	3	LOC
5	this	this	DT	_	6	NMOD
6	study	study	NN	_	4	PMOD
7	are	be	VBP	_	0	ROOT
8	:	:	:	_	7	P
9	(	(	-LRB-	_	10	P
10	1	0	LS	_	24	DEP
11	)	)	-RRB-	_	10	P
12	disruption	disruption	NN	_	24	SBJ
13	of	of	IN	_	12	NMOD
14	only	only	RB	_	15	NMOD
15	one	one	CD	_	13	PMOD
16	of	of	IN	_	15	NMOD
17	the	the	DT	_	19	NMOD
18	two	two	CD	_	19	NMOD
19	genes	gene	NNS	_	16	PMOD
20	comprising	comprise	VBG	_	19	NMOD
21	the	the	DT	_	23	NMOD
22	STSL	stsl	NN	_	23	NMOD
23	locus	locus	NN	_	20	OBJ
24	is	be	VBZ	_	7	PRD
25	necessary	necessary	JJ	_	24	PRD
26	and	and	CC	_	25	COORD
27	sufficient	sufficient	JJ	_	26	CONJ
28	to	to	TO	_	25	AMOD
29	cause	cause	VB	_	28	IM
30	sitosterolemia	sitosterolemia	NN	_	29	OBJ
31	,	,	,	_	24	P
32	(	(	-LRB-	_	33	P
33	2	0	LS	_	35	SUB
34	)	)	-RRB-	_	33	P
35	that	that	IN	_	24	CONJ
36	the	the	DT	_	37	NMOD
37	loss	loss	NN	_	44	SBJ
38	of	of	IN	_	37	NMOD
39	Abcg8	abcg0	NN	_	41	NMOD
40	/	/	HYPH	_	39	P
41	sterolin	sterolin	NN	_	38	PMOD
42	-	-	HYPH	_	41	P
43	2	0	CD	_	41	NMOD
44	leads	lead	VBZ	_	35	SUB
45	to	to	IN	_	44	ADV
46	the	the	DT	_	47	NMOD
47	loss	loss	NN	_	45	PMOD
48	of	of	IN	_	47	NMOD
49	biliary	biliary	JJ	_	51	NMOD
50	cholesterol	cholesterol	NN	_	51	NMOD
51	secretion	secretion	NN	_	48	PMOD
52	and	and	CC	_	35	COORD
53	(	(	-LRB-	_	54	P
54	3	0	LS	_	61	DEP
55	)	)	-RRB-	_	54	P
56	Abcg5	abcg0	NN	_	58	NMOD
57	/	/	HYPH	_	56	P
58	sterolin	sterolin	NN	_	61	SBJ
59	-	-	HYPH	_	58	P
60	1	0	CD	_	58	NMOD
61	appears	appear	VBZ	_	52	CONJ
62	to	to	TO	_	61	OPRD
63	be	be	VB	_	62	IM
64	still	still	RB	_	63	TMP
65	apically	apically	RB	_	63	ADV
66	-	-	HYPH	_	65	P
67	expressed	express	VBN	_	63	VC
68	despite	despite	IN	_	67	ADV
69	the	the	DT	_	70	NMOD
70	absence	absence	NN	_	68	PMOD
71	of	of	IN	_	70	NMOD
72	Abcg8	abcg0	NN	_	74	NMOD
73	/	/	HYPH	_	72	P
74	sterolin	sterolin	NN	_	71	PMOD
75	-	-	HYPH	_	74	P
76	2	0	CD	_	74	NMOD
77	.	.	.	_	7	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	4	SBJ
3	strongly	strongly	RB	_	4	ADV
4	support	support	VBP	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	direct	direct	JJ	_	7	NMOD
7	role	role	NN	_	4	OBJ
8	of	of	IN	_	7	NMOD
9	Abcg8	abcg0	NN	_	11	NMOD
10	/	/	HYPH	_	9	P
11	sterolin	sterolin	NN	_	8	PMOD
12	-	-	HYPH	_	11	P
13	2	0	CD	_	11	NMOD
14	as	as	IN	_	7	NMOD
15	a	a	DT	_	17	NMOD
16	key	key	JJ	_	17	NMOD
17	player	player	NN	_	14	PMOD
18	in	in	IN	_	17	NMOD
19	biliary	biliary	JJ	_	20	NMOD
20	cholesterol	cholesterol	NN	_	21	NMOD
21	secretion	secretion	NN	_	18	PMOD
22	,	,	,	_	4	P
23	although	although	IN	_	4	ADV
24	biliary	biliary	JJ	_	25	NMOD
25	sitosterol	sitosterol	NN	_	26	NMOD
26	secretion	secretion	NN	_	27	SBJ
27	was	be	VBD	_	23	SUB
28	apparently	apparently	RB	_	27	ADV
29	preserved	preserve	VBN	_	27	VC
30	.	.	.	_	4	P

1	These	these	DT	_	2	NMOD
2	data	datum	NNS	_	3	SBJ
3	suggest	suggest	VBP	_	0	ROOT
4	that	that	IN	_	3	OBJ
5	there	there	EX	_	6	SBJ
6	are	be	VBP	_	4	SUB
7	mechanisms	mechanism	NNS	_	6	PRD
8	other	other	JJ	_	7	NMOD
9	than	than	IN	_	8	AMOD
10	Abcg8	abcg0	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	9	PMOD
13	-	-	HYPH	_	12	P
14	2	0	CD	_	12	NMOD
15	that	that	WDT	_	16	SBJ
16	allow	allow	VBP	_	7	NMOD
17	for	for	IN	_	16	ADV
18	the	the	DT	_	19	NMOD
19	secretion	secretion	NN	_	17	PMOD
20	of	of	IN	_	19	NMOD
21	sitosterol	sitosterol	NN	_	20	PMOD
22	into	into	IN	_	19	NMOD
23	bile	bile	NN	_	22	PMOD
24	.	.	.	_	3	P

1	Competing	compete	VBG	_	2	NMOD
2	interests	interest	NNS	_	0	ROOT

1	None	none	NN	_	0	ROOT
2	declared	declare	VBD	_	1	DEP
3	.	.	.	_	1	P

1	Authors	author	NNS	_	3	NMOD
2	'	'	POS	_	1	NMOD
3	contributions	contribution	NNS	_	0	ROOT

1	ELK	elk	NN	_	2	SBJ
2	carried	carry	VBD	_	0	ROOT
3	out	out	RP	_	2	PRT
4	molecular	molecular	JJ	_	5	NMOD
5	genetics	genetics	NNS	_	6	NMOD
6	studies	study	NNS	_	2	OBJ
7	,	,	,	_	6	P
8	quantitative	quantitative	JJ	_	11	NMOD
9	RT	rt	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	PCR	pcr	NN	_	6	CONJ
12	,	,	,	_	11	P
13	and	and	CC	_	11	COORD
14	dynamic	dynamic	JJ	_	16	NMOD
15	bile	bile	NN	_	16	NMOD
16	collection	collection	NN	_	13	CONJ
17	for	for	IN	_	2	ADV
18	Figure	figure	NN	_	17	PMOD
19	9	0	CD	_	18	NMOD
20	.	.	.	_	2	P

1	KL	kl	NN	_	2	SBJ
2	carried	carry	VBD	_	0	ROOT
3	out	out	RP	_	2	PRT
4	molecular	molecular	JJ	_	6	NMOD
5	genetic	genetic	JJ	_	6	NMOD
6	studies	study	NNS	_	2	OBJ
7	and	and	CC	_	2	COORD
8	made	make	VBD	_	7	CONJ
9	the	the	DT	_	11	NMOD
10	targeting	targeting	NN	_	11	NMOD
11	construct	construct	NN	_	8	OBJ
12	.	.	.	_	2	P

1	The	the	DT	_	3	NMOD
2	knockout	knockout	NN	_	3	NMOD
3	mice	mouse	NNS	_	4	SBJ
4	were	be	VBD	_	0	ROOT
5	isolated	isolate	VBN	_	4	VC
6	in	in	IN	_	5	LOC
7	the	the	DT	_	9	NMOD
8	NM	nm	NNP	_	9	NMOD
9	laboratory	laboratory	NN	_	6	PMOD
10	.	.	.	_	4	P

1	HY	hy	NNP	_	2	SBJ
2	performed	perform	VBD	_	0	ROOT
3	Northern	northern	NNP	_	4	NMOD
4	blotting	blotting	NN	_	2	OBJ
5	.	.	.	_	2	P

1	ELK	elk	NNP	_	8	SBJ
2	,	,	,	_	1	P
3	AK	ak	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	EV	ev	NNP	_	3	CONJ
6	and	and	CC	_	5	COORD
7	MHL	mhl	NNP	_	6	CONJ
8	performed	perform	VBD	_	0	ROOT
9	Western	western	NNP	_	10	NMOD
10	blotting	blotting	NN	_	8	OBJ
11	and	and	CC	_	10	COORD
12	immunohistochemistry	immunohistochemistry	NN	_	13	NMOD
13	experiments	experiment	NNS	_	11	CONJ
14	.	.	.	_	8	P

1	AK	ak	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	NL	nl	NNP	_	2	CONJ
4	performed	perform	VBD	_	0	ROOT
5	bile	bile	NN	_	6	NMOD
6	collection	collection	NN	_	7	NMOD
7	experiments	experiment	NNS	_	4	OBJ
8	and	and	CC	_	7	COORD
9	bile	bile	NN	_	10	NMOD
10	characterization	characterization	NN	_	8	CONJ
11	for	for	IN	_	7	NMOD
12	Figure	figure	NN	_	11	PMOD
13	8	0	CD	_	12	NMOD
14	.	.	.	_	4	P

1	MA	ma	NNP	_	2	SBJ
2	performed	perform	VBN	_	0	ROOT
3	FPLC	fplc	NN	_	4	NMOD
4	analysis	analysis	NN	_	2	OBJ
5	.	.	.	_	2	P

1	SS	s	NNP	_	6	SBJ
2	,	,	,	_	1	P
3	AK	ak	NNP	_	1	CONJ
4	and	and	CC	_	3	COORD
5	RK	rk	NNP	_	4	CONJ
6	performed	perform	VBD	_	0	ROOT
7	GC	gc	NN	_	9	NMOD
8	sterol	sterol	NN	_	9	NMOD
9	analyses	analysis	NNS	_	6	OBJ
10	.	.	.	_	6	P

1	JC	jc	NNP	_	2	SBJ
2	assisted	assist	VBN	_	0	ROOT
3	with	with	IN	_	2	ADV
4	dynamic	dynamic	JJ	_	6	NMOD
5	bile	bile	NN	_	6	NMOD
6	collection	collection	NN	_	3	PMOD
7	and	and	CC	_	6	COORD
8	mouse	mouse	NN	_	9	NMOD
9	surgery	surgery	NN	_	7	CONJ
10	.	.	.	_	2	P

1	ROE	roe	NNP	_	10	SBJ
2	,	,	,	_	1	P
3	AG	ag	NNP	_	1	CONJ
4	,	,	,	_	3	P
5	NM	nm	NNP	_	3	CONJ
6	,	,	,	_	5	P
7	GS	g	NNP	_	5	CONJ
8	and	and	CC	_	7	COORD
9	SBP	sbp	NNP	_	8	CONJ
10	were	be	VBD	_	0	ROOT
11	responsible	responsible	JJ	_	10	PRD
12	for	for	IN	_	11	AMOD
13	supervision	supervision	NN	_	12	PMOD
14	,	,	,	_	13	P
15	data	datum	NNS	_	16	NMOD
16	analyses	analysis	NNS	_	13	APPO
17	of	of	IN	_	16	NMOD
18	experiments	experiment	NNS	_	17	PMOD
19	and	and	CC	_	12	COORD
20	for	for	IN	_	19	CONJ
21	providing	provide	VBG	_	20	PMOD
22	funding	funding	NN	_	21	OBJ
23	of	of	IN	_	22	NMOD
24	these	these	DT	_	25	NMOD
25	experiments	experiment	NNS	_	23	PMOD
26	.	.	.	_	10	P

1	ELK	elk	NNP	_	4	SBJ
2	and	and	CC	_	1	COORD
3	SBP	sbp	NNP	_	2	CONJ
4	wrote	write	VBD	_	0	ROOT
5	the	the	DT	_	6	NMOD
6	paper	paper	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Pre-publication	pre-publication	JJ	_	2	NMOD
2	history	history	NN	_	0	ROOT

1	The	the	DT	_	3	NMOD
2	pre-publication	pre-publication	JJ	_	3	NMOD
3	history	history	NN	_	7	SBJ
4	for	for	IN	_	3	NMOD
5	this	this	DT	_	6	NMOD
6	paper	paper	NN	_	4	PMOD
7	can	can	MD	_	0	ROOT
8	be	be	VB	_	7	VC
9	accessed	access	VBN	_	8	VC
10	here	here	RB	_	9	LOC
11	:	:	:	_	7	P

1	Acknowledgements	acknowledgement	NNS	_	0	ROOT

1	We	we	PRP	_	2	SBJ
2	would	would	MD	_	0	ROOT
3	like	like	VB	_	2	VC
4	to	to	TO	_	3	OPRD
5	thank	thank	VB	_	4	IM
6	Dr	dr	NNP	_	8	NMOD
7	B	b	NNP	_	8	NMOD
8	Stieger	stieger	NNP	_	5	OBJ
9	for	for	IN	_	5	ADV
10	kindly	kindly	RB	_	11	ADV
11	providing	provide	VBG	_	9	PMOD
12	anti-Bsep	anti-bsep	JJ	_	13	NMOD
13	antibody	antibody	NN	_	11	OBJ
14	and	and	CC	_	5	COORD
15	Dr	dr	NNP	_	17	NMOD
16	H	h	NNP	_	17	NMOD
17	Hobbs	hobbs	NNP	_	14	GAP
18	for	for	IN	_	17	ADV
19	providing	provide	VBG	_	18	PMOD
20	the	the	DT	_	27	NMOD
21	UTSW	utsw	NN	_	27	NMOD
22	anti-Abcg5	anti-abcg0	NN	_	24	AMOD
23	/	/	HYPH	_	22	P
24	sterolin	sterolin	NN	_	27	NMOD
25	-	-	HYPH	_	24	P
26	1	0	CD	_	24	AMOD
27	antibody	antibody	NN	_	19	OBJ
28	.	.	.	_	2	P

1	We	we	PRP	_	2	SBJ
2	would	would	MD	_	0	ROOT
3	also	also	RB	_	2	ADV
4	like	like	VB	_	2	VC
5	to	to	TO	_	4	OPRD
6	thank	thank	VB	_	5	IM
7	John	john	NNP	_	8	NMOD
8	Oatis	oatis	NNP	_	6	OBJ
9	,	,	,	_	8	P
10	III	iii	CD	_	8	NMOD
11	for	for	IN	_	6	PRP
12	his	his	PRP$	_	15	NMOD
13	excellent	excellent	JJ	_	15	NMOD
14	animal	animal	NN	_	15	NMOD
15	husbandry	husbandry	NN	_	11	PMOD
16	.	.	.	_	2	P

1	Grants	grant	NNS	_	65	SBJ
2	from	from	IN	_	1	NMOD
3	the	the	DT	_	6	NMOD
4	American	american	NNP	_	6	NMOD
5	Heart	heart	NNP	_	6	NMOD
6	Association	association	NNP	_	2	PMOD
7	,	,	,	_	1	P
8	Beginning	beginning	JJ	_	15	NMOD
9	Grant	grant	NN	_	15	NMOD
10	-	-	HYPH	_	9	P
11	In	in	IN	_	9	NMOD
12	-	-	HYPH	_	11	P
13	Aid	aid	NN	_	11	PMOD
14	Mid-Atlantic	mid-atlantic	JJ	_	15	NMOD
15	Affiliate	affiliate	NN	_	1	CONJ
16	(	(	-LRB-	_	17	P
17	KL	kl	NNP	_	15	PRN
18	)	)	-RRB-	_	17	P
19	,	,	,	_	15	P
20	NIH	nih	NNP	_	25	NMOD
21	Postdoctoral	postdoctoral	JJ	_	22	NMOD
22	Training	training	NN	_	25	NMOD
23	Grant	grant	NN	_	25	NMOD
24	T32	t0	NN	_	25	NMOD
25	HL07260	hl0	NN	_	27	NMOD
26	(	(	-LRB-	_	27	P
27	ELK	elk	NNP	_	15	CONJ
28	)	)	-RRB-	_	27	P
29	,	,	,	_	27	P
30	the	the	DT	_	32	NMOD
31	Netherlands	netherlands	NNP	_	32	NMOD
32	Organization	organization	NNP	_	37	NMOD
33	for	for	IN	_	32	NMOD
34	Scientific	scientific	NNP	_	35	NMOD
35	Research	research	NNP	_	33	PMOD
36	(	(	-LRB-	_	37	P
37	NOW	now	NN	_	45	NMOD
38	)	)	-RRB-	_	45	P
39	902	0	CD	_	43	NMOD
40	-	-	HYPH	_	39	P
41	23	0	CD	_	43	NMOD
42	-	-	HYPH	_	41	P
43	193	0	CD	_	45	NMOD
44	(	(	-LRB-	_	45	P
45	AK	ak	NNP	_	27	CONJ
46	)	)	-RRB-	_	45	P
47	as	as	RB	_	49	ADV
48	well	well	RB	_	49	ADV
49	as	as	IN	_	45	COORD
50	the	the	DT	_	52	NMOD
51	National	national	NNP	_	52	NMOD
52	Institutes	institute	NNPS	_	58	NMOD
53	of	of	IN	_	52	NMOD
54	Health	health	NNP	_	53	PMOD
55	Grant	grant	NN	_	58	NMOD
56	HL60613	hl0	NN	_	58	NMOD
57	(	(	-LRB-	_	58	P
58	SBP	sbp	NNP	_	49	CONJ
59	)	)	-RRB-	_	58	P
60	and	and	CC	_	58	COORD
61	DK56830	dk0	NN	_	63	NMOD
62	(	(	-LRB-	_	63	P
63	GS	g	NNP	_	60	CONJ
64	)	)	-RRB-	_	65	P
65	supported	support	VBD	_	0	ROOT
66	this	this	DT	_	67	NMOD
67	work	work	NN	_	65	OBJ
68	.	.	.	_	65	P

1	Figures	figure	NNS	_	0	ROOT
2	and	and	CC	_	1	COORD
3	Tables	table	NNS	_	2	CONJ

1	Figure	figure	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Generation	generation	NN	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	mice	mouse	NNS	_	2	PMOD
4	deficient	deficient	JJ	_	3	NMOD
5	in	in	IN	_	4	AMOD
6	Abcg8	abcg0	NN	_	8	NMOD
7	/	/	HYPH	_	6	P
8	sterolin	sterolin	NN	_	5	PMOD
9	-	-	HYPH	_	8	P
10	2	0	CD	_	8	NMOD
11	.	.	.	_	1	P

1	The	the	DT	_	4	NMOD
2	targeted	target	VBN	_	3	NMOD
3	disruption	disruption	NN	_	4	NMOD
4	strategy	strategy	NN	_	7	SBJ
5	of	of	IN	_	4	NMOD
6	Abcg8	abcg0	NN	_	5	PMOD
7	is	be	VBZ	_	0	ROOT
8	as	as	IN	_	7	PRD
9	shown	show	VBN	_	8	SUB
10	(	(	-LRB-	_	12	P
11	panel	panel	NN	_	12	NMOD
12	a	a	NN	_	7	PRN
13	)	)	-RRB-	_	12	P
14	.	.	.	_	7	P

1	Southern	southern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	6	SBJ
4	of	of	IN	_	3	NMOD
5	BamHI	bamhi	NN	_	4	PMOD
6	digested	digest	VBD	_	0	ROOT
7	mouse	mouse	NN	_	9	NMOD
8	genomic	genomic	JJ	_	9	NMOD
9	DNA	dna	NN	_	6	OBJ
10	,	,	,	_	9	P
11	probed	probe	VBN	_	9	NMOD
12	with	with	IN	_	11	MNR
13	[	[	-LRB-	_	19	P
14	32P	0p	NN	_	19	NMOD
15	]	]	-RRB-	_	19	P
16	-	-	HYPH	_	14	P
17	randomly	randomly	RB	_	18	AMOD
18	labelled	label	VBN	_	19	NMOD
19	probe	probe	NN	_	12	PMOD
20	resulting	result	VBG	_	6	ADV
21	in	in	IN	_	20	ADV
22	a	a	DT	_	25	NMOD
23	6.0	0	CD	_	24	NMOD
24	kb	kb	NN	_	25	NMOD
25	band	band	NN	_	21	PMOD
26	for	for	IN	_	25	NMOD
27	wild	wild	JJ	_	28	NMOD
28	type	type	NN	_	26	PMOD
29	,	,	,	_	25	P
30	a	a	DT	_	33	NMOD
31	2.7	0	CD	_	32	NMOD
32	kb	kb	NN	_	33	NMOD
33	band	band	NN	_	25	CONJ
34	for	for	IN	_	33	NMOD
35	homozygous	homozygous	JJ	_	34	PMOD
36	and	and	CC	_	33	COORD
37	two	two	CD	_	38	NMOD
38	bands	band	NNS	_	36	CONJ
39	of	of	IN	_	38	NMOD
40	5.9	0	CD	_	43	NMOD
41	and	and	CC	_	40	COORD
42	2.6	0	CD	_	41	CONJ
43	kb	kb	NN	_	39	PMOD
44	for	for	IN	_	38	NMOD
45	the	the	DT	_	46	NMOD
46	heterozygote	heterozygote	NN	_	44	PMOD
47	(	(	-LRB-	_	49	P
48	panel	panel	NN	_	49	NMOD
49	b	b	NN	_	6	PRN
50	)	)	-RRB-	_	49	P
51	.	.	.	_	6	P

1	Northern	northern	NNP	_	2	NMOD
2	blot	blot	NN	_	3	NMOD
3	analysis	analysis	NN	_	7	SBJ
4	of	of	IN	_	3	NMOD
5	hepatic	hepatic	JJ	_	6	NMOD
6	RNA	rna	NN	_	4	PMOD
7	showed	show	VBD	_	0	ROOT
8	a	a	DT	_	9	NMOD
9	loss	loss	NN	_	7	OBJ
10	of	of	IN	_	9	NMOD
11	Abcg8	abcg0	NN	_	13	NMOD
12	/	/	HYPH	_	11	P
13	sterolin	sterolin	NN	_	16	NMOD
14	-	-	HYPH	_	13	P
15	2	0	CD	_	13	NMOD
16	mRNA	mrna	NN	_	10	PMOD
17	in	in	IN	_	7	LOC
18	the	the	DT	_	19	NMOD
19	homozygote	homozygote	NN	_	17	PMOD
20	and	and	CC	_	7	COORD
21	decreased	decrease	VBD	_	20	CONJ
22	Abcg8	abcg0	NN	_	24	NMOD
23	/	/	HYPH	_	22	P
24	sterolin	sterolin	NN	_	27	NMOD
25	-	-	HYPH	_	24	P
26	2	0	CD	_	24	NMOD
27	mRNA	mrna	NN	_	21	OBJ
28	in	in	IN	_	21	LOC
29	the	the	DT	_	30	NMOD
30	heterozygote	heterozygote	NN	_	28	PMOD
31	,	,	,	_	7	P
32	although	although	IN	_	7	ADV
33	Abcg5	abcg0	NN	_	35	NMOD
34	/	/	HYPH	_	33	P
35	sterolin	sterolin	NN	_	38	NMOD
36	-	-	HYPH	_	35	P
37	1	0	CD	_	35	NMOD
38	mRNA	mrna	NN	_	39	SBJ
39	appeared	appear	VBD	_	32	SUB
40	relatively	relatively	RB	_	41	AMOD
41	unaffected	unaffected	JJ	_	39	OPRD
42	in	in	IN	_	39	LOC
43	the	the	DT	_	45	NMOD
44	knockout	knockout	NN	_	45	NMOD
45	mice	mouse	NNS	_	42	PMOD
46	(	(	-LRB-	_	48	P
47	panel	panel	NN	_	48	NMOD
48	c	c	NN	_	7	PRN
49	)	)	-RRB-	_	48	P
50	.	.	.	_	7	P

1	Probes	probe	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	approximately	approximately	RB	_	4	QMOD
4	1.9	0	CD	_	5	NMOD
5	kb	kb	NN	_	2	PRD
6	for	for	IN	_	5	NMOD
7	Abcg5	abcg0	NN	_	6	PMOD
8	and	and	CC	_	5	COORD
9	2	0	CD	_	10	NMOD
10	kb	kb	NN	_	8	CONJ
11	for	for	IN	_	10	NMOD
12	Abcg8	abcg0	NN	_	11	PMOD
13	(	(	-LRB-	_	14	P
14	see	see	VB	_	2	PRN
15	Methods	method	NNS	_	14	OBJ
16	for	for	IN	_	14	PRP
17	more	more	JJR	_	18	NMOD
18	detail	detail	NN	_	16	PMOD
19	)	)	-RRB-	_	14	P
20	.	.	.	_	2	P

1	RT	rt	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	PCR	pcr	NN	_	4	NMOD
4	analyses	analysis	NNS	_	8	SBJ
5	of	of	IN	_	4	NMOD
6	hepatic	hepatic	JJ	_	7	NMOD
7	cDNA	cdna	NN	_	5	PMOD
8	showed	show	VBD	_	0	ROOT
9	no	no	DT	_	15	NMOD
10	Abcg8	abcg0	NN	_	12	NMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	15	NMOD
13	-	-	HYPH	_	12	P
14	2	0	CD	_	12	NMOD
15	message	message	NN	_	8	OBJ
16	,	,	,	_	15	P
17	downstream	downstream	RB	_	15	LOC
18	of	of	IN	_	17	AMOD
19	exon	exon	NN	_	18	PMOD
20	4	0	CD	_	19	NMOD
21	in	in	IN	_	15	LOC
22	the	the	DT	_	27	NMOD
23	Abcg8	abcg0	NN	_	26	NMOD
24	-	-	SYM	_	26	P
25	/	/	HYPH	_	26	P
26	-	-	SYM	_	27	NMOD
27	mice	mouse	NNS	_	21	PMOD
28	,	,	,	_	8	P
29	whether	whether	IN	_	8	ADV
30	primers	primer	NNS	_	31	SBJ
31	were	be	VBD	_	29	SUB
32	located	locate	VBN	_	31	VC
33	in	in	IN	_	32	LOC
34	exons	exon	NNS	_	35	NMOD
35	4	0	CD	_	33	PMOD
36	and	and	CC	_	35	COORD
37	13	0	CD	_	36	CONJ
38	(	(	-LRB-	_	40	P
39	panel	panel	NN	_	40	NMOD
40	d	d	NN	_	35	PRN
41	)	)	-RRB-	_	40	P
42	,	,	,	_	35	P
43	exons	exon	NNS	_	44	NMOD
44	9	0	CD	_	35	CONJ
45	and	and	CC	_	44	COORD
46	13	0	CD	_	45	CONJ
47	or	or	CC	_	44	COORD
48	exons	exon	NNS	_	49	NMOD
49	10	0	CD	_	47	CONJ
50	and	and	CC	_	49	COORD
51	13	0	CD	_	50	CONJ
52	(	(	-LRB-	_	54	P
53	panel	panel	NN	_	54	NMOD
54	e	e	NN	_	49	PRN
55	)	)	-RRB-	_	54	P
56	.	.	.	_	8	P

1	Figure	figure	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Free	free	JJ	_	4	NMOD
2	versus	versus	CC	_	1	COORD
3	esterified	esterified	JJ	_	2	CONJ
4	sterol	sterol	NN	_	5	NMOD
5	levels	level	NNS	_	0	ROOT
6	in	in	IN	_	5	LOC
7	the	the	DT	_	8	NMOD
8	livers	liver	NNS	_	6	PMOD
9	of	of	IN	_	8	NMOD
10	Abcg8	abcg0	NN	_	24	NMOD
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	+	+	SYM	_	10	P
14	,	,	,	_	10	P
15	Abcg8	abcg0	NN	_	10	CONJ
16	+	+	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	-	-	SYM	_	15	P
19	and	and	CC	_	15	COORD
20	Abcg8	abcg0	NN	_	19	CONJ
21	-	-	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	-	-	SYM	_	20	P
24	mice	mouse	NNS	_	9	PMOD
25	.	.	.	_	5	P

1	Sterol	sterol	NN	_	2	NMOD
2	contents	content	NNS	_	24	SBJ
3	of	of	IN	_	2	NMOD
4	liver	liver	NN	_	5	NMOD
5	extracts	extract	NNS	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	12	0	CD	_	9	NMOD
8	-	-	HYPH	_	7	P
9	week	week	NN	_	11	AMOD
10	-	-	HYPH	_	9	P
11	old	old	JJ	_	13	NMOD
12	female	female	JJ	_	13	NMOD
13	mice	mouse	NNS	_	6	PMOD
14	fed	feed	VBN	_	13	NMOD
15	a	a	DT	_	18	NMOD
16	regular	regular	JJ	_	17	NMOD
17	chow	chow	NN	_	18	NMOD
18	diet	diet	NN	_	14	OBJ
19	,	,	,	_	2	P
20	determined	determine	VBN	_	2	NMOD
21	by	by	IN	_	20	MNR
22	GC	gc	NN	_	23	NMOD
23	analysis	analysis	NN	_	21	PMOD
24	show	show	VBP	_	0	ROOT
25	that	that	IN	_	24	OBJ
26	the	the	DT	_	27	NMOD
27	majority	majority	NN	_	33	SBJ
28	of	of	IN	_	27	NMOD
29	sterols	sterol	NNS	_	28	PMOD
30	in	in	IN	_	29	LOC
31	all	all	DT	_	32	NMOD
32	genotypes	genotype	NNS	_	30	PMOD
33	are	be	VBP	_	25	SUB
34	unesterified	unesterified	JJ	_	33	PRD
35	.	.	.	_	24	P

1	Esterified	esterified	JJ	_	2	NMOD
2	cholesterol	cholesterol	NN	_	7	SBJ
3	(	(	-LRB-	_	5	P
4	panel	panel	NN	_	5	NMOD
5	a	a	NN	_	2	PRN
6	)	)	-RRB-	_	5	P
7	remains	remain	VBZ	_	0	ROOT
8	relatively	relatively	RB	_	9	AMOD
9	constant	constant	JJ	_	7	PRD
10	for	for	IN	_	7	ADV
11	each	each	DT	_	12	NMOD
12	genotype	genotype	NN	_	10	PMOD
13	.	.	.	_	7	P

1	However	however	RB	_	29	ADV
2	,	,	,	_	29	P
3	no	no	DT	_	5	NMOD
4	esterified	esterify	VBN	_	5	NMOD
5	sitosterol	sitosterol	NN	_	29	SBJ
6	in	in	IN	_	5	LOC
7	the	the	DT	_	8	NMOD
8	livers	liver	NNS	_	6	PMOD
9	from	from	IN	_	8	NMOD
10	Abcg8	abcg0	NN	_	19	NMOD
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	+	+	SYM	_	10	P
14	and	and	CC	_	10	COORD
15	Abcg8	abcg0	NN	_	14	CONJ
16	+	+	SYM	_	15	P
17	/	/	HYPH	_	15	P
18	-	-	SYM	_	15	P
19	mice	mouse	NNS	_	9	PMOD
20	and	and	CC	_	5	COORD
21	very	very	RB	_	22	NMOD
22	little	little	JJ	_	20	CONJ
23	from	from	IN	_	22	NMOD
24	Abcg8	abcg0	NN	_	28	NMOD
25	-	-	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	-	-	SYM	_	24	P
28	mice	mouse	NNS	_	23	PMOD
29	was	be	VBD	_	0	ROOT
30	detected	detect	VBN	_	29	VC
31	(	(	-LRB-	_	33	P
32	panel	panel	NN	_	33	NMOD
33	b	b	NN	_	30	PRN
34	)	)	-RRB-	_	33	P
35	.	.	.	_	29	P

1	Small	small	JJ	_	2	NMOD
2	amounts	amount	NNS	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	esterified	esterify	VBN	_	5	NMOD
5	campesterol	campesterol	NN	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	detected	detect	VBN	_	6	VC
8	in	in	IN	_	7	LOC
9	each	each	DT	_	8	PMOD
10	of	of	IN	_	9	NMOD
11	the	the	DT	_	12	NMOD
12	genotypes	genotype	NNS	_	10	PMOD
13	(	(	-LRB-	_	15	P
14	panel	panel	NN	_	15	NMOD
15	c	c	NN	_	7	PRN
16	)	)	-RRB-	_	15	P
17	.	.	.	_	6	P

1	Figure	figure	NN	_	0	ROOT
2	3	0	CD	_	1	NMOD

1	Lipid	lipid	NN	_	2	NMOD
2	profiles	profile	NNS	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	the	the	DT	_	5	NMOD
5	plasma	plasma	NN	_	3	PMOD
6	of	of	IN	_	5	NMOD
7	Abcg8	abcg0	NN	_	21	NMOD
8	+	+	SYM	_	7	P
9	/	/	HYPH	_	7	P
10	+	+	SYM	_	7	P
11	,	,	,	_	7	P
12	Abcg8	abcg0	NN	_	7	CONJ
13	+	+	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	-	-	SYM	_	12	P
16	and	and	CC	_	12	COORD
17	Abcg8	abcg0	NN	_	16	CONJ
18	-	-	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	-	-	SYM	_	17	P
21	mice	mouse	NNS	_	6	PMOD
22	.	.	.	_	2	P

1	Lipoproteins	lipoprotein	NNS	_	2	SBJ
2	were	be	VBD	_	0	ROOT
3	separated	separate	VBN	_	2	VC
4	from	from	IN	_	3	ADV
5	pooled	pool	VBN	_	8	NMOD
6	mouse	mouse	NN	_	7	NMOD
7	plasma	plasma	NN	_	8	NMOD
8	samples	sample	NNS	_	4	PMOD
9	by	by	IN	_	3	MNR
10	FPLC	fplc	NN	_	9	PMOD
11	.	.	.	_	2	P

1	Total	total	JJ	_	2	NMOD
2	sterols	sterol	NNS	_	13	NMOD
3	(	(	-LRB-	_	4	P
4	panel	panel	NN	_	2	PRN
5	a	a	DT	_	4	NMOD
6	)	)	-RRB-	_	4	P
7	and	and	CC	_	2	COORD
8	triglyceride	triglyceride	NN	_	7	CONJ
9	(	(	-LRB-	_	11	P
10	panel	panel	NN	_	11	NMOD
11	b	b	NN	_	8	PRN
12	)	)	-RRB-	_	11	P
13	profiles	profile	NNS	_	17	SBJ
14	of	of	IN	_	13	NMOD
15	the	the	DT	_	16	NMOD
16	fractions	fraction	NNS	_	14	PMOD
17	are	be	VBP	_	0	ROOT
18	shown	show	VBN	_	17	VC
19	.	.	.	_	17	P

1	There	there	EX	_	2	SBJ
2	was	be	VBD	_	0	ROOT
3	no	no	DT	_	4	NMOD
4	difference	difference	NN	_	2	PRD
5	of	of	IN	_	4	NMOD
6	cholesterol	cholesterol	NN	_	7	NMOD
7	profiles	profile	NNS	_	5	PMOD
8	in	in	IN	_	4	LOC
9	the	the	DT	_	10	NMOD
10	groups	group	NNS	_	8	PMOD
11	,	,	,	_	2	P
12	but	but	CC	_	2	COORD
13	there	there	EX	_	14	SBJ
14	was	be	VBD	_	12	CONJ
15	a	a	DT	_	18	NMOD
16	small	small	JJ	_	18	NMOD
17	triglyceride	triglyceride	NN	_	18	NMOD
18	peak	peak	NN	_	14	PRD
19	in	in	IN	_	18	LOC
20	Abcg8	abcg0	NN	_	24	NMOD
21	-	-	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	-	-	SYM	_	20	P
24	mice	mouse	NNS	_	19	PMOD
25	in	in	IN	_	18	NMOD
26	fractions	fraction	NNS	_	27	NMOD
27	21	0	CD	_	25	PMOD
28	–	–	SYM	_	29	P
29	25	0	CD	_	27	NMOD
30	,	,	,	_	18	P
31	corresponding	correspond	VBG	_	18	NMOD
32	to	to	IN	_	31	ADV
33	the	the	DT	_	37	NMOD
34	LDL	ldl	NN	_	36	NMOD
35	-	-	HYPH	_	34	P
36	size	size	NN	_	37	NMOD
37	range	range	NN	_	32	PMOD
38	,	,	,	_	37	P
39	the	the	DT	_	40	NMOD
40	significance	significance	NN	_	43	SBJ
41	of	of	IN	_	40	NMOD
42	which	which	WDT	_	41	PMOD
43	is	be	VBZ	_	37	NMOD
44	not	not	RB	_	43	ADV
45	known	know	VBN	_	43	VC
46	at	at	IN	_	45	TMP
47	present	present	JJ	_	46	PMOD
48	.	.	.	_	2	P

1	Figure	figure	NN	_	0	ROOT
2	4	0	CD	_	1	NMOD

1	Analyses	analysis	NNS	_	0	ROOT
2	of	of	IN	_	1	NMOD
3	mRNA	mrna	NN	_	4	NMOD
4	expression	expression	NN	_	2	PMOD
5	and	and	CC	_	4	COORD
6	enzyme	enzyme	NN	_	7	NMOD
7	activity	activity	NN	_	5	CONJ
8	in	in	IN	_	4	LOC
9	mouse	mouse	NN	_	10	NMOD
10	livers	liver	NNS	_	8	PMOD
11	.	.	.	_	1	P

1	Panel	panel	NN	_	3	NMOD
2	(	(	-LRB-	_	3	P
3	a	a	NN	_	5	SBJ
4	)	)	-RRB-	_	3	P
5	shows	show	VBZ	_	0	ROOT
6	RT	rt	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	PCR	pcr	NN	_	9	NMOD
9	quantitation	quantitation	NN	_	5	OBJ
10	of	of	IN	_	9	NMOD
11	mRNA	mrna	NN	_	12	NMOD
12	levels	level	NNS	_	10	PMOD
13	for	for	IN	_	9	NMOD
14	Abcg5	abcg0	NN	_	13	PMOD
15	,	,	,	_	14	P
16	Abcg8	abcg0	NN	_	14	CONJ
17	,	,	,	_	16	P
18	Hmgr	hmgr	NN	_	16	CONJ
19	,	,	,	_	18	P
20	Cyp7a1	cyp0a0	NN	_	18	CONJ
21	,	,	,	_	20	P
22	Abca1	abca0	NN	_	20	CONJ
23	,	,	,	_	22	P
24	Mdr2	mdr0	NN	_	22	CONJ
25	,	,	,	_	24	P
26	Lxr	lxr	NN	_	24	CONJ
27	,	,	,	_	26	P
28	Srebp	srebp	NN	_	30	NMOD
29	-	-	HYPH	_	28	P
30	1c	0c	NN	_	26	CONJ
31	and	and	CC	_	30	COORD
32	Srebp	srebp	NN	_	31	CONJ
33	-	-	HYPH	_	32	P
34	2	0	CD	_	32	NMOD
35	in	in	IN	_	9	LOC
36	mouse	mouse	NN	_	37	NMOD
37	livers	liver	NNS	_	35	PMOD
38	from	from	IN	_	37	NMOD
39	Abcg8	abcg0	NN	_	38	PMOD
40	+	+	SYM	_	39	P
41	/	/	HYPH	_	39	P
42	+	+	SYM	_	39	P
43	(	(	-LRB-	_	45	P
44	open	open	JJ	_	45	NMOD
45	bars	bar	NNS	_	39	PRN
46	)	)	-RRB-	_	45	P
47	,	,	,	_	39	P
48	Abcg8	abcg0	HYPH	_	54	P
49	+	+	SYM	_	54	P
50	/	/	HYPH	_	54	P
51	-	-	SYM	_	54	P
52	(	(	-LRB-	_	54	P
53	hatched	hatch	VBN	_	54	NMOD
54	bars	bar	NNS	_	39	CONJ
55	)	)	-RRB-	_	54	P
56	and	and	CC	_	54	COORD
57	Abcg8	abcg0	NN	_	56	CONJ
58	-	-	SYM	_	57	P
59	/	/	HYPH	_	57	P
60	-	-	SYM	_	57	P
61	(	(	-LRB-	_	63	P
62	filled	fill	VBN	_	63	NMOD
63	bars	bar	NNS	_	57	PRN
64	)	)	-RRB-	_	63	P
65	.	.	.	_	5	P

1	Knockout	knockout	NN	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	showed	show	VBD	_	0	ROOT
4	an	an	DT	_	8	NMOD
5	~	~	SYM	_	6	P
6	60	0	CD	_	7	NMOD
7	%	%	NN	_	8	NMOD
8	reduction	reduction	NN	_	3	OBJ
9	in	in	IN	_	8	NMOD
10	mRNA	mrna	NN	_	9	PMOD
11	for	for	IN	_	10	NMOD
12	Abcg5	abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	11	PMOD
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	NMOD
17	and	and	CC	_	8	COORD
18	an	an	DT	_	21	NMOD
19	80	0	CD	_	20	NMOD
20	%	%	NN	_	21	NMOD
21	reduction	reduction	NN	_	17	CONJ
22	in	in	IN	_	21	NMOD
23	the	the	DT	_	24	NMOD
24	message	message	NN	_	22	PMOD
25	for	for	IN	_	24	NMOD
26	HMG	hmg	NN	_	28	NMOD
27	CoA	coa	NN	_	28	NMOD
28	reductase	reductase	NN	_	25	PMOD
29	.	.	.	_	3	P

1	Relatively	relatively	RB	_	3	NMOD
2	no	no	DT	_	3	NMOD
3	message	message	NN	_	10	SBJ
4	for	for	IN	_	3	NMOD
5	Abcg8	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	4	PMOD
8	-	-	HYPH	_	7	P
9	2	0	CD	_	7	NMOD
10	was	be	VBD	_	0	ROOT
11	detected	detect	VBN	_	10	VC
12	in	in	IN	_	11	LOC
13	the	the	DT	_	15	NMOD
14	knockout	knockout	NN	_	15	NMOD
15	mice	mouse	NNS	_	12	PMOD
16	.	.	.	_	10	P

1	Panel	panel	NN	_	3	NMOD
2	(	(	-LRB-	_	3	P
3	b	b	NN	_	5	SBJ
4	)	)	-RRB-	_	3	P
5	shows	show	VBZ	_	0	ROOT
6	the	the	DT	_	8	NMOD
7	enzyme	enzyme	NN	_	8	NMOD
8	activities	activity	NNS	_	5	OBJ
9	for	for	IN	_	8	NMOD
10	HMG	hmg	NN	_	12	NMOD
11	-	-	HYPH	_	10	P
12	CoA	coa	NN	_	13	NMOD
13	reductase	reductase	NN	_	9	PMOD
14	and	and	CC	_	13	COORD
15	CYP7a1	cyp0a0	NN	_	14	CONJ
16	in	in	IN	_	8	LOC
17	livers	liver	NNS	_	16	PMOD
18	from	from	IN	_	17	NMOD
19	Abcg8	abcg0	NN	_	33	NMOD
20	+	+	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	+	+	SYM	_	19	P
23	,	,	,	_	19	P
24	Abcg8	abcg0	NN	_	19	CONJ
25	+	+	SYM	_	24	P
26	/	/	HYPH	_	24	P
27	-	-	SYM	_	24	P
28	and	and	CC	_	24	COORD
29	Abcg8	abcg0	NN	_	28	CONJ
30	-	-	SYM	_	29	P
31	/	/	HYPH	_	29	P
32	-	-	SYM	_	29	P
33	mice	mouse	NNS	_	18	PMOD
34	.	.	.	_	5	P

1	Activities	activity	NNS	_	9	SBJ
2	of	of	IN	_	1	NMOD
3	HMG	hmg	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	CoA	coa	NN	_	6	NMOD
6	reductase	reductase	NN	_	2	PMOD
7	and	and	CC	_	6	COORD
8	CYP7a1	cyp0a0	NN	_	7	CONJ
9	were	be	VBD	_	0	ROOT
10	significantly	significantly	RB	_	9	ADV
11	reduced	reduce	VBN	_	9	VC
12	in	in	IN	_	11	LOC
13	the	the	DT	_	19	NMOD
14	Abcg8	abcg0	NN	_	19	NMOD
15	-	-	SYM	_	14	P
16	/	/	HYPH	_	14	P
17	-	-	SYM	_	14	P
18	mouse	mouse	NN	_	19	NMOD
19	liver	liver	NN	_	12	PMOD
20	(	(	-LRB-	_	25	P
21	*P	*p	NN	_	23	SBJ
22	<	<	SYM	_	23	P
23	0.05	0	CD	_	25	DEP
24	,	,	,	_	25	P
25	see	see	VB	_	11	PRN
26	text	text	NN	_	25	OBJ
27	for	for	IN	_	25	PRP
28	discussion	discussion	NN	_	27	PMOD
29	)	)	-RRB-	_	25	P
30	.	.	.	_	9	P

1	Figure	figure	NN	_	0	ROOT
2	5	0	CD	_	1	NMOD

1	N	n	NN	_	3	NMOD
2	-	-	HYPH	_	1	P
3	glycosylation	glycosylation	NN	_	0	ROOT
4	of	of	IN	_	3	NMOD
5	Abcg5	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	10	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	analyses	analysis	NNS	_	4	PMOD
11	in	in	IN	_	3	LOC
12	Abcg8	abcg0	HYPH	_	15	P
13	-	-	SYM	_	15	P
14	/	/	HYPH	_	15	P
15	-	-	SYM	_	17	NMOD
16	mouse	mouse	NN	_	17	NMOD
17	liver	liver	NN	_	11	PMOD
18	.	.	.	_	3	P

1	Mouse	mouse	NN	_	2	NMOD
2	liver	liver	NN	_	3	NMOD
3	homogenate	homogenate	NN	_	20	SBJ
4	stained	stain	VBN	_	3	NMOD
5	with	with	IN	_	4	MNR
6	SC	sc	NN	_	9	NMOD
7	anti-Abcg5	anti-abcg0	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	sterolin	sterolin	NN	_	5	PMOD
10	-	-	HYPH	_	9	P
11	1	0	CD	_	9	NMOD
12	after	after	IN	_	4	TMP
13	treatment	treatment	NN	_	12	PMOD
14	with	with	IN	_	13	NMOD
15	Endo	endo	NN	_	17	NMOD
16	-	-	HYPH	_	15	P
17	H	h	NN	_	14	PMOD
18	or	or	CC	_	17	COORD
19	PNGaseF	pngasef	NN	_	18	CONJ
20	shows	show	VBZ	_	0	ROOT
21	a	a	DT	_	24	NMOD
22	75	0	CD	_	23	NMOD
23	kDa	kda	NN	_	24	NMOD
24	band	band	NN	_	20	OBJ
25	present	present	JJ	_	24	NMOD
26	in	in	IN	_	25	LOC
27	both	both	DT	_	28	NMOD
28	genotypes	genotype	NNS	_	26	PMOD
29	,	,	,	_	24	P
30	which	which	WDT	_	31	SBJ
31	is	be	VBZ	_	24	NMOD
32	resistant	resistant	JJ	_	31	PRD
33	to	to	IN	_	32	AMOD
34	deglycosylation	deglycosylation	NN	_	33	PMOD
35	(	(	-LRB-	_	37	P
36	panel	panel	NN	_	37	NMOD
37	a	a	NN	_	20	PRN
38	)	)	-RRB-	_	37	P
39	.	.	.	_	20	P

1	Staining	staining	NN	_	11	SBJ
2	of	of	IN	_	1	NMOD
3	wild	wild	JJ	_	5	NMOD
4	-	-	HYPH	_	3	P
5	type	type	NN	_	7	NMOD
6	liver	liver	NN	_	7	NMOD
7	homogenate	homogenate	NN	_	2	PMOD
8	with	with	IN	_	1	NMOD
9	preimmune	preimmune	JJ	_	10	NMOD
10	serum	serum	NN	_	8	PMOD
11	showed	show	VBD	_	0	ROOT
12	no	no	DT	_	14	NMOD
13	detectable	detectable	JJ	_	14	NMOD
14	bands	band	NNS	_	11	OBJ
15	.	.	.	_	11	P

1	Lower	low	JJR	_	2	NMOD
2	portion	portion	NN	_	8	SBJ
3	of	of	IN	_	2	NMOD
4	panel	panel	NN	_	6	NMOD
5	(	(	-LRB-	_	6	P
6	a	a	NN	_	3	PMOD
7	)	)	-RRB-	_	6	P
8	shows	show	VBZ	_	0	ROOT
9	the	the	DT	_	11	NMOD
10	same	same	JJ	_	11	NMOD
11	aliquots	aliquot	NNS	_	8	OBJ
12	stained	stain	VBN	_	11	NMOD
13	for	for	IN	_	12	ADV
14	anti-transferrin	anti-transferrin	NN	_	13	PMOD
15	as	as	IN	_	11	NMOD
16	a	a	DT	_	17	NMOD
17	control	control	NN	_	15	PMOD
18	for	for	IN	_	17	NMOD
19	deglycosylation	deglycosylation	NN	_	18	PMOD
20	.	.	.	_	8	P

1	AMC	amc	NN	_	7	NMOD
2	anti-Abcg5	anti-abcg0	NN	_	4	AMOD
3	/	/	HYPH	_	2	P
4	sterolin	sterolin	NN	_	7	NMOD
5	-	-	HYPH	_	4	P
6	1	0	CD	_	4	AMOD
7	staining	staining	NN	_	12	SBJ
8	of	of	IN	_	7	NMOD
9	mouse	mouse	NN	_	10	NMOD
10	liver	liver	NN	_	11	NMOD
11	homogenate	homogenate	NN	_	8	PMOD
12	shows	show	VBZ	_	0	ROOT
13	a	a	DT	_	20	NMOD
14	'	'	``	_	20	P
15	mature	mature	JJ	_	20	NMOD
16	'	'	''	_	20	P
17	~	~	SYM	_	18	P
18	90	0	CD	_	19	NMOD
19	kDa	kda	NN	_	20	NMOD
20	band	band	NN	_	12	OBJ
21	in	in	IN	_	20	LOC
22	the	the	DT	_	26	NMOD
23	wild	wild	JJ	_	25	NMOD
24	-	-	HYPH	_	23	P
25	type	type	NN	_	26	NMOD
26	mice	mouse	NNS	_	21	PMOD
27	but	but	CC	_	21	COORD
28	not	not	RB	_	27	ADV
29	in	in	IN	_	27	CONJ
30	the	the	DT	_	35	NMOD
31	Abcg8	abcg0	NN	_	35	NMOD
32	-	-	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	-	-	SYM	_	31	P
35	mice	mouse	NNS	_	29	PMOD
36	(	(	-LRB-	_	38	P
37	panel	panel	NN	_	38	NMOD
38	b	b	NN	_	12	PRN
39	)	)	-RRB-	_	38	P
40	.	.	.	_	12	P

1	A	a	DT	_	4	NMOD
2	75	0	CD	_	3	NMOD
3	kDa	kda	NN	_	4	NMOD
4	form	form	NN	_	5	SBJ
5	is	be	VBZ	_	0	ROOT
6	present	present	JJ	_	5	PRD
7	which	which	WDT	_	8	SBJ
8	is	be	VBZ	_	4	NMOD
9	sensitive	sensitive	JJ	_	8	PRD
10	to	to	IN	_	9	AMOD
11	deglycosylation	deglycosylation	NN	_	10	PMOD
12	.	.	.	_	5	P

1	Mouse	mouse	NN	_	2	NMOD
2	liver	liver	NN	_	3	NMOD
3	homogenate	homogenate	NN	_	12	SBJ
4	stained	stain	VBN	_	3	NMOD
5	with	with	IN	_	4	MNR
6	UTSW	utsw	NN	_	9	NMOD
7	anti-Abcg5	anti-abcg0	NN	_	9	NMOD
8	/	/	HYPH	_	7	P
9	sterolin	sterolin	NN	_	5	PMOD
10	-	-	HYPH	_	9	P
11	1	0	CD	_	9	NMOD
12	shows	show	VBZ	_	0	ROOT
13	a	a	DT	_	20	NMOD
14	'	'	``	_	20	P
15	mature	mature	JJ	_	20	NMOD
16	'	'	''	_	20	P
17	~	~	SYM	_	18	P
18	90	0	CD	_	19	NMOD
19	kDa	kda	NN	_	20	NMOD
20	band	band	NN	_	12	OBJ
21	and	and	CC	_	20	COORD
22	an	an	DT	_	28	NMOD
23	'	'	``	_	28	P
24	immature	immature	JJ	_	28	NMOD
25	'	'	''	_	28	P
26	75	0	CD	_	27	NMOD
27	kDa	kda	NN	_	28	NMOD
28	band	band	NN	_	21	CONJ
29	in	in	IN	_	20	LOC
30	the	the	DT	_	34	NMOD
31	wild	wild	JJ	_	33	NMOD
32	-	-	HYPH	_	31	P
33	type	type	NN	_	34	NMOD
34	mice	mouse	NNS	_	29	PMOD
35	but	but	CC	_	12	COORD
36	no	no	DT	_	37	NMOD
37	signal	signal	NN	_	38	SBJ
38	is	be	VBZ	_	35	CONJ
39	detected	detect	VBN	_	38	VC
40	in	in	IN	_	39	LOC
41	the	the	DT	_	46	NMOD
42	Abcg8	abcg0	NN	_	46	NMOD
43	-	-	SYM	_	42	P
44	/	/	HYPH	_	42	P
45	-	-	SYM	_	42	P
46	mice	mouse	NNS	_	40	PMOD
47	.	.	.	_	12	P

1	Treatment	treatment	NN	_	8	SBJ
2	with	with	IN	_	1	NMOD
3	Endo	endo	NN	_	5	NMOD
4	-	-	HYPH	_	3	P
5	H	h	NN	_	2	PMOD
6	or	or	CC	_	5	COORD
7	PNGaseF	pngasef	NN	_	6	CONJ
8	results	result	VBZ	_	0	ROOT
9	in	in	IN	_	8	ADV
10	a	a	DT	_	14	NMOD
11	lower	low	JJR	_	14	NMOD
12	molecular	molecular	JJ	_	13	NMOD
13	weight	weight	NN	_	14	NMOD
14	protein	protein	NN	_	9	PMOD
15	in	in	IN	_	14	LOC
16	the	the	DT	_	20	NMOD
17	wild	wild	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	type	type	NN	_	20	NMOD
20	mice	mouse	NNS	_	15	PMOD
21	.	.	.	_	8	P

1	Abcg5	abcg0	NN	_	3	NMOD
2	/	/	HYPH	_	1	P
3	Abcg8	abcg0	NN	_	8	NMOD
4	-	-	SYM	_	3	P
5	/	/	HYPH	_	3	P
6	-	-	SYM	_	3	P
7	liver	liver	NN	_	8	NMOD
8	homogenate	homogenate	NN	_	0	ROOT
9	used	use	VBN	_	8	NMOD
10	for	for	IN	_	9	PRP
11	negative	negative	JJ	_	12	NMOD
12	control	control	NN	_	10	PMOD
13	.	.	.	_	8	P

1	Figure	figure	NN	_	0	ROOT
2	6	0	CD	_	1	NMOD

1	Immunohistochemical	immunohistochemical	JJ	_	2	NMOD
2	evaluation	evaluation	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	mouse	mouse	NN	_	7	NMOD
5	Abcg5	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	10	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	expression	expression	NN	_	3	PMOD
11	in	in	IN	_	10	LOC
12	liver	liver	NN	_	11	PMOD
13	and	and	CC	_	12	COORD
14	intestine	intestine	NN	_	13	CONJ
15	.	.	.	_	2	P

1	COS	co	NN	_	4	NMOD
2	-	-	HYPH	_	1	P
3	1	0	CD	_	1	NMOD
4	cells	cell	NNS	_	5	SBJ
5	were	be	VBD	_	0	ROOT
6	transiently	transiently	RB	_	7	ADV
7	transfected	transfected	VBN	_	5	VC
8	with	with	IN	_	7	MNR
9	pCMV	pcmv	NN	_	11	NMOD
10	-	-	HYPH	_	9	P
11	mouse	mouse	NN	_	12	NMOD
12	Abcg5	abcg0	NN	_	18	NMOD
13	or	or	CC	_	12	COORD
14	pCMV	pcmv	NN	_	16	NMOD
15	-	-	HYPH	_	14	P
16	mouse	mouse	NN	_	17	NMOD
17	Abcg8	abcg0	NN	_	13	CONJ
18	constructs	construct	NNS	_	8	PMOD
19	,	,	,	_	7	P
20	allowed	allow	VBN	_	7	VC
21	to	to	TO	_	20	OPRD
22	express	express	VB	_	21	IM
23	for	for	IN	_	22	ADV
24	48	0	CD	_	25	NMOD
25	hours	hour	NNS	_	23	PMOD
26	then	then	RB	_	27	TMP
27	fixed	fix	VBN	_	7	VC
28	and	and	CC	_	27	COORD
29	incubated	incubate	VBN	_	28	CONJ
30	with	with	IN	_	27	MNR
31	antibody	antibody	NN	_	30	PMOD
32	.	.	.	_	5	P

1	pCMV	pcmv	NN	_	3	NMOD
2	empty	empty	JJ	_	3	NMOD
3	vector	vector	NN	_	4	AMOD
4	transfected	transfected	VBN	_	8	NMOD
5	COS	co	NN	_	8	NMOD
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	cells	cell	NNS	_	17	SBJ
9	incubated	incubate	VBN	_	8	NMOD
10	with	with	IN	_	9	MNR
11	SC	sc	NN	_	14	NMOD
12	anti-Abcg5	anti-abcg0	NN	_	14	NMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	10	PMOD
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	NMOD
17	showed	show	VBD	_	0	ROOT
18	no	no	DT	_	20	NMOD
19	significant	significant	JJ	_	20	NMOD
20	fluorescence	fluorescence	NN	_	17	OBJ
21	(	(	-LRB-	_	23	P
22	panel	panel	NN	_	23	NMOD
23	a	a	NN	_	17	PRN
24	)	)	-RRB-	_	23	P
25	.	.	.	_	17	P

1	Abcg5	abcg0	NN	_	2	AMOD
2	transfected	transfected	VBN	_	6	NMOD
3	COS	co	NN	_	6	NMOD
4	-	-	HYPH	_	3	P
5	1	0	CD	_	3	NMOD
6	cells	cell	NNS	_	16	SBJ
7	incubated	incubate	VBN	_	6	NMOD
8	with	with	IN	_	7	MNR
9	SC	sc	NN	_	15	NMOD
10	anti-Abcg5	anti-abcg0	NN	_	12	AMOD
11	/	/	HYPH	_	10	P
12	sterolin	sterolin	NN	_	15	NMOD
13	-	-	HYPH	_	12	P
14	1	0	CD	_	12	AMOD
15	antibody	antibody	NN	_	8	PMOD
16	showed	show	VBD	_	0	ROOT
17	a	a	DT	_	19	NMOD
18	membrane	membrane	NN	_	19	NMOD
19	distribution	distribution	NN	_	16	OBJ
20	(	(	-LRB-	_	22	P
21	panel	panel	NN	_	22	NMOD
22	b	b	NN	_	16	PRN
23	)	)	-RRB-	_	22	P
24	,	,	,	_	16	P
25	where	where	RB	_	26	ADV
26	as	as	IN	_	16	ADV
27	Abcg8	abcg0	NN	_	28	AMOD
28	transfected	transfected	VBN	_	29	NMOD
29	cells	cell	NNS	_	35	SBJ
30	incubated	incubate	VBN	_	29	NMOD
31	with	with	IN	_	30	MNR
32	SC	sc	NN	_	34	NMOD
33	anti-Abcg5	anti-abcg0	NN	_	34	NMOD
34	antibody	antibody	NN	_	31	PMOD
35	showed	show	VBD	_	26	SUB
36	no	no	DT	_	38	NMOD
37	significant	significant	JJ	_	38	NMOD
38	fluorescence	fluorescence	NN	_	35	OBJ
39	(	(	-LRB-	_	41	P
40	panel	panel	NN	_	41	NMOD
41	c	c	NN	_	35	PRN
42	)	)	-RRB-	_	41	P
43	.	.	.	_	16	P

1	Abcg5	abcg0	NN	_	4	AMOD
2	and	and	CC	_	1	COORD
3	Abcg8	abcg0	NN	_	2	CONJ
4	co-transfected	co-transfected	JJ	_	8	NMOD
5	COS	co	NN	_	8	NMOD
6	-	-	HYPH	_	5	P
7	1	0	CD	_	5	NMOD
8	cells	cell	NNS	_	18	SBJ
9	incubated	incubate	VBN	_	8	NMOD
10	with	with	IN	_	9	MNR
11	SC	sc	NN	_	17	NMOD
12	anti-Abcg5	anti-abcg0	NN	_	14	AMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	17	NMOD
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	AMOD
17	antibody	antibody	NN	_	10	PMOD
18	resulted	result	VBD	_	0	ROOT
19	in	in	IN	_	18	ADV
20	a	a	DT	_	22	NMOD
21	fluorescence	fluorescence	NN	_	22	NMOD
22	pattern	pattern	NN	_	19	PMOD
23	similar	similar	JJ	_	22	NMOD
24	to	to	IN	_	23	AMOD
25	Abcg5	abcg0	NN	_	24	PMOD
26	alone	alone	RB	_	25	NMOD
27	(	(	-LRB-	_	29	P
28	panel	panel	NN	_	29	NMOD
29	d	d	NN	_	18	PRN
30	)	)	-RRB-	_	29	P
31	.	.	.	_	18	P

1	The	the	DT	_	3	NMOD
2	yellow	yellow	JJ	_	3	NMOD
3	bar	bar	NN	_	4	SBJ
4	represents	represent	VBZ	_	0	ROOT
5	20	0	CD	_	6	NMOD
6	μm	μm	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	4	NMOD
4	intestine	intestine	NN	_	32	SBJ
5	incubated	incubate	VBN	_	4	NMOD
6	with	with	IN	_	5	MNR
7	SC	sc	NN	_	9	NMOD
8	pre-immune	pre-immune	NN	_	9	NMOD
9	serum	serum	NN	_	6	PMOD
10	(	(	-LRB-	_	12	P
11	panel	panel	NN	_	12	NMOD
12	e	e	NN	_	4	PRN
13	)	)	-RRB-	_	12	P
14	,	,	,	_	4	P
15	or	or	CC	_	4	COORD
16	SC	sc	NN	_	22	NMOD
17	anti-Abcg5	anti-abcg0	NN	_	19	AMOD
18	/	/	HYPH	_	17	P
19	sterolin	sterolin	NN	_	22	NMOD
20	-	-	HYPH	_	19	P
21	1	0	CD	_	19	AMOD
22	antibody	antibody	NN	_	15	CONJ
23	pre-incubated	pre-incubated	VBN	_	22	NMOD
24	with	with	IN	_	23	ADV
25	the	the	DT	_	27	NMOD
26	blocking	block	VBG	_	27	NMOD
27	peptide	peptide	NN	_	24	PMOD
28	(	(	-LRB-	_	30	P
29	panel	panel	NN	_	30	NMOD
30	f	f	NN	_	22	PRN
31	)	)	-RRB-	_	30	P
32	showed	show	VBD	_	0	ROOT
33	no	no	DT	_	35	NMOD
34	specific	specific	JJ	_	35	NMOD
35	signals	signal	NNS	_	32	OBJ
36	.	.	.	_	32	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	14	NMOD
4	,	,	,	_	3	P
5	Abcg8	abcg0	NN	_	3	CONJ
6	+	+	SYM	_	5	P
7	/	/	HYPH	_	5	P
8	-	-	SYM	_	5	P
9	and	and	CC	_	5	COORD
10	Abcg8	abcg0	NN	_	9	CONJ
11	-	-	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	-	-	SYM	_	10	P
14	intestine	intestine	NN	_	34	SBJ
15	(	(	-LRB-	_	22	P
16	panels	panel	NNS	_	17	NMOD
17	g	g	NN	_	22	DEP
18	,	,	,	_	17	P
19	h	h	NN	_	17	CONJ
20	and	and	CC	_	19	COORD
21	i	i	NN	_	20	CONJ
22	respectively	respectively	RB	_	14	PRN
23	)	)	-RRB-	_	22	P
24	incubated	incubate	VBN	_	14	NMOD
25	with	with	IN	_	24	MNR
26	SC	sc	NN	_	32	NMOD
27	anti-Abcg5	anti-abcg0	NN	_	29	AMOD
28	/	/	HYPH	_	27	P
29	sterolin	sterolin	NN	_	32	NMOD
30	-	-	HYPH	_	29	P
31	1	0	CD	_	29	AMOD
32	antibody	antibody	NN	_	25	PMOD
33	,	,	,	_	34	P
34	showed	show	VBD	_	0	ROOT
35	no	no	DT	_	36	NMOD
36	difference	difference	NN	_	34	OBJ
37	in	in	IN	_	36	NMOD
38	expression	expression	NN	_	39	NMOD
39	patterns	pattern	NNS	_	37	PMOD
40	,	,	,	_	34	P
41	despite	despite	IN	_	34	ADV
42	the	the	DT	_	43	NMOD
43	loss	loss	NN	_	41	PMOD
44	of	of	IN	_	43	NMOD
45	Abcg8	abcg0	NN	_	47	NMOD
46	/	/	HYPH	_	45	P
47	sterolin	sterolin	NN	_	44	PMOD
48	-	-	HYPH	_	47	P
49	2	0	CD	_	47	NMOD
50	in	in	IN	_	43	LOC
51	the	the	DT	_	53	NMOD
52	knockout	knockout	NN	_	53	NMOD
53	mice	mouse	NNS	_	50	PMOD
54	.	.	.	_	34	P

1	Single	single	JJ	_	2	NMOD
2	arrowhead	arrowhead	NN	_	3	SBJ
3	shows	show	VBZ	_	0	ROOT
4	intestinal	intestinal	JJ	_	5	NMOD
5	villus	villus	NN	_	3	OBJ
6	and	and	CC	_	3	COORD
7	double	double	JJ	_	8	NMOD
8	arrowhead	arrowhead	NN	_	9	SBJ
9	shows	show	VBZ	_	6	CONJ
10	crypt	crypt	NN	_	9	OBJ
11	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	yellow	yellow	JJ	_	3	NMOD
3	bar	bar	NN	_	4	SBJ
4	represents	represent	VBZ	_	0	ROOT
5	50	0	CD	_	6	NMOD
6	μm	μm	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Antibody	antibody	NN	_	2	NMOD
2	staining	staining	NN	_	6	SBJ
3	of	of	IN	_	2	NMOD
4	liver	liver	NN	_	5	NMOD
5	sections	section	NNS	_	3	PMOD
6	was	be	VBD	_	0	ROOT
7	also	also	RB	_	6	ADV
8	performed	perform	VBN	_	6	VC
9	at	at	IN	_	8	LOC
10	the	the	DT	_	13	NMOD
11	AMC	amc	NNP	_	13	NMOD
12	Liver	liver	NNP	_	13	NMOD
13	Center	center	NNP	_	9	PMOD
14	.	.	.	_	6	P

1	As	as	IN	_	11	ADV
2	a	a	DT	_	3	NMOD
3	control	control	NN	_	1	PMOD
4	,	,	,	_	11	P
5	an	an	DT	_	6	NMOD
6	antibody	antibody	NN	_	11	SBJ
7	to	to	IN	_	6	NMOD
8	Bsep	bsep	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	Abcb11	abcb0	NN	_	7	PMOD
11	was	be	VBD	_	0	ROOT
12	used	use	VBN	_	11	VC
13	and	and	CC	_	11	COORD
14	showed	show	VBD	_	13	CONJ
15	a	a	DT	_	18	NMOD
16	clear	clear	JJ	_	18	NMOD
17	apical	apical	JJ	_	18	NMOD
18	distribution	distribution	NN	_	14	OBJ
19	in	in	IN	_	14	LOC
20	both	both	CC	_	23	COORD
21	wild	wild	JJ	_	23	NMOD
22	-	-	HYPH	_	21	P
23	type	type	NN	_	31	NMOD
24	(	(	-LRB-	_	26	P
25	panel	panel	NN	_	26	NMOD
26	j	j	NN	_	23	PRN
27	)	)	-RRB-	_	26	P
28	and	and	CC	_	23	COORD
29	Abcg8	abcg0	NN	_	30	NMOD
30	knockout	knockout	NN	_	28	CONJ
31	mice	mouse	NNS	_	19	PMOD
32	(	(	-LRB-	_	34	P
33	panel	panel	NN	_	34	NMOD
34	k	k	NN	_	31	PRN
35	)	)	-RRB-	_	34	P
36	.	.	.	_	11	P

1	Using	use	VBG	_	37	MNR
2	AMC	amc	NN	_	3	NMOD
3	antibody	antibody	NN	_	1	OBJ
4	against	against	IN	_	1	ADV
5	Abcg5	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	4	PMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	(	(	-LRB-	_	11	P
11	see	see	VB	_	1	PRN
12	text	text	NN	_	11	OBJ
13	)	)	-RRB-	_	11	P
14	,	,	,	_	1	P
15	in	in	IN	_	1	LOC
16	both	both	CC	_	19	COORD
17	wild	wild	JJ	_	19	NMOD
18	-	-	HYPH	_	17	P
19	type	type	NN	_	27	NMOD
20	(	(	-LRB-	_	22	P
21	panel	panel	NN	_	22	NMOD
22	l	l	NN	_	19	PRN
23	)	)	-RRB-	_	22	P
24	and	and	CC	_	19	COORD
25	Abcg8	abcg0	NN	_	26	NMOD
26	knockout	knockout	NN	_	24	CONJ
27	liver	liver	NN	_	15	PMOD
28	(	(	-LRB-	_	30	P
29	panel	panel	NN	_	30	NMOD
30	m	m	NN	_	27	PRN
31	)	)	-RRB-	_	30	P
32	,	,	,	_	37	P
33	the	the	DT	_	34	NMOD
34	pattern	pattern	NN	_	37	SBJ
35	of	of	IN	_	34	NMOD
36	expression	expression	NN	_	35	PMOD
37	was	be	VBD	_	0	ROOT
38	also	also	RB	_	37	ADV
39	apical	apical	JJ	_	37	PRD
40	and	and	CC	_	39	COORD
41	unchanged	unchanged	JJ	_	40	CONJ
42	although	although	IN	_	37	ADV
43	the	the	DT	_	44	NMOD
44	signal	signal	NN	_	45	SBJ
45	is	be	VBZ	_	42	SUB
46	fainter	faint	JJR	_	45	PRD
47	compared	compare	VBN	_	45	ADV
48	to	to	IN	_	47	PMOD
49	that	that	DT	_	48	PMOD
50	for	for	IN	_	49	NMOD
51	Bsep	bsep	NN	_	53	NMOD
52	/	/	HYPH	_	51	P
53	Abcb11	abcb0	NN	_	50	PMOD
54	(	(	-LRB-	_	55	P
55	see	see	VB	_	37	PRN
56	text	text	NN	_	55	OBJ
57	for	for	IN	_	56	NMOD
58	discussion	discussion	NN	_	57	PMOD
59	)	)	-RRB-	_	55	P
60	.	.	.	_	37	P

1	Arrows	arrow	NNS	_	2	SBJ
2	indicate	indicate	VBP	_	0	ROOT
3	bile	bile	NN	_	4	NMOD
4	canaliculi	canaliculus	NNS	_	2	OBJ
5	.	.	.	_	2	P

1	Figure	figure	NN	_	0	ROOT
2	7	0	CD	_	1	NMOD

1	Immunohistochemical	immunohistochemical	JJ	_	2	NMOD
2	evaluation	evaluation	NN	_	0	ROOT
3	of	of	IN	_	2	NMOD
4	mouse	mouse	NN	_	10	NMOD
5	Abcg5	abcg0	NN	_	7	NMOD
6	/	/	HYPH	_	5	P
7	sterolin	sterolin	NN	_	10	NMOD
8	-	-	HYPH	_	7	P
9	1	0	CD	_	7	NMOD
10	expression	expression	NN	_	3	PMOD
11	in	in	IN	_	10	LOC
12	liver	liver	NN	_	11	PMOD
13	.	.	.	_	2	P

1	Wild	wild	JJ	_	3	NMOD
2	-	-	HYPH	_	1	P
3	type	type	NN	_	4	NMOD
4	liver	liver	NN	_	13	SBJ
5	incubated	incubate	VBN	_	4	NMOD
6	with	with	IN	_	5	MNR
7	UTSW	utsw	NN	_	10	NMOD
8	anti-Abcg5	anti-abcg0	NN	_	10	NMOD
9	/	/	HYPH	_	8	P
10	sterolin	sterolin	NN	_	6	PMOD
11	-	-	HYPH	_	10	P
12	1	0	CD	_	10	NMOD
13	resulted	result	VBD	_	0	ROOT
14	in	in	IN	_	13	ADV
15	apical	apical	JJ	_	16	NMOD
16	expression	expression	NN	_	14	PMOD
17	(	(	-LRB-	_	19	P
18	panel	panel	NN	_	19	NMOD
19	a	a	NN	_	13	PRN
20	)	)	-RRB-	_	19	P
21	.	.	.	_	13	P

1	Merged	merge	VBN	_	2	NMOD
2	image	image	NN	_	4	SBJ
3	clearly	clearly	RB	_	4	ADV
4	shows	show	VBZ	_	0	ROOT
5	the	the	DT	_	7	NMOD
6	apical	apical	JJ	_	7	NMOD
7	distribution	distribution	NN	_	4	OBJ
8	.	.	.	_	4	P

1	Likewise	likewise	RB	_	18	ADV
2	Abcg8	abcg0	NN	_	5	NMOD
3	-	-	SYM	_	5	P
4	/	/	HYPH	_	5	P
5	-	-	SYM	_	6	NMOD
6	liver	liver	NN	_	18	SBJ
7	incubated	incubate	VBN	_	6	NMOD
8	with	with	IN	_	7	MNR
9	the	the	DT	_	17	NMOD
10	same	same	JJ	_	17	NMOD
11	UTSW	utsw	NN	_	17	NMOD
12	anti-Abcg5	anti-abcg0	NN	_	14	AMOD
13	/	/	HYPH	_	12	P
14	sterolin	sterolin	NN	_	17	NMOD
15	-	-	HYPH	_	14	P
16	1	0	CD	_	14	AMOD
17	antibody	antibody	NN	_	8	PMOD
18	resulted	result	VBD	_	0	ROOT
19	in	in	IN	_	18	ADV
20	a	a	DT	_	24	NMOD
21	similar	similar	JJ	_	24	NMOD
22	apical	apical	JJ	_	23	NMOD
23	expression	expression	NN	_	24	NMOD
24	pattern	pattern	NN	_	19	PMOD
25	relative	relative	JJ	_	18	ADV
26	to	to	IN	_	25	AMOD
27	the	the	DT	_	29	NMOD
28	wild	wild	JJ	_	29	NMOD
29	type	type	NN	_	26	PMOD
30	(	(	-LRB-	_	32	P
31	panel	panel	NN	_	32	NMOD
32	b	b	NN	_	18	PRN
33	)	)	-RRB-	_	32	P
34	.	.	.	_	18	P

1	White	white	JJ	_	2	NMOD
2	arrows	arrow	NNS	_	3	SBJ
3	indicate	indicate	VBP	_	0	ROOT
4	bile	bile	NN	_	5	NMOD
5	canaliculi	canaliculus	NNS	_	3	OBJ
6	and	and	CC	_	3	COORD
7	asterisk	asterisk	NN	_	8	SBJ
8	indicates	indicate	VBZ	_	6	CONJ
9	a	a	DT	_	11	NMOD
10	bile	bile	NN	_	11	NMOD
11	duct	duct	NN	_	8	OBJ
12	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	yellow	yellow	JJ	_	3	NMOD
3	bar	bar	NN	_	4	SBJ
4	represents	represent	VBZ	_	0	ROOT
5	50	0	CD	_	6	NMOD
6	μm	μm	NN	_	4	OBJ
7	.	.	.	_	4	P

1	Figure	figure	NN	_	0	ROOT
2	8	0	CD	_	1	NMOD

1	Biliary	biliary	JJ	_	2	NMOD
2	sterol	sterol	NN	_	8	NMOD
3	,	,	,	_	2	P
4	phospholipid	phospholipid	NN	_	2	CONJ
5	and	and	CC	_	4	COORD
6	bile	bile	NN	_	7	NMOD
7	salt	salt	NN	_	5	CONJ
8	analyses	analysis	NNS	_	0	ROOT
9	.	.	.	_	8	P

1	Bile	bile	NN	_	2	NMOD
2	salt	salt	NN	_	7	NMOD
3	,	,	,	_	2	P
4	sterol	sterol	NN	_	2	CONJ
5	and	and	CC	_	4	COORD
6	phospholipid	phospholipid	NN	_	5	CONJ
7	contents	content	NNS	_	41	SBJ
8	from	from	IN	_	7	NMOD
9	male	male	JJ	_	40	NMOD
10	Abcg8	abcg0	NN	_	40	NMOD
11	+	+	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	+	+	SYM	_	10	P
14	(	(	-LRB-	_	17	P
15	n	n	NN	_	17	SBJ
16	=	=	SYM	_	17	P
17	8	0	CD	_	10	PRN
18	)	)	-RRB-	_	17	P
19	,	,	,	_	10	P
20	Abcg8	abcg0	NN	_	10	CONJ
21	+	+	SYM	_	20	P
22	/	/	HYPH	_	20	P
23	-	-	SYM	_	20	P
24	(	(	-LRB-	_	27	P
25	n	n	NN	_	27	SBJ
26	=	=	SYM	_	27	P
27	7	0	CD	_	20	PRN
28	)	)	-RRB-	_	27	P
29	,	,	,	_	20	P
30	and	and	CC	_	20	COORD
31	Abcg8	abcg0	NN	_	30	CONJ
32	-	-	SYM	_	31	P
33	/	/	HYPH	_	31	P
34	-	-	SYM	_	31	P
35	(	(	-LRB-	_	38	P
36	n	n	NN	_	38	SBJ
37	=	=	SYM	_	38	P
38	5	0	CD	_	31	PRN
39	)	)	-RRB-	_	38	P
40	mice	mouse	NNS	_	8	PMOD
41	were	be	VBD	_	0	ROOT
42	examined	examine	VBN	_	41	VC
43	as	as	IN	_	42	MNR
44	described	describe	VBN	_	43	SUB
45	in	in	IN	_	44	LOC
46	Methods	method	NNS	_	45	PMOD
47	.	.	.	_	41	P

1	Bile	bile	NN	_	2	NMOD
2	salt	salt	NN	_	3	NMOD
3	secretion	secretion	NN	_	9	SBJ
4	following	follow	VBG	_	3	TMP
5	a	a	DT	_	8	NMOD
6	10	0	CD	_	7	NMOD
7	minute	minute	NN	_	8	NMOD
8	collection	collection	NN	_	4	PMOD
9	was	be	VBD	_	0	ROOT
10	lower	low	JJR	_	9	PRD
11	in	in	IN	_	9	ADV
12	Abcg8	abcg0	NN	_	21	NMOD
13	+	+	SYM	_	12	P
14	/	/	HYPH	_	12	P
15	-	-	SYM	_	12	P
16	and	and	CC	_	12	COORD
17	Abcg8	abcg0	NN	_	16	CONJ
18	-	-	SYM	_	17	P
19	/	/	HYPH	_	17	P
20	-	-	SYM	_	17	P
21	mice	mouse	NNS	_	11	PMOD
22	compared	compare	VBN	_	9	ADV
23	to	to	IN	_	22	PMOD
24	wild	wild	JJ	_	25	NMOD
25	type	type	NN	_	23	PMOD
26	(	(	-LRB-	_	28	P
27	panel	panel	NN	_	28	NMOD
28	a	a	NN	_	9	PRN
29	)	)	-RRB-	_	28	P
30	,	,	,	_	9	P
31	but	but	CC	_	9	COORD
32	these	these	DT	_	33	NMOD
33	differences	difference	NNS	_	34	SBJ
34	were	be	VBD	_	31	CONJ
35	not	not	RB	_	34	ADV
36	statistically	statistically	RB	_	37	AMOD
37	significant	significant	JJ	_	34	PRD
38	.	.	.	_	9	P

1	Biliary	biliary	JJ	_	2	NMOD
2	sterol	sterol	NN	_	5	SBJ
3	and	and	CC	_	2	COORD
4	phospholipid	phospholipid	NN	_	3	CONJ
5	were	be	VBD	_	0	ROOT
6	significantly	significantly	RB	_	5	ADV
7	reduced	reduce	VBN	_	5	VC
8	in	in	IN	_	7	LOC
9	the	the	DT	_	14	NMOD
10	Abcg8	abcg0	NN	_	14	NMOD
11	-	-	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	-	-	SYM	_	10	P
14	mice	mouse	NNS	_	8	PMOD
15	compared	compare	VBN	_	7	ADV
16	to	to	IN	_	15	PMOD
17	the	the	DT	_	20	NMOD
18	wild	wild	JJ	_	20	NMOD
19	-	-	HYPH	_	18	P
20	type	type	NN	_	16	PMOD
21	(	(	-LRB-	_	23	P
22	panels	panel	NNS	_	23	NMOD
23	b	b	NN	_	7	PRN
24	and	and	CC	_	23	COORD
25	c	c	NN	_	24	CONJ
26	)	)	-RRB-	_	23	P
27	.	.	.	_	5	P

1	*P	*p	NN	_	3	SBJ
2	<	<	SYM	_	3	P
3	0.05	0	CD	_	0	ROOT
4	.	.	.	_	3	P

1	The	the	DT	_	3	NMOD
2	lower	low	JJR	_	3	NMOD
3	panel	panel	NN	_	4	SBJ
4	shows	show	VBZ	_	0	ROOT
5	biliary	biliary	JJ	_	7	NMOD
6	bile	bile	NN	_	7	NMOD
7	salt	salt	NN	_	12	NMOD
8	,	,	,	_	7	P
9	sterol	sterol	NN	_	7	CONJ
10	and	and	CC	_	9	COORD
11	phospholipid	phospholipid	NN	_	10	CONJ
12	secretion	secretion	NN	_	13	NMOD
13	rates	rate	NNS	_	4	OBJ
14	from	from	IN	_	13	NMOD
15	female	female	JJ	_	46	NMOD
16	Abcg8	abcg0	NN	_	46	NMOD
17	+	+	SYM	_	16	P
18	/	/	HYPH	_	16	P
19	+	+	SYM	_	16	P
20	(	(	-LRB-	_	23	P
21	n	n	NN	_	23	SBJ
22	=	=	SYM	_	23	P
23	5	0	CD	_	16	PRN
24	)	)	-RRB-	_	23	P
25	,	,	,	_	16	P
26	Abcg8	abcg0	NN	_	16	CONJ
27	+	+	SYM	_	26	P
28	/	/	HYPH	_	26	P
29	-	-	SYM	_	26	P
30	(	(	-LRB-	_	33	P
31	n	n	NN	_	33	SBJ
32	=	=	SYM	_	33	P
33	4	0	CD	_	26	PRN
34	)	)	-RRB-	_	33	P
35	,	,	,	_	26	P
36	and	and	CC	_	26	COORD
37	Abcg8	abcg0	NN	_	36	CONJ
38	-	-	SYM	_	37	P
39	/	/	HYPH	_	37	P
40	-	-	SYM	_	37	P
41	(	(	-LRB-	_	44	P
42	n	n	NN	_	44	SBJ
43	=	=	SYM	_	44	P
44	3	0	CD	_	37	PRN
45	)	)	-RRB-	_	44	P
46	mice	mouse	NNS	_	14	PMOD
47	measured	measure	VBN	_	13	NMOD
48	following	follow	VBG	_	47	TMP
49	90	0	CD	_	51	NMOD
50	-	-	HYPH	_	49	P
51	minute	minute	NN	_	54	NMOD
52	bile	bile	NN	_	53	NMOD
53	salt	salt	NN	_	54	NMOD
54	depletion	depletion	NN	_	48	PMOD
55	followed	follow	VBN	_	54	NMOD
56	by	by	IN	_	55	LGS
57	stepwise	stepwise	JJ	_	59	NMOD
58	TUDC	tudc	NN	_	59	NMOD
59	infusion	infusion	NN	_	56	PMOD
60	as	as	IN	_	47	ADV
61	described	describe	VBN	_	60	SUB
62	in	in	IN	_	61	LOC
63	the	the	DT	_	64	NMOD
64	text	text	NN	_	62	PMOD
65	.	.	.	_	4	P

1	Bars	bar	NNS	_	2	SBJ
2	represent	represent	VBP	_	0	ROOT
3	phase	phase	NN	_	4	NMOD
4	TUDC	tudc	NN	_	5	NMOD
5	infusion	infusion	NN	_	6	NMOD
6	rates	rate	NNS	_	2	OBJ
7	.	.	.	_	2	P

1	No	no	DT	_	2	NMOD
2	differences	difference	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	observed	observe	VBN	_	3	VC
5	in	in	IN	_	4	ADV
6	the	the	DT	_	7	NMOD
7	ability	ability	NN	_	5	PMOD
8	of	of	IN	_	7	NMOD
9	the	the	DT	_	14	NMOD
10	Abcg8	abcg0	NN	_	14	NMOD
11	-	-	SYM	_	10	P
12	/	/	HYPH	_	10	P
13	-	-	SYM	_	10	P
14	mice	mouse	NNS	_	8	PMOD
15	to	to	TO	_	7	NMOD
16	secrete	secrete	VB	_	15	IM
17	bile	bile	NN	_	18	NMOD
18	salts	salt	NNS	_	16	OBJ
19	(	(	-LRB-	_	21	P
20	panel	panel	NN	_	21	NMOD
21	d	d	NN	_	4	PRN
22	)	)	-RRB-	_	21	P
23	,	,	,	_	3	P
24	but	but	CC	_	3	COORD
25	there	there	EX	_	26	SBJ
26	is	be	VBZ	_	24	CONJ
27	a	a	DT	_	29	NMOD
28	marked	marked	JJ	_	29	NMOD
29	inability	inability	NN	_	26	PRD
30	of	of	IN	_	29	NMOD
31	the	the	DT	_	33	NMOD
32	knockout	knockout	NN	_	33	NMOD
33	mice	mouse	NNS	_	30	PMOD
34	to	to	TO	_	29	NMOD
35	secrete	secrete	VB	_	34	IM
36	sterols	sterol	NNS	_	35	OBJ
37	(	(	-LRB-	_	39	P
38	panel	panel	NN	_	39	NMOD
39	e	e	NN	_	35	PRN
40	)	)	-RRB-	_	39	P
41	and	and	CC	_	29	COORD
42	a	a	DT	_	43	NMOD
43	trend	trend	NN	_	41	CONJ
44	towards	towards	IN	_	43	NMOD
45	a	a	DT	_	47	NMOD
46	reduced	reduce	VBN	_	47	NMOD
47	ability	ability	NN	_	44	PMOD
48	to	to	TO	_	47	NMOD
49	secrete	secrete	VB	_	48	IM
50	phospholipid	phospholipid	NN	_	49	OBJ
51	(	(	-LRB-	_	53	P
52	panel	panel	NN	_	53	NMOD
53	f	f	NN	_	49	PRN
54	)	)	-RRB-	_	53	P
55	compared	compare	VBN	_	26	ADV
56	to	to	IN	_	55	PMOD
57	wild	wild	JJ	_	58	NMOD
58	type	type	NN	_	56	PMOD
59	.	.	.	_	3	P

1	Figure	figure	NN	_	0	ROOT
2	9	0	CD	_	1	NMOD

1	Biliary	biliary	JJ	_	5	NMOD
2	cholesterol	cholesterol	NN	_	5	NMOD
3	and	and	CC	_	2	COORD
4	sitosterol	sitosterol	NN	_	3	CONJ
5	secretion	secretion	NN	_	0	ROOT
6	.	.	.	_	5	P

1	Biliary	biliary	JJ	_	2	NMOD
2	sterols	sterol	NNS	_	3	SBJ
3	were	be	VBD	_	0	ROOT
4	analyzed	analyze	VBN	_	3	VC
5	by	by	IN	_	4	MNR
6	GC	gc	NN	_	7	NMOD
7	analyses	analysis	NNS	_	5	PMOD
8	in	in	IN	_	4	LOC
9	Abcg8	abcg0	NN	_	38	NMOD
10	+	+	SYM	_	9	P
11	/	/	HYPH	_	9	P
12	+	+	SYM	_	9	P
13	(	(	-LRB-	_	16	P
14	n	n	NN	_	16	SBJ
15	=	=	SYM	_	16	P
16	4	0	CD	_	9	PRN
17	)	)	-RRB-	_	16	P
18	,	,	,	_	9	P
19	Abcg8	abcg0	NN	_	9	CONJ
20	+	+	SYM	_	19	P
21	/	/	HYPH	_	19	P
22	-	-	SYM	_	19	P
23	(	(	-LRB-	_	26	P
24	n	n	NN	_	26	SBJ
25	=	=	SYM	_	26	P
26	3	0	CD	_	19	PRN
27	)	)	-RRB-	_	26	P
28	and	and	CC	_	19	COORD
29	Abcg8	abcg0	NN	_	28	CONJ
30	-	-	SYM	_	29	P
31	/	/	HYPH	_	29	P
32	-	-	SYM	_	29	P
33	(	(	-LRB-	_	36	P
34	n	n	NN	_	36	SBJ
35	=	=	SYM	_	36	P
36	4	0	CD	_	29	PRN
37	)	)	-RRB-	_	36	P
38	mice	mouse	NNS	_	8	PMOD
39	following	follow	VBG	_	4	TMP
40	30	0	CD	_	42	NMOD
41	-	-	HYPH	_	40	P
42	minute	minute	NN	_	45	NMOD
43	bile	bile	NN	_	44	NMOD
44	salt	salt	NN	_	45	NMOD
45	depletion	depletion	NN	_	39	PMOD
46	followed	follow	VBN	_	45	NMOD
47	by	by	IN	_	46	LGS
48	a	a	DT	_	51	NMOD
49	continuous	continuous	JJ	_	51	NMOD
50	TUDC	tudc	NN	_	51	NMOD
51	infusion	infusion	NN	_	47	PMOD
52	as	as	IN	_	4	MNR
53	described	describe	VBN	_	52	SUB
54	in	in	IN	_	53	LOC
55	Methods	method	NNS	_	54	PMOD
56	.	.	.	_	3	P

1	Abcg8	abcg0	NN	_	5	NMOD
2	-	-	SYM	_	1	P
3	/	/	HYPH	_	1	P
4	-	-	SYM	_	1	P
5	mice	mouse	NNS	_	6	SBJ
6	were	be	VBD	_	0	ROOT
7	unable	unable	JJ	_	6	PRD
8	to	to	TO	_	7	AMOD
9	secrete	secrete	VB	_	8	IM
10	cholesterol	cholesterol	NN	_	9	OBJ
11	into	into	IN	_	9	DIR
12	bile	bile	NN	_	11	PMOD
13	with	with	IN	_	9	ADV
14	forced	force	VBN	_	16	NMOD
15	TUDC	tudc	NN	_	16	NMOD
16	administration	administration	NN	_	13	PMOD
17	relative	relative	JJ	_	6	ADV
18	to	to	IN	_	17	AMOD
19	the	the	DT	_	23	NMOD
20	wild	wild	JJ	_	22	NMOD
21	-	-	HYPH	_	20	P
22	type	type	NN	_	23	NMOD
23	mice	mouse	NNS	_	18	PMOD
24	(	(	-LRB-	_	30	P
25	panel	panel	NN	_	26	NMOD
26	a	a	NN	_	30	DEP
27	,	,	,	_	30	P
28	*P	*p	NN	_	30	SBJ
29	<	<	SYM	_	30	P
30	0.05	0	CD	_	6	PRN
31	)	)	-RRB-	_	30	P
32	.	.	.	_	6	P

1	Interestingly	interestingly	RB	_	9	ADV
2	,	,	,	_	9	P
3	the	the	DT	_	8	NMOD
4	Abcg8	abcg0	NN	_	8	NMOD
5	-	-	SYM	_	4	P
6	/	/	HYPH	_	4	P
7	-	-	SYM	_	4	P
8	mice	mouse	NNS	_	9	SBJ
9	were	be	VBD	_	0	ROOT
10	able	able	JJ	_	9	PRD
11	to	to	TO	_	10	AMOD
12	still	still	RB	_	11	TMP
13	secrete	secrete	VB	_	11	IM
14	sitosterol	sitosterol	NN	_	13	OBJ
15	(	(	-LRB-	_	17	P
16	panel	panel	NN	_	17	NMOD
17	b	b	NN	_	14	PRN
18	)	)	-RRB-	_	17	P
19	and	and	CC	_	14	COORD
20	campesterol	campesterol	NN	_	19	CONJ
21	(	(	-LRB-	_	23	P
22	panel	panel	NN	_	23	NMOD
23	c	c	NN	_	20	PRN
24	)	)	-RRB-	_	23	P
25	.	.	.	_	9	P

1	Heterozygous	heterozygous	JJ	_	2	NMOD
2	mice	mouse	NNS	_	3	SBJ
3	showed	show	VBD	_	0	ROOT
4	an	an	DT	_	6	NMOD
5	increased	increase	VBN	_	6	NMOD
6	ability	ability	NN	_	3	OBJ
7	to	to	TO	_	6	NMOD
8	secrete	secrete	VB	_	7	IM
9	all	all	DT	_	10	NMOD
10	sterols	sterol	NNS	_	8	OBJ
11	with	with	IN	_	8	MNR
12	forced	force	VBN	_	14	NMOD
13	TUDC	tudc	NN	_	14	NMOD
14	administration	administration	NN	_	11	PMOD
15	,	,	,	_	8	P
16	although	although	IN	_	8	ADV
17	the	the	DT	_	18	NMOD
18	results	result	NNS	_	19	SBJ
19	were	be	VBD	_	16	SUB
20	not	not	RB	_	19	ADV
21	statistically	statistically	RB	_	22	AMOD
22	significant	significant	JJ	_	19	PRD
23	.	.	.	_	3	P

1	Table	table	NN	_	0	ROOT
2	1	0	CD	_	1	NMOD

1	Oligonucleotide	oligonucleotide	NN	_	2	NMOD
2	primers	primer	NNS	_	0	ROOT
3	used	use	VBN	_	2	NMOD
4	for	for	IN	_	3	PRP
5	quantitative	quantitative	JJ	_	8	NMOD
6	RT	rt	NN	_	8	NMOD
7	-	-	HYPH	_	6	P
8	PCR	pcr	NN	_	4	PMOD

1	Table	table	NN	_	0	ROOT
2	2	0	CD	_	1	NMOD

1	Mouse	mouse	NN	_	2	NMOD
2	plasma	plasma	NN	_	6	NMOD
3	and	and	CC	_	2	COORD
4	tissue	tissue	NN	_	3	CONJ
5	sterol	sterol	NN	_	6	NMOD
6	analyses	analysis	NNS	_	0	ROOT

1	Animals	animal	NNS	_	6	SBJ
2	used	use	VBN	_	1	NMOD
3	in	in	IN	_	2	LOC
4	these	these	DT	_	5	NMOD
5	studies	study	NNS	_	3	PMOD
6	were	be	VBD	_	0	ROOT
7	12	0	CD	_	8	NMOD
8	weeks	week	NNS	_	6	PRD
9	of	of	IN	_	8	NMOD
10	age	age	NN	_	9	PMOD
11	,	,	,	_	8	P
12	a	a	DT	_	13	NMOD
13	mixture	mixture	NN	_	8	CONJ
14	of	of	IN	_	13	NMOD
15	male	male	JJ	_	14	PMOD
16	and	and	CC	_	15	COORD
17	female	female	JJ	_	16	CONJ
18	and	and	CC	_	13	COORD
19	fed	feed	VBN	_	18	CONJ
20	a	a	DT	_	23	NMOD
21	regular	regular	JJ	_	22	NMOD
22	chow	chow	NN	_	23	NMOD
23	diet	diet	NN	_	19	OBJ
24	.	.	.	_	6	P

1	*P	*p	NN	_	3	SBJ
2	<	<	SYM	_	3	P
3	0.05	0	CD	_	0	ROOT
4	for	for	IN	_	3	ADV
5	-	-	SYM	_	7	P
6	/	/	HYPH	_	7	P
7	-	-	SYM	_	4	PMOD
8	versus	versus	CC	_	7	COORD
9	+	+	SYM	_	11	P
10	/	/	HYPH	_	11	P
11	+	+	SYM	_	8	CONJ
12	and	and	CC	_	7	COORD
13	-	-	SYM	_	15	P
14	/	/	HYPH	_	15	P
15	-	-	SYM	_	12	CONJ
16	versus	versus	CC	_	15	COORD
17	+	+	SYM	_	19	P
18	/	/	HYPH	_	19	P
19	-	-	SYM	_	16	CONJ
20	.	.	.	_	3	P

1	ND	nd	NN	_	0	ROOT
2	,	,	,	_	1	P
3	not	not	RB	_	4	ADV
4	detectable	detectable	JJ	_	1	DEP
5	.	.	.	_	1	P

